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Abstract 
 
Purpose: Unlike the commercial industries, the risks arising from the healthcare industry’s 
internal system and the surrounding environment may cause serious consequences, even the 
patients’ health.  Concerning the increasing emphasis on risk management in the healthcare 
supply chain environment, there is an urgent demand for a novel decision support method 
that supports supply chain risk management in the hospital setting. As the topic is still in the 
early stage and only a few systematic academic studies on this topic can be found over the 
last decades. This research aims to propose a novel comprehensive framework and integrated 
risk management model that takes explicit account of multiple types of risk factors in aiding 
decision-making as well as compares and ranks the current implemented alternative risk 
mitigation strategies using fuzzy set theory and multiple criteria decision analysis (MCDA) 
methods. 
Methodology: In pursuit of meeting the requirements of the research objectives, this 
research conducts empirical studies from both China and UK healthcare industries and follows 
three steps of risk management procedure based on the proposed framework to conduct risk 
factors identification, assessment and risk mitigation strategies identification. In order to 
ensure that the analysis is systematic and inclusive, various types of risk factors are identified 
through a related systematic literature review and are validated through a set of empirical 
studies. Risk assessment is conducted through two stages of questionnaire surveys and 
evaluated through Fuzzy Analytic Hierarchy Process (AHP) and Interpretive Structural 
Modelling (ISM). Thereafter, risk mitigation strategies are identified through conducted 
empirical studies and evaluated through Fuzzy Technique for Order Preference by Similarity 
to Ideal Solution (TOPSIS).        
Research Implications: This is the first study which has developed a comprehensive risk 
management framework in the healthcare supply chain that effectively integrates supply 
chain risk factors identification, risk assessment as well as mitigation strategy identification 
and evaluation. The novelty of the developed framework lies in the fact that a systematic and 
practical decision making tools are proposed supporting hospital managers making strategic 
decisions on healthcare supply chain risk management. Furthermore, compared with several 
ii 
 
studies using secondary data, this thesis uses empirical data to conduct the identification and 
evaluation of risk mitigation strategies, enabling the results closes to the reality of the 
situation in the healthcare setting.   
Practical Implications: The profile of risk sources, the priority weighting and inter-relationship 
among these risks and, the ranking of mitigation strategies provide a guideline for hospital 
managers to anticipate and proactively deal with potential risks.  The proposed framework 
applies to both the UK and China healthcare industries, the finding can also be applied in other 
countries and regions.   
Keywords: Supply Chain Risk Management (SCRM), Healthcare Industry, Hospital, 
Pharmaceutical/Medicine/Drugs Supply Chain, Multiple Criteria Decision Analysis (MCDA), 
Fuzzy Set theory, ISM.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
iii 
 
Acknowledgements 
 
Despite all the challenges and sufferings during my three-year PhD course, I have finally 
reached the moment for which I have desired. Since it was a long journey, intellectually and 
emotionally, I would not have stood here without kind supports and inspiration from the 
people around me. In particular, I would like to take this opportunity to express my deep 
appreciation to: 
 Dr Jun Ren, Prof Jin Wang and Prof Charles Morecroft for providing me with 
illuminating ideas, constructive comments and encouraging me to keep going with 
confidence.  Indeed I am lucky enough to be the student under their supervision for 
three years. I could not have imagined having better guidance for my PhD study.  
 Prof Haiyan Wang, Prof Duangpun Kritchanchai, Dr Dimitrios Paraskevadakis, Dr 
Trakarn Prapaspongsa, Dr Dongmei Cao, Dr Di Zhang and Dr Wirachchaya 
Chanpuypetch for contributing their valuable suggestions and time to the quality of 
my research.  
 Mr Steve Begley, Mr Ye Yang, Ms Sue Donaldson, Mrs Trudy Bown, Mr Jianwei Yang, 
Mr Bo Zhang, Mr Gang Yao, Mr Renshun Zhang, Mr Xiaoguo Yang, Mr Xuebin Xia, Mr 
Yanchao Sun, Ms Jie Fei, Mr Zong Yu and Ms Yuanyuan Tian for supporting me to 
conduct the empirical studies and collect the data from their organizations.  
 Dr Zhisen Yang, Dr Chengpeng Wan, Dr Chaoyu Li, Ms Shiqi Fan, Mr Jun Hu, Dr 
Chengchun Li, Mr Haonan Cheng, Ms Jingjing Li, Mr Yuan Li for being my best friends 
whom I can lean on during the PhD journey.    
 My colleagues in LOOM Research Institute and other researchers at Liverpool John 
Moores University for giving me wonderful times at Liverpool.  
 Dr Robert Mason at Cardiff University and Mr Len Bird at Coventry University for 
providing me with confidence to finish this thesis.  
Lastly, but not least by no means, I would like to extend my honest appreciation to my 
parents, my partner, Dr Xiao Yang, and her parents, uncle Yang and aunt Dong, for their 
iv 
 
continuous support, encouragement and understanding throughout my doctoral research. 
Patience, sacrifice and love, intangible and invaluable assets provided by them kept me going 
during tough times in my life.    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
v 
 
 
Table of Contents 
 
Abstract ................................................................................................................................................... i 
Acknowledgements ............................................................................................................................... iii 
Table of Contents ................................................................................................................................... v 
List of Figures ........................................................................................................................................ viii 
List of Tables ........................................................................................................................................... x 
Abbreviations ........................................................................................................................................ xii 
1. CHAPTER ONE – INTRODUCTION ....................................................................................................... 2 
1.1 INTRODUCTION ............................................................................................................................ 2 
1.2 RESEARCH BACKGROUND ...................................................................................................... 2 
1.3 RESEARCH AIM AND OBJECTIVES .......................................................................................... 7 
1.4 RESEARCH SCOPE.................................................................................................................... 8 
1.5 RESEARCH METHODS ........................................................................................................... 10 
1.6 STRUCTURE OF THE THESIS .................................................................................................. 11 
2. CHAPTER TWO: LITERATURE REVIEW .............................................................................................. 14 
2.1 INTRODUCTION .......................................................................................................................... 14 
2.2 HEALTHCARE SUPPLY CHAIN MANAGEMENT (HCSCM) ............................................................ 15 
2.2.1 HCSCM research methodology ........................................................................................... 17 
2.2.2 Results of HCSCM literature review ................................................................................... 20 
2.3 SUPPLY CHAIN RISK MANAGEMENT .......................................................................................... 51 
2.3.1 SCRM literature review research methodology ................................................................. 52 
2.3.2 Data analysis ........................................................................................................................ 55 
2.3.3 Status of risk management in the healthcare supply chain .............................................. 80 
2.4 LITERATURE GAPS IDENTIFIED ................................................................................................... 95 
2.5 CONCLUSION .............................................................................................................................. 96 
3. CHAPTER THREE - RESEARCH METHODOLOGY ................................................................................ 99 
3.1 INTRODUCTION .......................................................................................................................... 99 
3.2 RESEARCH DESIGN .................................................................................................................... 101 
3.3 RESEARCH PHILOSOPHY ........................................................................................................... 102 
3.4 RESEARCH APPROACH .............................................................................................................. 103 
3.5 RESEARCH STRATEGIES AND CHOICES ..................................................................................... 105 
3.5.1 Exploratory and explanatory study .................................................................................. 105 
vi 
 
3.5.2 Mixed methods approach ................................................................................................. 105 
3.6 METHODOLOGY FOR DATA COLLECTION AND ANALYSIS ....................................................... 107 
3.6.1 Data collection methods ................................................................................................... 109 
3.6.2 Data analysis methods ...................................................................................................... 113 
3.7 CONCLUSION ............................................................................................................................ 113 
4. CHAPTER FOUR - CONCEPTUAL FRAMEWORK AND INTEGRATED RISK MANAGEMENT MODEL 114 
4.1 INTRODUCTION ........................................................................................................................ 114 
4.2 CONCEPTUAL FRAMEWORK ..................................................................................................... 114 
4.2.1 Risk drivers and sources .................................................................................................... 118 
4.2.2 Decision makers ................................................................................................................ 123 
4.2.3 Risk management process ................................................................................................ 124 
4.2.4 Supply chain risk management strategies ........................................................................ 125 
4.2.5 Performance outcomes ..................................................................................................... 126 
4.3 DEVELOPMENT OF INTEGRATED RM MODEL IN HCSC ............................................................ 126 
4.3.1 Phase 1 - Risk factors identification.................................................................................. 128 
4.3.2 Phase 2 - Risk assessment ................................................................................................. 130 
4.3.3 Phase 3 - Risk mitigation ................................................................................................... 139 
4.4 CONCLUSION ............................................................................................................................ 141 
5. CHAPTER FIVE - HEALTHCARE SUPPLY CHAIN RISK FACTORS IDENTIFICATION ........................... 142 
5.1 INTRODUCTION ........................................................................................................................ 142 
5.2 HEALTHCARE SUPPLY CHAIN RISK FACTORS IDENTIFICATION AND CLASSIFICATION ........... 142 
5.2.1 Process risks ...................................................................................................................... 152 
5.2.2 Control risks ....................................................................................................................... 157 
5.2.3 Demand risks ..................................................................................................................... 159 
5.2.4. Supply risks ....................................................................................................................... 161 
5.2.5. Environmental risks .......................................................................................................... 164 
5.3 RISK FACTORS IDENTIFICATION DATA ANALYSIS AND TAXONOMIC DIAGRAM VALIDATION
 ........................................................................................................................................................ 167 
5.3.1 Procedure for questionnaire design and pilot study ....................................................... 167 
5.3.2 Selection of experts for validation ................................................................................... 172 
5.3.3 Data analysis and description ........................................................................................... 174 
5.4 CONCLUSION ............................................................................................................................ 187 
6. CHAPTER SIX – HEALTHCARE SUPPLY CHAIN RISK ASSESSMENT ................................................. 188 
6.1 INTRODUCTION ........................................................................................................................ 188 
6.2 METHODOLOGY FOR RISK ASSESSMENT IN HEALTHCARE SUPPLY CHAIN ............................. 188 
6.3 RISK ASSESSMENT WITH FUZZY ANALYTIC HIERARCHY PROCESS (FUZZY AHP) .................... 191 
vii 
 
6.4 AN EMPIRICAL STUDY ON THE APPLICABILITY OF THE FUZZY AHP METHOD ........................ 199 
6.4.1 Conducting the Fuzzy AHP-based questionnaire survey .................................................. 199 
6.4.2 Numerical illustration ....................................................................................................... 202 
6.4.3 Testing the robustness of the proposed Fuzzy AHP approach ........................................ 212 
6.4.4 Findings from Fuzzy AHP method ..................................................................................... 219 
6.5 RISK ASSESSMENT WITH INTERPRETIVE STRUCTURAL MODELLING (ISM) ............................ 224 
6.6 AN EMPIRICAL STUDY ON THE APPLICABILITY OF THE ISM MODEL ....................................... 228 
6.6.1 Conducting the ISM-based questionnaire survey ............................................................ 228 
6.6.2 Interpretive structural modelling (ISM) and MICMAC analysis ....................................... 230 
6.6.3 Finding from ISM model .................................................................................................... 242 
6.7 CONCLUSION ............................................................................................................................ 248 
7. CHAPTER SEVEN – IDENTIFICATION AND EVALUATION OF RISK MITIGATION STRATEGIES ....... 249 
7.1 INTRODUCTION ........................................................................................................................ 249 
7.2 METHODOLOGY FOR RISK MITIGATION STRATEGY IDENTIFICATION AND EVALUATION ..... 249 
7.3 IDENTIFICATION OF RISK MITIGATION STRATEGIES FROM EMPIRICAL STUDIES .................. 251 
7.3.1 Description of the procedure of conducting the empirical studies ................................. 252 
7.3.2 Overview of identified implemented mitigation strategies in hospital setting .............. 255 
7.4 EVALUATION OF RISK MITIGATION STRATEGIES .................................................................... 276 
7.5 AN EMPIRICAL STUDY ON THE APPLICABILITY OF THE FUZZY TOPSIS METHOD ................... 282 
7.5.1 Conducting the Fuzzy TOPSIS-based questionnaire survey ............................................. 282 
7.5.2 Evaluation of identified risk mitigation strategies ........................................................... 284 
7.5.3 Sensitivity analysis ............................................................................................................ 292 
7.6 DISCUSSION AND MANAGERIAL IMPLICATIONS ..................................................................... 295 
7.7 CONCLUSION ............................................................................................................................ 298 
8. CHAPTER EIGHT - CONCLUSION ..................................................................................................... 300 
8.1 INTRODUCTION ........................................................................................................................ 300 
8.2 RESEARCH FINDINGS ................................................................................................................ 300 
8.3 RESEARCH CONTRIBUTION TO KNOWLEDGE .......................................................................... 306 
8.4 RESEARCH LIMITATION ............................................................................................................ 307 
8.5 RECOMMENDATION AND FUTURE RESEARCH ........................................................................ 308 
REFERENCES ........................................................................................................................................ 310 
APPENDIX ONE ................................................................................................................................... 350 
APPENDIX TWO .................................................................................................................................. 369 
APPENDIX THREE ................................................................................................................................ 386 
APPENDIX FOUR ................................................................................................................................. 395 
APPENDIX FIVE ................................................................................................................................... 398 
viii 
 
 
List of Figures 
 
Figure 1-1: Health care value chain ....................................................................................................... 3 
Figure 1-2: The structure of the thesis ................................................................................................. 13 
Figure 2-1: Three key areas of the literature review .......................................................................... 15 
Figure 2-2: Flowchart of the HCSCM literature review methodology ................................................ 18 
Figure 2-3: Distribution of the number of journal articles between 1995 and 2016 (369)................ 18 
Figure 2-4: Distribution of contributing countries in HCSCM in the world ........................................ 23 
Figure 2-5: Taxonomy of HCSCM literature ......................................................................................... 28 
Figure 2-6: Healthcare supply chain structure .................................................................................... 29 
Figure 2-7: Stages of supply chain integration .................................................................................... 30 
Figure 2-8: Hospital supply chain process for patient flow ................................................................ 38 
Figure 2-9: Historical development of research in lean healthcare ................................................... 41 
Figure 2-10. Healthcare delivery pipelines and location of the main DP ........................................... 43 
Figure 2-11: Flowchart of the SCRM research methodology for the present systematic literature 
review ................................................................................................................................................... 53 
Figure 2-12: Distribution of the publication years .............................................................................. 56 
Figure 2-13: Distribution of the contributing countries ...................................................................... 57 
Figure 2-14: Distribution of research methodologies ......................................................................... 65 
Figure 2-15: Distribution of quantitative and qualitative methods over the last decades ............... 66 
Figure 2-16: Number of categories of papers by the associated research areas ............................... 68 
Figure 3-1: Proposed methodology of Healthcare Supply Chain Risk Management ....................... 100 
Figure 3-2: Research onion................................................................................................................. 102 
Figure 4-1: Healthcare supply chain risk management conceptual framework by author ............. 116 
Figure 4-2: Conceptual model ............................................................................................................ 121 
Figure 4-3: A risk management framework for sustainability-related risks .................................... 122 
Figure 4-4: Proposed integrated risk management model in healthcare supply chain ................... 129 
Figure 4-5: A typical Fuzzy Logic control – Fuzzy control system schema ........................................ 134 
Figure 4-6: ISM-logic ........................................................................................................................... 137 
Figure 5-1: Proposed methodology for healthcare SC risk factors identification ............................ 143 
Figure 5-2: Sources of risks in the healthcare supply chain .............................................................. 144 
Figure 5-3: A schematic classification of sources of the process risks ............................................. 152 
Figure 5-4: A schematic classification of sources of the control risks .............................................. 157 
Figure 5-5: A schematic classification of sources of the demand risks ............................................ 159 
Figure 5-6: A schematic classification of sources of the supply risks ............................................... 162 
Figure 5-7: A schematic classification of sources of environmental risks ........................................ 165 
Figure 5-8: The preliminary hierarchical structure of healthcare supply chain risks ....................... 168 
Figure 5-9: The preliminary External to the hospital but internal to the supply chain network risks 
hierarchical structure for healthcare SC ............................................................................................ 169 
Figure 5-10: The preliminary Internal to the hospital risks hierarchical structure for healthcare SC
 ............................................................................................................................................................ 170 
Figure 5-11: The preliminary External to the supply chain network risks hierarchical structure for 
healthcare SC ...................................................................................................................................... 171 
Figure 5-12: Comparison the results based on Mean and Weighted Average ................................. 180 
Figure 5-13: The modified hierarchical structure of healthcare supply chain risks ......................... 181 
ix 
 
Figure 5-14: The modified External to the hospital but internal to the supply chain network risks 
hierarchical structure for healthcare SC ............................................................................................ 182 
Figure 5-15: The modified Internal to the hospital risks hierarchical structure for healthcare SC . 183 
Figure 5-16: The modified External to the supply chain network risks hierarchical structure for 
healthcare SC ...................................................................................................................................... 184 
Figure 5-17: Final hierarchical structure of healthcare supply chain risks ....................................... 186 
Figure 6-1: Proposed Fuzzy AHP and ISM based risk assessment model for healthcare SC ............ 190 
Figure 6-2: Membership function of TFN .......................................................................................... 192 
Figure 6-3: The intersection between 𝑴𝟏and 𝑴𝟐............................................................................ 196 
Figure 6-4: The membership functions of the triangular fuzzy numbers ......................................... 199 
Figure 6-5: Hierarchical structure of healthcare supply chain risks ................................................. 204 
Figure 6-6:  Results in relation to Arithmetic Mean Method ............................................................ 210 
Figure 6-7: Results in relation to Geometric Average Method ......................................................... 211 
Figure 6-8: Comparison of the results from Arithmetic Mean and Geometric Average methods .. 215 
Figure 6-9: Results of the sensitive analysis (multiplication) ........................................................... 216 
Figure 6-10: Results of the sensitive analysis (division) .................................................................... 217 
Figure 6-11: ISM-based hierarchy model ........................................................................................... 241 
Figure 6-12: Driving power and dependence diagram ...................................................................... 242 
Figure 7-1: A generic risk mitigation model for healthcare supply chain ........................................ 250 
Figure 7-2: Summary of the identified risk mitigation strategies ..................................................... 256 
Figure 7-3: GS1 Global Data Synchronization Network in NHS system ............................................ 268 
Figure 7-4: the architecture of PEPPOL messaging platform ............................................................ 270 
Figure 7-5: Fuzzy membership function for linguistic expressions ................................................... 279 
Figure 7-6: Distribution of respondents ............................................................................................ 284 
Figure 7-7: Decision hierarchy for the performance of implemented risk mitigation strategies .... 286 
Figure 7-8: Sensitivity analysis: computation of the relative closeness to the ideal solution for each 
evaluated combination ...................................................................................................................... 293 
 
 
 
 
 
 
 
 
 
 
 
 
 
x 
 
List of Tables  
 
Table 2.1: HCSCM literature review classification framework ........................................................... 20 
Table 2.2: List of journals publishing HCSCM research to date .......................................................... 21 
Table 2.3: Definitions of HSC given by researchers ............................................................................. 24 
Table 2.4: Approaches to definitions of HCSCM ................................................................................. 26 
Table 2.5: Articles classified by theory ................................................................................................ 45 
Table 2.6: Articles classified by research methods ............................................................................. 47 
Table 2.7: Summary of literature review in HCSCM research methods and findings ........................ 48 
Table 2.8: Number of articles in alphabetical order (appearing at least twice) ................................ 56 
Table 2.9: Supply chain risk types identified by researchers .............................................................. 62 
Table 2.10: Summary of reviewed risk mitigation strategies ............................................................. 74 
Table 2.11: Summary of 12 selected research papers ........................................................................ 82 
Table 2.12: Classification of the SCRM process in the healthcare setting ......................................... 86 
Table 2.13: Summary of HSC risk factors from previous studies ........................................................ 90 
Table 2.14: Summary of HSC risk mitigation strategies ...................................................................... 93 
Table 3.1: Methodologies used in the Positivist and Interpretivism Philosophies .......................... 103 
Table 3.2: Major differences between deductive and inductive research approaches ................... 104 
Table 3.3: Summaries of the research methods for data collection and analysis ........................... 108 
Table 4.1:  Nine-point pairwise comparison scale (Saaty, 2008) ...................................................... 132 
Table 5.1: Classification of healthcare supply chain risk factors identified by researchers ............ 146 
Table 5.2: Summary of the identified healthcare supply chain risk factors ..................................... 150 
Table 5.3: Experts’ Weighting Criteria（expert evaluation） .......................................................... 173 
Table 5.4: Research expert weighting respondents’ profile ............................................................. 174 
Table 5.5: The reliability test for the questionnaire survey ............................................................. 175 
Table 5.6: Results of the significance of healthcare supply chain risks (Questionnaire Survey) ..... 176 
Table 5.7: Ranking of the significance of healthcare supply chain risks (Questionnaire Survey) ... 178 
Table 6.1: Linguistic scales for difficulty and importance ................................................................. 198 
Table 6.2: Questionnaires return detail ............................................................................................ 201 
Table 6.3: respondents’ profile .......................................................................................................... 202 
Table 6.4: Linguistic judgements for Fuzzy AHP ................................................................................ 203 
Table 6.5: Linguistic scales for difficulty and importance ................................................................. 205 
Table 6.6: The fuzzy pair-wise comparison matrix of three criteria ................................................. 205 
Table 6.7: Average random index value ............................................................................................ 206 
Table 6.8: The fuzzy pair-wise comparison matrix of three criteria (Arithmetic Mean method) ... 207 
Table 6.9: The fuzzy pair-wise comparison matrix of three criteria (Geometric Average method) 207 
Table 6.10: The fuzzy pair-wise comparison matrix of three criteria (Geometric average method)
 ............................................................................................................................................................ 209 
Table 6.11: Summary of results from Arithmetic Mean and Geometric Average methods ............ 213 
Table 6.12: Sensitivity analysis for weight obtained by pairwise comparison ................................ 218 
Table 6.13: respondents’ profile ........................................................................................................ 229 
Table 6.14: Structural self-interaction matrix (SSIM) of risk factors in healthcare supply chain .... 232 
Table 6.15: Initial Reachability Matrix ............................................................................................... 233 
Table 6.16: Final Reachability Matrix ................................................................................................ 234 
Table 6.17: Iterations of the partition of reachability matrix to arrive at ISM diagram .................. 235 
Table 6.18: Iterations of the partition of reachability matrix to arrive at ISM diagram .................. 236 
xi 
 
Table 6.19: Iterations of the partition of reachability matrix to arrive at ISM diagram .................. 236 
Table 6.20: Iterations of the partition of reachability matrix to arrive at ISM diagram .................. 237 
Table 6.21: Iterations of the partition of reachability matrix to arrive at ISM diagram .................. 237 
Table 6.22: Iterations of the partition of reachability matrix to arrive at ISM diagram .................. 238 
Table 6.23: Iterations of the partition of reachability matrix to arrive at ISM diagram .................. 238 
Table 7.1: Respondents’ profile ......................................................................................................... 254 
Table 7.2: Linguistic variables for the importance weight of each criterion and sub-criteria ......... 278 
Table 7.3:  Linguistic variables for the ratings ................................................................................... 278 
Table 7.4: The profile of survey respondents .................................................................................... 283 
Table 7.5:  Linguistic variables for the ratings ................................................................................... 287 
Table 7.6: The ratings of alternatives by three experts under sub-criteria counterfeiting risks (S1)
 ............................................................................................................................................................ 287 
Table 7.7: Fuzzy evaluation matrix for the implementation of risk mitigation strategies .............. 287 
Table 7.8: Aggregate fuzzy decision matrix for the implementation of risk mitigation strategies . 289 
Table 7.9: Normalized fuzzy decision matrix for the implementation of risk mitigation strategies
 ............................................................................................................................................................ 289 
Table 7.10: Weighted normalized fuzzy decision matrix for the implementation of risk mitigation 
strategies ............................................................................................................................................ 290 
Table 7.11: Fuzzy TOPSIS results and final ranking for the implementation of risk mitigation 
strategies ............................................................................................................................................ 292 
Table 7.12: Results of the sensitivity analysis ................................................................................... 294 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
xii 
 
Abbreviations  
 
AHP                         Analytic Hierarchy Process 
AIDC Automatic identification and Data Capture 
B2B                          Business-to-Business 
CBA                         Cost Benefit Analysis 
CPD Continuous Professional Development 
CPFR                       Collaborative Planning Forecasting and Replenishment  
C.I.                           Consistency Index 
C.R.                          Consistency Ratio  
DEA                         Data Envelopment Analysis  
DH Department of Health 
DHL                         Deutsche Post DHL  
ED                           Emergency Department 
EDI                          Electronic Data Interchange 
EFPIA European Federation of Pharmaceutical Industries and 
Associations 
EPA Environmental Protection Agency 
ERP                         Enterprise Resource Planning 
ETA                         Event Tree Analysis 
EUC                        European Union Commission 
FAHP                      Fuzzy Analytic Hierarchy Process 
FEAHP                    Fuzzy Extended Analytic Hierarchy Process 
FFP                         Fuzzy Failure Probability 
FMEA                     Failure Mode and Effect Analysis 
FNIS                       Fuzzy Negative Ideal Solution 
FPIS                        Fuzzy Positive Ideal Solution 
FST                         Fuzzy Set Theory 
FTA                         Fault Tree Analysis  
FTOPSIS                 Fuzzy Technique for Order Preference by Similarity to Ideal 
Solutions  
GDP                       Gross Domestic product  
GDSS Global Data Synchronization Standards 
GMP Good Manufacturing Practice 
GP                          General Practice  
GPO  Group Purchasing Organization 
GSP Good Supply Practice 
GTINs   Global Trade Item Numbers 
HAZID                    HAZard Identification 
HAZOP                   HAZard and Operability 
HCSCRM                Healthcare Supply Chain Risk Management 
HL7                         Health Level Seven 
HTP Hazard Totem Pole 
ICT                          Information Communication Technology  
IDS                         Intelligence Decision System  
xiii 
 
IDSs                       Integrated Delivery Systems  
IRM                        Institute of Risk Management 
ISM                         Interpretive Structural Modelling  
ISO                          The International Organization for Standardisation 
IT                         Information Technology  
IS                         Information System  
JIT                        Just-in-Time  
KPI                     Key Performance Indicator  
MADA                 Multi-Attribute Decision-Analysis 
MADM                Multi-Attribute Decision-Making  
MCDM Multi Criteria Decision-Making 
MICMAC Matriced’Impacts Croisés Multiplication Appliquéea’un 
Classement 
NHS                     National Health Service  
PEPPOL Pan European Public Procurement On Line 
QSAM                  Quick-Scan Audit Methodology 
RFID                   Radio Frequency IDentification  
RM                       Risk Management 
R.I.                       Random Index 
S.D.                       Standard Deviation 
SEM                       Structural Equation Modelling  
SCM                       Supply Chain Management 
SCOR Supply Chain Operations Reference 
SCRM                     Supply Chain Risk Management 
SLR                       Systematic Literature Review  
SMEs                      Small and Medium-size Enterprises 
SWOT Analysis           Strengths, Weakness, opportunities and Threats analysis  
TFN                        Triangular Fuzzy Numbers 
TOPSIS                   Technique for Order Preference by Similarity to Ideal Solutions 
UCM                      Uncertainty Circle Model  
VMI                        Vendor Managed Inventory  
WHO                    World Health Organization  
 
 
 
 
 
 
 
 
 
 
2 
 
 
1.CHAPTER ONE – INTRODUCTION  
 
1.1 INTRODUCTION 
This chapter introduces a general research background and specific research questions, 
followed by the research aims and objectives, scope of the research as well as the research 
methods. The thesis outline is provided to present different stages in the healthcare supply 
chain risk management process, including risk factors identification, risk assessment, risk 
mitigation strategies identification and evaluation.  
 
1.2 RESEARCH BACKGROUND  
In the past two or three decades, the expenditure in the healthcare sector across the globe 
has increased tremendously. UK National Health Service (NHS) is one of the largest 
employers in the world (Towill and Christoper, 2005), UK healthcare costs are expected to 
increase at a faster rate than the growth of the GDP, reaching about $4.6 trillion (equate to 
£2.95 trillion) and accounting for more than 19% of the GDP by 2019 (Centers for Medicare 
and Medicaid Services, 2010). More recent data indicates that supply chain related 
expenses, including the cost of all activities, assets, information, infrastructure, and labour 
related to the accurate procurement, delivery, storage, return, and disposal of products and 
materials necessary to provide healthcare services, account for 33% of the average 
healthcare provider’s annual operating expense (Nachtmann and Pohl, 2009). It shows that 
though the delivery of services has generally improved, the cost incurred in providing the 
high quality is still high (Chandra et al., 2009).  
Research has revealed that the healthcare cost has soared to unprecedented levels 
threatening the sustainability of hospitals and the healthcare system in general (Vincent, 
2006).  Therefore, healthcare institutes and hospitals have been forced to adopting new 
models of operations (Bourlakis, 2011; Chakraborty, 2014). In particular, similar to other 
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industries, the healthcare sector (see Figure 1.1) generally consists of four main 
components: producers, purchasers, providers, and payers (Burns, 2008).  
 
Figure 1-1: Health care value chain  
(source adapted from ROi, Mercy case study and Burns, 2008) 
 
The philosophy of supply chain management (SCM) is founded on the management of all 
activities from upstream to the downstream process, which including identification of the 
customer demand, solving problems of functional division that occur within and between 
each party, storage, distribution, redistribution, procurement (Colletti, 1994; Andraski, 1998; 
Stank et al., 2001; Meijboom et al., 2011; Aronsson et al., 2011; Pinna et al., 2015). 
Healthcare supply chain management (HCSCM) is unique and different from the traditional 
SCM as it handles a diversity of items in widely varying quantities in response to the larger 
number of diagnosis types and procedures (AbuKhousa et al., 2014). Much of these items 
are of high value and require special handling to combat spoilage or obsolescence. Since 
clinical operations require adequate and accurate supplies according to the diverse needs of 
patients, healthcare supplies are mission critical to the health of the public (Beier, 1995). 
More importantly, healthcare supply selections are often driven by physician preference, 
which is largely based on medical training, experience with specific brands, and context-
specific demands. This is in contrast to manufacturing and retail industries where supply 
selections are largely driven by production/sales forecasts and const considerations. As 
shown in Figure 1.1, the healthcare supply chain consists of both internal chain (patient care 
units, hospital pharmacies) and the external chain (producers, purchasers, distributors and 
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payers). Many researchers assert that implementing SCM would reduce organizational costs 
and cycle time as well as leading to higher performance without compromising quality of 
services. An efficient, user-friendly supply chain can also impact the healthcare provider’s 
revenues by engendering physician loyalty and staff retention. However, studies have shown 
that the healthcare industry consistently lags commercial industry in adopting supply chain 
management. The topic of healthcare supply chain management is still in the early stage and 
its operational performance is immature, fragmented and more problematic (Kumar et al., 
2008; Mustaffa and Potter, 2009; Kwon et al., 2016). D. Elmuti et al., (2013) completed a 
survey of 700 organizations in the United States according to their familiarity and utilization 
of HCSCM initiatives. The results indicated that about 62% of the respondents reported that 
they did not have an existing HCSCM program. About 38% of the organizations surveyed 
reported that they were familiar with the HCSCM concept. The remaining organizations 
reported the duration of their HCSCM programs to be less than 1 year. Most of these 
companies are working to improve on only one aspect of the area of the total supply chain.  
Kwon et al., (2016) indicated that the healthcare supply chain is struggling with 
misunderstanding of the fundamentals of supply chain concepts. The functions of the 
healthcare supply chain have been mistakenly identified as merely purchasing and contract 
management. Moreover, other hindrances for implementing SCM in the healthcare industry 
include the lack of standard nomenclature for healthcare products and the clinicians’ 
preferences create further uncertainties (McKone-Sweet et al., 2005), and lack of trust 
between hospitals and suppliers (Mustaffa and Potter, 2009). Despite the above, it is still 
perceived that there is significant scope for improving the overall performance of the supply 
chain in healthcare sector. Since 2005, there is a dramatically increasing number of 
publications about this topic. A number of different SCM tools have been also applied in 
practice, such as Just-In-Time (JIT), Vendor managed inventory (VMI) as well as Collaborative 
Planning, Forecasting and Replenishment (CPFR), etc.  
Risks existing in the supply chain are referred to as the unexpected events which interrupt the 
operational process and have a negative impact on the whole system performance (Ho et al., 
2015). As a matter of fact, there is a growing number of disruptive cases with negative 
consequences on the performance of companies in recent years. There have been 
many cases of when disruption has paralysed the supply chain. For example, a fire 
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which lasted for only ten minutes in a Phillips semiconductor plant disrupted Ericsson’s 
delivery of microchips for more than one month, which eventually led to a $400 million 
loss (Chopra and Sodhi 2004).The bankruptcy of a UK-based supplier, UPF-Thompson, 
forced Land Rover to make 1,400 workers redundant (Tang 2006). Similarly, nearly 420 
KFC stores around UK were forced to close due to the delivery problems incurred by 
its delivery partner, a UK based food delivery special ist Bidvest Logistics in 2018. It is 
still possible to recall how the earthquake, tsunami and the subsequent nuclear crisis 
occurred in Japan in 2011 caused Toyota’s production to drop by 55,000 vehicles, 
costing $72 million in profits per year (Pettit et al., 2010). For the last decade, few 
areas of management interest have risen to prominence as rapidly as supply chain risk 
management (SCRM) (Colicchia and Strozzi, 2012).  
From the hospital or healthcare perspective, Harris (2000) investigated the ultimate 
objective of managing risks as the ability to identify, assess, reduce and control risks to staff, 
patients and visitors. Essentially, the risks can be considered broadly as anything that 
compromise service delivery (Rafele et al., 2005), for example, scarce service provision 
caused by inadequate resources or inefficient material management (Tomlin, 2009). The 
impact of risks accounts for the big proportion of hospital budgets hence risks management 
is a significant strategy to minimize expenditure and increase the service quality. Similarly, 
supply chain management must take account of risk management in hospital as there are 
many suppliers and customers with close interconnectivity. This often increases the risks in 
hospital supply chain because a disruption in one member may affect others. Usually, the 
supply chain capacity is decided by demand and supply (Tang, 2006) that are ever uncertain 
thus increasing the risk especially in healthcare where the resources are constrained. 
Organizations across supply chains may only focus on a given subset which is likely uncertain 
(Chopra et al., 2004).  
This thesis focuses on the risks in relation to the pharmaceutical products (i.e. medicine) in 
the hospital supply chain. It generally associated with medicine discontinuity, medicine 
shortages, poor performance, patient safety/dispensing errors, expiration and technological 
errors (e.g. causing stock shortages in pharmacies), all of which incur risk through disruption 
to the system. It is vital as medicines are a core input into healthcare treatment and are 
critical products (Breen, 2008). To tackle those risks, it is essential for the healthcare 
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providers (i.e. hospital) to understand what these risks are and how they affect the supply 
chain operations. Unless there is infinite resource that could be used to reduce such risks, 
healthcare providers will always have to prioritise their resources to deal with those risks 
that are most significant and imminent. This makes it important to evaluate the extent to 
which each risk factor affects the performance of the hospital supply chain and also to 
identify the relative importance of each risk factor. For the purpose of control and mitigation 
of the negative effects caused by multiple types of risks, a significant number of works in this 
field were undertaken in both practitioner and academic circles (Ho et al., 2015). In essence, 
the SCRM process often includes risk factor identification, risk assessment and mitigation. 
The existing studies reveal that at least one of these processes are covered in the 
research to analyse SC risks and their management while taking various SC contexts 
into account (Blackhurst et al., 2011; Christopher et al., 2011).  However, the findings 
of previous SCRM studies provide valuable insights, but little in a complete and 
systematic approach for the healthcare industry. According to the literature review, 
there are a small number of studies specifically focused on the healthcare supply chain risk 
management (HCSCRM), especially in hospital setting (Breen, 2008; Aguas et al., 2013; Illie 
and virgil, 2013; Kanyoma et al., 2013; Enyinda et al., 2014; Elleuch et al., 2014;  Kim et al., 
2016; Zepeda et al., 2016). Nevertheless, the finding of literature review reveals that the 
current healthcare systems’ SCRM models are not capable of meeting challenges faced by 
hospitals (Mckinsey&Company, 2013). The risks and uncertainties in the healthcare supply 
chain network have yet to be fully explored. In addition, no research has been published to 
develop a thorough and sound risk management framework for evaluating integrated SCRM 
performance across the whole chain in the public healthcare sector, especially in respect of 
the medicine perspective. Furthermore, the attention that is given to systematic risk factors 
identification is fairly limited and needs further investigation. Currently, no published studies 
have examined the efficiency of currently implemented supply chain risk mitigation 
strategies in the public healthcare organizations. These issues will be further discussed in the 
literature review in Chapter two and will be addressed in this thesis.  
This thesis, therefore, raises the following research questions and will answer them at the 
end of this research.  
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 RQ1. What is the most effective HCSCRM framework that can be implemented to deal 
with the HCSC risks? 
 RQ2. What are the main sources of risk factors causing public sector healthcare supply 
chains vulnerable and how to address those risks? 
 RQ3. Which risk factors are relatively more significant to a hospital’s supply chain 
management performance? 
 RQ4. How are these risk factors interacting with each other? 
 RQ5. How can the hospitals from both UK and China effectively manage their supply 
chain related risks?  
 RQ6. What are the main risk mitigation strategies to be considered?  
 
1.3 RESEARCH AIM AND OBJECTIVES  
In light of this, to address the practical needs and fulfil those research gaps, this thesis aims 
to propose a novel comprehensive framework and integrated risk management model that 
takes explicit account of multiple types of risk factors in aiding decision-making as well as 
comparing and ranking the current implemented alternative risk mitigation strategies using 
fuzzy set theory and multiple criteria decision analysis (MCDA) methods. The specific research 
objectives are:  
 To review the existing and current status of implementation of risk management 
technology/theory in hospital supply chain, to explore the characteristics of the 
healthcare supply chain and review supply chain risk management methods.    
 To develop a conceptual framework to identify, evaluate the risk level and mitigate 
the interrelated risk factors in the hospital supply chain operations.  
 To develop an integrated supply chain risk management model to support the 
proposed framework using fuzzy set theory and multiple criteria decision analysis 
(MCDA) methods. 
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 To examine the applicability of the proposed model through empirically based cases 
in order to find out the best solution to manage the risk in hospital supply chain 
operations.  
 To conduct case studies to justify and demonstrate applicability of the proposed 
model.  
 
1.4 RESEARCH SCOPE  
The diverse entities involved in the healthcare supply chain network, such as various flows 
(i.e. information, cash, service, material flow) and numerous stakeholders (i.e. manufacturers, 
suppliers, distributors, retailers, hospitals, governments and patients), are interweaved into 
a complex system, on the other hand, supply chain risk management is a broad topic that 
encompasses various aspects from which to look at the SC process. Therefore, it is essential 
to set the boundaries of the research at the early stage for the purpose of developing valuable 
insights.  
Existing literature reveals that most studies have focused on the upstream of the healthcare 
supply chain, especially on pharmaceutical companies.  Instead, the context of this thesis is 
confined to the general medicine flow in public hospital supply chain risk management.  The 
major difference between the public and private healthcare providers is their main goals. The 
private hospital is profit oriented while the public sector is oriented toward quality service 
delivery. Furthermore, the enablers of supply chain management (SCM) (which include 
integration, collaboration, coordination and information systems) are applicable both to the 
private and public sectors. However, the rate of application in the public hospital in limited 
due to complex rules and procedures. Despite the comprehensive legislation and measures 
implemented by the public hospital, there are always challenges to manage the risks of fraud 
and corruption in the supply chain. Incidence of financial mismanagement which includes the 
SCM process remains prevalent in the public hospital. Korosec (2003) states “SCM is a 
procurement tool that, strategically integrates the whole procurement process.” Thus, SCM 
is thought to be narrow in a functional sense, an element of procurement rather than 
spanning multiple functional areas in the public hospital. By contrast, in the private hospital 
context, Mason-Jones (2004) argues that “procurement is a crucial central element of SCM” 
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and SCM covers “all functions throughout organizations, from marketing and production to 
procurement.” Therefore, a system of comtinuously monitoring and improvement of the 
supply chain is crucial for the success of the public hospital.  
The research is mainly focusd on how to manage risks occurring from the upstream (i.e. 
manufacturer and distributor) to the downstream, end user (i.e. patients). More especially, it 
presumes that all supply chain activities (i.e. sourcing, distribution, storing, etc) within the 
interactions of different parties are carried out in association with material, finance and 
information flows to provide the medicine products to patients. Therefore, the risk types 
covered in this thesis are related to (1) the risks that are internal to the hospitals, (2) the risks 
external to the hospitals but internal to the supply chain networks and (3) the risks external 
to the supply chain networks. Comparing with other studies which only focus on one of the 
specific SCRM process, this thesis proposes an integrated method to identify the healthcare 
SC related risks, measure and analyse the risks, and evaluate the implemented risk mitigation 
strategies.  
The geographical focus of the research within this thesis is both the United Kingdom (UK) and 
China. The UK provides a good case for the research relating to healthcare industry, as the 
NHS and its commercial partners are internationally renowned for running the world’s largest 
integrated health system. At the same time, healthcare reforms have been initiated by the 
Chinese government for seeking the development of a new system, which providing “safe, 
effective, convenient and affordable” healthcare to both rural and urban residents by 2020. 
Thus, the UK’s experience of providing high quality hospitals and efficient SC are capable to 
assist China to develop new systems for meeting the urgent needs for healthcare reforms. 
China has learned UK healthcare model since 2013 and spearheaded a series of initiatives to 
promote the international co-operation in healthcare education and information exchange 
between both countries. Although this is beneficial for sharing the experience among each 
other, it also means that both healthcare industries would face the same issues.  Moreover, 
what is true of the analysis of supply chain related risks is becoming more imperative to both 
countries’ healthcare industries which pursue effectiveness and value in supply chain 
operations.   
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1.5 RESEARCH METHODS 
This thesis follows a deductive research approach using data triangulation of both qualitative 
and quantitative research methods. The research mainly aims to develop a comprehensive 
framework and an integrated risk management model for identifying and assessing the risk 
factors in hospital supply chains. Particularly, it explores the efficiency of currently 
implemented risk mitigation strategy in the hospital setting. Thus, the empirical study was 
chosen to enhance the understanding of this complex healthcare supply chain system and to 
support the researcher as well as practitioner retain an in-depth analysis of this real-life 
situation.  
Reporting of empirical in-depth studies on managing the medicine supply chain related risks 
in the hospital setting is rather scarce in scholarly work. Therefore, the empirical studies were 
conducted in both China and UK healthcare industries and data was collected via reviewing 
literature articles, official documentation and other published materials, direct observations, 
a series of interviews from industrial experts, consultants as well as academics with rich 
knowledge and experience of risk management, and questionnaire surveys. The 
questionnaires were pilot tested, with the results being used to modify the contents. In 
addition, the questionnaires were sent out via either email or web-link (i.e. eSurveyCreator) 
with a cover letter and content form to the targeted experts. The participant experts such as: 
Head of Procurement, Director of Hospital, Stock Manager, General Manager in 
Pharmaceutical Company, Chief Pharmacy Procurement IT Manager, Head of Supply Chain 
and E-commerce and academicians with industry experience are the knowledgeable 
individuals who are able to provide the valuable comments to all aspects of the survey.   
Relevant literature review was used as a base to identify risk sources and risk mitigation 
strategies. A risk-factor questionnaire survey and semi-structured interviews with participant 
experts from both academic and industrial fields were conducted to validate the identified 
risk factors and relevant risk mitigation strategies that were extracted from the existing 
resources and explore other risk factors and mitigation strategies that have not been 
mentioned in the literature and other documentation. Moreover, a series of email and face-
to-face interviews were distributed and conducted to further explore the appropriateness of 
the developed hierarchy model where the identified risk factors were summarized.  For the 
purpose of assessing the risk factors, it is essential to measure the risks by determining their 
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priority weighting and evaluating their inter-relationships. Other questionnaire surveys 
(termed risk assessment survey) were conducted and analysed using Fuzzy Analytic Hierarchy 
Process (AHP) and Interpretive Structural Modelling (ISM). In order to better understand the 
significance of the identified risk mitigation strategies with regard to different risk factors, 
further questionnaire surveys was conducted to collect the relevant primary data.   Fuzzy 
TOPSIS (Technique for Order Preference by Similarity to Ideal Solution) was then used to 
analyse the data and rank the relative importance of those mitigation strategies with respect 
to the performance under different risk contexts.   
 
1.6 STRUCTURE OF THE THESIS 
The thesis consists the following eight chapters:  
Chapter One – Introduction: This chapter states a general overview of the research 
background, aim, objectives, the generated research questions, the scope of research, and 
methodological approach and structure of this thesis. It briefly reviews the requirement for 
this research and outlined how the research will be conducted.   
Chapter Two – Literature review: This chapter extensively reviews the literature on the 
concepts of healthcare supply chain management, the status of risk management in the 
healthcare supply chain context and their development as well as definitions. This chapter 
discusses the current existing studies in association with supply chain risk management and 
assess the current knowledge on SCRM. Eventually, some research gaps are find out, 
particularly concerning the medicine supply chain related risks in the hospital sector.  
Chapter Three – Research methodology: This chapter explains the methodology, philosophy, 
approach, strategies and choices that established the foundation for the research work. After 
defining the overall research design, the chapter looks to justify the methodological choices 
to meet the research objectives by outlining the application of data collection and analysis 
methods. 
Chapter Four – Conceptual famework and integrated risk management model: This chapter 
presents the novel risk management conceptual framework as a platform that attempts to 
incorporate the five main components, namely risk drivers and sources,  decision-making, SC 
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strategies, supply chain risk management process and performance outcomes to address the 
industrial needs for practical decision support methodology. Based on the proposed 
framework, the integrated risk management model is developed by following three main risk 
management steps through organising and refining the previous methods.     
Chapter Five – Healthcare supply chain risk factors identification: This chapter presents the 
first step of the risk management process, i.e. risk factors identification. In order to expand 
the coverage of the risk factors identification and classify the unstructured risk factors, this 
chapter reviewes relevant literature and other published materials. The questionnaire 
surveys is developed to make inferences about the attitudes and opinions from participant 
academic and industrial experts. Based on the survey results, the developed hierarchical 
structure of identified risk factors are modified and further validated through a serial of email 
and face-to-face interviews with the experts.   
Chapter Six – Healthcare supply chain risk assessment:  This chapter focuses on the 
assessment of identified risk factors in the hospital setting. It illustrates second-round 
questionnaire surveys conducted by empirical studies, where the data collected are analysed 
using Fuzzy AHP and ISM methods. This is carried out to determine the relative significance 
and highlight the interactions between each risk leading to the supply chain disruption.    
Chapter Seven – Identification and evaluation of risk mitigation strategies: Instead of 
identifying the mitigation strategies based on the literature review, this research focuses on 
the current implemented strategies in the real-time context and identifies them through the 
empirical studies in both UK and China healthcare industries. The significant levels of risk 
mitigation strategies are evaluated through conducting the five-point Likert scale 
questionnaire survey and ranked by using a Fuzzy TOPSIS method. The chapter ends with the 
discussion and managerial implications.   
Chapter Eight – Conclusion: This chapter summarises the findings on the risk factors 
identification, risk assessment and risk mitigation in the previous chapters. It also suggests 
the limitations of this thesis and provides the direction and recommendations for further 
research agenda. Figure 1.2 illustrates the overall thesis structure.
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Figure 1-2: The structure of the thesis 
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2.CHAPTER TWO: LITERATURE REVIEW 
 
2.1 INTRODUCTION  
This chapter provides details of how the rigorous systematic literature review are conducted, 
highlights the gaps allowing to clarify the research problems in the proposed study. The 
review of the literature comprises of three key areas, which are critical to the research 
including: healthcare supply chain management (HCSCM), supply chain risk management 
(SCRM) and healthcare supply chain risk management (HCSCRM) as shown in Figure 2.1.  
It begins with the review of the current status of healthcare supply chain management and 
an introduction of the systematic review methodology. This is followed by the results section. 
The discussions of conceptual and research methodological issues are presented.  
Thereafter, this chapter reviews the previous research on SCRM and identifies the research 
gaps, particularly with respect to the healthcare supply chain risk management (HCSCRM) in 
the hospital setting. Due to the lack of in-depth studies on HCSCRM, it leads to this literature 
review focusing on how SCRM knowledge has been built up in order for the findings to be 
applied to healthcare supply chain contexts. To understand the existing body of literature, the 
overview of conventional SCRM literature, SCRM methodologies as well as the status of 
supply chain risk management in the healthcare sector are presented.   
The chapter concludes by summarising the key findings of the review, highlighting the 
contributions this study makes to the body of healthcare SCM and SCRM knowledge, and 
identifying the implications of the findings for practitioners and scholars. Thus, a future 
research agenda can be derived from the research gaps identified.  
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Figure 2-1: Three key areas of the literature review 
 
2.2 HEALTHCARE SUPPLY CHAIN MANAGEMENT (HCSCM)  
In recent years, healthcare and hospitals have been under increasing pressure to find ways of 
improving services and reducing costs. This is owing to the fact that competition in the 
healthcare sector has increased due to globalisation (Carter and Rogers, 2008), differentiation 
in customer demands, and resource pressure faced by private and public-service providers. 
Furthermore, the reforms have forced hospitals to find new ways to cut the costs of operation. 
Currently, statistics show that the healthcare sector loses approximately $5 billion annually in 
the implantable device supply chain due to waste, inefficiency, and sometimes inadequate 
visibility (Seuring and Müller, 2008). 
In most healthcare institutions, supply chain cost is the second highest cost after labour. As a 
result, most hospitals are looking for ways to reduce their supply chain costs while improving 
their efficiency (Kumar et al., 2009). There is evidence showing several opportunities where 
new thinking in commercial and industrial logistics and service supply chain management 
(SSCM) are being transformed into healthcare delivery to advantageous effect (Towill and 
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Christopher, 2003). Supply chain management (SCM) is a systematic approach to create a 
seamless and continuous process in supply chain operations (Mentzer et al., 2001). 
Harland (1997) suggested that the term supply chain management can be used to describe 
several concepts: the processes inside a manufacturing organisation, purchasing and supply 
management occurring within dyadic relationships, the total chain, and finally, a total firm 
network. Healthcare service providers are utilising SCM to reduce operation costs by 
automating manual processes, creating efficient trading partner’s relationships, reducing 
waste and excess product, capturing all supply data for business requirements, and enabling 
automation among regional care networks (Seuring and Müller, 2008; Aronsson et al., 2011). 
As an organisation, the hospital operations under certain supply chains are not only meant to 
increase the productivity of the hospitals but also to manage the risk associated with 
healthcare. There is no doubt that today’s healthcare supply chain is more complex, and it 
involves technology, partnerships, and consolidation within the supply chain community 
(Haszlinna et al., 2009). Healthcare and hospital operations are delivering goods and services 
from many suppliers to patients with a wide range of health requirements due to the need 
for hospitals to provide both planned and emergency care (Fenies et al., 2006; MacVaugh, 
2007). For example, some drugs require special temperature conditions for storing and 
delivery. Furthermore, a zero-defect condition is necessary for the healthcare delivery 
process to patients. Lillrank et al., (2011) examined straightforward applications of 
manufacturing methodologies that fail to capture some essential features of healthcare. 
In practice, performance measurement and process redesign have been proved as the two 
main approaches to improve hospital supply chain operation performance within the 
healthcare sector (Trautmann et al., 2009). It is, however, important for researchers and 
practitioners to fully understand the process involved to benefit from the chosen methods. 
Likewise, it is essential to be knowledgeable about the associated issues inherent in the 
service delivery processes and the supply chain because, in business planning, quality, 
quantity, cost, and risk are all closely interrelated (Chakraborty et al., 2014). In general, there 
is a vast and rapid change in the events in a hospital supply chain. It is vital to develop 
solutions that optimise profit by minimising wastage, while remaining flexible to the changing 
trends in the healthcare sector (Mustaffa and Potter, 2009). The objective of this section is 
two-fold. First, existing healthcare SCM research work between 1995 and 2016 is presented. 
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Second, a detailed review is undertaken associated with research developments in healthcare 
SCM.  
2.2.1 HCSCM research methodology 
A literature review is a major contribution to a research project, and it will provide a historical 
perspective of the different research areas and an in-depth account of independent research 
endeavors (Mentzer and Kahn, 1995). A systematic review procedure for retrieving and 
selecting the reviewed articles has been applied following Tranfield et al., (2003) to avoid bias 
and improve the validity of the outcomes. The flowchart of the systematic research 
methodology outlines the review procedure step by step as illustrated in Figure 2.2 (Ho et al., 
2015). 
2.2.1.1 Sourcing articles 
The search strings used in the review, such as ‘healthcare/hospital/pharmaceutical supply 
chain’, ‘healthcare service delivery’, ‘patient flow’, ‘logistics’, and ‘healthcare’, and the search 
were directed to ‘all fields’, which does not limit the search to the title or keywords. In view 
of this, reviewed journal articles were selected being published between 1995 and 2016. The 
academic databases that were used to identify journal articles included Emerald insight, 
IEEExplore, ProQuest, ScienceDirect, Taylor and Francis, Web of Science, and ResearchGate. 
In addition, the literature search was supplemented by Google Scholar and OpenAuthors to 
improve completeness. Choosing these established databases also helped in minimising any 
form of publication bias or reviewer prejudices. Cronin et al., (2008) maintained that some 
reviewers may refuse to publish some primary studies, particularly when they report findings 
that do not conform to their expectations. To achieve the highest level of relevance, as Moher 
et al., (2009) suggested, peer-reviewed journal articles provide credible information because, 
for an article to be published in a journal, it must be reviewed by a team of specialised 
personnel to ascertain its authenticity. Journal articles also provide sources of up-to-date 
information as compared to books (Moher et al., 2009). Thus, the peer-reviewed journal 
articles written in English were focused exclusively, whereas conference papers, master and 
doctoral dissertations, textbooks, book chapters, and notes were excluded in this review. 
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Figure 2-2: Flowchart of the HCSCM literature review methodology 
 (source adapted from Ho et al., 2015). 
 
The primary purpose for targeting databases was the fact that these databases contain a huge 
volume of peer-reviewed papers. A systematic review of the references cited in the resultant 
articles was also undertaken. The search retrieved a total of 369 papers. All the abstracts of 
the articles were examined to validate whether they covered one or more of the healthcare 
SCM topics, including material management, patient pathways, logistics, and research gap 
identification. Figure 2.3 illustrates a continuous increase in the number of papers focusing 
on the development of the healthcare supply chain in the past 20 years. 
 
 
 
Figure 2-3: Distribution of the number of journal articles between 1995 and 2016 (369) 
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2.2.1.2 Screening articles 
The retrieved articles were subjected to three stages of screening: 
 The term healthcare supply chain is used to describe the flow of goods and services 
from the supplier to the end user (i.e. patients). Because the research only focused 
on the downstream supply chain of the healthcare industry, especially in the hospital 
setting, the papers related to the upstream part of the healthcare industry will be 
excluded. This reduced the number of articles from 369 to 227. 
 Second, the retrieved articles based on the citations and the impact factor of each 
published journal were checked in order to ensure a high quality of articles. After this 
stage, a total of 87 papers were retained. 
 Third, the reference lists of the shortlisted articles were also carefully cross-checked 
to ensure that there were no other articles of relevance that were omitted in the 
research. In all, 87 articles met the inclusion criteria for healthcare SCM. Furthermore, 
because SCM can be considered as the processes inside an organisation, some studies 
in terms of lean healthcare used for healthcare service delivery could also be included 
for the review. In the end, this analysis resulted in 87 articles. 
 
2.2.1.3 Analysis and coding 
Finally, this stage involved extracting and documenting information from each of the 87 
sources. The seven dimensions along with the articles were analysed and integrated into a 
literature review framework suggested by Burgess et al., (2006). As Table 2.1 shows, the 
classification framework is structured by four main components that enable a holistic and 
systematic literature review. More specifically, Grouping 1 conducted an analysis of the 
selected articles used and examined the trends of the research on healthcare SCM. 
Grouping 2 provided an evaluation of the consistent and various definitions in healthcare SCM 
from different researcher perspectives. 
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Table 2.1: HCSCM literature review classification framework 
(source adapted from Burgess et al., 2006) 
 
Grouping Content Covered Rationale 
1. Descriptive features 
of healthcare SCM 
literature 
 
Time distribution 
of publications, 
journal names, 
contributing 
country 
Describe characteristics of sample of 
articles 
2. Definitional issues  
Approaches to 
definitions and 
taxonomy for 
healthcare SCM 
Explore consistency or variation in 
healthcare SCM definitions by researchers 
on a range of dimensions. Define the 
territory that the researchers claim falls 
within healthcare SCM 
3. Theoretical concerns  
Theoretical 
perspectives 
 
 
Determine the range of theories that are 
used to inform healthcare SCM and the 
ends to which they are applied 
4. Research 
methodological 
issues 
Research methods Determine the types of research methods 
that are used to explore healthcare SCM 
 
 
Moreover, it classified the taxonomy of healthcare SCM from both physical and patient 
service views. Grouping 3 also classified the articles but dealt with issues within the 
theoretical bases. Finally, Grouping 4 examined issues associated with research methodology 
that are used to explore healthcare SCM. The framework was designed to assist in establishing 
a clear ‘line of sight’ from information sources to definitional matters, and then through to 
theoretical concerns and research approaches (Burgess et al., 2006). 
2.2.2 Results of HCSCM literature review 
2.2.2.1 Descriptive features of HCSCM literature (grouping 1) 
2.2.2.1.1 Time distribution of publication of articles  
Owing to the limitation for exploring the trend of publication for healthcare SCM using the 
selected 87 papers, it provides an overview of the total retrieved 369 papers published in the 
last two decades, as shown in Figure 2.3. The first articles appeared in 1995. Until 2005, there 
          
21 
 
was a gradual increase in publications, with 334 out of 369 articles published between 2005 
and mid-2016. The year 2014 represented a promising year in healthcare SCM research, 
contributing the most in the volume of papers published. 
2.2.2.1.2 Journal titles 
The 87 selected articles were reviewed to identify the journals and the number of articles 
published in each journal. As shown in Table 2.2, a total of 55 journals covering diverse 
perspectives of healthcare SCM were captured in the review. Three journals, Production 
Planning and Control: The Management of Operations (5), International Journal of Health 
Care Quality Assurance (4), and Supply Chain Management: An International Journal (11), 
accounted for 23% of the publications. The remaining 77% of articles were ‘thinly’ spread over 
the remaining 52 journals. 
2.2.2.1.3 Contributing country  
Descriptive analysis of countries contributing to healthcare SCM showed that US academics 
researchers contributed the most healthcare SCM papers, which comprise 88% in America 
and 28% in the world (Figure 2.4). The UK followed with 41% in Europe and 14% in the world. 
In Asia, India dominated one-third of the published articles compared to other countries. In 
Oceania, the Middle East, and Africa, the countries of Australia, Iran, and Ghana comprised 
34%, 20%, and 34%, respectively, in those regions. In addition, there is collaborative research 
among co-authors representing more than two countries (e.g., Laureani et al., 2012; Aronsson 
et al., 2011; Chireu et al., 2014). 
Table 2.2: List of journals publishing HCSCM research to date 
Journal No. of 
papers 
Journal No. of 
papers 
Academy of Taiwan Business Review 1 Journal of Service, Science and 
Management 
1 
African Journal of Business and 
Economic Research 
1 Journal of Business Logistics 2 
Business Process Management Journal 2 Journal of Risk Research 1 
Computers in Biology and Medicine 1 Journal of Operations 
Management 
2 
Computers and Operations Research 1 Journal of Health Organization 
and Management 
3 
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Clinical Governance: An International 
Journal 
1 Journal of Management in 
Medicine 
1 
Health Policy 1 Journal of Purchasing and 
Supply Management 
1 
Health Care Management Science 2 Journal of Industrial Engineering 
and Management 
1 
Health Marketing Quarterly 1 Journal of Management and 
Strategy 
1 
Health Care Management Review 2 Journal of Health Service 
Research and Policy 
1 
Healthcare Financial Management 1 Journal of Healthcare 
Information Management 
1 
Health Affairs 1 Journal of Marketing 
Management 
1 
International Journal for Quality in 
Health Care 
1 Leadership in Health Services 3 
International Journal of Innovation and 
Technology Management 
1 Management Review: An 
International Journal 
1 
International Journal of Operations and 
Production Management 
3 Operations Research for Health 
Care 
2 
International Journal of Logistics 
Management 
2 Production Planning & Control: 
The Management of Operations 
5 
International Journal of Production 
Economics 
2 Public Money and Management 1 
International Journal of Health Care 
Quality Assurance 
4 Public Management Review 1 
International Journal of Value Chain 
Management 
1 Procedia Economics and Finance 1 
International Journal of Logistics 
Systems and Management 
1 Quality Management in 
Healthcare 
1 
International Journal of Productivity and 
Performance Management 
2 Research Journal of Recent 
Sciences 
1 
International Journal of Quality and 
Reliability Management 
1 Research in Social and 
Administrative Pharmacy 
1 
International Journal of Physical 
Distribution and Logistics Management 
2 Supply Chain Management: An 
International Journal 
11 
International Journal of Six Sigma and 
Competitive Advantage 
1 Strategic Outsourcing: An 
International Journal 
2 
Ingenieria e Investigacion 1 The International Journal of 
Human Resource Management 
1 
Technology and Health Care 1 The International Journal of 
Accounting 
1 
The Journal of Applied Business 
Research 
1   
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Figure 2-4: Distribution of contributing countries in HCSCM in the world 
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2.2.2.2 Definitional Issues (grouping 2) 
2.2.2.2.1 Definition of healthcare supply chain management 
As indicated in Figure 2.3, it appears that the development of the healthcare SCM is still in its 
early stage. The specific definition of the healthcare supply chain has emerged in the literature 
with diverse perspectives, as summarised in Table 2.3. It indicated that there is no consensus 
on the concepts of the healthcare supply chain. However, without a mutual understanding 
and clear definition, it will become difficult for researchers to communicate with practitioners 
and gain access to the industry to conduct empirical studies (Ho et al., 2015). 
It is impossible to build one’s own definitions subjectively without any foundations based on 
the literature. Thus, a conservative approach has been suggested by Burgess et al., (2006) 
who proposed that a definition must be explicitly stated, not merely implied, to be useful. As 
shown in Table 2.4, the literature has been classified into existing, modified, or original 
definitions. According to Table 2.4, about two-thirds of the articles (58) did not provide 
definitions. Moreover, 18 out of 87 used existing definitions. However, little consistency was 
found in the specific definitions used. Four of the 18 articles utilised the definition proposed 
by Burns (2008), who suggested the four main components in the healthcare supply chain 
(producer, purchaser, provider, and payer). The remaining articles only focus on the supply 
chain partially or on a specific aspect, such as the healthcare service delivery process. Only 
eight papers developed their own definitions in healthcare SCM. However, most of these have 
not been utilised or developed by other researchers. 
Table 2.3: Definitions of HSC given by researchers 
AUTHORS Definitions of Healthcare SC Scopes 
Brennan (1998) The supply chain is the chain of activities, 
information, and flow of funds that extends 
from manufacturers to the customer or patient. 
Integrated delivery 
systems 
Rivard-Royer et 
al., (2002) 
A major characteristic of the healthcare sector 
supply chain is the simultaneous presence of 
two chains: one external and the other internal. 
From the multitude of different supplies used by 
the institutions and the myriad distribution 
channels through which they flow, these 
supplies may come directly from the 
manufacturer or through a distributor. The 
healthcare institutions are not the end 
Supply chain 
integrating 
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customers. Hospitals must deploy their own 
logistics networks for delivering suppliers to the 
patient care units and users. 
Lina et al., (2005) Healthcare SCM is considered more problematic 
compared to the industrial sector. This is 
because the volume of diverse support services 
required to deliver the product (patient care) is 
unique, and the decision maker must consider 
information, material, and cash flows in the 
system.  
Inventory 
management 
Christopher and 
Towill (2005) 
The authors defined the healthcare supply chain 
as the healthcare delivery pipelines, which 
refers to the flow of patients in pursuance of all 
phases of their treatment from referral to full 
recovery. In that sense, ‘patient flow’ is 
analogous to ‘product flow’ with corresponding 
value-added activities in the pipeline and similar 
valid concerns regarding quality management 
and delivery cycle times.  
Pipeline 
differentiation 
Kitsiou et al., 
(2007) 
 
The current healthcare supply chain is a 
multifaceted system consisting of several 
processes, tasks, intermediaries, and interfaces, 
where numerous responsibilities are highly 
segregated from the manufacturer to the end 
user: the patient. 
Information systems 
 
Samuel et al., 
(2008) 
The supply chain process is the essential link for 
all programs and services offered by a hospital. 
Hence, any improvement in managing the 
supply chain can positively affect the bottom 
line profitability of any hospital operations. 
Performance 
improvement 
Jan and Robert 
(2011) 
The healthcare supply chain refers to the 
information, supplies, and finances involved 
with the acquisition and movement of goods 
and services from the supplier to the user to 
enhance clinical outcomes while controlling 
costs.  
Integrated health 
supply chain 
Shou (2013) Healthcare SCM processes have three types of 
flows: physical product flow, information flow, 
and financial flow. The physical product flow 
manages customised products and services for 
the treatment of patients and their needs. 
Information and financial flows are related to 
supply chain design decisions for effective 
product flow and improved organisational 
performance.  
Application of 
healthcare SCM in 
developing 
countries 
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Tillmann et al., 
(2013) 
Healthcare supply chains can be considered the 
‘value stream’, which is defined as the special 
activities required to design, order, and provide 
a specific service to patients.  
Performance 
measurement 
Daniel et al., 
(2013) 
Hospital supply chains are unique and different 
from the typical industrial supply chains in many 
aspects, such as requiring accurate supplies, 
requiring special handling conditions for 
supplies, supply driven by physician preference, 
and rapid development of technology. 
IT investment and 
hospital-supplier 
integration 
Umang and 
Ramesh (2015) 
Healthcare SCM is a set of approaches to link 
medicines, equipment, laundry, food, supplies, 
vendors, hospitals, and transport for efficient 
and effective use of resources to achieve total 
quality management.  
Performance 
measurement 
Abu et al., (2015) Hospital SCM ensures control of product flow 
through participation of three major 
stakeholders: producers, purchasers, and 
providers. 
Value healthcare 
supply chain 
integrated hospital 
management 
Chris et al., 
(2014) 
Healthcare supply chain represents the conduit 
in which pharmaceutical products take 
ingredients from the suppliers of active 
pharmaceuticals to the manufacturers of 
pharmaceuticals to the healthcare providers 
(hospitals and medical clinics) and clinicians to 
the ultimate end user: the patient. 
Healthcare supply 
chain risk 
management 
Schneller and 
Smeltzer (2006) 
The healthcare supply chain is defined as ‘the 
information, supplies, and finances involved in 
the acquisition and movement of goods and 
services from supplier to the end user in order 
to enhance clinical outcomes while controlling 
costs’. 
  
 
Table 2.4: Approaches to definitions of HCSCM 
Approach to 
Definition 
Articles Count 
 
Developed 
own 
definition 
Kitsiou et al., (2007); Vries and Huijsman (2011); Brennan (1998); 
Chen et al., (2013); Breen (2008); Enyinda et al., (2014); Bourlakis 
and Patten (2011); Langabeer (2005) 
8 
Used existing 
definitions 
Elmuti et al., (2013); Mustaffa and Potter (2009); Matopoulos and 
Michailidou (2013); Priyan and Uthayakumar (2013); Böhme et 
al., (2013); Kumar et al., (2008, 2009); Pan and Pokharel (2007); 
Kjos et al., (2016); Rivard-Royer et al., (2002); Meijboom et al., 
(2011); Samuel et al., (2010); Drupsteen et al., (2013); Rahimnia 
18 
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and Moghadasian (2010); Hugo et al., (2002); Narayana et al., 
(2014); Kim and Kwon (2015); Aronsson et al., (2011). 
Incrementally 
changed 
existing 
definitions 
Villa et al., (2014); Parnaby and Towill (2009); Towill (2005) 3 
None used Behzad et al., (2011); McKone-Sweet et al., (2005); Kumar and 
Blair (2013); Chakraborty et al., (2014); Agwunobi and London 
(2009); Burns and Lee (2008); Jin et al., (2008); Gebicki et al., 
(2014); Guimaraes et al., (2013); Heibuch (1995); Jurado et al., 
(2016); Kelle et al., (2012); Böhme et al., (2014, 2016); Kumar et 
al., (2005, 2008); Bakar et al., (2009); Fernie and Rees (1995); Lega 
et al., (2013); Bhaoo et al., (2012); Rego et al., (2014); Grose and 
Richardson (2014); Aptel and Pourjalali (2001); Jarrett (1998); Xie 
et al., (2016); Elleuch et al., (2014); Aguas et al., (2013); Kanyoma 
et al., (2013); Cullen and Taylor (2009); Ketikidis and Stalidis 
(2010); Lin and Ho (2014); Sampson et al., (2015); Lillrank et al., 
(2011); Ghorani (2015); Breen and Crawford (2005); Bendavid et 
al., (2010); Chireu (2014); Laureani et al., (2013); Radnor et al., 
(2013); Al-Balushi et al., (2014); Brandao de Sourza (2009); 
Chadha et al., (2012); Stanton et al., (2014); Joosten et al., (2009); 
Curatolo et al., (2014); Poksinska (2010); Souza and Pidd (2011); 
Guven-Uslu et al., (2014); Guimaraes and Carvalho (2013); 
Burgess and Radnor (2013); Kollberg et al., (2006); Olsson and 
Aronsson (2015); Dobrzykowski et al., (2014); Machado et al., 
(2015); Granlund and Wiktorsson (2013); Lapierre and Ruiz 
(2007); Vries (2011); Lent et al., (2012). 
58 
Total  87 
 
2.2.2.2.2 Taxonomy for healthcare SCM literature  
Over the last few years, the literature on healthcare SCM has been broadening to include not 
only medical and surgical supplies but also a focus on patient flow i.e. the process in which 
patients enter the hospital until discharge (Jan et al., 2011; Paul and Johan, 2011; Walley, 
2007; Towill and Christopher, 2006; Cherian et al., 2010; Olsson and Aronsson, 2015). The 
reviewed literature shows that different researchers studied this area through diverse 
perspectives. As it describes above, there is no consensus on the concept of the healthcare 
supply chain; most researchers only focus on the supply chain partially or on a specific aspect. 
These publications can be placed into three main categories: physical flow, patient flow, and 
whole supply chain. Further classification can be divided into seven sub-categories as follows: 
physical flow (logistics management, information communication system implementation, 
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performance measurement, process improvement orientation, risk management) and 
patient flow (performance measurement and process reengineering). Figure 2.5 illustrates 
this proposed taxonomy. 
 
   
Figure 2-5: Taxonomy of HCSCM literature 
 
2.2.2.3 Profiling published literature 
2.2.2.3.1 Whole supply chain perspective 
There is evidence of several opportunities where new thinking in commercial and industrial 
logistics and SCM are being transformed into healthcare delivery to advantageous effect 
(Towill and Christopher, 2003). According to Mentzer et al., (2001), SCM can be defined as 
the systemic, strategic coordination of traditional business functions and tactics across these 
business functions within a company and across businesses within the supply chain to 
improve the long-term performance of individual companies and the supply chain.  
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Individual businesses no longer compete as stand-alone entities but as supply chains 
(Christopher, 2000). It is noteworthy that the great competitions in the future will not be 
between companies but rather between supply chains. Arthur Andersen and Co, (1990) 
developed a structure of a healthcare supply chain, as shown in Figure 2.6. They give the 
operational definition of the healthcare supply chain process: ‘the vendor delivers products 
in ‘eaches’ (single), sorted by user department, to the hospital receiving dock where they are 
transported directly to the department, usually on a daily basis’. In addition to hospital, 
pharmacies are the final step on the healthcare supply chain before drugs reach the 
consumer/patient. Pharmacies purchase drugs from wholesalers, and occasionally directly 
from manufacturers, and then take physical possession of the drug products. After purchasing 
pharmaceuticals, pharmacies assume responsibility for their safe storage and dispensing to 
consumers. Pharmacy operations include maintaining an adequate stock of drug products, 
providing information to consumers about the safe and effective use of prescription drugs, 
and dacilitating billing and paument for consumers participating in group health benefit plans.  
 
Vendors
Manufacturers
Distributors
Hospital
Hospital storeroom
External 
chain
Internal 
chain
Patient care units
Points of care
 
Figure 2-6: Healthcare supply chain structure 
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Due to the fact that, SCM is based on a systematic approach, only a few researchers have 
evaluated the healthcare supply chain through both physical and patient flows perspectives. 
Most studies have devoted the contributions into SCM partially or regarding a specific aspect. 
More specifically, Vries and Huijsman (2011) argued that the characteristics of the healthcare 
supply chain have some unique features, which make it difficult for the transition of the 
managerial knowledge directly from industrial to healthcare settings to take place. However, 
they have not denied that the healthcare sector can benefit from the knowledge learned in 
the industrial sector. They discussed the healthcare setting towards more process-oriented 
and greater integration of the healthcare supply chain through transformation. They 
suggested the healthcare processes might refer to physical products, such as pharmaceuticals, 
medical devices, and health aids as well as processes associated with the flow of patients. The 
authors produced a schematic overview of supply chain integrated development in Figure 2.7. 
In addition, de Vries and Huijsman (2011) discussed the following five main research areas 
with respect to healthcare supply chain integration development: (1) use of IT, (2) the 
influence of power and interest relationships between stakeholders, (3) lean and agile 
management practices, (4) performance measurements, and (5) applying SCM concepts to 
patient flows. Nevertheless, it lacks the empirical study to test the suggestion by the authors. 
 
 
Figure 2-7: Stages of supply chain integration 
(adopted from de Vries and Huijsman, 2011). 
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2.2.2.3.2 Physical flow perspective 
a) Logistics management 
Logistics activities involve planning, designing, implementing, and managing material flows in 
a supply chain to support functions such as procurement, distribution, inventory 
management, packaging, and manufacturing (Pokharel, 2005). In the healthcare sector, the 
demand for the items is quite difficult to predict (Jarrett, 1998). Moreover, Van Merode et al., 
(2004) also mentioned that the stochasticity in the patient mix and the average length of in-
patient stays are big problems in scheduling resources. The two main approaches used to plan 
the logistics activities in hospitals are inventory oriented and schedule oriented (Lapierre and 
Ruiz, 2007). The healthcare logistics aimed to deliver the right drugs and medical supplies in 
the right quantities and the right conditions at the right health service delivery points and at 
the right time for the right patients/users for the right cost (Chikumba, 2010). 
b) Procurement management 
Decision procurement professionals always play a vital role in influencing inventory levels and, 
ultimately, the service provided to the consumer of the hospital or clinic, as they tend to have 
control over many supplier relationships. Inefficient procurement will eventually be passed 
along to the patient as additional costs. Thus, any advances in efficiencies must first begin 
with procurement (Parker and Anderson, 2002). Based on a survey by the National Health 
Service (NHS, 2011), 30% of a hospital’s budget is spent on procurement. The NHS aims to 
achieve £1.2 bn in efficiency savings through improved procurement.  
According to Messelbeck and Sutherland (2000), the US Environmental Protection Agency 
(EPA) investigated medical waste as the fourth largest contributor of mercury in the 
environment. Therefore, better packaging could reduce medical waste and simultaneously 
lead to logistical efficiencies (Shah, 2004). However, the packaging of supplies is ignored as 
part of the purchasing decision-making process within the healthcare industry (Kumar et al., 
2008). Kumar et al., (2008) studied the effect of packaging design on procurement decisions 
in hospitals and examined inefficiencies in the US hospital supply chain. The researchers 
conducted surveys of 75 hospitals across the US in different regions. The survey results 
revealed that packaging and environmental friendly supplier/medical products do not 
currently play a role in hospital procurement decisions. Nevertheless, it has effectively been 
shown that the opportunities for improvement in the packaging industry, engaged in supply 
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of products to the healthcare industry, require an environmentally conscious approach for 
long-term cost effectiveness.  
c) Inventory management 
An area of hospital SCM that particularly warrants close study is inventory (Zepeda et al., 
2016). However, the inventory and obsolescence in the healthcare sector are several times 
higher than in the retail/industrial sector. This is caused by the main driver of hospital 
inventory decisions, which is not cost but the need to meet service performance outcomes. 
It is a complex problem due to the uncertainty in the drug demands and the variety of 
constraints to be considered.  
Nevertheless, the budget for healthcare organisations is under increasing strain. It faces a 
major challenge to reduce costs. Thus, some researchers assessed the best trade-off between 
cost savings and the high quality of service performance. Moreover, the risk associated with 
a stock out is also much higher because the demand is hard to predict (Kowalski, 1986). Thus, 
most researchers (Mustaffa and Potter, 2009; Matopoulos and Michailidou, 2013; Guimaraes 
et al., 2013) suggested that a vendor-managed inventory approach appears to be the best 
solution for inventory control. Bhakoo et al., (2012) extended the vendor-managed inventory 
implementation in the healthcare domain. Furthermore, they suggested that the hospital can 
participate in myriad collaborative arrangements with supply chain partners to manage 
inventory. The critical success factor for this arrangement is the compatibility of information 
systems technology between the third party and the hospital pharmacy. 
In the 1980s, US distributors offered hospitals the inventory managerial method called the 
stockless system. According to Arthur Andersen and Co. (1990), the stockless method means 
a programme under which the vendor takes over the hospital’s central distribution function 
and delivers products in ‘eaches’ (single), sorted by the user department, to the hospital 
receiving dock where they are transported directly to the department, usually daily. Further, 
by the late 1990s, the method seemed to be losing popularity.  
Thus, Rivard-Royer et al., (2002) examined a hybrid version of the stockless system, combining 
stockless material management and a conventional approach to patient care unit 
replenishment. The hybrid approach promised further benefits beyond the distributor-
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patient care unit interface, to seek opportunities to reengineer the logistics processes for both 
internal and external unit logistics.  
d) Performance measurement 
According to Neely (1999), performance measurement can be considered the process of 
quantifying action, where measurement is the process of quantification and action, which 
leads to performance. The application of measurement would help organisations calibrate 
their capabilities and move forward via targeted continual improvement initiatives (Bakar, 
2009). Fernie and Rees (1995) evaluated the performance of supply services from three 
perspectives: the NHS supply managers (service providers), trust hospital chief executives 
(purchasers of services), and companies supplying products to the NHS. The authors 
suggested that the establishment of a new internal market within the NHS in the wake of the 
1990 legislation has had major implications for the members involved in SCM. Owing to the 
uncertainty that exists in the market environment, ‘partnershipping’ was introduced in the 
research.  
Some researchers (Lai et al., 2002; Sharahi and Abedian, 2009) argued that one of the major 
problems of SCM is the lack of a relevant methodology for performance measures. Further, 
the Supply Chain Council developed the supply chain reference model (SCOR), which be used 
in the scientific literature and provides a useful framework for assessing supply chain 
performance (Lai et al., 2002; Zanjirani et al., 2009). However, Bolstorff (2006) argued that 
the SCOR model does not focus on the important dimensions of performance that 
characterise the value chain and thus suggested the use of the balanced scorecard framework 
(Kaplan and Norton, 1992). In addition, Kumar et al., (2005) developed a procurement 
performance measurement model combining the generic measures (e.g., efficiency, 
effectiveness, time, and IT system reliability), healthcare supply chain environment and 
structure, and procurement procedures. Further, a balanced scorecard is proposed by 
considering these three main components of the measurement model through six 
perspectives as follows: customer, supplier, process, IT system, learning, and growth overall. 
e) Performance improvement 
Brennan and Charles (1998) considered integrated delivery systems (IDSs) to be a key 
dimension of the integrated supply chain process, which aims to simplify clinical and business 
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processes within and across entire organisations. In this paper, the authors examined the 
need for IDSs to meet and exceed the ‘best practice’ performance in healthcare SCM for 
demand management, order management, supplier management, logistics management, and 
inventory management. Further, the limitation of IDSs in implementing service changes, such 
as user resistance, should be addressed by balancing the customer demand and plan 
objectives. In addition, IT systems and expertise, human resources, change management, 
organisational structure, and the relationship between the customer and supplier are the key 
enablers that can help prepare an organisation to transition to an integrated supply chain.  
Healthcare organisations must overcome years of adversarial supplier relationships and 
dramatic internal and external inefficiencies to reengineer their supply chain (Toba et al., 
2008). Risk pooling among the hospitals could be a strategic policy to increase the cost 
effectiveness of hospitals (Pan and Pokharel, 2007). With the increasing requirement to 
rationalise healthcare services, there have been diverse attempts to improve the efficiency 
and effectiveness of hospital systems through vertical or horizontal and direct or indirect 
supply chain collaboration (Rego et al., 2014).  
Moreover, Nyaga et al., (2015) conducted an evaluation of the effects of intra- and inter-
organisational arrangements by examining the effect of incentive mechanisms for internal 
stakeholders and negotiating leverage with external partners on supply chain efficiency in the 
hospital sector. The result indicated that a higher percentage of physician employment and 
recruitment of supply chain professionals from the retail and industrial sectors will bring well-
established best practices to enhance supply chain efficiency. According to Chakraborty et al., 
(2014), supply chain collaboration has been established as an antecedent to value co-creation, 
which acts as a mediator role in the relationship between supply chain collaboration and firm 
performance. The novel conceptual framework has been proposed using a service dominant 
logic lens to conceptualise supply chain collaboration and its components in the context of 
the healthcare supply chain. 
McKone-Sweet et al., (2005) explored some barriers to the implementation of SCM practices, 
which include the lack of executive support, misaligned or conflicting incentives, the need for 
data collection and performance measurement, limited education about the supply chain, 
and inconsistent relationships with GPOs and other supply chain partners. Therefore, the 
authors conducted in-depth interviews with hospital executives and material managers, GPO 
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executives, distributors, and industry experts from November 2002 to June 2003 to obtain 
accurate information regarding the above barriers. Further, they divided the healthcare 
industry into three levels of the hospital supply chain: the environmental level (GPOs and 
distributors), the organisational level (hospital executives), and the operational level (material 
and supply chain managers). Then, the authors gave some recommendations for improving 
the healthcare supply chain regarding the levels, such as:  
 Leveraging information systems to standardise, measure, analyse, and report 
performance metrics in a necessary step to streamline the healthcare supply chain. 
 Building a long-term relationship with GPOs for potential advantages in reducing costs 
and achieving information sharing.  
 Creating a structural training programme about supply chain knowledge is necessary 
for executives and material managers to develop good decision-making and planning 
capabilities.  
 Supply chain performance (delivery performance, clinician and patient satisfaction, 
etc.) measurement plays a vital role for material/supply chain managers to track not 
only product costs but also other kind of costs.  
f) Information communication systems 
I. Computer application and electronic data interchange 
Healthcare institutions are now adapting to supply chain information management systems 
to help them manage their procurements and increase efficiency (Zhu et al., 2008). Various 
customised SCM software for the healthcare sector exists on the market (Gosling and Naim, 
2009). Additionally, SCM helps procurement managers make informed decisions when it 
comes to matters related to the health supply chain. Various information management 
systems can be used in healthcare supply management data warehousing and analysis of 
healthcare big data (Carter and Rogers, 2008). However, education on healthcare SCM 
remains underdeveloped. For the world to achieve efficient healthcare SCM, more emphasis 
must be focused on healthcare SCM (Wisner et al., 2015).  
Kitsiou et al., (2007) conducted the evaluation of various integration technology approaches 
that can be used as a potential guideline for assessing integration technology alternatives to 
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add value to a healthcare SCM system. In this study, the different information system 
technologies have been investigated, such as electronic data interchange (EDI), XML, Health 
Level Seven (HL7), common object request broker architecture, distributed healthcare 
environment, and web services. 
The RFID technology is a wireless automatic identification and data capture technology 
(Wamba et al., 2008) used to track and manage products, people, and assets with minimal 
human intervention. Clearly, RFID technology can provide many benefits for healthcare and 
pharmaceutical applications that allow service providers to design more efficient processes, 
reduce costs, and improve service and patient safety. In addition, pharmaceutical companies 
are using RFID to protect against counterfeit drugs (Kumar et al., 2009). In fact, RFID spending 
in healthcare organisations was expected to increase rapidly from $474 million in 2008 to $3.1 
billion in 2013 (Kalorama, 2008).  
Bendavid et al., (2011) examined the implementation of an RFID-based two-bin ‘e-Kanban’ 
replenishment system solution to improve the replenishment processes of medical supplies 
in a hospital distributed storage location through case study analysis. The results 
demonstrated that automating the nursing unit supply chain with the RFID system in 
conjunction with the redesign of the ward floor and of the roles and functions can 
substantially improve business and operational performance. However, the current RFID 
technology is too expensive for broad implementation within the healthcare sectors; thus, it 
must be calculated carefully to ensure proper investment for the organisations (Kumar et al., 
2009).  
Pan and Pokharel (2007) investigated the motivators and barriers to the use of ICT in logistics 
in Singapore hospital settings. In this study, the authors mentioned that increasing efficiency, 
reducing data entry error, decreasing operational cost, and decreasing labour costs are some 
of the main reasons for ICT adoption in hospitals. In contrast, the cost of implementation, the 
availability of expertise to handle such new ICT, and a long period could be the main barriers.  
II. E-commerce 
The term e-commerce has been defined as ‘the sharing of business information, maintaining 
business relationships, and conducting business transactions by means of telecommunication 
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networks (Dutta, 1997). While e-commerce is in its infancy in the hospital supply chain, it can 
be considered an important facet of SCM.  
Breen and Crawford (2005) examined the role of e-commerce in a hospital pharmacy in the 
procurement of pharmaceuticals through EDI application. The researchers conducted an 
evaluation of the barriers and benefits for an applied EDI system in a hospital pharmacy, such 
as the lack of funding, security issues, and time saving. In addition, they suggested that 
internal customer satisfaction is central to the success of e-procurement deployment. The 
limitation of the study is that they only conducted a case study of a specific regional area of 
the NHS, which could have been applied to a larger national sample group. Cullen and Taylor 
(2009) determined five composite factors that are perceived by users to influence successful 
on-going use of e-commerce systems in business-to-business (B2B) buying and selling 
transactions in the UK NHS pharmaceutical supply chain. ‘System quality’, ‘information 
quality’, ‘management and use’, ‘world wide web – assurance and empathy’, and ‘trust’ were 
proposed as potential critical success factors. In a questionnaire based on this in the UK NHS 
pharmaceutical supply chain, all respondents ranked information quality, system quality, and 
trust as being the most crucial factors. However, they are not devoid of limitations, as they 
only focused on a single supply network. 
2.2.2.3.3 Patient flow perspective 
a) Process reengineering 
I. Process orientation improvement 
The redesign of supply chain processes for a smoother, faster response has become the main 
research topic since the classic contribution by Jay Forrester (1961) over 50 years ago. Most 
key ideas by Jay Forrester have been subsumed within business process reengineering. Berry 
et al., (1995) further examined this approach in the electronic products supply chain for 
improving performance. According to Aronsson and Abrahamsson (2011), the healthcare 
supply chain can be considered the patient flow, which means the customer is part of the 
production process. Instead of going to the store to buy a finished product, a patient seeks 
medical help and is then a part of the entire process until the treatment is finished, as shown 
in Figure 2.8 (Bourlakis and Patten, 2011). 
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Figure 2-8: Hospital supply chain process for patient flow 
(adopted from Bourlakis and Patten, 2011). 
 
In terms of the viewpoint, the healthcare supply chain fits within the broader research 
discussion of the service supply chain, which should be managed differently because it has 
the following characteristics that are not found in manufacturing supply chains: intangibility, 
heterogeneity, simultaneous production and consumption, and perishability (Zeithaml et al., 
2009). Meijboom et al., (2011) investigated the applicability of SCM in health services. In this 
study, they discussed four organisational problems (communication, patient safety, waiting 
times, and integration) that occur in situations that are complex because the patient 
treatment process requires multiple healthcare providers. Regarding these issues, they 
suggested breaking down the boundaries of each department, within healthcare providers 
and inter-organisationally, which is a necessary condition for enhanced patient-centred 
integration. Although it is necessary to implement the commercial SCM strategies into the 
healthcare sector, the research on the healthcare service supply chain is still in its infancy.  
In the healthcare sector, improving patient flow is considered of immense importance in 
boosting hospital performance (Litvak, 2009; Villa et al., 2009). Towill and Christopher (2005) 
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introduced a new concept of ‘pipeline differentiation’ as different supply chain strategies to 
deal with different requirements from patients in multiple situations. They argued that the 
perspective of ‘one size does not fit all’ should be adopted by the NHS system because they 
always meet different treatment processes. They cannot rely on the same pipeline to handle 
multiple demands, such as elective and emergency treatment. In the paper, four types of 
pipelines were implemented as follows: 1) HOLPIP, emergency care or multi-task activity 
requirements; 2) PARPIP, regular and high-volume elective surgery requirements; 3) SINPIP, 
GP services; and 4) SEQPIP, convalescent care.  
II. Lean and Agile Practices 
The use of technology and the changing medical field has given rise to the need to reduce 
waste and operation costs. From this perspective, lean SCM is beneficial. The lean concept 
originated from the Japanese manufacturing system, especially Toyota car manufacturing. 
The philosophy was developed to fit the Japanese post-war context, where natural resources 
were scarce, and the demand was very high (Kumar et al., 2009). Due to its multinational 
status, the Toyota lean philosophy was spread to other countries and other fields (Fawcett et 
al., 2014).  
In fact, lean philosophy focuses on how to eliminate non-value-added activities in the chain 
to use less money to do more things. The five principles of lean (identify value, map the value 
stream, create flow, establish pull, and seek perfection) are utilised to identify and eliminate 
waste, improving the flow of activities to maximise the value for customers. It considers 
standardisation and specification of work processes, organisation of work in such a way that 
unexpected events are easy to spot, and deployment of activities that find and fix mistakes 
that could result in potential risks (Ohno, 1988; Womack and Jones, 2003). Therefore, lean 
tools, such as the fishbone diagram and failure mode and effect analysis (FMEA), can also be 
used for risk analysis and mitigation (Faisal and Ebrahim, 2014).  
Instead of lean philosophy, the key to being agile is to accommodate unpredictable demand, 
including low volumes per individual ‘product’ and high levels of ‘product variety’ 
(Christopher and Towill, 2000). However, the following limitations of applying lean thinking 
in the healthcare sector have been argued by many researchers: narrow technical solutions, 
a limited system approach, and a focus on internal efficiency with limited consideration of 
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external effectiveness, which is insufficient for handling the increasingly turbulent external 
complexity that characterises the hospital setting (Mazzocato et al., 2010; Radnor and 
Osborne, 2013). Thus, Dove (1999) described the concept of agile as the ability of an 
organisation to thrive in a continuously changing, unpredictable business environment.  
The healthcare sector is characterised by high levels of uncertainty, complexity, and 
fragmentation. Organisations require agility in their supply chains to provide superior value 
and to manage risks and ensure uninterrupted service to patients (Michael and Nallan, 2009). 
The agile supply chain manufacturing programme was coined by researchers at the University 
of Leigh in 1991 (Kumar et al., 2008). It described the various strategies that are crucial to 
enterprise success in environments of rapid and unpredictable changes (Melo et al., 2009). 
Today, the healthcare landscape is at an inflection point where the two key issues that persist 
in the minds of healthcare providers are the changing reimbursement landscape and all the 
changes in the healthcare service delivery model. 
In recent times, lean and agile supply management has considered supplements rather than 
alternatives. Some companies require implementing both lean and agile supply management 
for a successful SCM (Zsidisin and Ritchie, 2008). A hybrid of agile and lean SCM applies to a 
company that wishes to become a ‘mass customizer’ (Kumar et al., 2009). A lean supply chain 
focuses mainly on adding value for business customers while reducing waste and cost. Being 
agile means that the supply chain can handle unpredictability. Whenever organisations 
choose to adopt a hybrid of lean and agile SCM, it is easier said than done since it has so many 
moving parts (Fawcett et al., 2014). Several methods to combine agile and lean supply 
management methodologies exist, and the choice depends on the type and size of the 
business. Today’s business environment is ever-changing, volatile, and very competitive, 
especially on the global front. As a result, it is important to adapt to an agile and lean supply 
chain (Lee and Schniederjans, 2011). 
However, the lean principles that have been adopted in the healthcare context first appeared 
in a work published by the NHS Modernisation Agency (2001). Figure 2.9 illustrates the 
historical development of lean healthcare. Healthcare delivery is still far from achieving the 
level of excellence of lean applications in manufacturing (Berwick et al., 2005). The lean 
healthcare supply chain is about simplifying the process by understanding what adds value 
and eliminating the non-value-added activities. The implementation in the healthcare setup 
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seeks to reduce patient delays in the emergency department (ED) and the number of return 
patient visits and to eliminate errors in the medical process (Melo et al., 2009). Adaptation of 
lean in the healthcare context has been challenging since the redesign efforts expose patients 
and health service providers to unnecessary risks (Parker and DeLay, 2008). 
Hospital Management                                      
Service Management
Operations Management
Auto Industry
Lean Healthcare
Lean Thinking
Lean manufacturing
TPS
1940s 1984s 1992s 2002s
 
 
Figure 2-9: Historical development of research in lean healthcare 
 
Chadha et al., (2012) explored a lean healthcare transformation model that integrates 
queuing theory and lean methodology to improve the dynamic performance of the healthcare 
system. A system dynamic model and value stream mapping or other lean technologies were 
adapted in an ED at a hospital. The results that can be achieved include improved patient flow 
and decreased length of stay.  
Laureani et al., (2013) conducted a case study of the implementation of lean six sigma 
techniques (e.g., 5S, DMAIC, process mapping, seven wastes, and control charts) through 
serious projects (e.g., ward inventory, medical records, laboratory processes, fall prevention, 
and psychiatric clinic) in the Irish hospital sector. The results showed that support from top 
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management and regular communication with stakeholders were identified as key factors for 
success by three of the five project teams.  
Similarly, Stanton et al., (2014) explored a process improvement project based on lean six 
sigma techniques in the ED of a large Australian hospital. They found that the engagement of 
clinicians with the project and having extra resources provided improved patient flow from 
the ED to the hospital wards, leading to some changes having a positive effect on the work of 
staff.  Burgess and Radnor (2013) evaluated the divergent approaches to lean implementation 
in English hospitals. In this study, they learned that implementation tends to be isolated 
rather than system-wide. The study reflects the perception of lean implementation in 
healthcare, which is fragmented, focusing on visible lean elements, tools and technology, but 
failing to address the less-visible strategic elements that relate to leadership and 
organisational readiness.  
Nevertheless, Souza and Pidd (2011) identified and analysed the barriers to lean healthcare 
implementation in the UK NHS. In this study, they provided a list of barriers based on the 
experiences and interview results, such as perception, terminology, and organisational 
momentum and functional and professional resistance to change/scepticism. More specially, 
functional and professional silos can be found as major barriers to lean implementation 
because lean focuses on process improvement, which requires the elimination of 
impediments to the flow of patients.  
Radnor and Osborne (2013) also found that the implementation of lean to data has been 
defective. They suggested that lean can only achieve its potential in public services when 
based within a public-service dominant business logic, which is context-specific to public 
services, embraces the true nature of services rather than products, and provides fertile 
rather than sterile directions for the evolution of public services that are both internally 
efficient and externally effective. 
The redesign of the healthcare system depends on the lean paradigm that tends to focus on 
reducing waste processes and increasing efficiency. Lean SCM in the field of healthcare has 
experienced some opposition. According to Haszlinna et al., (2009), lean SCM is not 
appropriate in a field with very high demand variability and high customisation demands. The 
healthcare sector is among these fields; thus, it is inappropriate to use lean supply 
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management.  Agility is the fundamental characteristic of a successful supply chain faced with 
unprecedented and volatile demand (Martínez-Jurado and Moyano-Fuentes, 2014). The agile 
approach is the most promising paradigm for healthcare SCM. In the healthcare context, 
service supply chain integration is becoming more prevalent as the team-based care model is 
becoming standardised. The question of whether it is possible to combine lean and agile SCM 
in the healthcare context remains a major cause of disagreement since the experiments are 
expensive and risky for both the patient and service providers (Monczka et al., 2008; 
Distelhorst et al., 2014). Rahimnia and Moghadasian (2011) proposed that the decoupling 
point (DP) is the main concern in leagility to best suit the need to respond to downstream 
volatile demand while providing level scheduling upstream from the market place. The 
authors divided the healthcare service processes into three pipelines based on patient needs. 
According to the DP, they suggested that, from this point on, the treatment process is 
customised and specialised for each patient, as shown in Figure 2.10. However, Aronsson et 
al., (2011) argued that leagility was not considered applicable in the studied healthcare 
organisations because the investigated processes had a high level of variety in demand and a 
high level of uncertainty. They concluded that it was not easy to define a DP among the 
processes, and they developed a hybrid strategy so that lean and agile methods could be 
efficiently applied throughout the system.  
 
Figure 2-10. Healthcare delivery pipelines and location of the main DP 
 (adopted from Rahimnia and Moghadasian, 2011) 
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Guven-Uslu et al., (2014) further indicated that a purposefully designed DP as a reference 
model can help improve integration between the processes, technology, and people 
components of service operations. They have a potential to help document the details of each 
sub-process so that people at various parts of the organisation can become aware of the 
technological and process-related necessities of the service. 
b) Performance measurement 
A considerable number of studies have examined patient satisfaction in various healthcare-
related areas. However, few studies are focused on the performance measurement of doctor 
satisfaction. Bakar et al., (2009) filled this gap and investigated the efficiency level of the 
decision-making units with hospital laboratories through the utilisation of resources to satisfy 
doctors’ demands based on a data envelopment analysis. The study achieved its objective of 
evaluating the supply chain performance of two hospital laboratory supply chains in 
Singapore based on the important dimensions of doctor satisfaction and hospital laboratory 
inputs. The researcher observed that some dimensions are considered important that satisfy 
doctors and require more attention from hospital laboratory administrators, such as 
obtaining the necessary medical results and quality and services given by the laboratory staff.  
Analysing hospital-wide patient flow performance, Villa et al., (2014) developed a framework 
that adopts a system-wide approach to patient flow management. The conducted framework 
is structured into three distinct levels: the hospital, the pipeline (patient flow in hospital), and 
the production units (e.g., ED, operating rooms, or outpatient clinics). In this study, patient 
flow variability caused by a bad allocation of capacity represents a key problem concerning 
hospital patient flow problems. The authors suggested the creation of a standardised flow of 
data and information, which is an essential prerequisite for establishing effective patient flow. 
2.2.2.4 Theoretical concerns (grouping 3)    
Theoretical perspective  
Theory development is an essential requirement for proper development of any field (Wacker, 
1998). However, the theory building process is controversial. Some researchers suggest that 
theories should be built based on existing theories (Pfeffer, 1995), while other researchers 
encourage building new innovative theories (Van Maanen, 1995). For the field of healthcare 
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SCM, the exploration of which theories have been developed and where existing theories are 
being used is still limited. This study adapts an expanded version of theories suggested by 
Ammundan (1998) who offered a suitably comprehensive list to classify the theoretical stance. 
The existing theories can be classified into three types: economics (transaction costs and 
others that include agency), strategic management (resource-based view of the firm and 
competitive advantage), and psychology and sociology (organisational learning and inter-
organisational networks). The results of classifying the articles based on the theoretical stance 
are summarised in Table 2.5. 
Table 2.5 shows several articles that had no discernible theories for now (34%). All the 
remaining articles used existing theories, while none proposed an innovative healthcare SCM 
theory. Closer examination of specific theories that were utilised indicated that the 
organisational learning and inter-organisational network were most attractive to researchers 
(28% and 13%, respectively). In contrast, transaction cost, resource-based view, and 
competitive advantages were not as popular (9%, 9%, and 1%, respectively). Only two papers 
attempted multi-theory grounding. 
Table 2.5: Articles classified by theory 
Theory Articles Count 
No discernible 
theories 
Cullen and Taylor (2009); Aguas et al., (2013); Enyinda et al., 
(2014); Elleuch et al., (2014); Breen (2008); Dobrzykowski et al., 
(2014); Grose and Richardson (2014); Kjos et al., (2016); Aptel 
and Pourjalali (2001); Heinbuch (1995); Gebicki et al., (2014); 
Guimaraes et al., (2013); Fernie and Rees (1995);Baker et al., 
(2009); Samuel et al., (2010); Lent et al., (2012); Aronsson and 
Olsson (2015); Aronsson et al., (2011); Souza and Pidd (2011); 
Poksinska (2010); Souza (2009); Balushi et al., (2014); Bendavid 
et al., (2010); Chircu et al., (2014); Kumar et al., (2009); Ghorani 
(2015);Narayana et al., (2014); Machado et al., (2015); Kim and 
Kwon (2015); Elmuti et al., (2013);  
30 
New Healthcare SCM-specific Theories   
Economic 
transaction cost Mustaffa and Potter (2009); Jarrett (1998); Kumar et al., (2008); 
Burns and Lee (2008); Rego et al., (2014); Breen and Crawford 
(2005); Kumar and Blair (2013); Agwunobi and London (2009) 
8 
Strategic Management 
Resource-based 
view of firm 
Jin et al., (2008); Uthayakumar and Priyan (2013); Kelle et al., 
(2012); Jurado et al., (2016); Drupsteen et al., (2013); Lillrank et 
al., (2011); Langabeer (2005); Kitsiou et al., (2007) 
8 
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2.2.2.5 Research approaches (grouping 4) 
Research methods  
Researchers have a wide range of options, depending on the nature of knowledge and the 
certainty with which it is presented (Burgess et al., 2006). According to Ghadge et al., (2012), 
the research methodologies used for decision making in the healthcare SCM field were 
broadly classified as qualitative and quantitative methods. Qualitative research methods are 
further categorised as empirical study, conceptual theory/model, and literature review. 
Accordingly, quantitative research methods include mathematical modelling, probability and 
statistics theory, and simulation for detailed thematic analysis. Results of classifying the 
articles according to adopted research methods are shown in Table 2.6.  
As Table 2.6 shows, most of the articles were classified as using qualitative methods (76 out 
of 87 articles or 87%). Within the utilised qualitative methods, empirical study has been 
conducted by researchers in 55 articles (63%). Obviously, the quantitative methods have 
attracted much less attention than qualitative methods (11 out of 87 or 13%). None of the 
articles used either probability or statistics theory. Regarding previous literature reviews in 
healthcare SCM, only six researchers conducted a literature review in healthcare SCM, as 
Competitive 
advantage 
Lega et al., (2013); Bourlakis and Patten (2011); Guimaraes and 
Carvalho (2013); Guven-Uslu et al., (2014) 
4 
Psychological/Sociological 
Organisational 
learning 
 
Bhakoo et al., (2012); Matopoulos and Michailidou (2013); Lin 
and Ho (2014); Granlund and Wiktorsson (2013); Lapierre and 
Ruiz (2007); Böhme et al., (2013, 2014, 2016); Kumar et al., 
(2005, 2008); Villa et al., (2014); Sampson et al., (2015); Behzad 
et al., (2011); Radnor and Osborne (2013); Burgess and Radnor 
(2013); Curatolo et al., (2014); Chadha et al., (2012); Joosten et 
al., (2009); Kollberg et al., (2006); Laureani et al., (2013); 
Stanton et al., (2014); Rahimnia and Moghadasian (2010); Vries 
and Huijsman (2011); Xie et al., (2016)  
24 
Inter-
organisational 
networks 
Vries (2011); Rivard-Royer et al., (2002); Zepeda et al., (2010); 
Kanyoma et al., (2013); Meijboom et al., (2011); Pan and 
Pokharel (2007); Charles (1998); Nyaga et al., (2015); McKone-
Sweet et al., (2005); Chen et al., (2013); Chakraborty et al., 
(2014) 
11 
Multiple 
theories 
Towill and Christopher (2005); Parnaby and Towill (2009) 2 
Total   87 
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shown in Table 2.7. A list of all past literature reviews with the adopted research 
methodologies and key findings/contributions is presented in Table 2.7. 
Table 2.6: Articles classified by research methods 
Research 
Methodologies 
Articles Count 
Qualitative Methods 76 
Empirical study Heinbuch (1995); Elleuch et al., (2014); Kjos et al., (2016); Lent 
et al., (2012); Vries (2011); Breen (2008); Enyinda et al., (2014); 
Xie et al., (2016); Laureani et al., (2013); Granlund and 
Wiktorsson (2013); Böhme et al., (2013, 2014, 2016); Elmuti et 
al., (2013); Bhakoo et al., (2012); Cullen and Taylor (2009); 
Aronsson et al., (2011); Chen et al., (2013); Burgess and Radnor 
(2013); Souza and Pidd (2011); Chircu et al., (2014); Mustaffa 
and Potter (2009); Matopoulos and Michailidou (2013); Burns 
and Lee (2008); Rivard-Royer et al., (2002); Standon et al., 
(2014); Aptel and Pourjalali (2001); Breen and Crawford 
(2005); Guven-Uslu et al., (2014); Drupsteen et al., (2013); 
Charles (1998); Pan and Pokharel (2007); Olsson and Aronsson 
(2015); Kollberg et al., (2006); Baker et al., (2009); Ghorani 
(2015); Sampson et al., (2015); Lillrank et al., (2011); Kumar et 
al., (2005, 2008); Bendavid et al., (2010); Agwunobi and 
London (2009); Lapierre and Ruiz (2007); Jin et al., (2008); 
Kanyoma et al., (2013); Grose and Richardson (2014); 
Rahimnia and Moghadasian (2010); Vries and Huijsman 
(2011); McKone-Sweet et al., (2005); Langabeer, (2004); Lin 
and Ho (2014); Kumar and Blair (2013); Bourlakis and Patten 
(2011); Guimaraes et al., (2013) 
55 
Conceptual 
theory/model 
Villa et al., (2014); Nyaga et al., (2015); Lega et al., (2013); 
Towill and Christopher (2005); Joosten et al., (2009); Parnaby 
and Towill (2009); Kitsiou et al., (2007); Chakraborty et al., 
(2014); Fernie and Rees (1995); Meijboom et al., (2011) 
10 
Literature review Curatolo et al., (2014); Dobrzykowski et al., (2014); Radnor and 
Osborne (2013); Jarrett (1998); Machado et al., (2015); 
Narayana et al., (2014); Al-Balushi et al., (2014); Guimaraes 
and Carvalho (2013); Poksinska (2010); Kim and Kwon (2015); 
De Souza (2009) 
11 
Quantitative Methods 11 
Mathematical 
modelling 
Rego et al., (2014); Chadha et al., (2012); Behzad et al., (2013); 
Priyan and Uthayakumar (2014); Uthayakumar and Priyan 
(2013); Kelle et al., (2012); Jurado et al., (2015) 
7 
Probability and 
statistics theory 
None 0 
Simulation Gebicki et al., (2014); Kumar et al., (2009); Samuel et al., 
(2010); Aguas et al., (2013) 
4 
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Total  87 
 
Table 2.7: Summary of literature review in HCSCM research methods and findings 
Author(s) Research Methodology Key Findings/Contributions 
Vries and 
Huijsman 
(2011) 
This paper adopted an 
exploratory, qualitative 
approach based on an analysis 
of existing literature in SCM in 
health services. Twenty-one 
papers were attracted based on 
the papers submitted to Supply 
Chain Management: An 
International Journal, and four 
papers were accepted for 
publication in this special issue.  
 
Starting from a classification of existing 
research, five main research areas with 
respect to SCM in a healthcare setting 
are defined (IT, stakeholders, 
management philosophies, 
performance measurement, and patient 
flows). Additionally, next to studies with 
a non-disciplinary focus, an 
interdisciplinary focus on SCM issues in 
health services seems to be necessary.  
Smith et al., 
(2011) 
Thorough review of the related 
literature focusing on 
management strategies, cost 
containment, IT, and 
collaboration in the healthcare 
supply chain.  
The high cost and immaturity associated 
with the healthcare supply chain 
provides opportunities to make great 
strides towards supply chain excellence. 
The experience level of healthcare 
supply chain professionals and the 
collaborative nature of the industry are 
strong catalysts for improvement once 
the improvement opportunities and 
their associated barriers are revealed.  
 
Shou 
(2013) 
Literature review of broad 
literature on SCM in the 
healthcare industry.  
Major managerial issues were identified 
and discussed, including healthcare 
supply chain performance, cost 
reduction, inventory management, the 
bullwhip effect, quality and security, and 
supply chain innovation. Some research 
methods were also discussed.  
 
Dobrzykowski 
et al., (2014) 
Through a structured, analytical 
review and screening of 9,979 
papers from 1982 to 2011 in 
healthcare operation 
management and SCM to 
explore the important trends 
and reporting on the current 
knowledge.  
 
Use of quantitative methods to identify 
the current investigatory themes and 
quantifying methodological trends. A 
qualitative narrative description of the 
top research themes is provided and 
qualitatively described for future 
research.  
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Narayana et 
al., 
(2014) 
A systematic review of peer-
reviewed academic journals in 
the pharmaceutical supply 
chain (PSC).  
Research efforts depict a traditional 
focus on efficiency improvement, with 
an emerging interest in process analysis 
and technology implementation in the 
PSC. The review broadly outlines the 
scope for integrating research efforts 
from research and development to final 
healthcare delivery and for more studies 
in emerging economies.  
 
Kim and Kwon 
(2015) 
Review of the literature on 
healthcare SCM published in 
the United States for the most 
recent ten years (2004-2015), 
which ranges widely from 
hospital and pharmaceutical 
industries (cold chain) to public 
policy for healthcare.  
The review has placed literature broadly 
under four categories: overviews of 
healthcare SCM, comparative studies on 
commercial SCM and healthcare SCM, 
major tools in SCM, and the barriers to 
adopting healthcare SCM.  
 
2.2.2.6 Discussion 
Description features of healthcare SCM literature (grouping 1) 
The research focus was initially profound for UK researchers in 1995, followed by rapid growth 
from 2005, demonstrating that the topic is relatively new and with increasing attention from 
researchers. Especially from 2013 to mid-2016, the numbers of published articles rapidly rose 
to around 40% of publications in the last 20 years. This also reflects the fact that SCM is 
becoming a successful approach for improvement in the healthcare sector.  
In terms of journal titles, while three journals comprise one-fifth of the articles, there is a 
broad range of journals that publish articles in the healthcare SCM area. This indicates that 
healthcare SCM is of interest to researchers from a vast array of backgrounds. In relation to 
the contributing countries, the field is growing at a fast pace in the USA and UK healthcare 
industries. This is believed to be driven by the fact that the healthcare system in the USA and 
Europe is more advanced than other countries. Publications from other continents are 
considerably fewer. Therefore, this is assumed to drive the interest of researchers from other 
countries. 
Definitional issues (grouping 2) 
Approaches to definitions of healthcare SCM 
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As Mentzer et al., (2001) highlighted, the lack of clear definitions will inhibit SCM theoretical 
development. A good indication of the maturity level of a field is determined by researchers 
using existing standard definitions (Burgess et al., 2006). However, as Table 2.3 shows, only 
21% (18) of articles used existing standard definitions; in contrast, about 66% of researchers 
only followed the definition of the traditional SCM. Definitional consensus does not exist in 
this field. Furthermore, this suggests that healthcare SCM is still in the developmental mode 
and has not yet reached maturity. Thus, in the future, it can be expected that more new or 
modified definitions will be proposed. 
Taxonomy of healthcare SCM 
Among the selected articles, only four articles conducted an evaluation of the healthcare 
supply chain from both patient and physical flow perspectives. Many articles (53) focused on 
the performance of physical flow in the healthcare supply chain. They provided some 
improvement techniques from different perspectives, such as inventory management, 
procurement strategy, IT, and performance measurement. More specifically, within the 
improvement of physical flow in hospitals, logistics management in healthcare SCM has been 
the focus of strong research attention (22). In contrast, the remaining 30 articles focus on the 
service process in the supply chain. Moreover, 17 out of 30 reviewed journal articles applied 
lean and agile practices to improve the patient flow in the hospital setting. In addition, from 
the patient flow perspective, performance measurement has been the subject of few studies 
(2). 
Theoretical concersn (grouping 3) 
Theoretical perspective  
Table 2.4 illustrates that the researchers did not propose original theories for the healthcare 
SCM body of knowledge. Thus, most researchers believed that healthcare SCM can be 
described through an extension of existing ideas. Nevertheless, since there are multiple 
theories being used in the field, Burgess et al., (2006) suggested that a single existing theory 
could not demonstrate all that is embraced under SCM. Moreover, two theories are more 
popular than others: organisational learning and inter-organisational network theories. In 
contrast, a limited number of studies have proposed the competitive advantage, and this 
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suggests a specific feature of the healthcare industry. The current theories are insufficient to 
explain healthcare SCM completely, and the field requires further theory development. 
Research methodological issues (grouping 4) 
Research methods  
It is evident that the most prevalent empirical research method is the case study. One of the 
key reasons is that an increasing number of practitioners seek collaboration opportunities 
with academics to find the optimal way to achieve competitive advantage in the healthcare 
industry. Thus, it is now much easier for researchers to communicate with practitioners and 
gain access to the industry to conduct empirical studies than before. Moreover, the absence 
of probability and statistics theory is similar to that found in other studies. For example, 
Burgess et al., (2006) examined a similar pattern in traditional SCM literature. Until now, in 
terms of using of research methodologies, the focus has only been on a narrow range (Burgess 
et al., 2006). Another issue of concern is the relative lack of quantitative research methods 
being used. Therefore, this could have an adverse effect on the development of the field. 
 
2.3 SUPPLY CHAIN RISK MANAGEMENT 
As an organisation, hospital operations under a certain supply chain are not only meant to 
increase productivity of the hospitals but also to manage the risk associated with healthcare. 
However, existing research on hospital supply chain management (SCM) indicates that 
healthcare and hospital operations are much more complex and fragmented than other 
industries. This is because the healthcare and hospital operations are delivering goods and 
services from several suppliers to patients with a wide range of health requirements 
according to the need for hospitals to provide both planned and emergency care (Fenies et 
al., 2006; MacVaugh, 2007). For example, some drugs require special temperature conditions 
for storing and delivery. Furthermore, zero-defect conditions are necessary for the healthcare 
delivery process to patients.  
In general, there is a vast and rapid change in the events in the hospital supply chain. It is vital 
to develop solutions that optimise profit by minimising waste while remaining flexible to the 
changing trends in the healthcare sector (Mustaffa and Potter, 2009). It is important for 
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researchers and practitioners to fully understand the process involved to benefit from the 
choice of methods. Likewise, it is essential to be knowledgeable about the associated issues 
inherent in the service delivery processes and the supply chain because, in business planning, 
quality, quantity, cost, and risk are all closely interrelated (Chakraborty et al., 2014). From the 
hospital or healthcare perspective, Harris (2000) investigated the ultimate objective of 
managing risks as the ability to identify, assess, reduce, and control hazards to staff, patients, 
and visitors. Essentially, the hazards can be considered broadly as anything that compromises 
service delivery (Rafele et al., 2005), such as scarce services caused by inadequate resources 
or inefficient material management (Tomlin, 2009).  
In fact, the effect of risk accounts for the substantial proportion of hospital budgets, hence, 
risk management is a significant strategy to minimise expenditure and increase service quality 
(Scannell et al., 2013). Similarly, SCM must cover risk management. In hospitals, there are so 
many supplies and customers with close interconnectivity. This often increases the risks in 
hospital supply chains because a disruption in one member may affect another. Usually, the 
supply chain capacity is decided by demand and supply (Tang, 2006), which are uncertain, 
thus increasing the risk, especially in healthcare, where the resources are constrained. 
Organisations across supply chains may only focus on a given subset, which is likely uncertain 
(Chopra et al., 2005). However, the literature review reveals that the current healthcare 
systems’ supply chain risk management (SCRM) model is not capable of meeting these 
challenges (McKinsey and Company, 2013). 
To understand healthcare SCM, it is important to critically review the available literature 
about how conventional SCRM knowledge has been built up in order for the findings to be 
applied to healthcare supply chain contexts. In this regard, the purpose of this section is to 
explore the literature about SCRM to obtain the definition of some of the terms used, classify 
the risks, provide a comprehensive coverage of the risk management methodologies, and 
assess the status of risk management in the healthcare supply chain, especially for the 
pharmaceutical flow in the hospital setting. 
2.3.1 SCRM literature review research methodology 
As indicated in the introduction chapter, the purpose of this thesis was to critically analyse 
the available literature about conventional SCRM and its application in the healthcare 
industry. This implies that the review work is desk-based or is a literature-based study where 
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data from secondary sources, such as peer-reviewed journal articles, textbooks, previously 
conducted research studies, and published organisational reports have been used.  
 
 
 
 
 
 
 
Figure 2-11: Flowchart of the SCRM research methodology for the present systematic 
literature review 
(adapted from Ho et al., 2015) 
 
The research followed the SLR methodology suggested by Ho et al., (2015) for developing an 
evidence-informed knowledge management process. The adapted SLR methodology for 
identifying the scope of literature is addressed in five distinctive phases, as shown in Figure 
2.11. This section provides a presentation of the literature search procedures, databases 
used, search terms used, and the inclusion criteria and exclusion criteria used. 
2.3.1.1 Literature search procedures and databases  
A literature search was conducted to review the available literature regarding conventional 
SCRM and risk management in the downstream healthcare pharmaceutical supply chain, 
especially in the hospital setting. The literature search was restricted to peer-reviewed journal 
articles, textbooks, and organisational reports. As Moher et al., (2009) suggested, peer-
reviewed journal articles provide credible information because, for an article to be published 
in a journal, it must be reviewed by a team of specialised personnel to ascertain its 
authenticity. Journal articles also provide sources of up-to-date information compared to 
books (Moher et al., 2009). 
Define the search terms 
Identify the databases 
Determine and apply criteria for inclusion and exclusion  
Refer to the reference lists of the shortlisted articles 
Ensure that the resulting articles are representative 
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The literature search involved leading databases, such as Emerald Insight, Google Scholar, 
Science Direct, Springer, Taylor and Francis, Web of Science, and Wiley. The primary purpose 
for targeting these databases was the fact that these databases contain a huge volume of 
peer-reviewed papers. Choosing these established databases also minimised any form of 
publication bias or reviewer prejudices because, as Cronin et al., (2008) maintained, some 
reviewers may refuse to publish certain primary studies, particularly when they report 
findings that do not conform to their expectations. 
The researcher first conducted a systematic computer-assisted literature search in the above-
mentioned databases, a process that was supplemented using a manual search. Combining 
the two literature search strategies facilitated the comprehensive analysis of journal issues, 
articles, and case studies that may not be published in the core databases. Footnote chasing 
or citation searching was applied to identify relevant studies captured during the database 
search. The researcher also used various database packages, such as Mendeley, to handle the 
bibliography list in a systematic manner. This made it easier to process, streamline, and 
produce a reference list in a straightforward way without duplication. 
Search terms 
Next, the chosen electronic subject databases were scanned to the defined keywords for 
articles published between 2003 and 2017. The search terms used in conducting this research 
included ‘risk management’ and ‘supply chain’. In additional, the search terms ‘supply chain 
risk(s)’ or ‘supply chain risk management’ were used in the article abstract with the keywords 
‘hospital/healthcare/pharmaceutical’ in the abstract, keywords, and title search. 
Inclusion and exclusion criteria  
The researcher included studies that were published between 2003 and 2017. In addition, the 
included studies or peer-reviewed journal articles must be published in English. For a study to 
be included, it must be available in full, meaning that studies available in the form of a title 
and abstract were not included. Moreover, essays, letters, reports, conference papers, and 
comments were also disqualified. The abstracts and conclusions were reviewed to determine 
the relevance to hospital SCRM. Thus, after the examination, 32 references were excluded 
because they did not seem relevant to the topic. However, among the excluded papers, three 
were published as a conference paper but have been attracted by other researchers. Thus, 
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these papers were added to the retrieved reference lists. In the end, to ensure the 
comprehensiveness, the cross-checked references of the selected papers were further 
conducted and did not find any other relevant papers. Overall, 213 papers were included in 
this literature review. Among these 213 articles, 11 papers plus one official report are focused 
on the healthcare pharmaceutical supply chain in the hospital sector, which are relevant to 
this research. 
 
2.3.2 Data analysis 
2.3.2.1 Descriptive analysis 
2.3.2.1.1 Year of Publication and journal 
There is a continuous growth in the number of research works focusing on SCRM in the last 
14 years, as seen in Figure 2.12. We can discern that more focus on this area was mainly 
triggered after disasters like the 9/11 terrorist attack in 2001. Until 2003, few researchers 
were dedicated to this field or indicated the potential of the future research agenda (Jüttner 
et al., 2003; Harland et al., 2003). After that, by 2004, the first peak was reached in this 
research field. The number of publications showed that some scholars made substantial 
contributions. Their findings laid the foundations for future work to understand the 
complexity of the risks in supply chain networks (Finch, 2004; Christopher and Peck, 2004; 
Chopra and Sodhi, 2004; Sinha et al., 2004; Christopher and Lee, 2004; Norrman and Jansson, 
2004; Hallikas et al., 2004). In fact, most of the reviewed journal articles were published from 
2012 onwards (60%, 127 out of 213). In 2012 20 (9%) were published, followed by 14 each in 
2013 and 2014 (7% each), 20 in 2015 (9%), and 34 in 2016 (16%), which reached the peak. 
There are some special issues that can explain the reason for some peaks on these topics 
(Kilubi, 2016). 
          
56 
 
 
Figure 2-12: Distribution of the publication years 
In this review, 213 articles were derived from 66 journals as shown in Table 2.8. In detail, the 
top eight journals were as follows: International Journal of Production Economics (39 papers), 
International Journal of Production Research (20 papers), International Journal of Physical 
Distribution and Logistics Management (15 papers), International Journal of Logistics 
Research and Applications (11 papers), Journal of Operations Management (9 papers), Journal 
of Purchasing and Supply Management (9 papers), Supply Chain Management: An 
International Journal (9 papers), and European Journal of Operational Research (8 papers on 
SCRM). That also indicates the prominent level of scientific relevance and significance of these 
journals. In addition, among these 66 published journals, the top eight journals had published 
about 56% of the articles. Besides the top eight ranking, it was also observed that 42 journals 
have published only one article related to SCRM. 
Table 2.8: Number of articles in alphabetical order (appearing at least twice) 
Academic Journals No. of 
Articles 
% 
Computers and Chemical Engineering  3 1.4 
Computers in Industry  2 0.9 
Computers and Industrial Engineering  4 1.9 
Computers and Operations Research 2 0.9 
European Journal of Operational Research  8 3.8 
Expert Systems with Applications 3 1.4 
International Journal of Production Research  20 9.4 
International Journal of Production Economics  39 18 
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International Journal of Logistics Research and Applications  11 5.1 
International Journal of Logistics Management 7 3.3 
International Journal of Physical Distribution and Logistics Management  15 7 
International Journal of Operations and Production Management 2 0.9 
Journal of Business Logistics 2 0.9 
Journal of Manufacturing Technology Management 4 1.9 
Journal of Risk Research  4 1.9 
Journal of Operations Management  9 4.2 
Journal of the Operational Research Society 2 0.9 
Journal of Purchasing and Supply Management  9 4.2 
Omega 4 1.9 
Production Planning and Control 2 0.9 
Production and Operations Management 2 0.9 
Safety Science  2 0.9 
Supply Chain Management: An International Journal  9 4.2 
Transportation Research 4 1.9 
 
2.3.2.1.2 Demographics  
With reference to the Figure 2.13, one-third of the contributions were from the USA (71 
papers). Other leading countries, such as the UK (33 papers), China (23 papers), Germany (19 
papers), and India (13 papers) also demonstrated their increasing attention to this topic. The 
finding is in line with that of Prakash et al., (2017) who also found that developing countries, 
such as China and India, are working more on SCRM because Asian markets are being 
recognised as a source of economic activity for all sectors, especially manufacturing. 
Moreover, an increasing trend for co-author collaboration research has been observed all 
over the world. 
 
Figure 2-13: Distribution of the contributing countries 
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2.3.2.2 Thematic analysis 
2.3.2.2.1 Evolving definitions for SCRM 
In recent years, many companies are reporting increased concerns about the risk of supply 
chain vulnerability. Per Snyder and Shen (2006), ‘for as long as there have been supply chains, 
there have been disruptions, and no supply chain, logistics system, or infrastructure network 
is immune to them’. According to a study conducted by the Computer Sciences Corporation, 
60% of the surveyed companies recognised that their supply chains are vulnerable to 
disruptions (CSC, 2004). For example, a fire at a Phillips plant in 2000 disrupted production, 
leading to a $400 million loss (Chopra and Sodhi, 2004). Natural disasters, terrorist attacks, 
labour strikes, accidents, and inefficient management can all be the causes for supply chain 
disruption and delay (Berger et al., 2004; Christopher and Lee, 2004; LaLonde, 2004; Norrman 
and Jansson, 2004; Poirier et al., 2007; Quinn, 2006; Tang, 2006). The above examples show 
that any environmental, internal, and external risks with supply chain practices will cause 
delay and even disruption.  
Few areas of management interest have risen to prominence as rapidly as SCRM, from the 
perspective of practitioners as a research area (Colicchia and Strozzi, 2012). Krajic (1983) is 
referred to as a pioneer in this research area. According to Haszlinna et al., (2009), ‘risk 
management refers to the identification, prioritisation and assessment of risks’. Risk 
management also encompasses coordination and economical application of resources with 
an aim of minimising, monitoring, and controlling the probability of unfortunate events 
(Kumar et al., 2009). 
Ghadge et al., (2011) observed that there are considerable number of researchers that started 
researching SCRM in early 2000, according to their preliminary search. The 9/11 terrorist 
attack (2001) affected the major global supply chain, and this triggered interest in the SCRM 
field (Chopra and Sodhi, 2004; Sheffi, 2005), causing the increase in the number of articles on 
SCRM during 2003 and 2004 (Ghadge et al., 2011).  
The early research tended to be a reactive approach to risk management. They explored the 
improvement of the capability to respond to uncertain events. Moreover, the focus was on 
the supply chain network design to address a single company. Further, the business 
environment is becoming more unpredictable and increasingly unstable due to globalisation, 
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shorter product life time, and the series of crises and economic recessions. The risk 
management process has become more proactive and the focus goes beyond the boundaries 
of the single company until 2003, as the collaborative sharing of information and best 
practices among supply chain partners received increased attention. Accordingly, Jüttner et 
al., (2003) built a foundation of effective SCRM as ‘the specification and management of risks 
for the supply chain, through a co-ordinated approach amongst supply chain members, to 
reduce supply chain vulnerability as a whole’. Tang (2006) extended this definition by 
combining with others to define SCRM as ‘the management of supply chain risks through 
coordination or collaboration among the supply chain partners so as to ensure profitability 
and continuity’. There is a slight difference in the managerial objectives for both definitions. 
In comparison with the former, Tang (2006) aimed not just to reduce risks but also to achieve 
business continuity. The author reviewed different quantitative models for managing supply 
chain risks and proposed four basic approaches: supply management, product management, 
demand management, and information management.  
Ritchie and Brindley (2007) studied five main components of SCRM: risk drivers, risk 
management influencers, decision-maker characteristics, risk management responses, and 
performance outcomes. The performance and risk in SCM are interconnected and require the 
robust implementation of management tools and controls to maximise performance while 
controlling the consequential risks (Lonsdale and Cox, 1998). Thus, Ritchie and Brindley (2007) 
studied the supply chain performance in terms of efficiency and effectiveness, which is linked 
to risk drivers and risk management responses, and provided insight into managing and 
measuring risk in supply chains. However, this topic is still under considerable development 
for theory-building.  
Furthermore, Vanany et al., (2009) reviewed the current literature and found that SCRM was 
a relatively ‘immature’ stage from the academics’ perspective. Until 2011, Wieland and 
Wallenburg (2011) found that SCRM helps supply chains proactively reduce vulnerabilities by 
supporting robustness reactively by supporting agility. Both approaches are identified to have 
an influence on the supply chain’s customer value and on business performance.  
Further, Abolghasemi et al., (2015) also mentioned that SCRM has a close relationship with 
supply chain performance. They identified some key factors of supply chain performance 
based on the supply chain operation reference (SCOR) model through the predictive and 
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diagnostic abilities of Bayesian networks (BN). After a sensitivity analysis, the authors found 
that ‘total cost’ and its criteria, which include costs of labour, warranty, transportation, and 
inventory, have the widest range and most effect on supply chain performance; thus, 
managing them and controlling their related risk play a vital role for supply chain performance.  
Heckmann et al., (2015) demonstrated that the contributions in SCRM mainly focus on the 
identification of triggering events and the assessment of their likelihood of occurrence, 
although this risk perception might be limited for the supply chain. Nevertheless, Kilubi and 
Haasis (2015) found that the SCRM definition of Jüttner et al., (2003) is the most frequently 
used in journal articles studying SCRM. Their definition is based on a synthesis of traditional 
risk management and SCM principles. Without incorporating the concepts of SCM into supply 
chain risk mitigation practices, the mitigation efforts are unlikely to be effective (Li et al., 
2015). 
In SCM, risk management entails the implementation of various strategies to manage daily 
and exceptional risk along the supply chain (Carvalho and Cruz-Machado, 2011). However, 
there is no consensus for the researchers to define the meaning for SCRM (Jüttner, 2003; 
Sodhi, 2012). After reviewing the literature from 2000 to 2015, Kilubi and Haasis (2015) 
indicated that a definitional consensus does not exist and that SCRM is still in the evolving 
stage and has not yet reached maturity. Senior managers from Cisco (McMorrow, 2009) and 
Deloitte (Zhou, 2009) also realised the definition gap of SCRM among company executives 
and emphasised the need to develop a clear definition of SCRM.  
Without a mutual understanding and clear definitions, researchers could be confused when 
communicating with practitioners. Alternatively, a consistent definition would help 
researchers estimate and evaluate the probability and consequences of the full set of supply 
chain risks and measure the effectiveness of SCRM methods (Ho et al., 2015). One 
comprehensive definition of SCRM was suggested by Ho et al., (2015) who defined SCRM as 
an inter-organisational collaborative endeavour using quantitative and qualitative risk 
management methodologies to identify, evaluate, mitigate, and monitor unexpected macro 
and micro level events or conditions that might adversely affect any part of a supply chain. 
Their definition is built on the existing literature (Jüttner et al., 2003; Jutter, 2005; Norrman 
and Jansson, 2004; Tang, 2006; Thun, 2011). 
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2.3.2.2.2 Supply chain risk types and classification methods 
Several studies demonstrated different definitions and types of risk in the supply chain 
(Jüttner et al., 2003; Gaokar and Viswanadham, 2004; Tang, 2006; Manuj and Mentzer, 2008; 
Tummala and Schoenherr, 2011). These definitions have applicability to specific decision 
contexts and types. According to Tang and Musa (2011), a better definition of supply chain 
risk should refer to the events with a small probability that may occur abruptly and that can 
bring substantial negative consequences to the system. Ho et al., (2015) defined supply chain 
risk as: ‘the likelihood and impact of unexpected macro and/or micro level events or 
conditions that adversely influence any part of a supply chain leading to operational, tactical, 
or strategic level failures or irregularities’. What most definitions of risk have in common are 
the three dimensions: (1) likelihood of occurrence of a particular event or outcome, (2) 
consequences of a particular event or outcome occurring, and (3) causal pathways leading to 
the event (Ritchie and Brindley, 2007). 
Among the 213 reviewed journal articles, 45 articles discussed supply chain risk types as 
shown in Table 2.9. Rangel et al., (2015) mentioned the lack of uniformity of the classification 
methods. According to some studies, supply chain risks can be divided into different 
perspectives. Specifically, some researchers simply classified the risk types into two 
categories, such as internal (e.g., human errors, equipment failures, and material quality that 
can be controlled by the organisation) or external (e.g., exchange rate changes, legislation, 
and natural events like earthquakes that cannot be controlled by the organisation). Some 
classified the risk types in terms of the controllable degree of the organisation (Trkman and 
McCormack, 2009; Cagliano et al., 2012; Tukamuhabwa et al., 2017), the supply-side risks and 
demand-side risks (Nagurney et al., 2005; Manuj et al., 2014), operational and disruption risks 
(Tang, 2006; Kὄnig and Spinler, 2016), purchasing and demand risks (Thun and Hoenig, 2011), 
or macro and micro risks (Ho et al., 2015). In addition, some scholars have added one or two 
more risk factors on the basis of the above studies (Wagner and Bode, 2006; Manuj and 
Mentzer, 2008; Jiang et al., 2009; Oke and Gopalakrishnan, 2009; Cruz, 2013; Aguas et al., 
2013; Sreedevi and Saranga, 2017). Moreover, some researchers listed the risk types without 
explicit classification (Harland et al., 2003; Chopra and Sodhi, 2004; Blackhurst et al., 2008; 
Tummala and Schoenherr, 2011; Ghadge et al., 2013; Aqlan and Lam, 2015; Rangel et al., 2015; 
Blos et al., 2016; Rogers et al., 2016; Quang and Hara, 2017).  
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Moreover, some risk types have been extensively proposed and studied, such as supply risks 
(35 out of 45 papers), demand risks (27 out of 45 papers), and environmental risks (28 out of 
45 papers) because their effects are observed more clearly within organisations that are 
configured in a supply chain array than in other organisations (Rangel et al., 2015). In contrast, 
some risk types have obtained less attention from scholars (reputation, technology, and 
financial risks). Although the origins of risk research initially focused on the banking sector, 
most scholars have paid more attention to the physical and information flows rather than 
cash flow in SCM. 
Table 2.9: Supply chain risk types identified by researchers 
Authors Risk Types 
Harland et al., 
(2003) 
Strategic risks, operation risks, supply risks, customer risks, asset 
impairment risks, competitive risks, reputation risks, financial risks, 
fiscal risks, regulatory risks, and legal risks 
Jὓttner et al., 
(2003) 
Environmental risks, network-related risks, and organisational risks 
Christopher and 
Peck (2004) 
Internal to the firm: process and control risks, external to the firm but 
internal to the supply chain network: demand and supply risks, and 
external to the network: environmental risks 
Chopra and Sodhi 
(2004) 
Disruption, delays, systems, forecast, intellectual property, 
procurement, receivables, inventory, and capacity risks 
Nagurney et al., 
(2005) 
Supply-side risks and demand-side risks 
Tang (2006) Operational risks and disruption risks 
Wagner and Bode 
(2006) 
Demand-side risks, supply-side risks, and catastrophic risks 
Bogataj and 
Bogataj (2007) 
Supply risks, process risks, demand risks, control risks, and 
environmental risks 
Deleris and Erhun 
(2007) 
Operational/technological risks, social risks, natural hazard, 
economy/competition risks, and legal/political risks 
Cheng and Kam 
(2008) 
Environmental risks, infrastructure risks, service delivery risks, and 
organisational and relationship risks 
Manuj and 
Mentzer (2008) 
Supply risks, demand risks, operational risks, and security risks 
Blackhurst et al., 
(2008) 
Disruptions/disasters, logistics, supplier dependence, quality, 
information systems, forecast, legal, intellectual property, 
procurement, receivables (accounting) inventory, capacity, and 
management security 
Tang and Tomlin 
(2008) 
Supply risks, process risks, demand risks, intellectual property risks, 
behavioural risks, and political/social risks 
Jiang et al., 
(2009) 
Cost risks, operational risks, and reputational risks 
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Oke and 
Gopalakrishnan 
(2009) 
Supply related risks: imports, climate, man-made disasters, natural 
disasters, socio-economic, loss of key suppliers, demand related risks: 
economic, demand variability and unpredictability, and miscellaneous 
risks 
Rao and Goldsby 
(2009) 
Organisational risks, industry risks, and environment risks 
Trkman and 
McCormack 
(2009) 
Endogenous risks: market and technology turbulence and exogenous 
risks: discrete events (e.g., terrorist attacks, contagious diseases, 
workers’ strikes), and continuous risks (e.g., inflation rate, consumer 
price index changes)  
Thun and Hoenig 
(2011) 
Purchasing risks and demand risks 
Tummala and 
Schoenherr 
(2011) 
Demand risks, delay risks, disruption risks, inventory risks, 
manufacturing (process) breakdown risks, physical plant (capacity) 
risks, supply (procurement) risks, system risks, sovereign risks, and 
transportation risks 
Cagliano et al., 
(2012) 
External risks: catastrophic, political, economic, social, legal, culture, 
industrial, partner and internal risks: strategic, tactical, and operational  
Jnandev et al., 
(2012) 
Regulatory risks, counterfeit risks, inventory risks, and financial risks 
Lockamy and 
McCormack 
(2012) 
Network risks, operational risks, and external risks 
Vilko and Hallikas 
(2012) 
Supply risks, operational risks, security risks, macro risks, policy risks, 
and environment risks 
Ghadge et al., 
(2013) 
Product design information risks, distortion risks, demand risks, quality 
risks, disruption risks, operational risks, financial risks, 
skill/performance risks, poor management risks, safety/security risks, 
reputation risks, supply safety risks, geopolitical risks, supply capacity 
risks, intellectual property risks, regulatory/legal risks, information 
distortion risks, integration risk, network risks, and technology risks  
Cruz (2013) Supply-side risks, demand-side risks, exchange rate risks, and social 
risks 
Aguas et al., 
(2013) 
Supply delays, disruptions in the supply, differences in quantities 
received, and demand forecast errors 
Enyinda et al., 
(2014) 
Supply risks, operational risks, infrastructure risks, and political risks 
Manuj et al., 
(2014) 
Supply-side risks and demand-side risks 
Aqlan and Lam 
(2015) 
Supplier risks, customer risks, process and control risks, technology 
risks, product risks, occupational risks, culture risks, transportation 
risks, and commodity risks 
Jaberidoost et al., 
(2015) 
Supply and supplier risks, organisation and strategies risks, financial 
risks, market risks, political risks, logistics risks, and regulation risks 
Rangel et al., 
(2015) 
Strategic risks, inertia risks, informational risks, capacity risks, demand 
risks, supply risks, financial risks, relational risks, operational risks, 
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disruption risks, customer risks, legal risks, environmental risks, and 
culture risks 
Ceryno et al., 
(2015) 
Organisational risks, network-related risks, industry risks, and 
environmental risks 
Ho et al., (2015) Macro risks: man-made and natural risks, and micro risks: demand 
risks, manufacturing risks, supply risks, information risks, 
transportation risks, and financial risks 
Aqlan and Lam 
(2015) 
Demand risks, supply risks, process risks, control risks, and 
environmental risks 
Blos et al., (2016) Water risks, raw material risks, ingredient risks, packaging risks, 
manufacturing process risks, infrastructure and nature hazard risks, 
energy risks, environmental risks, worker safety and health risks, 
people, skills and availability risks, information and systems risks, route 
to market and in market risks, legal, legislative, and regulatory risks, 
and workplace rights and social responsibility risks 
Mokrini et al., 
(2016) 
Operational risks, financial risks, technology risks, information-related 
risks, relational risks, and internal risks 
Torabi et al., 
(2016) 
Supplier risks, internal risks, environmental risks, and market risks 
Govindan and 
Chaudhuri (2016) 
Risk in internal operations of logistics service providers, financial risks, 
and customer-related risks 
Rogers et al., 
(2016) 
Operational risks, infrastructure risks, legal risks, cultural risks, 
economic risks, supplier risks, forecasting risks, warehouse risks, 
transportation risks, labour risks, and natural disaster risks 
Kὄnig and Spinler 
(2016) 
Operational risks: process risks, control risks, supply risks, demand 
risks, and disruption risks: man-made risks, and natural risks 
Nakandala et al., 
(2017) 
Internal risks: process and control risks, operational risk external to the 
firm: supply and demand risks, and macro-level risks 
Prakash et al., 
(2017) 
Environmental risks, supply risks, demand risks, and process risks 
Quang and Hara 
(2017) 
External risks, time risks, information risks, financial risks, supply risks, 
operational risks, and demand risks  
Tukamuhabwa et 
al., (2017) 
Endogenous risks: supply-side, firm level, demand side, and exogenous 
risks: geopolitical and economic risks  
Sreedevi and 
Saranga (2017) 
Supply risks, manufacturing process risks, and delivery risks 
 
2.3.2.2.3 Applied research methodologies  
Generally, the research methodologies developed and applied for decision making in the 
SCRM field were broadly divided into two categories, as qualitative and quantitative methods. 
More specially, qualitative research methods were further divided based on research design, 
conceptual theory, empirical study (e.g., case study, industrial survey, structured/informal 
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interview, and focus group methodologies), and literature review. Comparatively, 
quantitative methods were divided into mathematical modelling, simulation, and statistics 
and probabilistic theory for a more detailed thematic analysis (Ghadge et al., 2012).  
Figure 2.14 displays the distribution of the number of journal articles applying both 
methodologies and mixed methods between 2003 and 2017.The analysis found that empirical 
study was the primary methodology adopted to deal with contemporary industrial problems 
over the last few years (28%, 60 papers). Moreover, a wide range of studies have used the 
case study method to study supply chain risks. These studies focus on the various aspects and 
sectors, such as the risks in an uncertain global supply chain environment (Barry, 2004), 
strategies for the fragile food supply chain (Dani and Deep, 2010), managing the supply chain 
relational risk caused by cultural differences between China and the West (Jia and Rutherford, 
2010), and mitigating supply chain risk through improved confidence (Christopher and Lee, 
2004).  
Additionally, Ghadge et al., (2012) found that 80% of the case studies were focused on 
network-related risks. Mixed methods are the second most-used research methodology (25%, 
54 papers), which shows that an increasing number of scholars pay more attention to using 
combined research to create new evidentiary knowledge. Figure 2.15 gives the growth trend 
of using mixed methods since 2012. This finding is also in line with the results by Tang and 
Musa (2010) and Ho et al., (2015).  
 
Figure 2-14: Distribution of research methodologies 
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Moreover, scholars have also frequently applied mathematical modelling (20%, 42 papers) to 
deal with SCRM strategy and policy formulation, followed by conceptual theory (17%, 36 
papers). Mathematical modelling can be further divided into hard OR and soft OR techniques, 
which comprise multi-objective programming, linear and nonlinear programming, game 
theory, queuing theory, scenario planning, system thinking, etc.  
The most popular approach is fuzzy-based multi-objective mathematical programming 
(Oliveira et al., 2013; Yu and Goh, 2014; Nooraie and Parast, 2015). For example, Oliveira et 
al., (2013) used the multi-objective mathematic modelling method to weigh the priority of 
risk-reduction investments through the financial perspective to deal with optimised decision 
making under demand uncertainty.  
Fuzzy TOPSIS and Fuzzy analytical hierarchy/network process also have attracted more 
attention in the SCRM literature to easily quantify risk in many cases (Wang et al., 2012; 
Samvedi et al., 2013; Jaberidoost et al., 2015; Li et al., 2015). Using conceptual theory, 
researchers could represent a research methodology describing fundamental concepts on 
SCRM (Vanany et al., 2009).  
 
Figure 2-15: Distribution of quantitative and qualitative methods over the last decades 
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Based on the above findings, most scholars made outstanding contributions to this field, 
laying the foundation for future research in the initial stage (Jüttner et al., 2003; Harland et 
al., 2003; Finch, 2004; Christopher and Peck, 2004; Chopra and Sodhi, 2004; Sinha et al., 2004; 
Christopher and Lee, 2004; Hallikas et al., 2004; Tang, 2006). Thus, several conceptual 
theories or framework developments were frequently attempted by these scholars. As Figure 
2.15 shows, the first SCRM literature review was published in 2009. At this stage, a large 
number of scholars had been dedicated to this topic for many years. It is necessary to provide 
the whole picture of associated issues in past works, which serves as a basis and guide to 
proposed future research. Although simulation (6%, 12 papers) and statistics/probability (2%, 
4 papers) have attracted less attention in the literature, some researchers have argued that 
simulation will play a key role in SCRM, as it is able to devise decision options for well-defined 
risk-mitigating techniques (Talluri et al., 2013; Kilubi, 2016). 
2.3.2.2.4 Supply chain risk management process  
In most cases, SCRM involves four processes that include identification, assessment, and 
controlling and monitoring of supply chain risks (Sarac et al., 2010). The complexities of some 
supply chains make it difficult to apply these processes in preparing for all eventualities 
(Ganeshan and Magazine, 2012).  
Tummala and Schoenherr (2011) extended the previous studies (Tummala et al., 1994; 
Tummala and Mak, 2001) based on the structured risk management process (RMP), consisting 
of the following five phases: risk factors identification, risk measurement, risk assessment, 
risk evaluation, and risk control and monitoring. They also extracted further studies 
conducted by Ellegaard (2008), Finch (2004), Manuj and Mentzer (2008), and Schoenherr et 
al., (2008) who proposed an approach consisting of a modified RMP to identify, assess, and 
manage supply chain risks. The final modified approach is an SCRM process including three 
phases, which are risk identification, risk measurement, and risk assessment in Phase I; risk 
evaluation, risk mitigation, and contingency plans in Phase II; and risk control and monitoring 
in Phase III. This approach provides a foundation of the SCRM process framework for supply 
chain managers for strategic decision making, considering the different supply chain risk 
profiles associated with a given situation. 
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More specifically, various processes make up the process of risk management in the supply 
chain. The process of risk management usually begins with identifying internal and external 
factors in the supply chain environment (Walker et al., 2008). For example, in the 
manufacturing industry, some industries are faced with climatic risk, such as severe weather, 
while others experience the risk of the high cost of transporting goods.  
Organisations can identify their supply chain risks by mapping the supply chain. Supply chain 
mapping also helps an organisation to prioritise various risks and address them effectively 
(Sarac et al., 2010). In most cases, the starting point in supply chain mapping is the product 
or service that can greatly affect a company or organisation’s profitability (Mollenkopf et al., 
2010). After understanding how to identify risk types, factors or both, the next steps involve 
risk assessment. The process involves prioritising risks according to the threat they pose to 
the well-being of a business. Risk assessment is associated with the occurrence of the trigger 
event and the severity of the consequences (Harland et al., 2003). After identification and 
assessment of the risk, the next step entails devising risk treatment plans. At this point, it is 
important to devise measures that can protect the supply chain from risks, creating plans to 
respond to events that may be caused by the identified risks and developing plans to help 
continue operations in the case of disruptions (Gosling and Naim, 2009). 
 
Figure 2-16: Number of categories of papers by the associated research areas 
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Finally, the process can also entail determining metrics and ways of measuring risk and the 
effectiveness of various plans put in place to mitigate risk (Fawcett et al., 2014). By analysing 
the data based on the reviewed articles, most of the studies were focused on risk mitigation 
activity (49%, 104 papers). This indicated the relative maturity stage of researchers in SCRM. 
The RMP is not complete without monitoring and review. Risk monitoring can be defined as 
monitoring developments in the supply chain that may increase or decrease risks on an on-
going basis (Zsidisn et al., 2005). The four main principles of SCRM include leadership, 
governance, management of change, and the development of a business case (Carter and 
Rogers, 2008). Monitoring and review not only entails checking the effectiveness of risk 
management practice but also maintaining various plans to meet changes in processes and 
suppliers and the regulation of any other elements that influence the supply chain (Walker et 
al., 2008). Less focus has been centred on the last stage of the SCRM process, risk monitoring, 
which embeds risk management into the daily practices of organisations (1 paper). As shown 
in Figure 2.16, many articles studied a specific or individual SCRM process, while a few 
researchers considered holistic RMPs (24%, 51 papers). 
2.3.2.2.5 Supply chain risk sources identification  
As a decision-making support tool, the analytic hierarchy process (AHP) method has been 
applied by several researchers. It can support managers in setting up a priority hierarchy of 
risk management. Gaudenzi and Borghesi (2006) proposed the AHP method to identify supply 
chain risk factors with a view to improving the objective of customer value. However, the 
limitation of the research is the focus on the single focal company; thus, the risk indicators 
would not be applicable to other industries. Besides this, the following approaches can help 
in the identification of potential supply chain risks: supply chain mapping, checklists or check 
sheets, event tree analysis, fault tree analysis, Ishikawa cause and effect analysis (Tummala 
et al., 1994), and failure mode and effect analysis (FMEA) (Tuncel and Alpan, 2010). According 
to Adhitya et al., (2009), the hazard and operability analysis method from chemical process 
risk management has been employed for risk factors identification and consequence analysis.  
Blos et al., (2009) identified the supply chain risks in the automotive and electronic industries 
in Brazil by implementing a supply chain vulnerability map. The drawback of their study comes 
from the small sample size. A fishbone diagram has been used as an efficient method to 
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identify and visually depict the potential causes of common problems in the supply chain 
(Desai et al., 2015). Four categories of potential effects have been examined in their study, 
such as defects, delays, counterfeits, and general errors. However, the lack of a case study is 
the main drawback for this research. 
2.3.2.2.6 Supply chain risk assessment 
An increasing number of risk assessment methods have been developed in the last two 
decades, especially for supply risk assessment (Ho et al., 2015). Techniques such as the Delphi 
method, expert focus groups, five-point estimation, or Monte Carlo simulation can aid in the 
assessment of the probabilities of the risks (Tummala et al., 1994).  
There are plenty of research studies focused on the financial risk assessment in the supply 
chain. Value at risk and conditional value at risk are common methods that have been used 
in portfolio theory as percentile measures of downside-risk associated with undesirable 
outcomes (Chen and Yano, 2010; Hahn and Kuhn, 2012; Lockamy and McCormack, 2010; 
Poojari et al., 2008; Sawik, 2013; Soleimani and Govindan, 2014). Furthermore, variance or 
standard deviation are largely used as a measure of supply chain financial risks as well (Azaron 
et al., 2008; Babazadeh and Razmi, 2012; Hahn and Kuhn, 2012).  
However, some articles argued that deviation-based measures are problematic measures of 
risk in general (Cox, 2008; Pedersen and Satchell, 1998). Cigolini and Rossi (2010) conducted 
a fault tree method to assess the operational risk at three stages of the oil supply chain 
(drilling, primary transport, and refining). The limitation of the study is ignoring operational 
risk assessment at other important stages like design, construction, and outsourcing.  
Wagner and Neshat (2010) applied graph theory to convert the ‘fuzzy’ construct of supply 
chain vulnerability to an index (the SCVI). They revealed that graphs can be used as visual 
maps that facilitate the understanding of supply chain vulnerability and support decision 
making in SCRM. However, the proposed approach heavily depends on the expert judgements 
and availability of data that quantifies the drivers of SCV.  
Ruiz-Torres et al., (2013) proposed the model to utilise the decision tree approach to consider 
the possible situation in which one or more suppliers fail and develop contingency plans. 
However, the research did not consider the dynamic characteristics of the supply chain 
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network and all the input parameters and supplier characteristics were considered 
deterministic.  
Kumar et al., (2010) applied the artificial bee colony technique, genetic algorithms, and 
particle swarm optimisation to identify operational risk factors, their expected value, the 
probability of occurrence, and the associated additional cost. However, they are not devoid 
of limitations, as they only focused on a single-product supply chain network.  
Tummala and Schoenherr (2011) suggested the hazard totem pole (HTP) analysis for the 
systematic evaluation of supply chain risks, integrating the risk assessment aspects of their 
severity, probability, and cost. Ramkumar (2016) proposed a risk assessment methodology 
for in-house and third-party type of e-procurement implementation based on a modified 
analytic network process (ANP) coupled with fuzzy inference systems. They investigated the 
technological implementation risks, which are found to be higher for both in-house and third-
party e-procurement systems. However, the above two methods are also mostly depending 
on the assumption and subjective nature of the rankings and evaluations.  
Moreover, there is a substantial number of quantitative methods that have been broadly 
proposed for the risk assessment, such as multicriteria decision-making and AHP approaches 
(Gaudenzi and Borghesi, 2006; Kull and Talluri, 2008; Levary, 2008; Kamath et al., 2012; Wang 
et al., 2012; Ling, 2014; Li et al., 2015; Jaberidoost et al., 2015; Dong and Cooper, 2016; Mu 
and Carroll, 2016), MRP-DRP stochastic modelling (Bogataj and Bogataj, 2007), fuzzy TOPSIS 
(Chatterjee and Kar, 2016), BNs (Lockamy and McCormack, 2012; Badurdeen et al., 2014), 
modified FMEA method (Chen and Wu, 2013), and hierarchical holographic modelling 
(Nakandala et al., 2017). It is obvious that there is a large body of literature on risk assessment 
focused on the priority of risk factors.  
Nevertheless, it is also necessary to identify cause-effect relations between each risk factor in 
terms of their direct and indirect influence in the network. Hence, approaches such as 
interpretive structural modelling (ISM) or decision-making trial and evaluation laboratory can 
be used to present a hierarchical model showing the interrelationships between the risk 
sources (Hachicha and Elmsalmi, 2014; Govindan and Chaudhuri, 2016). The main drawback 
of those approaches is the lack of capability to deal with the complex system, while only 
considering a limited number of variables in the development of the model. 
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2.3.2.2.7 Supply chain risk mitigation and control strategies 
As discussed above, among the 213 reviewed journal articles, 104 articles discussed risk 
mitigation strategies. According to Grötsh et al., (2013), the research found that supplier 
insolvencies are a major source of interruption of the supply chain. Regarding these issues, 
they explored a mechanistic management control system, a rational cognitive style, and 
relational buyer-supplier relationships, which have positive effects on proactively managing 
supplier insolvency risks.  
Yu et al., (2015) proposed a novel conceptual model combining two variables: supply chain 
integration and organisational risk propensity for mitigating supply chain risk. The mechanism 
of supply chain risk on company performance through supply chain integration and 
organisational risk propensity can also help firms solve the problem of strategy choice under 
such a risk.  
Ghadge et al., (2012) surveyed the articles and found that, at a strategic level, contingency 
planning and risk-sharing outsourcing contracts are prominently used as risk mitigation 
strategies. Likewise, Li et al., (2015) identified risk information sharing and risk-sharing 
mechanisms as two important joint SCRM practices in improving financial performance that 
can be strengthened by collaborative relationship characteristics, including relationship 
length, supplier trust, and shared SCRM understanding.  
Bayesian networks are graphical models that display a set of possible variables and their 
conditional dependencies as a decision-making tool that can help managers mitigate risks 
within different fields (Abolghasemi et al., 2015). An evaluation technique, the HTP analysis, 
has already been applied by Tummala et al., (1994; Tummala and Mak, 2001). However, the 
limitations of the method must be noted regarding the assumptions and subjective nature of 
the ranking and evaluations.  
Some similar strategies were stressed by different studies, which showed that supply chain 
risks can be mitigated by implementing flexibility (Chang et al., 2015; Tang, 2006; Miller, 1992; 
Wieland and Wallenburg, 2012), redundancy (Chang et al., 2015; Manuj et al., 2014; Miller, 
1992; Bucklin, 1965), hedging (Manuj et al., 2014; Achrol et al., 1983; Agrawal and Seshadri, 
2000; Cachon, 2004; Miller, 1992; Tang, 2006), robustness (Wieland and Wallenburg, 2012; 
Tang, 2006; Downey, 2004), postponement (Manuj et al., 2008; Tang, 2006; Bucklin, 1965; 
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Chiou et al., 2002; Zinn and Bowersox, 1988), co-operation (Miller, 1992; Nooraie and Parast, 
2015; Manuj et al., 2008; Tang, 2006; Manuj et al., 2014), and information technology (Tang, 
2006). 
There are limitations associated with the above articles. Wieland and Wallenburg (2012), 
Grötsh et al., (2013), and Li et al., (2015) surveyed samples that are geographically limited to 
only one country (i.e., Germany or China) and have a small sample size. Manuj and Mentzer 
(2008) only focused on internal stakeholders. The proposed risk mitigation model was based 
on stable demand instead of fluctuating demand (Nooraie et al., 2015). Chang et al., (2015) 
proposed the conceptual framework mainly considers risk mitigation approaches rather than 
more fine-grained strategic options and contexts. Yu et al., (2015) have not applied an 
empirical study to test the model. 
Risk mitigation and control strategies that have been proposed by several researchers were 
mainly classified into two approaches: proactive and reactive. Furthermore, many more 
researchers have conducted proactive mitigation strategies than those that have proposed 
reactive strategies (Perry, 2007; Hopp et al., 2012; Richey, 2009; Kumar and Havey, 2013).  
Grötsh et al., (2013) also learned that scholars have continuously suggested managing SCRM 
proactively to mitigate risks. After reviewing 87 peer-reviewed academic articles from 2000 
to mid-2015, Kilubi and Haasis (2015) classified the most frequently mentioned enablers on 
SCRM based on two risk-mitigating methods: preventive and responsive. For the preventive 
approach, the strategy constitutes the enablers of visibility, relationships, collaboration, 
multiple sourcing, postponement, and redundancy. For the responsive methods, the strategy 
comprises visibility, flexibility, multiple sourcing, redundancy, and coordination. Proactive 
SCRM can be defined as planning and operating ahead to mitigate risks before they emerge 
(Mitroff and Alpaslan, 2003; Knemeyer et al., 2009) while reactive SCRM are applied after a 
disruption has occurred to respond to or aid recovery (Tukamuhabwa et al., 2017).  
Moreover, few researchers use other classifications of strategies that focus on whether they 
support the robustness and/or agility of the supply chain under uncertainty (Wieland and 
Wallenburg, 2013). Some strategies could be proactive or reactive based on when and why 
they are applied, such as collaboration, agility, and postponement.  
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Agility, for example, can help to mitigate the emergency incident when the disruption occurs 
or afterward. However, agility also helps to manage the hazards before disruption occurs by 
investing in people and information (Jüttner et al., 2003; Schmitt and Singh, 2012). Meanwhile, 
some strategies should be planned before a disruption, such as building a risk management 
culture (Tang, 2006; Dani and Deep, 2010; Diabat et al., 2012; Grötsh et al., 2013; Yu et al., 
2015; Oliva, 2016).  
In Table 2.10, the SCRM strategies that have been put forward by researchers are summarised 
based on whether they are employed proactively or reactively. Table 2.10 represents visibility 
and transparency; collaboration and agility have been frequently adopted to mitigate risks. 
The findings are in line with findings by other scholars. For example, Kilubi (2016) found that 
the top three identified SCRM strategies were visibility and transparency, 
relationship/partnerships, and flexibility. Flexibility can be defined as a primary component 
of agility (Saravanapandi and Kumaran, 2015). However, the research deals with these 
strategies individually rather than collectively.  
Some strategies can facilitate each other. For example, increasing visibility and transparency 
can improve collaboration within the organisation or with other supply chain members by 
sharing the risk information. In addition, although some strategies appear to complement 
each other dramatically, they can also conflict. For instance, horizontal collaboration between 
suppliers may increase supply chain risk through collusion (Choi and Krause, 2006). Moreover, 
a wide range of studies are adopting a ‘one size fits all’ approach to risk mitigation strategies. 
There are few research studies that consider the efficiency of alternative supply chain risk 
mitigation strategies under related contexts (Chang et al., 2015). Consequently, the spread of 
disruption can be due to the lack of effective mitigation strategies (Ghadge et al., 2012). 
Table 2.10: Summary of reviewed risk mitigation strategies 
SCRM Strategies References 
Proactive strategies 
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Increasing visibility and transparency, 
for example, information sharing (risk-
related information) between supply 
chain members and intra-
organisational departments 
(information sharing mechanism), 
communication, use of information 
technology to enhance connectivity 
and traceability, etc. 
Jüttner et al., (2003); Christopher and Peck 
(2004); Christopher and Lee (2004); Giunipero 
and Eltantawy (2004); Hallikas et al., (2004); 
Blackhurst et al., (2005); Faisal et al., (2006); 
Tang (2006); Ritchie and Brindley (2007); 
Enyinda and Szmerekovsky (2008); Chen and 
Huang (2010); Dani and Deep (2010); 
Giannakis and Louis (2011); Thun and Hoenig 
(2011); Diabat et al., (2012); Groznik and 
Trkman (2012); Lavastre et al., (2012); Lei et al., 
(2012); Tse and Tan (2012); Zou and Couani 
(2012); Ilie and Popa (2013); Maryland (2013); 
Xue et al., (2013); Yu and Goh (2014); Chang et 
al., (2015); Li et al., (2015); Nooraie and Parast 
(2015); Rajesh and Ravi (2015); Singh (2015); 
Choi et al., (2016); Mishra et al., (2016); Oliva 
(2016); Riley et al., (2016); Yang and Fan 
(2016); Fan et al., (2017); Kurniswan et al., 
(2017); Namdar et al., (2017); Nguyen et al., 
(2017); Tsai (2017); Tukamuhabwa et al., 
(2017); Urciuoli and Hintsa (2017) 
Collaboration: The ability to work 
effectively with either other supply 
chain entities or within the 
organisation for mutual benefit, for 
example, sharing information and 
other resources to reduce 
vulnerability, participative 
management, cross functional 
involvement, risk sharing, etc.  
Jüttner et al., (2003); Christopher and Peck 
(2004); Giunipero and Eltantawy (2004); 
Hallikas et al., (2004); Spekman and Davis 
(2004); Kleindorfer and Saad (2005); Cucchiella 
and Gastaldi (2006); Faisal et al., (2006); 
Blackhurst et al., (2008); Jiang et al., (2008); 
Khan et al., (2008); Lai et al., (2009); Scheller-
Wolf and Tayur (2009); Dani and Deep (2010); 
Jia and Rutherford (2010); Thun and Hoenig 
(2011); Lavastre et al., (2012); Zou and Couani 
(2012); Elzarka (2013); Grötsh et al., (2013); 
Maryland (2013); Bandaly et al., (2014); Kim 
and park (2014); Lavastre et al., (2014); 
Scholten et al., (2014); Ellinger et al., (2015); 
Gao (2015); Li et al., (2015); Yu et al., (2015); 
Cheng and Chen (2016); Mishra et al., (2016); 
Oliva (2016); Riley et al., (2016); Zepeda et al., 
(2016); Tukamuhabwa et al., (2017); 
Wiengarten et al., (2016); Fan et al., (2017); 
Ghadge et al., (2017); Revilla and Saenz (2017); 
Wang et al., (2017) 
Postponement: The manufacturer 
produces a generic product, which can 
be modified at the later stages before 
the final transport to the customer. 
Jüttner et al., (2003) 
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Agility: The ability to efficiently change 
operating states in response to 
uncertain and changing market 
conditions, for example, flexibility to 
adapt to changing requirements with 
minimum time and effort, visibility, 
joint planning, customer 
responsiveness, etc. 
Jüttner et al., (2003); Schmitt and Singh (2012) 
Knowledge management: The 
exploitation of computational systems 
that can store, process, and transmit 
knowledge from one individual to 
another, to facilitate daily operations 
within the supply chain (e.g., staff 
training, etc.)  
Hallikas et al., (2004); Sinha et al., (2004); Faisal 
et al., (2006); Maryland (2013); Scholten et al., 
(2014); Riley et al., (2016) 
Multiple sourcing and flexible 
contractual agreements  
Zsidisin and Ellram (2003); Christopher and 
Peck (2004); Tang (2006); Trkman and 
McCormack (2009); Diabat et al., (2012); 
Wieland and Wallenburg (2012); Xanthopoulos 
et al., (2012); Fang et al., (2013); Kanyoma et 
al., (2013); Gaudenzi et al., (2017); Lücker and 
Seifert (2017); Tukamuhabwa et al., (2017); 
Wang et al., (2017) 
Redundancy or buffering strategy, for 
example, buffer (emergency) stock, 
excess productive capability, back 
sourcing, etc.  
Jüttner et al., (2003); Zsidisin and Ellram 
(2003); Chopra and Sodhi (2004); Colicchia et 
al., (2011); Chang et al., (2015); Aven (2016); 
Mishra et al., (2016); Park et al., (2016); 
Mohammaddust et al., (2017)  
Building risk management culture, for 
example, managers’ attitude towards 
risks, top management support, firm 
integration/team work, risk 
governance, etc.  
Eltantawy (2004); Faisal et al., (2006); Tang 
(2006); Dani and Deep (2010); Diabat et al., 
(2012); Grötsh et al., (2013); Yu et al., (2015); 
Oliva (2016); Park et al., (2016); Fattahi et al., 
(2017); Urciuoli and Hintsa (2017)  
Increasing logistics capabilities, for 
example, increasing transportation 
equipment capability, inventory 
management, investment in new 
facilities, etc. 
Chopra and Sodhi (2004); Sinha et al., (2004); 
Kleindorfer and Saad (2005); Schmitt (2011); 
Wieland and Wallenburg (2012); Maryland 
(2013); Micheli et al., (2014); Gao (2015); Choi 
et al., (2016); Li et al., (2016); Tsai (2017); 
Tukamuhabwa et al., (2017); Urciuoli and 
Hintsa (2017) 
Supplier development, for example, 
supplier assessment; supplier 
certification; quality management 
programmes; financial, training, and 
technical knowledge to improve 
efficiency, commitment, reliability, etc.  
Zsidisin and Ellram (2003); Christopher and 
Peck (2004); Blackhurst et al., (2005); 
Blackhurst et al., (2008); Thun and Hoenig 
(2011); Diabat et al., (2012); Micheli et al., 
(2014); Kurniswan et al., (2017); Tukamuhabwa 
et al., (2017) 
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Increasing innovativeness: The 
motivation and capability to seek and 
invest in new business ideas, for 
example, research and development, 
technologies, processes, and 
strategies that can reduce 
vulnerability, etc.  
Norrman and Jansson (2004); Scholten et al., 
(2014); Bandaly et al., (2016); Prakash et al., 
(2017)  
Outsourcing: Outsourcing non-core 
product offshore and insourcing core 
products and developing offshore 
insourcing capabilities.  
Huq et al., (2016); Tukamuhabwa et al., (2017)  
Financial management, for example, 
financial hedging, borrowing from 
customers, effective credit 
management, insurance, etc.  
Elleuch et al., (2014); Tukamuhabwa et al., 
(2017) 
Reactive Strategies 
Collaboration: The ability to work 
effectively with either other supply 
chain entities or within the 
organisation for mutual benefit, for 
example, sharing information and 
other resources to reduce 
vulnerability, participative 
management, cross functional 
involvement, risk sharing, etc.  
Ojala and Hallikas (2006); Oke and 
Gopalakrishnan (2009); Simchi-Levi et al., 
(2013); Rajesh and Ravi (2015)  
Agility: The ability to efficiently change 
operating states in response to 
uncertain and changing market 
conditions, for example, flexibility to 
adapt to changing requirements with 
minimum time and effort, visibility, 
joint planning, customer 
responsiveness, etc. 
Christopher and Peck (2004); Chopra et al., 
(2004); Sodhi (2004); Blackhurst et al., (2005); 
Kleindorfer and Saad (2005); Cucchiella and 
Gastaldi (2006); Faisal et al., (2006); Tang 
(2006); Tomlin (2006); Enyinda et al., (2008); 
Khan et al., (2008); Tang and Tomlin (2008); 
Braunscheidel and Suresh (2009); Narasimhan 
and Talluri (2009); Oke and Gopalakrishnan 
(2009); Chen and Huang (2010); Dani and Deep 
(2010); Christopher and Holweg (2011); Thun 
and Hoenig (2011); Wallace and Choi (2011); 
Diabat et al., (2012); Wieland and Wallenburg 
(2012); Zou and Couani (2012); Simchi-Levi et 
al., (2013); Scholten et al., (2014); Varzandeh 
et al., (2014); Abolghasemi et al., (2015); 
Chang et al., (2015); Rajesh and Ravi (2015); 
Singh (2015); Sahay and Ierapetritou (2015); 
Kurniswan et al., (2017); Lücker and Seifert 
(2017); Sreedevi and Saranga (2017); Wang et 
al., (2017) 
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2.3.2.2.8 Supply Chain Risk Monitoring and Review 
Compared with risk assessment and mitigation strategies, there is only one article that 
assessed risk monitoring and review so far. However, in the growing research based on supply 
chain risk, some studies have developed an SCRM framework and stress the need for risk 
monitoring (Hallikas et al., 2004; Norrman and Jansson, 2004; Zsidisin and Ellram, 1999). The 
current business environment is becoming more uncertain. To identify new types of risk 
requires monitoring changes in the network, customer needs, technology, partner strategies, 
and competitors and updating the risk assessment correspondingly (Hallikas et al., 2004).  
Redundancy or buffering strategy, for 
example, buffer (emergency) stock, 
excess productive capability, back 
sourcing, investments in a back-up IT 
system, etc. 
Schmitt (2011); Thun and Hoenig (2011); 
Schmitt and Singh (2012); Simchi-Levi et al., 
(2013) 
Increasing logistics capabilities, for 
example, increasing transportation 
equipment capability; inventory 
management; investment in new 
facilities, etc. 
Nooraie and Parast (2016) 
Business contingency planning Norrman and Jansson (2004); Finch (2004); 
Kleindorfer and Saad (2005); Oke and 
Gopalakrishnan (2009); Colicchia et al., (2011); 
Diabat et al., (2012); Wieland and Wallenburg 
(2012) 
Demand management, for example, 
silent product rollover; dynamic 
assortment planning, creating 
customer flexibility, customer 
incentives, demand forecasting, etc. 
Chopra and Sodhi (2004); Diabat et al., (2012); 
Elleuch et al., (2014); Rajesh and Ravi (2015); 
Tukamuhabwa et al., (2017); Urciuoli and 
Hintsa (2017) 
Financial management, for example, 
financial hedging, borrowing from 
customers, effective credit 
management, insurance, etc. 
Gaudenzi et al., (2017); Tukamuhabwa et al., 
(2017) 
Multiple sourcing and flexible 
contractual agreements  
Jüttner et al., (2003); Oke and Gopalakrishnan 
(2009); Thun and Hoenig (2011); 
Mohammaddust et al., (2017); Namdar et al., 
(2017) 
Postponement: The manufacturer 
produces a generic product, which can 
be modified at the later stages before 
the final transport to the customer. 
Jüttner et al., (2003); Tang (2006); Manuj and 
Mentzer (2008); Yang and Yang (2010); 
Wieland and Wallenburg (2012); Manuj et al., 
(2014); Rajesh and Ravi (2015); Wang et al., 
(2017) 
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Blome et al., (2011) found that most of their surveyed sample firms incorporated risk 
monitoring into their regular supplier monitoring activities, shortened the assessment cycle, 
and increased the monitoring depth during the financial crises. Moreover, the existing 
disruption is not only determined by the nature of the disruption but is also influenced by the 
organisational maturity level to handle such disruption issues (Qzai et al., 2015).  
Tummala and Schoenherr (2011) determined that data management systems can be utilised 
in the risk control and monitoring process for storing and updating the related risk 
information. This would help the organisation implement risk response action plans and 
provide guidelines for future improvement. In addition, there are plenty of sophisticated 
SCRM software applications that offer commercial solutions for risk management.  
Zhang et al., (2011) developed an integrated mathematical abnormality diagnosis model by 
combining radial base function neural network, fuzzy control, and statistical analysis methods 
to propose a pre-warning system of production quality issues in the food supply chain. The 
pre-warning system can effectively identify abnormal data types and accurately determine 
whether a warning should be issued. The drawback of the study is the narrow focus on quality 
risk in the food supply chain. 
2.3.2.2.9 Integrated SCRM processes 
A wide variety of studies focused on more than one stage of the SCRM process (24%, 51 
papers). Ritchie and Brindley (2007) proposed a conceptual framework for SCRM consisting 
of five major components: risk sources and profile, risk and performance drivers, risk and 
performance consequences, risk management responses, and risk and performance 
outcomes. Tummala and Schoenherr (2011) modified the previous RMP to identify, assess, 
and manage supply chain risks. The complete SCRM process constitutes three phases: Phase 
I (risk factors identification, risk measurement, risk assessment), Phase II (risk evaluation, risk 
mitigation, and contingency plans), and Phase III (risk control and monitoring).  
Bandaly et al., (2014) developed an integrated approach to SCRM using operational methods 
and financial instruments. They suggested that the SCRM process requires the collaboration 
of supply chain members (e.g., suppliers, manufacturers, and distributors) and the 
collaboration of functional units (operations and finance) of these members. In addition, 
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some research only covered two SCRM processes, such as risk identification and assessment 
(4%, 9 papers) or risk assessment and mitigation (8%, 18 papers). For instance, Jennifer et al. 
(2008) explored a proposed supplier risk assessment and monitoring framework related to a 
project with a US-based automotive manufacturer. A multi-criterion scoring procedure is 
proposed to evaluate part and supplier risk indices. 
Tuncel and Alpan (2010) presented a failure mode, effects, and criticality analysis (FMECA) 
technique to examine the disruption factors in the supply chain network and proposed a 
timed Petri nets framework to analyse the effectiveness and efficiency of various risk 
mitigation actions. Abolghasemi et al., (2015) proposed a novel approach for SCRM, which 
combined SCOR metrics and BNs to measure the supply chain performance for selecting the 
best alternative to mitigate risks. 
There are limitations associated with the above studies. Abolghasemi et al., (2015) only 
focused on a single industry with limited real data for the performance metrics. Tuncel and 
Alpan (2010) focused only on the perspective of the manufacturer. Tummala and Schoenherr 
(2011) demonstrated only the phases of the SCRM approaches but did not explain how the 
approach could be applied in practice. Ritchie and Brindley (2007) and Bandaly et al., (2014) 
only conducted a single-case study. The development of alternative risk assessment 
approaches would increase the sensitivity of the risk analysis (Jennifer et al., 2008), and there 
was a lack of empirical study to test the proposed risk management concept (Hofmann et al., 
2014). 
 
2.3.3 Status of risk management in the healthcare supply chain 
All activities in the health supply chain have risks to a certain extent. In the health supply chain, 
members of staff work in the procurement department, storage, distribution, and inventory 
with the aim of ensuring that all clients and customers in the health sector obtain all the 
services they need. A potential problem that can erupt from this process is called supply chain 
risks (Kumar et al., 2009). Like other industries, the healthcare industry is not immune from 
both predictable and unpredictable supply chain disruptions, which have significant effects 
on costs and patient care (e.g., losses due to downtime, shortage of essential drugs, and loss 
of life; Enyinda et al., 2014).  
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However, the biggest difference compared to other industries is that risk has a direct serious 
effect on the patient’s life. Research has indicated that, in Europe, medicine can travel 
through as many as 20 to 30 pairs of hands before it finally reaches the patient (Haigh, 2004). 
Consequently, operational failures in hospitals can result from the inability of a hospital’s 
work system to reliably provide supplies when, where, and to whom they are needed (Tucker, 
2004). Therefore, successful SCM is a significant element of an organisation’s ability to 
increase efficiency and ensure the safety of the patients’ lives. 
To manage the healthcare supply chain, most organisations identify the types and sources of 
risk and then derive effective strategies to mitigate the effects of the risk in their operations 
(Wisner et al., 2015). Risk management from a healthcare perspective refers to a formal 
approach that is employed to identify and mitigate all sources of disruption and dysfunction 
within the healthcare supply chain (Gosling and Naim, 2009).  
There are various benefits of risk management in the healthcare supply chain. First, effective 
risk management helps a firm or organisation achieve its supply chain objective. Risk 
management enables organisations to reduce the cost of enhancing efficiency in the 
healthcare supply chain operations. Risk management in the healthcare supply chain helps to 
improve the governance and leadership of the supply chain (Haszlinna et al., 2009). In 
addition, risk management in the healthcare supply chain can help to improve the confidence 
and trust in the supply chain of various stakeholders and customers (Tummala and 
Schoenherr, 2011). Finally, effective risk management in the healthcare supply chain helps 
supply chain managers focus more on proactive risk management rather than reacting to 
unforeseen events (Kumar et al., 2009). 
Risk management in the healthcare supply chain has continued to improve (Simpson et al., 
2015). Various enablers of risk management in the healthcare supply chain have been 
identified; they include information sharing, building trust among supply chain partners, 
building a responsive supply chain, collaborative relationships among healthcare supply chain 
partners, strategic risk planning, aligning initiatives, and risk sharing in the healthcare supply 
chain. Other enablers of healthcare SCRM include knowledge about risks in the healthcare 
supply chain and continual risk assessment and benchmarking of various healthcare SCM 
practices (Tummala and Schoenherr, 2011). 
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Healthcare institutions are now adapting to supply chain information management systems 
to help them manage their procurement and increase efficiency (Zhu et al., 2008). Various 
customised SCM software packages for the healthcare sector exist in the market (Gosling and 
Naim, 2009). The SCM helps procurement managers make informed decisions in matters 
related to the health supply chain. Various information management systems can also be used 
in healthcare supply management data warehousing and analysis of healthcare big data 
(Carter and Rogers, 2008). However, education on healthcare SCRM remains underdeveloped.  
According to Burn (2008), the healthcare supply chain consists of four main components: 
producer, purchaser, provider, and patient. In this study, particular focus is placed on the 
downstream chain (e.g., hospital), from the sourcing of the pharmaceutical products and 
materials from distributors/suppliers to the dispensation of medication in the care 
department. There is scarce research data on risk management within the healthcare supply 
chain pertaining to hospitals. Thus, in this study, after reviewing 213 quality papers in the 
SCRM field, only 11 papers and one official report were selected that were related to the 
hospital pharmaceutical SCRM. Similarly, there is no consensus on the concepts of healthcare 
SCRM as there are in SCRM in traditional industries. Among the reviewed articles, only one 
researcher defined healthcare SCRM as: ‘Risk management in the healthcare supply chain 
represents a systematic approach of identifying, analysing, treating and monitoring the risks 
that affect patient care process’ (Enyinda et al., 2014). To provide a meaningful analysis, Table 
2.11 summarises the selected papers in terms of the title, authors, publication year, research 
objectives, research methodology, and key findings. 
Table 2.11: Summary of 12 selected research papers 
Paper Citation Focus Method 
Type 
Key Finding 
‘A Preliminary 
Examination of 
Risk in The 
Pharmaceutical 
Supply Chain 
(PSC) In the 
National Health 
Service 
(NHS)(UK)’ 
(Breen, 2008) 
Gain a more realistic 
understanding of the 
nature and 
prevalence of risk in 
the PSC in the UK 
NHS.  
Qualitative Thirty-five prevalent risks have 
been identified, similar to 
those prevalent in industrial 
supply chains, regardless of 
the idiosyncrasies of the PSC, 
via a workshop forum held in 
November 2005. Suggesting 
that caution must be applied 
in how such risks are 
addressed, there are aspects 
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of the product that highlight 
its uniqueness (e.g., criticality).  
‘Evaluation of 
Different types of 
Risks in 
Pharmaceutical 
Supply Chain’ 
(Kamath et al., 
2012) 
Analysing and 
mitigating four 
major risks affecting 
the PSC.  
Hybrid Outsourcing, incorporating the 
latest anti-counterfeiting 
technologies, inventory 
management logistics 
planning, and good 
warehousing practices, 
insurance of products, and 
facilities and proper risk 
management strategies are 
suggested by the authors to 
mitigate risks.  
‘Summary of the 
executive session 
on critical threats 
to the pharmacy 
supply chain and 
the effects on 
patient care’ 
(Maryland, 2012) 
Focusing on the 
viable solutions to 
various critical 
threats to the PSC.  
Qualitative A discussion group taken by 
various stakeholders in the 
PSC on August 2012 in 
Bethesda, Maryland. Viable 
solutions to critical threats to 
the PSC were suggested during 
the discussion. Collaboration 
among all stakeholders 
involved in the PSC is needed 
to ensure a reliable PSC and to 
protect public safety. 
‘Supply risk 
analysis: applying 
system dynamics 
to the Colombian 
healthcare sector’ 
(Aguas et al., 
2013) 
This paper addresses 
supply risk in the 
oncological medicine 
supply chain in 
Colombia. A system 
dynamics model was 
developed for 
assessing supply risk 
effect on supply 
chain operation and 
performance.  
Quantitative The results show the market 
response level, implying a 
deficit in the medication 
system. Logistics service 
supply present delays in 
delivery times. It was found 
that the waiting time for 
receiving treatment was 
longer than three months in 
most cases. On average, it is 
known that only few patients 
requiring drugs will receive 
them in normal conditions. 
‘Efficient 
Healthcare 
Consumer Supply 
Chain 
Optimization’ (Ilie 
and Popa, 2013) 
The article aims to 
present the supply 
chain of the 
Romanian public 
healthcare system to 
determine if the end 
results of this  work 
are positive and 
meet current 
requirements and 
Qualitative Romanians will require more 
money to buy a vaccine 
because imported drugs have 
a higher price than domestic 
production. Another 
conclusion is that policies 
developed by local healthcare 
institutions remain faithful to 
the MS to protect the interests 
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challenges faced by 
society. 
of patients and consumers and 
to build a safer future.  
‘Sourcing Strategy 
and Supply Chain 
Risk Management 
in the Healthcare 
Sector: A Case 
Study of Malawi’s 
Public Healthcare 
Delivery Supply 
Chain’ (Kanyoma 
et al., 2013) 
The study primarily 
investigated the role 
of a single sourcing 
strategy in either 
exacerbating or 
mitigating persistent 
supply failure in 
Malawi’s public 
healthcare delivery 
supply chain.  
Qualitative The study findings confirmed 
that single sourcing 
exacerbates the risk of supply 
failure, evidenced by 
persistent stock outs of drugs 
in hospitals that consequently 
risk the lives of many patients 
who rely on the public 
healthcare system.  
‘An Analytical 
Model for 
Healthcare Supply 
Chain Risk 
Management’ 
(Enyinda et al., 
2014) 
This research is 
concerned with the 
quantification of risk 
in the healthcare 
supply chain using 
AHP.  
Hybrid The results indicated that 
infrastructure is the most 
important risk in the 
healthcare supply chain, 
followed by operational, 
supply, and political risk. 
Moreover, risk reduction is the 
overall best risk management 
option rather than risk 
avoidance, risk acceptance, 
and risk transfer.  
‘A combined 
approach for 
supply chain risk 
management: 
description and 
application to a 
real hospital 
pharmaceutical 
case study’ 
(Elleuch et al., 
2014) 
The paper describes 
a supply network 
risk approach to 
assist supply chain 
decision makers to 
risk identification, 
assessment, and 
management. 
Hybrid The proposed approach is 
based on combining many 
techniques and methods 
include the following: 1) 
FMECA to identify risk and its 
current location and assess 
risks, 2) design of experiment 
to design risks mitigation and 
action scenarios, 3) discrete 
event simulation to assess 
risks mitigation action 
scenario, 4) AHP method to 
evaluate risk management 
scenarios, and 5) desirability 
optimisation to perform the 
best risk scenario.  
‘Supply chain risk 
management and 
hospital 
In this study, the 
authors examine the 
effects of horizontal 
Quantitative Results suggest that, while 
affiliation with local, regional, 
and national systems has 
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inventory: Effects 
of system 
affiliation’ 
(Zepeda et al., 
2016) 
inter-organisational 
arrangements on 
inventory costs for 
hospitals facing two 
key environmental 
conditions: the 
logistics services 
infrastructure at the 
hospital and the 
demand uncertainty 
for clinical 
requirements that a 
hospital 
experiences. 
mitigating effects under weak 
logistics services 
infrastructure, the mitigating 
effect is greatest for affiliation 
with local systems.  
‘i-RM: An 
intelligent risk 
management 
framework for 
context-aware 
ubiquitous cold 
chain logistics’ 
(Kim et al., 2016) 
The research focus is 
on a special type of 
logistics in the 
healthcare setting, 
called ubiquitous 
cold chain logistics 
(UCCL).  
Quantitative An intelligent risk 
management framework for 
UCCL, namely, i-RM was 
suggested to automatically 
handle risks.  
‘How internal 
integration, 
information 
sharing and 
training affect 
supply chain risk 
management 
capabilities’ (Riley 
et al., 2016) 
The research 
determined if 
internal integration, 
information sharing, 
and training 
constitute direct 
antecedents to 
organisations’ 
warning and 
recovery 
capabilities.  
 Hybrid The findings suggested that 
building SCRM capabilities and 
their antecedents can better 
address an array of supply 
chain risks. They examined 
internal integration and 
training competencies as 
abilities to strengthen 
organisations’ warning and 
recovery capabilities.  
‘Operational 
productivity and 
performance in 
English NHS acute 
hospitals: 
Unwarranted 
variations’ 
(Lord Carter’s 
report, 2016) 
Lord Carter of Coles’ 
final report sets out 
how non-specialist 
acute trusts can 
reduce unwarranted 
variation in 
productivity and 
efficiency across 
every area in the 
hospital to save the 
NHS £5 billion each 
year by 2020/2021. 
Qualitative The 15 core recommendations 
on hospital productivity were 
designed to tackle 
unwarranted variation and 
help NHS trusts improve their 
performance.  
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2.3.3.1 Supply chain risk management methodologies in healthcare setting  
Risk management in the healthcare supply chain represents a systematic approach of 
identifying, analysing, treating, and monitoring the risks that affect the patient care process 
(Enyinda et al., 2014). To do so, risk factors identification, assessment, mitigation, and 
monitoring processes were reviewed along with the selected papers. As shown in Table 2.12, 
the divergent strategies explored by researchers are summarised. 
Table 2.12: Classification of the SCRM process in the healthcare setting 
Articles Risk Factors 
Identification 
Risk 
Assessment 
Risk 
Mitigation 
Risk 
Monitoring 
Breen (2008) X      
Kamath, et al., 
(2012) 
X X X  
Maryland (2012)   X  
Ilie and Popa 
(2013) 
  X  
Kanyoma et al., 
(2013) 
X X X  
Aguas et al., 
(2013) 
X X   
Elleuch et al., 
(2014) 
X X X  
Enyinda et al., 
(2014) 
X X   
Kim et al., (2016) X X X  
Zepeda et al., 
(2016) 
  X  
Riley et al., (2016)     
Lord Carter’s 
report (2016) 
X  X  
 
2.3.3.1.1 Healthcare supply chain risk factors identification 
Risk factors identification defines the cause of accidents in the healthcare supply chain. It is a 
first and essential step in SCRM. Brainstorming is employed to define the risk factors 
according to the perception of decision makers (Elleuch et al., 2014).  
As a pioneer of studying risk management in the UK NHS pharmaceutical supply chain (PSC), 
Breen (2008) conducted a workshop forum that focused on risk factors identification within 
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the PSC. The outputs of the workshop showed that there were 35 prevalent risks with varying 
levels of criticality. The participants were split into two groups to rate the criticality of the 
selected risk factors and to produce a general structure of the PSC. Furthermore, those 
identified risk factors have been divided into three distinct sections: supply chain structure, 
controllability, and strategy. The fragmentation of the supply chain has the highest rating due 
to a lack of uniformity in decision making within the PSC. This was followed by the lack of 
visibility of stock, unexpected increases in demand, demand versus capacity, and lack of 
information, which also have high ratings. 
Maryland (2012) discussed the fragmentation of the drug distribution processes and the use 
of restricted drug distribution systems, grey-market activity, counterfeiting, and drug 
shortage, which are critical threats to the PSC in the healthcare setting. Fake medicines range 
from useless to highly dangerous, and they often contain the wrong level of active ingredient 
or an active ingredient intended for a different purpose. The individuals taking counterfeit 
medicine put their health and even their lives at high risk. These risk factors are also 
mentioned by other researchers (Breen, 2008; Kamath et al., 2012; Enyinda et al., 2014).  
Moreover, several researchers also found that the shortage of drugs is another high-risk 
factor in the healthcare supply chain (Breen, 2008; Ilie and Popa, 2013; Aguas et al., 2013; 
Elleuch et al., 2014). With nearly 40% of hospital budgets dedicated to inventory (McKone-
Sweet et al., 2005), managers must explore available SCRM techniques to reduce inventory-
related risks. In a review of over 500,000 medication incidents reported to the National 
Reporting and Learning System between 2005 and 2010, omitted and delayed medicine was 
the category with the greatest number (16%) of reported medicine incidents (David, 2012). 
Colombian pharmaceutical policy shows that some of the main problems in the Colombian 
health systems are related to the availability of essential medicines (Aguas et al., 2013).  
Kanyoma and Khomba (2013) also revealed that stock outs have paralysed healthcare delivery 
systems and caused the deaths of patients, delays in medical surgery, and worsened medical 
conditions of patients, among other effects. Furthermore, Kanyoma et al., (2013) also learned 
of the major causes of medicine shortage in complementary empirical studies of Malawi’s 
public hospitals. The risk factors have been identified as follows: single sourcing strategy, 
insufficient inventory at the Central Medical Store (CMS), delays by procurement staff, and 
withholding of funds by donors. Moreover, other risk factors mentioned in their study that 
          
88 
 
are potential causes of recurrent stock outs include wrong demand forecasting, unexpected 
disease outbreaks, lack of funds at the hospital level, poor inventory management, and 
unavailability of drugs on the market. In this study, they found that the government instituted 
only a single supplier, namely, the ‘Central Medical Stores’, which is the main cause of 
medicine shortages. Moreover, variation in demand is another major factor influencing 
inventory management. Because of the higher demand uncertainty for alternative clinical 
services, the risk of stock out of needed items has higher uncertainty, which makes it difficult 
to reliably forecast (Davis, 1993; Lee et al., 1997; Sodhi and Lee, 2007). 
Supplier failure is another important risk factor that would lead to high cost or other serious 
consequences. It could be caused by either the location of the manufacture/supplier (not 
domestic based) or contract problems with hospitals, and so on (Breen, 2008; Kanyoma et al., 
2013; Ilie and Popa, 2013; Elleuch et al., 2014; Enyinda et al., 2014). Some researchers also 
identified the risk factors associated with regulation and political issues because the 
healthcare supply chain is regulated and monitored by various parties, such as the 
Department of Health, National Institute for Health and Clinical Effectiveness (NICE), 
Medicine and Healthcare Products Regulatory Agency, and the NHS Purchasing and Supply 
Agency (NHS PASA), to name but a few (Breen, 2008; Kamath et al., 2012; Kanyoma et al., 
2013; Ilie and Popa, 2013). 
Inventory risks could incur significant costs to healthcare providers. Kamath et al., (2012) and 
Enyinda et al., (2014) investigated the effects of inventory risk in the Indian and Nigerian 
healthcare industries, respectively. In general, inventory accumulation and obsolescence in 
the hospital sector are several times higher than in the retail/industrial sector (Ebel et al., 
2013). This is due to the unique characteristics of the healthcare industry, which does not 
regard the supply chain costs as the main driver of inventory decisions. Instead, inventory 
level is dictated by the need to meet service performance outcomes (Zepeda et al., 2016). 
Several researchers have determined that organisations encounter issues in managing 
inventory due to the different types of supply chain risks; demand exceeds supply, resulting 
in stock outs, or supply exceeds demand, resulting in surplus inventory (Craighead et al., 2007; 
Kremer and Wassenhove, 2014; Sodhi et al., 2012; Talluri et al., 2013). 
Some researchers stated that information-related risks have been a threat to the healthcare 
industry for many years (Breen 2008; Ilie and Popa, 2013; Aguas et al., 2013). They identified 
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several information-related issues including ‘Slow information transmission and single 
channel’, ‘asymmetries of the information’, ‘information flow or lack of demand information’, 
‘too much information’, ‘fragmentation of SC-no single source, multiple channels, no 
communication, unilateral decisions’, ‘lack of data standardisation (common codes)’. It was 
reported that the lack of data standardisation (common codes) is the top pharmaceutical 
information-related risk factor in terms of risk severity. 
As described above, supply chain risk refers to the ‘variation in the distribution of possible 
supply chain outcomes, their likelihoods, and their subjective values’ (Jüttner et al., 2003). 
Labour Peer Lord Carter (2016) produced a report for the government that reviewed what 
could be done to eliminate the unwarranted variations, to improve efficiency in hospitals in 
England. In this report, the various unwarranted variations can be considered as the risk 
factors. Since 2015, Lord Carter has engaged with 136 acute hospitals in England and further 
conducted empirical studies in 40 of those hospitals about the challenges in delivering 
improved productivity and improving efficiency. Nevertheless, this report disclosed some 
major issues related to the NHS SCM. In this report, Lord Carter found an astonishing variety 
in the numbers of products and suppliers used across and within NHS trusts. A sample of 22 
trusts used 30,000 suppliers, 20,000 different product brands, over 400,000 manufacturer 
products codes, and more than 7,000 people can place orders. There is a dramatic increase in 
the average price paid for procurements each year. Lord Carter also mentioned the significant 
variation in inadequate medicine stockholding between 11 and 36 days, holding £200 m of 
stock at any one time. Additionally, Lord Carter found that about 50% of medicine deliveries 
come from a small number of wholesalers, while the other 50% come directly from the 
manufacturers. That can mean that an NHS trust will receive up to 30 medicine deliveries 
every day, which would lead to dispensing or picking errors of medication and is time-
consuming for staff. 
Table 2.13 summaries the risk factors in healthcare supply chain operations from previous 
studies. A common limitation of the above articles is the applied qualitative methods for risk 
factors identification (Breen, 2008; Maryland, 2012; Enyinda et al., 2014; Kanyoma et al., 
2013), and they did not quantify the negative effects and severity of the risk factors. Some 
researchers conducted studies based on a sample of hospitals from a single state (Enyinda et 
al., 2014; Kanyoma et al., 2013; Zepeda et al., 2016). 
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Table 2.13: Summary of HSC risk factors from previous studies 
Risk Factors Authors 
Drive competitors out of the market, manufacturer defence 
tactic diversions of manufacturing capacity, cash-flow threat 
associated with small pharmaceutical companies and hospitals, 
demand versus capacity, lack of forecasting-customer side, 
demand/economics not able to respond to demand, increase in 
demand due to NICE approval, short-term supply chain 
planning, prioritisation conflict between patients/profits, 
regulatory issues such as manufacturing licensing, change of 
standards, drug recalls, risk of litigation, and influence on 
market. 
Breen (2008) 
Counterfeit risk and grey-market activity. Breen (2008), Kamath et 
al., (2012), Maryland 
(2012), Enyinda et al., 
(2014) 
Unexpected increase in demand, fluctuation in customer 
demands, and demand uncertainty for clinical requirements. 
Breen (2008), Elleuch et 
al., (2014), Zepeda et al., 
(2016) 
Unavailability of raw material, true and commercially induced, 
and domestic drug shortages. 
Breen (2008), Ilie and 
Popa (2013), Maryland 
(2012), Aguas et al., 
(2013), Elleuch et al., 
(2014) 
Unavailability of supplier, location of manufacture/supplier (not 
domestic based), inferior quality of purchased drugs from 
supplier, supplier failure, contract problems with suppliers, and 
contracting treated as a commodity, where big contracts equal 
big risk. 
Breen (2008), Kanyoma 
et al., (2013), Ilie and 
Popa (2013), Elleuch et 
al., (2014), Enyinda et al., 
(2014) 
Time limit of drugs. Enyinda et al., (2014) 
Inventory risk, insufficient inventory at Central Medical Store 
(CMS), lack of visibility of stock, inadequate buffer stock 
(JIT/lean), and poor inventory management by pharmacies. 
Breen (2008), Kamath et 
al., (2012), Kanyoma et 
al., (2013), Lord Carter’s 
report, (2016) 
Delay by procurement staff, procurement hubs – introduce 
more complexity. 
Breen (2008), Kanyoma 
et al., (2013) 
Clinician’s preference. Ilie and Popa (2013) 
Slow information transmission and single channel, asymmetries 
of the information, information flow or lack of demand 
information, too much information, fragmentation of supply 
chain (no single source, multiple channels, no communication, 
unilateral decisions), and lack of data standardisation (common 
codes). 
Breen (2008), Ilie and 
Popa (2013), Aguas et al., 
(2013) 
Fragmentation of drug distribution processes and use of 
restricted drug distribution systems, transportation 
(unavailability of fuel, congestion, weather, illness), 
Breen (2008), Maryland 
(2012), Aguas et al., 
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dispensing/picking error-medication/packaging, storage/cold 
chain, and capacities of logistics systems. 
(2013), Lord Carter’s 
report, (2016) 
Lack of incentive mechanism. Maryland (2012) 
Financial risk and lack of funds at the hospital. Kamath et al., (2012), 
Kanyoma et al., (2013) 
Reimbursement policies not consistent, regulatory risk, 
rigorous government intervention, and regulation risks (EU). 
Breen (2008), Kamath et 
al., (2012), Kanyoma et 
al., (2013), Ilie and Popa 
(2013) 
Unexpected disease outbreaks and external influences-disaster 
recovery. 
Breen (2008), Kanyoma 
et al., (2013)  
High purchase price and high product and supplier/brand 
variety.  
Lord Carter’s report, 
(2016) 
 
2.3.3.1.2 Healthcare supply chain risk assessment 
Breen (2008) recommended that further examinations could apply the AHP method to rate 
identified risk factors to assist in more structured decision making. Furthermore, this method 
has been used by several researchers (Kamath et al., 2012; Enyinda et al., 2014) in healthcare 
SCRM. Regulation risk has been ranked as the priority risk factor by Kamath et al., (2012). 
Moreover, Enyinda et al., (2014) investigated infrastructure risks (transportation logistics, 
electricity, and technology risks), which are important risks. Meanwhile, for sub-risk 
categories, the most important risk is counterfeits. 
The system dynamics model has been applied in various types of organisations, leading to 
capturing complex dynamics for representing causal relationships and inter-dependence 
between variables (Sterman, 2002). Wang and Zhang (2010) set the risk rate as the rate of 
emergency process in completion by utilising the system dynamics model. They revealed that 
there is a higher risk rate when the patient quantity is random, and the hospital staff is stable, 
while there is an obvious drop in the risk rate when medical affairs are adjusted in time on 
the condition of actual demand. Aguas et al., (2013) also developed a system dynamics model 
for assessing oncological medicine supply risk effect on supply chain operation and 
performance. They pointed out that the risk mitigation and management strategies focused 
on policy definition and negotiation rules with market provider and agent coordination, 
where logistics service operators and suitable information systems for management would 
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cause the reduction of overall supply chain costs and improve service and quality 
performance.  
Elleuch and Chabchoub (2011) evaluated the FMECA technique to identify and assess the risks 
in the PSC and proposed a simulation method to analyse the proposed scenarios according to 
the risk exposure levels. The methodology was illustrated by a real case study in a drugstore.  
Limitations exist in the above articles. Kamath et al., (2012) and Enyinda et al., (2014) 
surveyed samples that are geographically limited to only one country (i.e., India or Nigeria) 
with a small sample size. Moreover, AHP has a subjective modelling process nature, which is 
a constraint. That means that the methodology cannot guarantee the decisions as definitely 
true. The historical data was used to determine the severity index, and the probability of the 
identified risk factors would not be reliable (Elleuch et al., 2014). The major limitation of the 
study is that it was conducted at a time when stock outs of drugs were at crisis levels in 
Malawi’s public hospitals (Kanyoma et al., 2013). The data were collected based on subjective 
opinions, which will cause bias for the results (Breen, 2008). Elleuch et al., (2014) surveyed 
one hospital for the case study, which is limited to examining the structure of the hospital 
PSC. 
2.3.3.1.3 Healthcare supply chain risk mitigation  
Many risk mitigation strategies in the healthcare supply chain have been mentioned in the 
previous studies. Kamath et al., (2012) examined the four reactive risk mitigation strategies 
based on the different types of risk by applying the AHP method. In this study, transfer of risk, 
such as outsourcing insurance, was determined as the best management strategy with 
respect to regulatory risk and financial risk.  
Lord Carter (2016) presented five strategies for managing the unwarranted variations in the 
NHS supply chain as follows: collaboration, supply chain integration, outsourcing the non-core 
supply chain activities to a third party, NHS e-procurement strategy, and implementing 
information system technology. Moreover, some other researchers also indicated that 
building vertical inter-organisational relationships between an organisation and its suppliers 
is a key element to manage supply chain risk (e.g., Wiengarten et al., 2014; Zsidisin and Ellram, 
2003).  
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Table 2.14 summaries the risk mitigation strategies in healthcare supply chain operations 
from previous studies. However, there are limited studies focused on the establishment of 
horizontal inter-organisational arrangements among organisations with regards to the 
management of supply chain risks (Chen et al., 2013). To fill this gap, Zepeda et al., (2016) 
examined the moderating effects of horizontal inter-organisational arrangements on hospital 
inventory accumulation in the presence of supply chain risks arising from its environmental 
conditions, namely, the logistics services infrastructure where the hospital is located and the 
demand uncertainty for clinical requirements that the hospital experiences. The authors 
suggested that affiliation with a local system safeguards hospitals from supply chain risk under 
the conditions of a weak logistics service infrastructure. Furthermore, Riley et al., (2016) 
suggested that interaction and exchange of information between intra-organisational entities 
would positively affect organisations’ warning and recovery capabilities. 
Employee training can reduce risks in the healthcare industry. Most studies have paid much 
attention to it. This is because most supply chain activities are handled by pharmacists who 
lack skills to provide proper training of personnel and ensure adherence to quality-control 
policies and procedures for compounding sterile products and repackaging bulk medication 
supplies in all settings in the healthcare industry (Maryland, 2012). Ellench et al., (2014) 
examined personnel training and reward systems, which are important mechanisms to reduce 
human error in handling and storing drugs. Training also can identify risk factors and handle 
anomalies (Riley et al., 2016). 
2.3.3.1.4 Healthcare supply chain risk monitoring  
Until now, no studies in the academic literature have focused on risk monitoring in the 
healthcare SCRM process. 
Table 2.14: Summary of HSC risk mitigation strategies 
Risk Mitigation Strategies Authors 
Collaboration with the manager of the care units, forecasting, 
ERP, involvement of doctors and nurses of the care units, 
communication and information sharing with suppliers, 
collaboration with FDA to develop guidelines for importing drugs 
in short supply, and affiliation with local healthcare systems for 
hospital inventory management.  
Breen (2008), Maryland 
(2012), Lord Carter’s 
report, (2016), Riley et 
al., (2016), Zepeda et 
al., (2016) 
Employee training, ameliorating working ergonomics, reward 
system revision, investment in handling materials, motivation, 
Maryland (2012), 
Ellench et al., (2014), 
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relation with labour union, career management, providing 
proper training of personnel and ensuring adherence to quality-
control policies and procedures for compounding sterile 
products and repackaging bulk medication supplies in all settings, 
and educate personnel about how to comply with FDA and USP 
requirements for sterile compounding and repackaging of bulk 
supplies. 
Riley et al., (2016) 
Outsourcing the non-core supply chain activities to a third party. Kamath et al., (2012), 
Lord Carter’s report,  
(2016) 
NHS e-procurement strategy. Lord Carter’s report, 
(2016) 
Implement information system technology (RFID), traceability 
and information systems, and EDI. 
Lord Carter’s report 
(2016), Kim et al., 
(2016), Ellench et al., 
(2014) 
Inventory management and improving just-in-time and other 
inventory management practices. 
Maryland (2012), 
Jurado et al., (2016), 
Zepeda et al., (2016) 
Multiple sourcing strategies and development of contractual 
arrangements between health systems and multiple suppliers of 
selected essential products to avoid relying on a sole source.  
Maryland (2012), 
Kanyoma et al., (2013) 
Statistical quality control, inspection, and quality control. Ellench et al., (2014) 
Periodic maintenance and statistical process control.  Ellench et al., (2014) 
Design PSC systems to support a patient-centred model of 
healthcare delivery (integrate all drug distribution channels, 
implement electronic medical record technologies that support 
data exchange with multiple provider functional profiles, such as 
pharmacist–pharmacy provider electronic health records), 
standardise communication (eligibility for receipt of drugs with 
restricted distribution and file format for reports), develop a 
national standard for tracking and tracing medications that 
includes pricing information to deter price gouging, encourage 
greater manufacturer transparency and communication about 
the anticipated duration of shortages to allow practitioners to 
address the shortage, and encourage the FDA to compile and 
maintain a list of approved foreign sources of drugs in short 
supply in the United States.  
Maryland (2012) 
 
2.3.3.1.5 Integrated HCSCRM process 
Most researchers applied SCRM strategies in more than one stage. Most of these studies 
focused on two SCRM processes, such as risk factors identification and assessment (Aguas et 
al., 2013) or risk factors identification and mitigation (Maryland, 2012; Kanyoma, et al., 2013; 
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Kim et al., 2016; Lord Carter, 2016). Additionally, four out of 12 papers dealt with the entire 
process of SCRM in the healthcare setting. Kamath et al., (2012) conducted a literature review 
to identify four major risks affecting the PSC, and then the AHP model was proposed for 
ranking the identified risks. In addition, those solutions, based on risks, were provided in the 
results of the survey questionnaires and literature study.  
Similarly, Enyinda et al., (2014) explored SCRM using a questionnaire survey and AHP based 
on the qualitative judgements or opinions of the experts. Elleuch et al., (2014) developed a 
combined approach including FMECA, design of experiment, discrete event simulation, AHP, 
and the desirability function approach to deal with the SCRM process. Moreover, i-RM was 
suggested by Kim et al., (2016) as a divide-and-combine approach comprising context 
identification, risk detection, and response action judgement in semantic ontologies. 
 
2.4 LITERATURE GAPS IDENTIFIED  
From the research aspect, the importance of understanding the current research status and 
finding the research gaps based on the existing knowledge should be mentioned (Boote and 
Beile, 2005). Although the studies reviewed in this chapter have provided some valuable 
insight on risks and risk management in the healthcare supply chain, it shows that the research 
in this area is still in the early stage and is rather fragmented. For example, there has been 
limited academic research on the effects of external risks on healthcare supply chain 
disruption. Therefore, identifying the effects of risks on supply chain processes and functions 
should be considered in this research. During the last ten years, a considerable number of 
studies have emphasised the importance of process redesign and performance measurement 
to rationalise supply chain processes to improve the performance of patient risk flows. The 
existing studies indicated that most of the research focus has been on some specific risk 
management steps (e.g., risk factors identification or risk mitigation).  
However, there is a lack of research that has explicitly developed a thorough and sound risk 
management framework for evaluating integrated SCRM (e.g., risk factors identification, risk 
assessment, and risk mitigation) performance in the public healthcare sector, especially 
concerning physical flows. Moreover, to employ a single method is not appropriate as a risk 
management technique, as a multiple model would help reduce each models’ drawbacks. 
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Thus, it is imperative to develop a combined risk management model that contains several 
fuzzy-based MCDA models to deal with the complex supply chain risk-related decisions in an 
efficient manner. Besides, the majority of extant SCRM research regarding risk assessment 
only explored risks and provided typologies or taxonomies of those identified risks without 
concerning interrelationships between each risk. Mason-Jones and Towill (1999) have 
emphasized the significance of discovering risk interactions because it would support decision 
makers by understanding and tackling the root causes inherent in each of the risk area, and, 
equally importantly, how they interact with each other.      
Risk factors identification is the first step of SCRM to recognise the cause of risks across the 
healthcare supply chain. Although some studies can be found that deal with healthcare supply 
chain risk factors, the attention that is given to systematic identification is limited. A further 
analysis of risk factors identification is required to capture a more exhaustive variety of risk 
factors under a broader context. More importantly, no studies have examined the efficiency 
of the current implemented supply chain risk mitigation strategies in public healthcare 
organisations, although many risk mitigation strategies could be used to manage the effect of 
risk factors.  
However, due to the limited budget and resources of each public healthcare organisation, they 
must first pay more attention to the most imminent and significant risk factors. It is therefore 
necessary to evaluate the relative importance of different implemented risk mitigation 
strategies under given performance criteria.  
 
2.5 CONCLUSION  
The literature on HCSCM, SCRM and HCSCRM have been thoroughly reviewed in this chapter. 
Definitions of most of the terms used in healthcare supply chains, the developments of 
conventional SCRM, the status of risk management in the healthcare supply chain, and risk 
management methodologies implemented have been presented. Based on the analysis 
conducted in this paper, the healthcare supply chain can be expounded to include the supply 
of medical and surgical supplies, technology, partnerships, and consolidation within the 
supply chain community. Afterwards, the term risk management, which has previously been 
used to mean identification, prioritisation, and assessment of risks, can be used to include 
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coordination and economical application of resources with the aims of minimising, 
monitoring, and controlling the probability of unfortunate events. Thirdly, SCRM in the 
healthcare sector is subjected to a wide range of challenges, hence, procurement department 
leaders among other personnel who are in charge of whole supply chain activities in the 
hospital setting should be aware of the vulnerability of HCSC and adopt appropriate risk 
management methodologies. In general, it is fair to conclude that the analysis carried out in 
this paper has made a crucial contribution to the field of SCRM in a hospital setting. Finally, 
literature gaps on healthcare supply chain risk management were identified and summarised 
as follows: 
 There is no research that has explicitly developed a thorough and sound risk 
management framework for evaluating integrated SCRM (e.g., risk factors 
identification, risk assessment, and risk mitigation) performance in the public 
healthcare sector, especially concerning physical flows. 
 There is a deficiency in the research relating to external risks stemming from 
healthcare supply chains.  
 Although a number of studies have been found dealing with HCSCRM problems, the 
systematic way of risk factors identification and classification have not been provided 
by the existing literature.  
 There is a lack of consideration on the interdependencies between different risk 
factors. 
 No studies have examined the efficiency of the currently implemented supply chain 
risk mitigation strategies in public healthcare organisations. 
In order to address the research gaps aforementioned and to bridge the existing literature 
with healthcare supply chain risk management, this thesis proposes research questions 
outlined below. More specifically, RQ1 is associated with the first research gaps (risk 
management conceptual framework) while RQ2 relate to the second and third research gaps 
(risk factors identification and classification), thereafter, RQ3 and RQ4 dealing with the fourth 
research gaps (risk assessment) and lastly, RQ 5 and RQ6 are associated with the fifth research 
gap which highlight risk management strategies identification and evaluation.    
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 RQ1. What is the most effective HCSCRM framework that can be implemented to deal 
with the HCSC risks? 
 RQ2. What are the main sources of risk factors causing public sector healthcare supply 
chains to be vulnerable and how to identify and classify those risks? 
 RQ3. Which risk factors are relatively more significant to a hospital’s supply chain 
management performance? 
 RQ4. How are these risk factors interacting with each other? 
 RQ5. How can the hospitals from both UK and China effectively manage their supply 
chain related risks?  
 RQ6. What are the main risk mitigation strategies to be considered?  
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3.CHAPTER THREE - RESEARCH METHODOLOGY  
 
3.1 INTRODUCTION 
This chapter aims to explain research methods that can adequately address the research 
questions in the previous chapter based on the research gaps found in the literature review. 
As the interests of this research encompass all three phases of the risk management process, 
namely risk factors identification, risk assessment and risk mitigation, one research method 
is not able to sufficiently cover the entire topic of risk management. Rather, selection of 
appropriate research methods for each phase will be more desirable, which eventually leads 
to serves Chapters five, six and seven which are at the core of this thesis.  Meanwhile, this 
chapter also helps for the selection of the appropriate methodology to validate and further 
develop the proposed model of this research. 
This chapter starts by presenting an overall structure of the research methodology to 
illustrate the philosophical stance of this research. The next section focuses more on the data 
collection methods and analysis techniques that will be applied in Chapter five, six and seven 
respectively.  It needs to be mentioned that this research conducts the empirical studies from 
both the UK and China healthcare industries as well as other healthcare SCM research centers 
such as LogHealth Center in Thailand. Questionnaire survey and Semi-structured interviews 
are employed for the empirical study design. In addition, direct observation and official 
documentation were implemented as data input.  Figure 3.1 demonstrates an overview of a 
methodological framework for the purpose of this thesis upon which the research 
methodology will be developed.  
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Figure 3-1: Proposed methodology of Healthcare Supply Chain Risk Management 
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3.2 RESEARCH DESIGN   
Research onion can be regarded to as an overview framework, which has been developed by 
Saunders et al., (2009) as indicated in Figure 3.2, to facilitate the research process of the 
researchers. The research onion is a multiple layer model, and in this model, each inside layer 
is more detailed as compared to the outside layer of the model. The research onion essentially 
starts with the layer which deals with the research philosophies. After this, it considers 
research approaches, research strategies, choices, time horizons and lastly the research 
techniques and procedures. 
As far as the outermost layer of the research onion is concerned, it deals with the research 
philosophies, which includes four types of research philosophies, namely positivism, realism, 
pragmatism and interpretivism. The second layer of the research onion deals with the 
research approaches, which includes two types of research approaches, namely deductive 
and inductive. The third layer of the research onion deals with the research strategies. 
Depending on the nature of the research work, there are various strategies that can be 
adopted by a researcher, such as an experiment, survey method, ethnography, grounded 
theory and many more. The fourth layer of the research onion deals with the research 
choices. Here, the researchers need to decide whether they wish to apply a mono-method, 
multi-method or a mixed method to the research. The fifth layer of the research onion deals 
with the time horizons, which classifies the research work into either cross-sectional research 
or a longitudinal research. The last layer, the innermost layer, deals with techniques and the 
procedures, which include the data collection and data analysis methods which can be 
adopted by the researcher to carry out the research work.  
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Figure 3-2: Research onion 
 [Source from Saunders et al., 2009] 
 
3.3 RESEARCH PHILOSOPHY  
The first task for any researcher is to examine the research philosophy, which essentially deals 
with the knowledge development and assessment of the nature of that knowledge as 
highlighted by Taylor et al.,(2015). The choice made by any researcher regarding the research 
philosophy is largely dependent upon the way of the researcher of viewing the world. It is 
because each researcher views the similar situation in a different manner as expressed by 
Wilson (2010). For instance, one researcher might be factual and wish to assess the resources 
required in a manufacturing process. On the other hand, the other researchers might be 
concerned with the feelings and attitudes of the employees in an organization in the same 
research set up. Primarily, there are two types of research philosophies, namely the positivist 
research philosophy, which is also known as scientific as well as the interpretivist research 
philosophy, which is also regarded as the antipositivism as highlighted by Panneerselvam 
(2014).  
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As far as the positivist research philosophy is concerned, the reality is essentially assumed to 
be stable and the positivist believes that the reality can be observed as well as described from 
an objective viewpoint and the researcher to have minimal contact with the research 
participants thus the researcher should be independent and detached. The researcher, in this 
case, prefers ‘working with observable social reality and that the end product of such research 
can be law-like generalisations similar to those produced by the physical and natural 
scientists' (Easterby-Smith et al., 2002). The analysis of observations and results are usually 
quantitative as it follows rigid guidelines when conducting empirical reseach (Creswell, 2003). 
In an interpretivist research philosophy, the researcher is essentially critical of the positivist 
philosophy and is of the view that the social world is a complex system and it is not possible 
to theorise this social world by certain definite scientific laws (Gray, 2013). According to this 
philosophy, there is a difference between researching human beings and some objects. 
Human beings are considered as social actors in this philosophy as indicated by Babbie (2015). 
The author further elaborated that the interpretivist philosophy is based on two intellectual 
traditions, namely phenomenology and symbolic interactionism. Here, phenomenology 
refers to the way of assigning meaning to the external world by humans and social 
interactionism refers to the process in which humans continuously interpret the surrounding 
social world. In other words, humans interpret the actions of other human beings during their 
interaction.  Table 3.1 illustrates the difference between these two research philosophies. 
Table 3.1: Methodologies used in the Positivist and Interpretivism Philosophies 
 Positivism Interpretivism 
Ontology It considers reality to be real 
as well as apprehensible. 
It assumes that reality can 
be multiple as well as 
constructed. 
Epistemology It assumes the findings to 
be true, i.e., objectivist 
It assumes the findings to 
be created, i.e., subjectivist 
Research Methodologies Experiments and surveys Hermeneutical or dialectical 
 
3.4 RESEARCH APPROACH 
To carry out a research work, the researcher has to make a choice between the two 
approaches, namely the deductive approach and the inductive approach as mentioned by  
Brannen (2017). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
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In a deductive approach, a research work is thought of as a scientific study by the researcher 
as expressed by Brannen (2017). The author further expressed that this approach deals with 
the development of a theory, which is rigorously tested by the researcher. Robson (2002) 
indicates that in order to conduct a deductive research, it is suggested to progress through 
five sequential stages. In the first stage, the researcher starts with developing hypothesises, 
which can be referred to as a theory testing process covering the relationship between two 
or more variables or concepts. In the second stage, the task of the researcher is to express 
the deduced hypothesis in the operational terms. In the third stage, the operational 
hypothesis should be tested by the researcher to check whether the theory applies to 
particular situations. In the fourth stage, specific outcome of the inquiry will be examined by 
researcher, i.e., the researcher should check whether the outcome confirms the theory or 
there are any needs for the modification. In the last stage, the theory on the basis of the 
findings will be modified by researcher. This approach is mainly related to quantitative 
research techniques.  
In contrast, in an inductive approach, the researcher is required to develop a theory on the 
basis of the analysis performed on the collected empirical data as highlighted by Jebb et 
al.,(2017).  It usually begins by observing and investigating a real life phenomenon based on 
which generalisations are established and theories are constructed. In addition, this 
approache is usually linked to qualitiative research techniques.  The nature of this research 
implies the need for intensive literature investigations regarding the concepts, theories and 
possible practices in supply chain risk management, furthermore, collecting appropriate data 
through the empirical studies to support the developed framework and models. This research 
will employ a deductive approach where observations and facts will be clustered together 
and analysed to test the theory. Table 3.2 indicates the difference between the two research 
approaches. 
  .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . .  
Table 3.2: Major differences between deductive and inductive research approaches 
Deductive Approach Inductive Approach 
It focuses on the scientific principles. It emphasises on gaining an insight regarding the 
meanings attached by the  human beings to 
particular events 
It deals with the collection of quantitative 
data. 
It deals with the collection of qualitative data. 
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It moves from theory to data. It moves from data to theory. 
It is highly structured research approach. It is comparatively more flexible research 
approach. 
Here, it is necessary to come with 
generalized conclusion.  
Here, there is no need to come up with 
generalized conclusion. 
 
3.5 RESEARCH STRATEGIES AND CHOICES 
3.5.1 Exploratory and explanatory study  
An exploratory study is generally conducted when there is a little knowledge about the 
subject matter in the existing literature (Robson and McCartan, 2016).  Or if the research 
subject is something which is highly uncertain, then an exploratory method is required. In 
addition, this particular type of research strategy can be characterised as the one which 
possesses a high degree of flexibility. However, Kotzab (2000) indicated that this type of 
strategy essentially lacks a formal structure. The main aim behind conducting an exploratory 
research, as expressed by Ghauri et al., (1995) is to identify the boundaries of the 
environment in which the events, situations, opportunities or any problem which is of utmost 
interest to the researcher are likely to reside. An exploratory research is also aiming to identify 
the significant factors or variables which might be found in that environment and are of 
utmost relevance to the research as mentioned by Naeslund (2002). 
On the other hand, an explanatory research, which is sometimes called as analytical study, is 
conducted by the researcher with the major aim of identifying any causal links, which might 
be present between the variables or factors that are of relevance to the research problem. 
Unlike exploratory research, an explanatory research is very structured in nature (Robson and 
McCartan, 2016). In this thesis, the above two types of research strategies are applied to carry 
out this research. In this thesis, Chapter five provides a preliminary exploratory analysis to fill 
the gap in risk factors identification. In order to investigate the risk generation mechanism, 
the explanatory strategy is implemented to explain what is going on and conceptualise the 
risk propagation mechanism (Saunders et al., 2007).  
3.5.2 Mixed methods approach 
Mixed methods approach can be described “as a method which focuses on collecting, 
analysing, and mixing both quantitative and qualitative data in a single study or series of 
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studies. Its central premise is that the use of quantitative and qualitative approaches, in 
combination, provides a better understanding of research problems than either approach 
alone” (Creswell and Clark, 2011).   
There are multifarious characteristics associated with mixed methods research as expressed 
by Creswell and Clark (2011). Firstly, in this type of research, the researcher collects and 
analyses both quantitative and qualitative data. Secondly, it gives an opportunity to the 
researcher to mix the two types of data in different ways. Thirdly, it essentially gives priority 
to either one of the types of data, or both the types of data. Lastly, it can be used by the 
researcher in a single study or multiple phases of a study. This phenomenon is also known as 
triangulation technique, as no research methodology is being considered universally superior 
to the other as each has its drawbacks and advantages. “By combining multiple observers, 
theories, methods, and empirical materials, researchers can hope to overcome the weakness 
or intrinsic biases and the problems that come from single-method, single-observer and 
single-theory studies.  
Often the purpose of triangulation in specific contexts is to obtain confirmation of findings 
through the convergence of different perspectives. The point at which the perspectives 
converge is seen to represent reality.” (Liouka, 2007). The researchers expressed their 
concern by stating that in the contemporary era, scholars and researchers are often 
interested in utilizing both the qualitative and quantitative methods in order to analyse the 
same phenomenon. Due to this, there is an observable growth in the practice of utilizing some 
sort of 'triangulation'. Further, Mangan et al., (2004) described Triangulation' as a process 
which involves the verification, which certainly increases the validity of any research work via 
the incorporation of multiple viewpoints as well as research methods. Based on the research 
paper produced by Yeasmin and Rahman (2012), indicated that the triangulation method 
could be used by the researchers for two main reasons, i.e. for confirmatory and for 
completeness purposes. With confirmation, Young (2007) refers to the validation of results 
of the qualitative study by quantitative studies, and with completeness, Yeasmin and Rahman 
(2012) refer to the increase in the in-depth knowledge as well as understanding of the 
researcher regarding the phenomenon under investigation because the researcher has 
essentially utilized the combination of multiple methods and theories to come up with the 
outcome. Amaratunga et al., (2002) concluded their research by stating that the triangulation 
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technique is essentially a good technique because it allows the researcher to reap the benefits 
of both qualitative and quantitative methods.  
The choice of data collection method should be in line with the research questions and its aim 
and the objectives (Saunders et al., 2009). Two types of data collection methods will be used 
in this thesis. Primary data collective involves collecting new data, whereas secondary data 
collection concerns the collection of existing data. Therefore, both qualitative and 
quantitative methods are applied to identify, assess and mitigate SC related risks in the 
healthcare setting. To determine the risk factors in healthcare SC, literature review and 
questionnaire surveys are adapted to investigate and categorise unstructured risks. The 
questionnaire is proposed to verify the comprehensiveness and validation of identified risk 
factors as well as to examine the appropriateness of the risk classification method. Another 
questionnaire surveys and semi-structured interview are used for the data collection in risk 
assessment and mitigation stages. The data collection method applied in this thesis is mainly 
based on expert judgements. The obtained risk data are used as inputs of the proposed 
integrated risk management models to understand the priority of risks and evaluation of 
currently implemented risk mitigation strategies. Full details about research methods and 
research techniques will be discussed in the following sections.   
 
 
3.6 METHODOLOGY FOR DATA COLLECTION AND ANALYSIS 
This section presents a detailed explanation of the data collection and analysis methods used 
in the research. For the purpose of systematically identifying and understanding the relevant 
risk factors, it is necessary to employ an approach involving the use of both qualitative and 
quantitative methods to obtain and investigate the risks along with justification. The first sub-
section describes the data collection method in each risk management phase. More 
specifically, the first phase of questionnaire survey covering the key concepts of the identified 
risk factors will be conducted to verify the comprehensiveness of risk factors identification 
and the initial assessment of addressed risks as well as the validation of the proposed 
classification method. The second and third phase of the questionnaire survey will be 
conducted to quantifying the level of identified risks along with their contextual 
interrelationships. The empirical studies are conducted to extract identified supply chain risk 
mitigation strategies for further evaluation. Moreover, the last questionnaire survey is 
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designed to acquire the priority ratings of identified strategies for mitigating supply chain 
risks. The second sub-section introduces the data analysis methods in each risk management 
phase. Table 3.3 describes the methodologies for data collection and data analysis, which 
involves the three main risk management steps, and the related approaches and purposes of 
these approaches. 
Table 3.3: Summaries of the research methods for data collection and analysis 
Steps Approaches Purposes 
Risk factors 
identification 
Literature review To identify the existing risk factors in 
healthcare supply chain from the 
selected articles. 
 Questionnaire survey To investigate the reliability and 
validation of identified risk factors and 
risk classification method, and explore if 
there are more risk factors that are not 
mentioned in previous studies.  
 Email and face to face 
interviews 
To further explore the appropriateness of 
the developed hierarchy model. 
Risk assessment Fuzzy Analytic Hierarchy 
Process survey (web-based 
questionnaire (eSurvey 
Creator) 
To evaluate the risk factors for 
determining of their priority (weight) of 
concern. 
 Interpretive Structural 
Modelling survey 
(telephone, email and face-
to-face interview) 
To develop contextual relationships to 
analyze the inter-relationships among 
healthcare supply chain risk factors. 
Risk mitigation 
strategies 
identification 
Empirical studies (semi-
structured interview, direct 
observation, official 
documentation) 
 
According to the finding from previous 
chapter, to explore the current 
complemented risk mitigation strategies 
from both UK and China hospital cases. 
Meanwhile, to validate the identified risk 
mitigation strategies through 
documentation review and direct 
observation during the semi-structured 
interview,   
Risk mitigation 
strategies 
evaluation 
Fuzzy TOPSIS (Technique for 
Order Preference by 
Similarity to Ideal Solution) 
survey (email 
questionnaire) 
To rank the importance of the identified 
risk mitigation strategies under 
difference risk context.  
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3.6.1 Data collection methods 
The data collection will be presented in relation to each step of the risk management process. 
In order to capture and understand the risk factors, it is necessary to conduct an approach 
involving the use of both qualitative and quantitative methods to gather and examine the risk 
source along with justification due to the scarcity of the existing research in this field. In 
general, the purpose of empirical study is to verify the existing or newly proposed collected 
evidence about a piece of research on the basis of empirical data. A well-structured 
methodology, based on experienced should enable organizations to take full advantage of the 
findings. In this thesis, the purpose of conducting the empirical studies are to refine the 
understanding of risk factors that lead to major disruption and identify the currently 
implemented risk mitigation strategies in the hospital sector. Empirical studies were 
conducted separately for Chapters five, six, and seven respectively.  The first sub-section 
introduces the data collection methods in risk factors identification phase. Questionnaire 
survey A covering the key definitions of the identified healthcare SC risk factors will be 
conducted to verify the comprehensiveness of risk factors identification and the importance 
of addressed risk factors as well as the appropriateness of the risk classification model. The 
second sub-section discusses the data collection methods in risk assessment phase. Another 
two questionnaire surveys B and C will be proposed to evaluate the weighted priority and 
contextual relationships between each risk factor.  The third sub-section describes the data 
collection methods in risk mitigation strategies identification, validation and analysis.  Some 
source of evidence in empirical studies, i.e., semi-structured interview, site observation, 
official documentation are utilized in order to identify the current implemented risk 
mitigation strategies from both the UK and China hospitals. Then the questionnaire survey D 
will be conducted to analyse those identified strategies by ranking their priority.  
3.6.1.1 Data collection methods in risk factors identification and validation 
To conduct the systematic risk factors identification and decomposition, the research 
continues with the empirical studies including the key definitions of the identified risk 
sources.  Chapter five provides a detailed description of data analysis and taxonomic diagram 
validation in risk factors identification phase. 
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Several methods can be used for identifying risk factors such as, historical data collection, 
interviews, relevant document review and group meetings (Water, 2007). Researchers also 
used a literature review to identify the risks in the supply chain sector (Barry 2004; Wagner 
and Bode 2006; Kayis and Karningsih 2012; Ranger et al., 2015; Blos et al., 2016; Rogers et al., 
2016). This research first reviewed the relevant literature in order to identify all the risk 
factors that have been directly addressed in the healthcare supply chain, especially in the 
hospital drugs/pharmaceutical supply chain. The advantage of literature review is that it saves 
time since it has already been collected, and it is also less expensive than other methods 
(Saunders et al., 2009). After this, some experts from both academic and practitioner fields 
will be invited to take part in the expert panel so as to validate the identified risk factors and 
explore other potential risks. The experts are selected based on their professional working 
experience, job position as well as the qualification to the research topic.   
Following the rigorous approaches, the questionnaire is developed in line with research 
questions and the relevant studies to collect the opinions from the experts who are most 
familiar with conditions to clarify the ambiguity (McCormack and Hill, 1997).  Besides, behind 
doing this, the researcher also aims to investigate the reliability of the proposed risk 
classification model in the healthcare supply chain. In general, the number of parameters in 
the construct, the selection of a Likert scale and avoiding negative words are the critical 
issues, which must be given more attention (Hinkin, 1995). This research adapts a five-point 
Likert scale so as to investigate the level of agreement with each question from the experts.  
Initially, the questionnaire is developed in English language by the researcher, however, it is 
later translated from English language to the Chinese language by the researcher because the 
targeted experts are both from China as well as the UK. It is deliberately done by the 
researcher to make it easy for the experts from China to understand the questionnaire in the 
Chinese language. In order to verify the appropriateness as well as accuracy of the 
questionnaire after it is translated to the Chinese language, the researcher has made use of 
both forward and backward translation methods in order to examine the developed 
questionnaire. Two forward translators, native speakers of the Chinese and fluent in English. 
Both translators are come from Wuhan University of Technology in China and conduct 
translations independently. Any disagreements are resolved via a reconciliation process, 
resulting in a single provisional forward translation. Using this translation, backward 
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translation is carried out by a translator (fluent in Chinese and English, and different from the 
forward-translators) from Liverpool John Moores University to subsequently translate back 
the Chinese questionnaire into the English language. 
The draft of questionnaire A is then pilot tested on the target participant before being field-
tested on a larger sample. Face-to-face and telephonic interviews are carried out to assist the 
questionnaire builder to obtain a clear picture of the meaningful advice.  After the 
questionnaire feedbacks are received, a validity test was required to be conducted so as to 
test whether the study measured the necessary items and whether the study received the 
reliable responses. Based on the comments, the questionnaire is properly modified to fit in 
with the requirements (See Appendix One). By the end, the identified risk factors will be 
summarized into a hierarchy structure. Before conducting the further larger-scale risk 
assessment survey (to measure their weight priority and inter-relationships), the developed 
hierarchy structure will be send to the “validation team” by email and the face-to-face 
interviews are distributed and conducted with them so as to further explore the 
appropriateness of the developed hierarchy. Based on the obtained results, the identified risk 
factors are summarized into a final hierarchy structure, which provides a comprehensive risk 
database to healthcare SCRM research.   
 
3.6.1.2 Data collection methods in risk assessment stage  
Following the questionnaire development procedures described in section 3.6.1.1, the 
questionnaire surveys B and C are constructed to elicit expert opinion on the healthcare SC 
risk factors regarding their weight priority and inter-relationships. The Chinese/English 
translation processes are applied on both of these questionnaires, the same as applied in 
questionnaire survey A. The draft of both the questionnaires will be send to experts with very 
good knowledge and experience firstly as pilot study and then questionnaire Survey B will 
send to the experts from both UK and China hospitals, pharmaceutical manufacturer, 
pharmaceutical companies and supply chain service consultant organizations. According to 
Saaty (1980), an AHP-based questionnaire survey is acceptable when the consistency ratio 
(C.R.) is smaller than 0.1. Therefore, if the consistency ratio (C.R.) is over the standard 
acceptable value (0.1), the received survey will be returned to the experts to modify the 
answer.  After the results obtained from questionnaire B, following the same procedure, the 
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questionnaire Survey C is developed and conducted via the email, telephonic and face-to-face 
interview to the experts both from academic and practitioner fields.  Full explanations and 
discussion in respect of those two questionnaire survey procedures are explained in Chapter 
six. The finalised English and Chinese questionnaires B and C are attached in Appendix Two 
and Three.  
3.6.1.3 Data collection methods in risk mitigation strategies identification and analysis 
An empirical approach with surveys, followed by reviewing the official documentation, direct 
observation and semi-structured interview from both China and the UK hospitals, 
pharmaceutical companies. The current implemented risk mitigation strategies will firstly be 
identified, validated, and finally evaluated.  
Based on the obtained results from risk assessment phase, this thesis firstly reviews the most 
relevant official documentations to identify the risk mitigation strategies in the healthcare 
industry.  The following step is conducting the direct observation in the relevant departments 
hospitals and pharmaceutical company (e.g. procurement department; material department, 
pharmacy department etc.).  According to Yin (2009), the leading strength of conducting direct 
observation in the case based organization is to ensure the reality in real time and cover the 
event context. The semi-structured interview will be constructed to identify more risk 
mitigation strategies. During these formal interviews, the above results will be presented to 
the experts, and they are supposed to decide whether the identified strategies are relevant 
or not.  In addition, these experts will be asked if they would be willing to accept the invitation 
of the interview in advance.  
In the last phase, depending on the results obtained from above, another questionnaire 
survey D will be conducted aiming to evaluate the efficiency of the identified risk mitigation 
strategies with related to each risk factor. Following the same procedure of developing the 
questionnaire survey above, the Chinese/English translation process will applied on 
questionnaire D and the forward format is the pilot tested by four academic researchers 
before being field-tested on a larger sample. The finalised English and Chinese questionnaire 
D is attached in Appendix Four. 
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3.6.2 Data analysis methods 
The data collected in the previous sections are explained and analysed prior to being used in 
other stages of the research. According to Yin (2009), some specific methodologies and 
techniques are required to analyse collected data in order to produce high quality results. In 
this thesis, Fuzzy AHP and ISM models have been used to analyse the survey results from 
questionnaire B and C respectively and further fuzzy TOPSIS has been utilized to analyse the 
survey results from questionnaire D. For the purpose of ensuring the reliability and 
consistency of the gathered data, a series of tests (e.g. statistical test, consistency check and 
sensitivity analysis) should be conducted prior to carrying out the evaluation of risk factors 
and mitigation strategic research. The procedure of applying each model and producing a 
high-quality data analysis will be presented in Chapter six and Chapter seven.    
3.7 CONCLUSION 
In this chapter, various research methodologies were reviewed based on the “research onion” 
categorization which serves as an approach constituted by different layers of the research in 
a strategic manner. Based on the literature study, the appropriate methodologies for this 
research were identified and outlined. The techniques for the data collection and analysis by 
conducting the empirical studies have been described in this chapter.  There are three main 
parts for the data collection methods, which are: (1) data collection methods in risk factors 
identification, validation, (2) data collection methods in risk assessment phase, and (3) data 
collection methods in risk mitigation strategies identification, validation and evaluation.  In 
the first part, the risk factors are identified through literature review, and then the validation 
and exploration of the identified risks are done through questionnaire survey with both 
industrial and academic experts. Next, another two questionnaire surveys and telephone 
interview are conducted for the assessment of risk factors. In the last part, the implemented 
risk mitigation strategies are identified and validated by conducting the empirical studies (e.g. 
interview, direct observation and official documentation). In order to evaluate the identified 
risk mitigation strategies, a mitigation-strategy questionnaire survey is conducted. This 
enables the researcher to select the most efficient risk mitigation strategies. The techniques 
for the analysis of data are based on the employment of combined Fuzzy AHP, ISM and Fuzzy 
TOPSIS for the risk assessment and mitigation strategy evaluation.   
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4.CHAPTER FOUR - CONCEPTUAL FRAMEWORK AND INTEGRATED 
RISK MANAGEMENT MODEL 
 
4.1 INTRODUCTION  
The previous literature review indicated that there is lack of knowledge about how to control 
supply chain related risks in the healthcare industry. The majority of existing studies on 
healthcare SCRM merely imitated the traditional risk management approaches from 
manufacturing industry directly without considering the unique characteristicd of the 
healthcare setting. Specifically, there is a lack of risk management framework in healthcare 
organizations as a guidance or foundation which would support decision makers in the 
achievement of efficient risk management. The objective of this chapter is to develop a novel 
supply chain risk management conceptual framework. Hence, the chapter is structured as 
follows: firstly, the development of a risk management framework in the context of 
healthcare setting will be presented.  Based on the proposed conceptual framework, the 
three steps risk management process (i.e. risk factors identification, assessment and 
mitigation) as the main guideline to structure the research process are discussed. Finally, the 
chapter concludes by developing an integrated risk management model incorporating the 
reviewed MCDM and qualitative models.  
 
4.2 CONCEPTUAL FRAMEWORK 
Risk management has an integral role in the establishment of an effective supply chain that 
operates in the existence of different turbulences. In any supply chain, a risk management 
framework depicts an integrated process that takes place across a number of business 
settings before a turbulent event happens. The importance of a contemporary healthcare 
supply chain is evident in the improvement of patient care quality through practices of 
removing unnecessary costs and in the achievement of more robustness as well as resilience. 
Most healthcare providers and suppliers are committed to automating and streamlining 
supply chain processes with the aim of improving its efficiency. In fact, the current healthcare 
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supply chain is extensive and intricate and hence increases the level of potential risks for all 
the organizations involved.  
The proposed risk management conceptual framework is based on the idea of determining 
different factors that creates a risk-supporting environment as shown in Figure 4.1. It has five 
unique components that elaborate on the sequence that is supposed to be followed in 
assessing and managing uncertainties in a healthcare supply chain. They are the component 
of risk drivers and sources, decision makers, SC strategies, SCRM process and performance 
outcomes. The feature of the framework is more than simply to aggregate all the elements 
together but far more interactive and repetitive. The framework has a sequential process that 
is repetitive in nature and is centered around the risk management process, which is 
connected in circulation process, indicating that one component is dependent on another 
component. The literature on SCRM show that a common risk management process is 
generally organized into three steps: risk identification, risk assessment and risk mitigation 
(Kleindorfer and Saad, 2005; Hendricks and Singhal, 2005; Bode and Wagner, 2009; Kern et 
al., 2012). These three key steps are adapted in the framework for managing supply chain 
risks.  Besides, many researchers also emphasiszed the importance of an ongoing risk 
monitoring and iterative risk management process that is constantly adapted to the requirem 
ents of a changing environment (Kleindorfer and Saad, 2005; Hendricks and Singhal, 2005; 
Bode and Wagner, 2009; Kern et al., 2012). Without continuous improvement, even 
successful risk management processes will become weak and unable to identify and address 
risks with the risk measures when environmental conditions change and new risks arise. 
Therefore, risk management activities need to go hand-in-hand with a continuous 
improvement process in the long run.  
For risk management to be successful, there is a need to identify the risk driving factors that 
have a direct impact on SC performance. Several SC disruptions reported were clearly caused 
by these driving factors, or at least exacerbated by them. The term driver has been introduced 
to differentiate those factors likely to have a significant impact on the exposure to undesirable 
performance and risk outcomes, or possibly providing the opportunity to improve 
performance, albeit with increased risk (Ritchie and Brindley, 2007).    
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Figure 4-1: Healthcare supply chain risk management conceptual framework by author
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To assess supply chain risk, triggering events are modeled as a function of their severity in 
terms of impact on the supply chain goals and their frequency of occurrence. Different 
researchers have identified and configured risk drivers from different perspectives, such as 
the globalisation of supply chains or the trend towards outsourcing, have exacerbated the risk 
exposure as well as the impact of any supply chain disruption (Christopher and Lee, 2001). 
Since competitive pressures are often the drivers of risk, Svensson (2002) uses the term 
“calculated risks” that a company takes in order to improve competitiveness, reduce costs 
and increase or maintain profitability. The risk drivers in the developed framework are 
comprised more generically under five categories, linking to the level at which they are likely 
to have most impact (e.g. external environment risks likely to impact every organization, 
whereas node specific will impact only the organization itself). The idea also based on the 
suggestion of Jὓttner et al., (2003), who discovered the potential disruptions faced by 
organizations in supply chains into three categories: environmental-related (i.e. external 
environment and industry specific), network-related (i.e. supply chain configuration and 
partner specific) and organizational-related (i.e. note specific).  This is then followed with the 
phase of determining the available risk sources that are expected to facilitate and support risk 
management initiatives. Based on different types of decision-making unit, the perception and 
attitude towards risks might be different. The subjective perception of the significance or risks 
in divided into five groups: risk transfer (i.e. transfer the risk to another actor in the supply 
logistics (e.g. supplier, subcontractor, service, distributor, customer. etc) so they bear the risk), 
risk share (i.e. share or divide the risk with another actor in the supply chain networks), 
elimination using internal solutions (i.e. singlehandedly try to reduce or eliminate this risk 
using internal solutions), reduction with other partners (e.g. supplier, service, customer, etc), 
risk avoidance (i.e. do nothing at all and ignore the risk). These attitudes may drive managers’ 
decision-making processes and lead to different solutions. Supply chain risk, as risk in general, 
may be regarded as a subjective concept that relies on the individual’s assessment of 
potential outcomes, rather than an objective concepts (Heckmann et al., 2015).  The decision 
maker’s degree of acceptance with respect to the deterioration of target-values defines their 
attitude towards supply chain risks. For example, risk taker supply chain managers would 
behave in a way that can potentially cause harm and financial loss, but also have opportunities 
to get reward. On the other hand, risk avoidance decision makers would avoid the activities 
that may lead to exposure to a risk, such as not select suppliers that use unsustaintable 
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technique and process. In addition to this, the framework also highlights the essence of 
implementing appropriate SC strategies that should be tied to both risk context and type of 
decision-making units.  
Moreover, the contingency theory is used to describe the importance of situational influences 
on the risk management initiatives due to different SC networks being unique in certain 
respects and requiring the tailored strategies.  Otherwise, risk management helps to reduce 
the adverse impact while absorbing many resources and increasing the supply chain 
vulnerability. This feedback loop acknowledges that attempts to manage risks can sometione 
have an impact on that risk itself either positively or negatively, or another risk source. For 
example, Enterprise Resource Planning (ERP) system can be used to improve production 
planning and reduce control risks. However, highly dependency on such computer-based 
system may initiate another risks in terms of delayed processes caused by 
computer/hardware problem. Regarding to the performance outcomes, due to the different 
perspectives, the focus in the healthcare provider is towards both cost reduction and service 
quality improvement as well as employee satisfaction. The detailed discussions of each 
component are given below.  
4.2.1 Risk drivers and sources 
The component of risk sources and drivers are based on the assumptions that the supply chain 
is conceptually and practically holistic and supply chain risk resources are triggered by various 
factors. This framework can be acting as a platform to group them into five sectors:  external 
environmental, industry specific, supply chain configuration, partner specific, and node 
specific.  
External environmental factors are associated with the changes in the natural disasters, 
unexpected disease, and economic, social as well as political environments, basically on a 
local, national and global scale and how they affect the performance of healthcare 
organizations. In China, since the initiation of economic reforms in 1978, the country has 
undergone profound transformations in its social and economic structures associated with 
healthcare reform. As a matter of fact, the reform has brought tremendous opportunities and 
also the huge challenges to the healthcare industry. These challenges are associated with 
growing inequality in access to healthcare services, ineffective supervision and increased 
financial burden on hospitals. At the same time, the regulated pharmaceutical supply chain 
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system in China has always lacked the competitive mechanisms and leads to bureaucratic 
behaviour, inefficiencies and an imbalanced supply. It is widely acknowledged that the UK 
National Health System (NHS) is hugely reliant on EU-trained health professional staff who 
come to work in the UK from 27 other EU countries. Since the UK voted to leave the EU, there 
are about 10,000 NHS staff who have opted to go back to the EU or other countries. The staff 
losses will intensify the shortfall problems of the NHS, which is struggling to retain qualified 
staff.   
Some specific risks are also generated within the particular industry (i.e. Industry specific) or 
sector exposing those operating primarily within the sector.  Based on the findings of some 
reports, human life expectancy increased from 67.3 years in 1950 to 77.6 years in 2011 (OECO 
2013), it can be expected that the life expectancy will reach 88.5 years by 2050 (Miken 
Institute, 2013). As people live longer, there is more needs for frequent treatment and quality 
of healthcare service. Medical tourism is generally referred to as the act of patients travelling 
away their home country for the purpose of receiving better medical treatment and 
alternative care. The growth trend has been driven by a great affordability of medical care in 
other countries, high quality of speciality care, avoidance of long waiting times for certain 
medical procedures etc. According to Transparency Market Research (2013), the global 
medical tourism market was estimated to be £10. 6 billion in 2013 and is expected to reach a 
market worth £33.6 billion by 2020. Moreover, the healthcare reform in the UK includes 
‘Patient Choice’ which aims to provide patients more choices of hospitals for their elective 
care (Department of Health, 2006a). As a consequence of intensified competition, the 
healthcare providers have to improve their quality, efficiency and responsiveness. As a result 
of globalization of the economy, the healthcare supply chain has increased reliance on foreign 
sources of pharmaceuticals and raw materials with questionable quality. There is evidence 
that nearly half of the injectable drug shortages were caused by manufacturing quality 
problems in 2015. More significantly, the increased drug shortages could lead to the 
emergence of a grey market in which drugs are obtained and aggressively marketed to 
healthcare providers, usually at inflated prices, or even worse, counterfeiting drugs.  
Supply chain configuration, on the other hand, refers to the number of nodes or members 
within the chain and their relative influence are examples of variables that may influence the 
risk perceived at any node in the chain. Hospital operations should handle the multifaceted 
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distribution system consisting of multiple storerooms and warehouses where different 
pharmaceutical products are stored according to various instructions and regulations. Breen 
(2008) asserts that the convoluted nature of the pharmaceutical SC is suffering from issues 
like counterfeit medications, product shortages etc. Similarly, other research has described 
that in Europe drugs can pass through as many as 20-30 pairs of hands before they can 
eventually be delivered to patients (Haigh, 2004).  
Thus, the total 25 effective pharmaceutical markets in Europe have made the SC network 
more fragmented, which has resulted in a decline in the transparency of the whole SC 
(European Federation of Pharmaceutical Industries and Associations (EFPIA), 2005). 
According to the EFPIA, more than 2,500 medicines have some stage of manufacturer in the 
UK and 46m patient packs are supplied from the UK to EU countries every month, while 
another 38m flow in the opposite direction. Therefore, under the no-deal Brexit scenario, it 
should be considered that medicine supply chain would face ‘chaotic disruption’ and a rise in 
prices for UK and some EU hospitals.   
Partner specific refers to the key considerations in sustaining an efficiency of relationship 
between healthcare organization and pharmaceutical supplier and distributor. This can be 
realized through the introduction of consignment stockholding, retention of skilled labour, 
service quality and support, financial performance of the pharmaceutical company and 
training and development especially technical expertise. Moreover, neighbouring hospitals 
are encouraged to collaborate horizontally to achieve the goal of controlling procurement 
costs and sharing SCM knowledge (Rego et al., 2014).  
Node specific represents relevant considerations for the capabilities of healthcare 
organizations to respond to the demands of the end user in the supply chain, i.e. patients. 
The reasons for the above are such things as ill-equipped or poorly trained staff, inadequate 
management control and ineffective communications (Ritchie and Brindley 2007). For 
example, the Chapel Allerton Orthopaedic Centre (CHOC) in the UK faced the overstock 
problem due to inefficient inventory management. The centre spent over £3 million per year 
to improve the inventory management performance (Medwell, 2009). Similarly, in UK NHS, 
nursing staff have to spend on average 15 per cent of working hours to operate inventory 
management instead of clinical functions due to the lack of professionals.    
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It is indicated by Chopra and Sodhi (2004) that the main sources of supply chain risk are 
delays, capacity, disruptions, receivables, intellectual property, systems, inventory, forecasts, 
and procurement. Trkman and McCormack (2009) suggested a new theoretical framework in 
identifying and predicting different supply chain risks as shown in Figure 4.2.  
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Figure 4-2: Conceptual model 
[Source: Trkman and McCormack (2009)] 
It is noted that the factors in the specific environment of the supplier, which are endogenous 
and exogenous uncertainty, transform the nature and functionality of a supply chain. 
Endogenous uncertainty refers to turbulent situations that are exemplified by recurrent and 
volatile technological and/or market changes in a given industry that heighten risk and makes 
it difficult for accurate forecasting. Exogenous uncertainty, on the other hand, refers to 
environmental disruptions experienced in either human-centred problems (fraud, terrorism, 
labor strike, delays in logistics) or in the appearance of natural disasters (earthquakes, floods, 
hurricanes). The proposition of the model is that the relationships between supply chain 
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attributes, supplier risk of disruption or non-performance in a chain, supplier characteristics, 
and chain structure and strategy are transformed by environmental, market and technology 
turbulence. Giannakis and Papadopoulos (2016) also offer a significant contribution in 
defining a strategic risk management framework that focuses only on sustainability-related 
risks (Figure 4.3). A supply chain is impacted by environmental risks, financial risks and social 
risks, which are categorized under two key drivers: endogenous and exogenous.  
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Figure 4-3: A risk management framework for sustainability-related risks 
 [Source: Giannakis and Papadopoulos (2016)] 
Same as discussed by Trkman and McCormack (2009), endogenous and exogenous risks are 
characterized by disruptive situations that seek to heighten the uncertainty in forecasting and 
flow of supplies as demanded. It is believed that endogenous environmental risks have a 
relatively higher interconnectedness between different sustainability-related risks and, 
hence, are perceived as the most important element of consideration. As a result, there is a 
need to have integrated sustainability risk management models that assist in the 
determination and implementation of realistic sustainable initiatives. It is through such 
proactive projection that the adoption of a sustainability risk-related framework is found to 
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be useful. The significance of this sustainability risk management framework is that it can be 
used on various levels of the supply chain. One of the levels can be for the organization that 
is concerned with integrating sustainability-related risks to its decisions for strategic 
operations. Another level could be the dyadic connections with some suppliers as a way of 
improving the selection and assessment process for suppliers. Finally, the framework can be 
used for the general supply chain strategy, particularly where sustainability-related risks are 
associated with the decisions on investment and relationship with other networks such as 
shareholders, customers, and governments. The framework elaborates on an opportunity for 
creating distinction between typical supply chain risks and sustainability-related supply chain 
risks. This provides constructive insights concerning the causes and impacts of such risks and 
the appropriate measures to be taken as risk responses. In this thesis, the proposed risk 
management framework suggests the categorization of these sources into different areas of 
focus, including internal to the hospital, external to the hospital but relevant to the supply 
chain network, and external to the network. Any form of turbulence that is likely to happen 
in a defined supply chain will definitely have a source, which when determined proper 
measures can be put in place to ensure that the supply chain is efficient.  Chapter five provides 
a detailed explanation about the risk factors identification and classification.  
4.2.2 Decision makers  
Individual and/or groups  
In terms of the decision-making types, it depends on the whether the external SC partners 
are participating in the decision making process. In general, the healthcare providers 
exhibited the combination of individual and group decision-making. Informing policy and 
operational decisions by identifying supply chain related risks and their likelihood as well as 
consequences usually involved at least one hospital manager interacting with their 
corresponding colleagues in the Procurement Department, such as, in order to avoid the 
shortage of vital drugs would typically involve the Procurement Department and the Material 
Management Department. In this case, the likelihood and the serious consequence of the 
shortage in terms of performance measurement (e.g. patient’s health, service quality, and 
cost of emergency delivery) are reasonably predictable. If the problem becomes increasingly 
prominent and escalates into considerations about replacement of the major suppliers and 
increased stockholding, this might expand the scope of participation based on department 
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functions and working experience. Hence, as the main unit of pharmaceutical administration, 
the Hospital Pharmacy Management Committee (HPMC) would be involved in the decision 
process. The evidence also suggested that in the context of RM strategies and policies in 
hospital, the decision-making process is rarely the outcomes of a single individual or within a 
single time period. The process also engaged clinical involvement and the participants 
including suppliers and the other stakeholders (e.g. Finance and Staff training). In terms of 
risks and performance outcomes, the more strategically the decision is made, the more 
extensively this engagement took place (Ritchie and Brindley, 2007).            
Attitude towards risks 
According to Lavastre et al., (2012), attitude towards risk determines the level of success in 
its management. There are ways that a healthcare organization can adopt in addressing the 
identified risks in a supply chain. The nature of a given business and individual behaviour and 
style influences the attitude toward risk. The managerial perception of risks is critical for 
SCRM has been studied by few researchers (Zsidisinm, 2003b; Sodhi et al., 2012). Some of the 
generic attitudes that are adopted at this phase include risk transfer, risk share, risk 
elimination by using internal solutions, risk reduction by other partners, and risk avoidance. 
The element of attitude towards supply chain risks is associated with organizations’ trade-offs 
or what is considered as a tolerable level of risk. It is also deemed as the attitude of an 
organization and size of potential benefit with reference to risk taking, and it is such a 
perspective that determines whether an organization is a risk-taker or a risk-averse, which 
will have a direct impact on the risk mitigation.    
4.2.3 Risk management process  
The main tasks of risk management (RM) include the identification of risk sources, assessment 
of risks and mitigation of risks. Good practice of risk management depends on the 
preparedness of the whole risk management process, which provides a clear pathway for 
finding appropriate solutions for the potential turbulences in a supply chain. It should also be 
understood that the process of risk management is a circular and repetitive process. 
Therefore, some risk mitigation strategies can turn out to be new risk triggers.  As indicated 
in the framework, the iterative risk management process should adopt the continuous 
monitoring and improvement process because of the continually changing environment. 
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When environment conditions change and new risks occur, even efficient risk management 
processes would become weak and lack capability to identify and reduce risks with the right 
assessment without continuous improvement. It means the application of the current RM 
activities needs regular review, measurement and the continuous improvement being made 
with new inputs at each stages. Learning from previous mistakes will facilitates risk factors 
identification activities to investigate the root cause of the accidents across the SC. 
Transparency about an organization’s ongoing improvement in the effectiveness of RM can 
also promote the enormous motivations for staff to raise awareness of crisis and justify 
financial investment into staff training and other additional resources (Kleindorfer and Saad, 
2005).Therefore, the continuous evaluation of an organization’s RM processes helps to clarify 
potential areas for improvement and recognize the contribution of effective measurement 
and lessons learned from past accidents.   
4.2.4 Supply chain risk management strategies 
A key assumption established by this conceptual framework is that a number of risks will be 
reduced while others will be increased when various risk mitigation strategies are used. For 
example, in a conventional perspective, healthcare providers will increase the level of their 
stock as a way of mitigating the demand risks. At the same time, an increase in stock level 
would cause the risk of experiencing costs in terms of losses as the shelf life of some specific 
drugs is relatively short.  The assumption draws upon contingency theory, which emphasized 
that there is no one-size-fits-all strategy to govern the organization, manage the leadership 
and decision-making due to different environments providing different antecedents (Fiedler, 
1964). The theory argues that implementing the optimal decisions within the organization is 
contingent on both internal and external factors and the optimal solutions to adopt depend 
on the characteristic of industry and nature of the organization’s environment. That is to say, 
decision makers should consider that some tailored strategies are more fit than others for 
given circumstances. The organization’s performance is affected by the degree of matching 
of its organizational resources with the corresponding industry environment (Kim and Pae, 
2007).  Otherwise, risk management helps to control the impact of turbulence on 
organizational performance, this brings many benefits, on the other hand, due to some 
strategies (e.g. Lean philosophy) focus on cost reduction could remove all slack from the SC 
network, increasing vulnerability with unexpected implications for profit. Based on the 
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contingency theory, it seeks to provide decision makers with guidance to evaluate and 
implement appropriate mitigation strategies by considering various risk drivers, risk 
categories, type of decision maker, priority or risk factors as well as the performance 
outcomes.  
4.2.5 Performance outcomes  
There are different studies define the meaning of the term performances from the various 
perspectives. Child (1975) expresses performance on the basis of profitability and efficiency, 
while Hage and Dewar (1973) define performance in relation to employee satisfaction. Such 
differences reflect the different purpose and strategic objectives of the organization and the 
stakeholder composition. It is widely acknowledged that cost reduction and service quality 
improvement are two main performance objectives for building an efficient healthcare supply 
chain operation. However, in the meanwhile, most researchers often ignore the serious 
consequences incurred by the employee dissatisfaction in hospital operations.  It can be 
acknowledge that workforce quality and talent management are not only related to the 
organizational performance but also cover the entire SC activities (Hohenstein et al., 2014). 
Thus, existing studies have identified workforce as the key success factor in SCM, even beyond 
pursuit of quality and profitability (Scott et al., 2015). For example, the UK NHS junior doctors’ 
strikes had significant negative impacts on patient care. There were over 100,000 operations 
and exceeding 1 million outpatient appointments which were cancelled in 2016. In fact, 
decision makers should understand what factors both influence the retention of SC 
professionals and support the effective working environments within the organization, which 
is crucial for the long-term sustainability and performance of the field. 
 
4.3 DEVELOPMENT OF INTEGRATED RM MODEL IN HCSC 
The above novel risk management conceptual framework offers a comprehensive overview 
of the steps that needs to be followed in addressing various turbulences in a healthcare supply 
chain. However, due to the time and workload limitations, all the components cannot be 
covered in this research. Besides, Kleindorfer and Saad (2005) underlined the effective SCRM 
on the basis of three key tasks: specification of risk sources, risk assessment and risk 
mitigation. Therefore, based on the guideline of the framework, this research extracts a piece 
          
127 
 
of structure to develop an integrated risk management model comprising of three main SCRM 
steps (i.e. risk factors identification, assessment and mitigation) as presented in Figure 4.4.  
The concept of risks has all the time been associated with the supply chain, and this is based 
on the fact that it represents a clear picture of what an organization is all about. Both in the 
upstream of an organization and downstream supply chain, streamlining of operations is an 
important affair as it minimizes legal, financial, operational, confidentiality and reputational 
risk. The management of risk sources is a constructive decision-making process that sets a 
platform of understanding the engineering, social, political and economic factors as they are 
related to a scenario. In the case of supply chain management, risk management analyses 
these factors with regard to how they are related to a potential turbulence. This requires a 
methodology that allows the assessment of such a scenario from all perspectives with the 
objective of analysing organizational, SC network as well as environmental risks and 
accordingly, evaluation of the relevant risk management strategies.  
Hence, the adoption of an integrated risk management model has also been used in various 
frameworks and decision models (Samvedi et al., 2013; Elleuch et al., 2014; Nazam et al., 
2015). Among these studies. Samvedi et al., (2013) integrated Fuzzy AHP and Fuzzy TOPSIS 
for quantifying supply chain risks in relation to the probability and severity.  Meanwhile, they 
have the benefit of combining approaches like fuzzy set theory, which by its nature is built to 
handle subjective assessments. However, there is no systematic approach to identify supply 
chain risks in this study. By using the combined approach including: (1) Failure model, effects, 
and criticality analysis (FMEA), (2) Design of experiment (DOE), (3) Discrete event simulation 
(DSE), (4) Analytic hierarchy process (AHP) and (5) Desirability function approach (DFA)  to 
managing risks in hospital sector. The main focus on this study is centred on determining the 
most signification supply chain risks mitigation strategy for a supply chain but not to evaluate 
the contextual relations as hidden influences between the risks which are focused on in this 
thesis. Using the same set of MCDA methods with Samvedi et al., (2013), Nazam et al., (2015) 
proposed a decision making model to support ranking and assessing the risks associated with 
implementation of green supply chain management practices under the fuzzy environment. 
Nevertheless, this research does not primarily concentrate on estimation of the efficiency of 
specific risk mitigation strategies but instead on the evaluation of when the GSCM initiatives 
should be implemented.  Moreover, there is also lack of a systematic approach for identifying 
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the current implemented risk management strategies. Although there is increased attention 
on SCRM in the literature, only a few studies have focused on the effective risk management 
methods which support healthcare organizations to make appropriate decisions for a more 
resilient supply chain.  
The integrated risk management model, illustrated in Figure 4.4, focuses on the identification 
and assessment of supply chain risk factors as well as prioritising implemented risk mitigation 
strategies through the fuzzy set theory, qualitative and interpretive as well as MCDM 
methods. Firstly, both literature review and questionnaire survey are employed to 
systematically identify and classify relevant risks and conduct an initial assessment. It is 
followed by quantifying the priority weight of identified risks through the use of Analytic 
Hierarchy Process (AHP) incorporating with fuzzy set theory. Interpretive Structural Modelling 
(ISM) is then applied to investigate the interrelation among the risks. Lastly, empirical studies 
are conducted to extract identified current implemented risk mitigation strategies for further 
evaluation. Thereafter, Fuzzy TOPSIS is employed to capture the priority ratings of identified 
strategies for managing SC related risks. 
4.3.1 Phase 1 - Risk factors identification  
Risk factors identification is the first step in the process of risk management and it is an 
essential stage in the risk management process as the organizations can understand the 
unfavourable factors in the projects (Norrman and Jansson, 2004). Besides, risk factors 
identification provide the list of risks that not only impact on the one piece of process but also 
the whole supply chain network.  
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Recognize and select the risk factors
Finalized the criteria to be used in risk assessment
Establishing hierarchical structure
Literature 
review
Obtaining 
expert s opinion
Phase 1
Approval of hierarchy
Phase 2 FAHPYes
No
Structure problem hierarchy
Construct the fuzzy comparison matrix
Transform linguistic judgements into fuzzy numbers
Consistency check
Calculate the fuzzy weight of criteria and sub-criteria s
Ranking of the risk factors
Yes
Triangular fuzzy 
number (TFN)
No
Phase 3 ISM
Construction of structural self-interaction matrix 
(SSIM) by pairwise comparison
Developing a reachability matrix from the SSIM and 
checking for transitivity
Ensuring the reachability matrix is appropriately 
partitioned into several levels 
Conversion of diagraph with removed transitivity links
MICMAC analysis
Drawing of diagraph with removed transitivity links
Remove the risk factors with weak drivers and 
dependents
Phase 4 FTOPSIS
Conduct the empirical studies for identified the 
implemented risk mitigation strategies 
Choose the appropriate linguistic values for 
alternatives with respect to criteria
Compute aggregate fuzzy ratings for the alternatives
Construct the weighted normalized fuzzy decision 
matrix
Construct the fuzzy decision matrix and the normalized 
fuzzy decision matrix
Determine and calculate the distance of each 
alternative from FPIS and FNIS
Calculate the closeness coefficient (CCI) of each 
alternative
Rank the alternative 
Triangular fuzzy 
number (TFN)
 
Figure 4-4: Proposed integrated risk management model in healthcare supply chain 
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Hazard and operability (HAZOP) analysis is a systematic and structured method of examining 
an intricate operation or process for the purpose of identifying issues that are potential risks. 
As argued by Venkatasubramanian, Zhao and Viswanathan (2000), HAZOP is based on the 
idea of breaking the complicated process design into straightforward sections known as 
‘nodes’ for reviewing. As a qualitative method, HAZOP focuses on stimulating the idea of 
identifying operability issues and potential turbulences in a supply chain. Conducting a semi-
structured interview or organizing the focus group through brainstorming session are other 
appropriate risk factors identification methods that consider the experience of managers in 
dealing with challenges in supply chains. There are qualitative methods that can be used in 
inquiring about the nature of risks and the root causes in the supply chain. This is realized by 
combining a pre-determined set of open-ended questions.   
Moreover, literature review and qualitative questionnaire survey are other risk factors 
identification methods which serves as a base and guide to build upon throughout the risk 
factors identification research process. In this thesis, it starts with the literature review and 
then an initial healthcare supply chain risk taxonomic diagram is developed. More specifically, 
the focus of the risk review needs to be defined in advance and an organized HCSC risk 
classification schema is mapped for creating a more complete picture of each stakeholder, 
responsibilities and three different kind of flows (i.e. material, information and cash flow) in 
the network. It provides an overview by enumerating all possible threats that could produce 
the adverse consequences for the SC performance. However, it is clear that not all risks are 
easy to find out. Feedback loops and dependent events chains often pose additional 
challenges for risk factors identification (Hallikas et al., 2004). Therefore, by conducting the 
qualitative survey, the obtained risks are analysed to verify the comprehensiveness and 
validation as well as to confirm the appropriateness of risk classification method. Besides this, 
an initial assessment is conducted to quantify the important level of identified risks as this 
thesis only focuses on those risks requiring most attention by experts.   
4.3.2 Phase 2 - Risk assessment  
Risk assessment is the second step in the risk management process. It provides a quantitative 
view of the priority of the risks and would help decision makers to understand which risks 
should be payed more attention as well as which risks are less critical. Risk assessment in a 
supply chain is an imperative fraction of the SCRM process, and this is based on the idea that 
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it is an extensive criterion for decision making while under unclear environments. It is always 
concerned with the probabilities for identifying risk-taking events in the SC system and 
determining the consequences of these risk events defined in the previous stage. Norrman 
and Jansson (2004) provide an in-depth analysis of the supply chain risk management model 
by Ericsson, which proposes the assessment of the impact of risk on profitability. The 
approach elaborates on the economic damage caused by disruption in a supply chain. It also 
focuses of the probability of occurrence of a risk. Deleris and Erhun (2011) offer a quantitative 
model of risk assessment that is a derivative of probabilistic risk analysis (PRA). It is an 
important method that can be used for various scenarios as it becomes realistic to simulate 
the impact of risk scenarios on supply chain performance. However, uncertainty issues cannot 
be presented simply by using the concept of probabilistic or crisp values.  The fact that there 
are a lot of subjective judgements involved in the multiple factor analysis hinders the 
applicability of many risk assessment methods. Nevertheless, the application of Multiple-
Criteria Decision Making (MCDM) methods combined with the fuzzy set theory (FST) in the 
risk assessment allows the qualitative risk assessment descriptions to be mathematically 
modelled (Wang et al., 2017). Meanwhile, by applying another interpretive method for 
developing understanding of the complex relationships among system element aims to 
analyze the impact of each individual risk on another.  
As described above, risk assessment involves multiple factor analysis. Many researchers have 
conducted studies to assess and measure the supply chain related risks by using multi-criteria 
decision-making (MCDM) methods from different perspectives. It is a powerful tool widely 
used for evaluating and ranking problems containing multiple criteria. Moeinzadeh and 
Hajfathaliha (2009) developed a SC risk assessment approach based on the analytic network 
process (ANP) and the VIKOR methods to evaluate the risks through ranking the relative 
importance of the risk categories. Analytic network process (ANP) is a MCDM method, which 
is capable of handling interdependence and feedback among the evaluation criteria. 
Feedback can better capture the complex effects of interplay in human society. Each criteria, 
sub-criteria and alternative are treated equally as nodes in a network. Each node might be 
compared to another node as long as there is a relation. For example, the ranking of 
alternatives might not only depend on the weighting of criteria, but also given alternatives 
can influence the ranking of criteria. However, the method require a specific software to 
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calculate results and the explanation of concept and process to management extremely 
challenging.  Furthermore, the inconsistency may occur, leading to doubtful or wrong results. 
Therefore, Wang et al., (2012) applied fuzzy Analytic Hierarchy Process (FAHP) to assess risk 
of implementing various green initiatives in the fashion industry. Samvedi et al., (2013) 
applied fuzzy AHP and fuzzy TOPSIS (Technique for Order Preference by Similarity to an Ideal 
Solution) to quantify the risks in a supply chain, and aggregated the values into a 
comprehensive risk index. Similarly, Nazam et al., (2015) proposed a hybrid model to rank and 
assess the risks associated with implementation of green supply chain management (GSCM) 
practices under the fuzzy environment using fuzzy AHP and fuzzy TOPSIS approaches.  
Founded by Thomas Saaty in 1971, the Analytic Hierarchy Process (AHP) is an MCDM method 
to deal with intricate decision making by creating a series of pair-wise comparisons from 
complex decisions and synthesize the outcome. It is also effective in capturing both objective 
and subjective elements of decision and, hence, providing a comprehensive analysis of a 
situation and helps decision makers evaluate whether the problems in each level are of the 
same order of magnitude. In other words, it provides the decomposition of a complex 
problem into a systematic hierarchical level. In the conventional AHP model, the pairwise 
comparison is made using a nine-point scale which converts the human preferences between 
available criteria and alternatives as equally, moderately, strong, very strong or extremely 
preferred as shown in Table 4.1.  
Table 4.1:  Nine-point pairwise comparison scale (Saaty, 2008) 
Measure scale  Definition  Description  
1  Equal importance  Two factors contribute equally to 
the objective  
3  Weak importance of one over 
another  
Experience and judgement 
slightly favour one over another.  
5  Essential or strong importance  Experience and judgement 
strongly favour one over another.  
7  Very strong or demonstrated 
importance  
A decision element is favoured 
very strongly over another. Its 
dominance demonstrated in 
practice.  
9  Absolutely importance  The evidence favouring one 
decision element over another is 
of the highest possible order of 
affirmation.  
2, 4, 6, 8  Intermediate values  When compromise is needed.  
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Reciprocals of 
above nonzero  
If decision element i has one of the 
above nonzero numbers assigned to 
it when compared with decision 
element j, then j has the reciprocal 
value when compared with i  
A reasonable assumption  
Rational  Ratios arising from the scale  If consistency were to be forced 
by obtaining n numerical values 
to span the matrix  
 
By incorporating essential techniques of checking evaluation consistency, AHP assists in 
addressing any form of bias in a decision-making process. Compared with other decision-
making approaches, there are three mainly advantageous features of the differentiated AHP: 
its ability to handle both tangible and intangible attributes; its ability to structure the 
problems in a hierarchical manner to gain insights into the decision-making process; and its 
ability to monitor the consistency with which a decision maker makes a judgement (Vargas, 
1990; Wedley, 1990). Moreover, Golden et al., (1989) determined the characteristics of AHP 
as including simplicity, ease of use, flexibility and the ability to deal with ill-structured 
problems; its principles have been successfully applied on many complex real-life decision-
making scenarios. On the other hand, despite the popularity and simplicity of applying AHP, 
this model is often criticized because it does not adequately address the inherent 
uncertainties and inaccuracies associated with mapping decision-maker’s perception to exact 
numbers (Chan et al., 2008; Gopalan et al., 2015). In addition, the subjective evaluation is 
evident with following the capacity of the decision maker, which can be misleading at times. 
It also over relies on the decision maker and any form on conflict in the decision affects the 
whole process.  
As discussed above, the traditional AHP cannot be directly applied to solving uncertain 
decision-making problems as it is not able to reflect human cognitive processes. Thus, Bellman 
and Zadeh (1970) investigated the decision-making method in fuzzy environments, and the 
fuzzy set theory has been applied by an increasing number of researchers to handle uncertain 
fuzzy problems. It has proven advantages within vague, imprecise and uncertain contexts and 
it resembles human reasoning in its use of approximate information and uncertainty to 
generate decisions (Chan and Kumar, 2007). There are more than 7,000 journal articles, 
reports, monographs and books on fuzzy set theory and applications that have been 
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published since 1965 (Kaufmann and Gupta, 1988). The procedure of fuzzy theory is shown 
at Figure 4.5.  
 
Fuzzy Inference Rules
Process Under Control
DefuzzificationFuzzification
Output Fuzzy 
Linguistic Variables
Input Fuzzy Linguistic 
Variables
Input Crisp 
Variables
Output Crisp 
Variables
Figure 4-5: A typical Fuzzy Logic control – Fuzzy control system schema 
[Source: Kὂse and Deperlioglu 2015] 
The crisp variable is entered into the fuzzy controller and then another crisp variable is output 
for further evaluation. There are four main components in the fuzzy control system (Kὂse and 
Deperlioglu 2015): “(1) the rule-base learns how to best control the system in the form of a 
series of rules,  (2) the reasoning mechanism determines which control rules are currently 
more relevant at the current time and then decides what the input variables to the plant 
should be; (3) the fuzzy interface simply modifies the inputs so that it can be interpreted and 
compared with the rules in the rule-base; and (4) the defuzzification interface converts the 
conclusions reached by the inference mechanism into the inputs to the plant”. Zimmermann 
(2010) defined fuzzy set theory is an expansion of classical set theory with the capacity of 
allowing varying assessment of a set element’s membership. This is effectively illustrated by 
the help of membership function, which normally has real unit interval of [0, 1]. A title “~” is 
placed above a symbol if the symbol represents a fuzzy set. Therefore, fuzzy logic goes beyond 
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the use of ‘True’ and ‘False’ when expounding on human reasoning by using ‘0’ to indicate 
‘False’ and 1 to indicate ‘True’ when describing the reasoning of humans. Conversion scales 
are used in fuzzy set theory for the purpose of transforming the linguistic concepts into the 
fuzzy numbers.   
The Fuzzy Analytic Hierarchy process (FAHP) method extends the classic AHP method by 
combining the concepts of fuzzy set theory as the conventional AHP fails to reflect human 
thinking style. It provides a solution to the drawback of pairwise comparison, which is unable 
to deal with uncertainty and imprecision related to the mapping of the decision makers’ 
preference to a crisp number (Deng, 1999).  According to Wang and Chin (2011), fuzzy AHP is 
a practical method that can be used for several criteria decision-making, particularly in fuzzy 
environments. Van Laarhoven and Pedrycz (1983) initially applied Fuzzy AHP to compare fuzzy 
ratios described by triangular membership functions. Buckley (1985) conducted a Fuzzy 
Hierarchy Analysis in which “experts are allowed to replace exact ratio by using fuzzy ratio”. 
The majority of fuzzy AHP applications focus on the crisp point estimate method, therefore, 
the basis of this thesis is on Chang’s extent analysis method as it is a widely accepted FAHP 
method by many researchers (Kahraman et al., 2003; Chan and Kumar, 2007; Chan et al., 2008; 
Kumar and Singh, 2012; Ganguly and Guin, 2013; Samvedi et al., 2013; Radivojević and gajović 
2014; Gopalan et al., 2015; Prakash and Barua, 2016 etc.).  Chang (1992, 1996) introduced a 
new extent analysis approach for the synthetic extent values of the pairwise comparison for 
handling fuzzy AHP. The proposed method with extent analysis is simply and easy to 
implement to prioritise decision variables as compared with the conventional AHP (Chan and 
Kumar, 2007). However, the disadvantage of this method is that it lacks the capacity of 
handling any form of vagueness possible in numbers as only triangular fuzzy numbers are 
allowed in the application. The computational procedure for calculating the priority weights 
of the different criteria and sub-criteria using Chang’s extent analysis method can be 
summarized as follows: 
 Construct the fuzzy comparison matrix of criteria and sub-criteria with respect to the 
goal.  
 Determine the fuzzy synthetic extent value with respect to the each criterion with the 
help of the equations. 
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 Determine the degree of possibility of the superiority of each fuzzy synthetic extent 
value with respect to each other.  
 Decide the minimum degree of possibility of the superiority of each criterion over 
another.  
 Determine the weight vectors of the criteria with the help of minimum degree of 
possibility of superiority of each criterion. 
 Normalize this weight vectors and determine the final weight of the criteria with 
respect to the goal.   
 Repeat this process to decision weight of all the sub-criteria with respect with their 
specific criteria.  
In this research, the proposed risk management model aims to interpret the fuzzy logic for 
dominance of one risk factor over the other by determining and confirming of their relative 
importance. By choosing one method out of all the existing ones should based on its 
multicriteria task and appropriateness of the data, the structure of the problem, method 
applicability, acceptance of the decision, etc. Moreover, the method should be easy to 
understand and apply and match the human thinking. Also, as compared to the ANP, AHP is 
a linear assessment type of method. It provides an easily understandable and defensible 
approach to practitioners. It allows practitioners to be involved in the analysis and actually to 
guide the decision more effectively. This managerial transparency and lack of complexity 
allow for greater acceptance by both researchers and pracitioners. Therefore, fuzzy AHP is 
considered to be the most appropriate method for assessing the priority weights of supply 
chain risks in this research.     
The technique, ISM, proposed by Warfield (1974) is qualitative in its approach used in 
identifying key relations among explicit items that define an issue. The model is described as 
interpretive since a group discussion is deciding, whether and how the elements are related 
(Srivastava et al., 2015). It involves a set of elements that are directly and indirectly related, 
which are structured into an all-inclusive systematic model. Thus, such a model represents 
the structure of an intricate problem depicted in words as well as graphics.  
Figure 4.6 presents the basic logic of the ISM model. The complex problem or the 
dependencies between each element to be examined are interpreted as a complex system 
(object system). The modelling converts the object system into a well-defined and 
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representative system consisting of directed graphs (digraph). Then the object system 
mapped as digraphs becomes the “basic structural model”. The expansion with content finally 
leads to an “interpretive structural model” (Szyperski and Eul-Bischoff, 1983). Thus, its basic 
idea is to use expert’s practical experience and knowledge to decompose a complicated 
system into several elements and construct a multilevel structural model (Warfield, 1974). 
The model is developed since the complex variables are structured comprehensively by 
considering all possible pairwise interaction between each other.  
 
 
 
 
 
 
 
 
 
 
Figure 4-6: ISM-logic 
 
Interpretive Structural Modelling (ISM) has been widely used by multiple authors for supply 
chain risk management (Faisal et al., 2007; Alawamleh and Popplewell, 2011; Hachicha and 
Elmsalmi, 2013; Chaudhuri et al., 2016; Prakash et al., 2017), modelling of supply chain risks 
(Pfohl et al., 2011, Srivastava et al., 2015), risk mitigation (Diabat et al., 2012), the 
measurement of supply chain resilience by using ISM for evaluating enablers for supply chain 
resilience and their relationships (Soni et al., 2014) as well as a framework built for designing 
robust food supply chain (Vlajic et al., 2014). Under the supply chain context, it is not sufficient 
for merely understanding the significance of each individual risk for the organization as there 
are various types of risks which may affect each other. The direct and indirect relationships 
among risk driver reflect the situation more accurately than the individual risk taken into 
isolation (Chaudhuri et al., 2016). Therefore, the model provides an insightful understanding 
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by which the decision maker can impose and structure risks and highlight interrelationships 
between each risk in the SC sector (Mandal and Deshmukh, 1994).    
The modelling process of ISM is systematic, efficient, easily applicable, and produces a 
graphical representation or structured model for the problem. It transforms unclear, poorly 
articulated models of systems into clear, well-defined-models (Sage, 1977). On the other 
hand, the disadvantage of this method is that the possibility of having many variables to an 
issue increases the difficulty of the ISM method. This makes it difficult to be used in situations 
where there are many variables to a problem (Lim et al., 2017). Another disadvantage is that 
the model constructed may be strongly influenced by the bias of the subjective judgement by 
the experts since the relationships between each variable always based on the expert’s 
experience and familiarity with the organization and industry. In addition, in the ISM model, 
no weights are associated with the variables to take into account their relative importance.  
As illustrated in Figure 4.4, ISM is being employed with the following steps: 
 Construction of structural self-interaction matrix (SSIM) by pairwise comparison. 
 Developing a reachability matrix from the SSIM and checking for transitivity. 
 Ensuring that the reachability matrix is appropriately partitioned into several levels 
 Drawing of diagraph with removed transitivity links. 
 Conversion of digraph into an ISM and checking of conceptual inconsistency. 
 Matriced’Impacts Croisés Multiplication Appliquéea’un Classement (MICMAC) 
analysis 
Decision-Mking Trial and Evaluation Laboratory (DEMATEL) can be another approach used to 
develop relationships between the various elements but requires selection of a threshold 
value to generate impact diagraph map. DEMATEL and ISM are similar as both use diagraphs. 
DEMATEL can divide the factors into cause group and effect group. Fazli et al., (2015) applied 
the approach to determine the interdependency between risks in crude oil supply chain, while 
Rajesh and Ravi (2015) uses it to find out cause/effect relationships among the enablers of 
supply chain risk mitigation. In this thesis, the author are not particularly focused on dividing 
the risk factors into cause and effect groups, but pay more attention on how interaction 
between each risk factor, ISM is considered to be the most appropriate methodoloy for this 
thesis.    
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Lastly, it needs to be mentioned that using quantitative or qualitative risk assessment 
methods solely is inadequate for prioritising risks (Wang et al., 2017), as the main drawback 
of employing Fuzzy AHP is that it cannot examine the contextual relations between each 
variable. By contrast, in the ISM model, no weights are associated with the variables to take 
into account their relative importance. The model should combine both numerical and 
graphical results. Thus, in this thesis, both Fuzzy AHP and ISM models are incorporated to 
complement each other, in order to effectively evaluate and analyze supply chain risks.   
4.3.3 Phase 3 - Risk mitigation  
There is a need for decision makers to adopt some risk mitigation strategies in order to reduce 
any adverse impacts.  The risk mitigation procedure represents the method of dealing with 
unexpected hazardous events. The literature in SCRM has provided extensive researches in 
assisting decision making for analysing and mitigating various types of supply chain risks like 
Multiple Criteria/attribute Decision Making, Bayesian Theory, System Dynamics (SD), Data 
Envelopment Analysis and Structural Equation  Modelling (SEM), etc. However, there are 
some drawbacks in each of these method. For example, by employing Bayesian theory, a large 
amount of data is required in order to generate stable results; Data Envelopment Analysis 
focuses on measuring organizational performance in respect of the inputs; in order to apply 
Artificial Neural Networks, Genetic Algorithms, and Simulation-based Methods, high 
computer language design skills and extensive quantitative data are usually required.  
Among the mentioned MCDM methods, TOPSIS is a practical and advantageous technique for 
ranking and choosing the best alternatives. TOPSIS (Technique for Order Preference by 
Similarity to an Ideal Solution) is based on the suggestion that the selected option should be 
closer to the positive ideal exposition and far from the negative ideal exposition when 
addressing complex issues. The most preferred alternatives should have the shortest distance 
from the positive ideal solution and the longest distance from the negative ideal solution 
(Hwang and Yoon 1981). As indicated by Abidin et al., (2016), the method sensibly represent 
the cogent option with consideration of both the best and the worst-case scenario of the 
alternatives in a simultaneous way, which is highlighted by a scalar value. The capability for 
TOPSIS to be effective in dealing with various weight estimation systems makes it to be a 
scalable method for risk mitigation strategies evaluation. However, the limitation of TOPSIS 
is in its inability to handle the vagueness and imprecision inherent in the cognitive process of 
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mapping the perceptions of decision makers which also leads to its combination with fuzzy 
set theory (Krohling and Campanharo, 2011). Thus, it is affirmed by Sodhi and TV (2012) that 
Fuzzy TOPSIS is effective in systematic and objective evaluation of multiple criteria’s 
alternatives. The technique can be used in evaluating different alternatives at the same time 
and against the identified criteria. Just as the TOPSIS method is conducted, an optimal value 
is arrived at in Fuzzy TOPSIS by identifying and selecting an alternative that is closer to the 
Fuzzy Positive Ideal Solution (FPIS) and far from the Fuzzy Negative Ideal Solution (FNIS). The 
FPIS and FNIS are best and worst performance values respectively. Fuzzy TOPSIS has 
successfully been applied to solve different types of MCDA issues, such as supply chain risk 
management strategies evaluation and mitigation (Nazam et al., 2015; Chatterjee and Kar 
2016; Wang et al., 2017), supply chain risk modelling (Samvedi et al., 2013; Wang and Hao 
2016), supplier selection and evaluation (Chen et al., 2006; Sevkli et al., 2008; Zouggari and 
Benyoucef, 2012), evaluation of the banks’ performance (Seçme et al., 2009), location 
selection for the ITU Faculty of Management (Suder and Kahraman, 2015), logistics provider 
selection and evaluation (Kannan et al., 2009, Selçuk 2009) and rank the solutions of 
knowledge management adoption in SC (Patil and kant, 2014).  
As presented in Figure 4.4, the following steps of Fuzzy TOPSIS are given:  
 Conduct the empirical studies for identified the implemented risk management 
strategies.  
 Choose the appropriate linguistic ratings values for alternatives with respect to criteria. 
 Aggregate the weight of criteria to get the aggregated fuzzy weight of criterion. 
 Construct the fuzzy decision matrix and the normalized fuzzy decision matrix. 
 Construct the weighted normalized fuzzy decision matrix. 
 Determine the fuzzy positive ideal solution (FPIS) and fuzzy negative ideal solution 
(FNIS) and calculate the distance of each alternative from FPIS and FNSI, respectively. 
 Calculate the closeness coefficient of each alternative. 
 According to the closeness coefficient, the ranking order of all alternatives can be 
determined.   
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4.4 CONCLUSION  
This chapter develops a conceptual framework in the healthcare supply chain sector as a 
research platform. It takes considerations of risk drivers, risk sources, decision makers, risk 
management process, SC strategies as well as performance outcomes. The proposed 
framework can be built as a guidance to address the industrial needs for practical decision 
support methodology. Based on the framework, an integrated healthcare supply chain risk 
management model is proposed to support effective risk factors identification, assessment as 
well as sensible decision-making on the adoption of supply chain risk mitigation strategies.  
With the increasing emphasis on risk management across different industries, many 
approaches including both quantitative and quanlitative methods have been suggested in the 
literature. However, neglecting the call to integrate modern risk management models has a 
negative impact on the whole procedure as most of the risks behind the failures experienced 
in the supply chain of healthcare organizations are complex in nature. There are a lot of 
complex systems and procedures involved in facilitating the supply chain and the application 
of the suggested risk management framework offers a dynamic approach to dealing with the 
causes of such turbulences. It enables us to take explicit account of multiple types of risk in 
the analysis systematically and to compare and prioritise current alternative mitigation 
strategies based on the experts’ professional experience and knowledge both from academic 
and industrial fields. The proposed model has the capacity of reflecting the internal 
hierarchical nature of a healthcare organization’s extensive systems, and this allows a deeper 
analysis of complicated systems as they are linked to a supply chain. Integrating these risk 
management methods allows the facilitation of trade-off analysis, particularly among 
different subsystems and the general system. Finally, the method adds realism to the overall 
risk management process by identifying any form of disruptions in a supply chain and 
determining useful measures that can be numerable for the efficiency of a healthcare 
organization. The application of the proposed integrated risk management model is followed 
in the next chapters to identify risk factors, assessment and reduce the associated risks in the 
healthcare supply chain.  
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5.CHAPTER FIVE - HEALTHCARE SUPPLY CHAIN RISK FACTORS    
IDENTIFICATION 
 
5.1 INTRODUCTION 
Identification of the relevant supply chain related risk factors is the vital step for employing 
efficient risk management in the healthcare industry.  Furthermore, there is a substantial 
number of supply chain risk classification methods that can be found in the current literature. 
Most researchers identify sources of risks related to the unpredictable environment, 
organizational operations, and supply chain related networks with the potential to directly 
affect the outcome of supply chain activities. This chapter describes risk factors identification 
undertaken to capture and verify risk issues through a questionnaire survey. It also presents 
a modified comprehensive taxonomy and classification approach to decompose the 
unstructured risks to strengthen the knowledge base in healthcare SCRM. In further risk 
assessment research, the classified risks can be evaluated through analysing various risk 
assessment methods to find out the unacceptable ones.  Figure 5.1 illustrates the proposed 
methodology for risk factors identification.  
 
5.2 HEALTHCARE SUPPLY CHAIN RISK FACTORS IDENTIFICATION AND CLASSIFICATION 
The objective of this chapter is to develop a comprehensive supply chain risk factors 
identification and classification model within the context of the healthcare industry.  The 
procedure for risk factors identification and classification is one of the most significant steps 
in SCRM process. Risk classification helps firms to identify the causes of possible disruptions 
of supply activities (Heckmann et al., 2015) and helps risk managers to understand the events 
and the circumstances from which they arise (Harland et al., 2003; Chopra and Sodhi, 2004). 
However, many researchers note the lack of a standard classification for SC resulting in a 
research gap due to the conception of risks (Harland et al., 2003; Jὓttner et al., 2003; Chopra 
and Sodhi, 2004; Christopher and Peck, 2004; Tang 2006; Wu et al., 2006; Manuj and Mentzer, 
2008; Tang and Tomlin, 2008).  
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A Methodological Framework For Healthcare Supply Chain Risk Factors Identification  
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Figure 5-1: Proposed methodology for healthcare SC risk factors identification 
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The extensive review of the literature in the previous chapter provides an outline for critical 
insight into the supply chain risks characterised with contemporary firms. The literature 
review showed that many researchers have identified several different supply chain risk 
classification methods, sources, or types. However, the literature review also showed the lack 
of a common methodology or consensus among researchers that can outline a universally 
accepted supply chain risk classification. The present methods and approaches of 
classification demonstrate the ever-growing complexity and difficulty of the process. It is 
evident that researchers have yet to arrive at a universally acceptable supply chain risks 
classification method.  Thus, it is necessary to establish a standard vocabulary that can be 
used to assess and to identify risk fators between organizations operating within the 
healthcare supply chain for strategy with the most potential to mitigate risks.  
In this thesis, the researcher adopted the risk classification model suggested by Christopher 
and Peck (2004) to build a new organized classification model in the context of healthcare SC 
as presented in Figure 5.2.  
 
Figure 5-2: Sources of risks in the healthcare supply chain 
Based on the uncertainty framework originally proposed by Mason-jones and Towill (1998), 
Christopher and Peck (2004) suggested a classification model to divide SC risks into three 
broad categories which can be sub-divided into five main types: 
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Internal to the firm (i.e. arise from the boundaries of the cross-functional 
departments and range from labour (e.g. strikes) or production uncertainties to IT-
system uncertainties).  
o Process risks and control risks 
External to the organization yet internal within the supply chain (i.e. arise from 
interactions between organizations within the supply chain).  
o Demand risks and supply risks 
External to the supply chain network (i.e. any uncertainties arising from the 
supply chain-environment interaction).  
o Environmental 
 
More specifically, integrating the distinct risk perspectives in the healthcare SC strengthens 
the knowledge base in risk factors identification that comprises the risk portfolio for the 
material, information and cash flows from original pharmaceutical manufacturer through the 
healthcare provider to end-user, i.e. patients. It enhances the understanding of different 
sources of risks and the interrelation of risk factors that can disrupt the processes, control, 
demand, distribution, or supply of healthcare services and products. Using the model, this 
thesis adopts and presents a new healthcare supply chain risk factors identification and 
classification method. The new approach divides the five sub-categories of Christopher and 
Peck’s (2004) model into eleven sub-category levels: process risks are divided into 
information risks, logistics risks, and procurement risks. Control risks are divided into strategic 
risks and labour risks; demand risks are divided into capability risks and focus risks; supply 
risks are divided into quality risks and supplier risks; and lastly, environmental risks are 
divided into natural risks and man-made risks. Based on the initial literature review in Chapter 
two, the risk factors have been identified and classified into the Table 5.1 and summarized in 
Table 5.2.  Thereafter, the eleven sub-levels of healthcare supply chain risks are discussed in 
detail in the section below. 
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Table 5.1: Classification of healthcare supply chain risk factors identified by researchers 
 External to the hospital but internal to the supply 
chain network  
Internal to the hospital  External to the 
supply chain 
network  
Authors Supply risks Demand risks Process risks Control risks Environmental 
risks 
Breen 
(2008) 
Counterfeiting; 
Drive competitors out of 
market; Manufacturer 
defence tactics diversion 
of manufacturing 
capacity; Unavailability of 
raw material – true and 
commercially induced; 
Cash flow threat 
associated with small 
pharmaceutical 
companies and hospitals; 
Unexpected 
increase in demand; 
Demand versus 
capacity; Lack of 
forecasting-
customer side; 
Demand/economics-
not able to respond 
to demand; Increase 
in demand due to 
NICE approval; 
Demand trigged by 
the nurse, not the 
patient 
 
Lack of visibility of 
stock; Inadequate 
buffer stock-JIT/Lean; 
Transportation-
unavailability of fuel, 
congestion, weather, 
illness; 
Dispensing/picking 
error-
medication/packaging; 
storage/cold chain; 
Procurement Hubs- 
introduce more 
complexity.  
Information flow or 
lack of demand 
information; Too much 
information;  
Fragmentation of SC-
no single source, 
multiple channels, no 
communication, 
unilateral decisions; 
Short term SC 
planning; 
Prioritisation-
conflict between 
patients/profits.    
 
 
The requirement 
of environment 
protection 
Regulatory issues-
manufacturing 
licensing/change 
of standards/drug 
recalls; External 
influences-disaster 
recovery; Risk of 
litigation- 
influence on 
market. 
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Lack of data 
standardization 
(common codes); 
Contract problems 
with suppliers; 
contracting treated as 
a commodity-big 
contracts equals big 
risk; 
Kamath et 
al.,  (2012) 
Counterfeit risk  Inventory risk  Financial risk; 
Regulatory risk 
Kanyoma et 
al.,  (2013) 
Unavailability of supplier Wrong demand forecasting Insufficient inventory 
at central medical 
store (CMS); delay by 
procurement staff,  
poor inventory 
management by 
pharmacies; 
Withholding of 
funds by donor 
partners; lack of 
funds at the 
hospital; rigorous 
government 
intervention; 
unexpected 
disease outbreaks. 
Ilie, C., and 
Popa, V., 
(2013) 
Domestic drug shortages, 
location of 
manufacture/supplier(not 
domestic based) 
 Clinician’s preference; 
Slowly information 
transmission and 
single channel;  
 Regulation risks 
(EU);  
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Maryland 
(2012) 
Grey-market activity, 
counterfeiting, and 
diversion of drugs; drugs 
shortage;  
 Fragmentation of the 
drug distribution 
processes and use of 
restricted drug 
distribution systems; 
Lack of incentive 
mechanism;  
 
Aguas et al.,  
(2013) 
Medicine availability in 
the market;  
 Capacities of logistics 
systems; Asymmetries 
of the information;  
  
Elleuch et 
al., (2014) 
Poor quality in the 
purchased drugs from 
supplier; shortage of 
drugs (without 
substitute); Time limit of 
drugs;  
Fluctuation in customer 
demands;  
 Lack of 
personnel; 
human error. 
 
Enyinda et 
al., (2014) 
Supplier failure; 
counterfeiting. 
 Transportation 
logistics, electricity; 
technology 
Strikes and lack 
of key talents.  
Geopolitical; 
public opinion; 
regulations and 
laws. 
Kim et al., 
(2016) 
    Unexpected 
changes in 
environmental 
conditions. 
Zepeda et 
al.,  (2016) 
 Demand uncertainty for 
clinical requirements. 
Weak logistics services 
infrastructure 
(obsolete equipment 
in the warehouse, 
improper distribution 
facility, route)  
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Lord 
Carter’s 
report 
(2016) 
  High purchase price; 
High product and 
supplier/brand 
variety; 
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Table 5.2: Summary of the identified healthcare supply chain risk factors 
External to the hospital but internal to the supply 
chain network  
Internal to the hospital  External to the supply 
chain network  
Supply risks Demand risks Process risks Control risks Environmental risks 
- Counterfeiting， 
Grey- market activity; 
(S1) 
- Poor quality in the 
purchased drugs 
from suppliers; 
(S2) 
- Time limit of drugs, 
drugs perishability;  
(S3) 
- Shortage of drugs, 
unavailability of 
drugs on the market;  
(S4) 
- Location of 
manufacture/supplier 
(not domestic based)  
(S5) 
- Unavailability of raw 
material – true and 
commercially 
induced. 
(S6) 
- Cash flow threat 
associated with small 
- Capability versus 
demand; inability of 
capacity to meet 
demand; 
(S8) 
- Demand trigged by 
the nurse, not the 
patient 
(S9) 
- Demand 
uncertainty; 
(S10) 
- Wrong demand 
forecasting;  
   (S11) 
 
- Poor IT system, lack of 
data standardization;   
(S12) 
- Asymmetries of the 
information, unilateral 
decision; collaboration 
issues, restriction, not 
share information 
between each 
department;  
        (S13) 
- Dispensing/ picking 
error-medication/ 
packaging; 
(S14) 
- Weak logistics service 
infrastructure 
(S15) 
- Fragmentation of the 
drug distribution 
process;  
(S16) 
- Inadequate buffer 
stock-JIT/Lean  
(S17) 
- Focus on short term 
SC planning than long 
term; 
(S24) 
- Prioritization-conflict 
between 
patients/profits; 
(S25) 
- Strikes and lack of key 
talents; 
(S26) 
- Lack of incentive 
mechanism;  
(S27) 
  
 
 
- External influences- 
disaster recovery; 
(S28) 
- Unexpected disease 
outbreaks; 
(S29) 
- Unexpected changes 
in environmental 
conditions; 
(S30) 
- Regulatory issues- 
manufacturing 
licensing/change of 
standards/ drug 
recalls;  
(S31) 
- Rigorous government 
interventions; 
(S32) 
- Lack of funds from 
government to the 
hospital; 
(S33) 
- The requirement of 
environment 
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pharmaceutical 
companies and 
hospitals; 
(S7)  
- Lack of visibility 
concerning placement 
and availability of 
stock; 
 (S18) 
- Procurement Hub-
introduce more 
complexity, long lead 
time; 
(S19) 
- Contract problems 
with suppliers; 
contracting treated as 
a commodity-big 
contracts equals big 
risk; (S20) 
- Clinician’s preference; 
(S21) 
- High purchase price; 
(S22) 
- High product and 
supplier/brand variety; 
(S23) 
 
protection; 
 (S34) 
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5.2.1 Process risks 
The processes refer to the managerial and value-adding activities the firm undertakes 
(Christopher and Peck, 2004). The success of these activities depends on internally owned or 
managed assets, such as the infrastructure, that can support the firm’s transport and 
communication, and process risks that arise when they are disrupted (Breen, 2008). The sub-
levels of process risks include information risks, logistics risks, and procurement risks. 
Information risks arise from poor information technology (IT), asymmetries of information, 
and high product or supplier/brand variety. Logistics risks occur from dispensing or picking 
error, lack of stock visibility, distribution fragmentation, contract problems with suppliers, and 
weak logistics service infrastructure. Lastly, procurement risks arise from long lead time, high 
purchase prices, lack of visibility, and inadequate buffer stock as shown in Figure 5.3.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5-3: A schematic classification of sources of the process risks 
 
Process risks
Information risks
poor IT system, too much information, lack of data 
standardization
Asymmetries of information
Logistics risks
Dispensing/picking error-medication/packaging
Weak logistics service infrastructure
Fragmentation of the drug distribution process
Inadequate buffer stock-JIT/Lean
lack of visibility concerning placement and availability 
of stock
Procurement 
risks
Procurement hub-introduce more complexity, 
long lead time
Contract problems with suppliers
Clinician's preferences
High purchase price
High product and supplier/brand variety
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Information risks are associated with the potential disruption in the flow of information or 
failure in communication within the healthcare supply chain network. They may also arise 
from the probability and impact of cooperation from shared information with suppliers, or an 
internal cross-functional department. A poor IT system is likely to lead to information 
dissemination causing disruptions in communication or information flow such as poor access 
to information on demand. Decision based on poor quality information provides ineffective 
healthcare services which negatively affects the outcome of treatment for patients and 
provides to the healthcare provider with significant and avoidable cost (Gibbons, 2009). In 
the United Stated, most health industries have been greatly affected by the inconsistent as 
well as inaccurate information about drugs hence ending up giving poor service to the 
patients. In addition, results from a study by Pleasant, (2009) showed that more than $ 11 
billion has been wasted because of inadequate processes, use of outdated information and 
technology, and invoice and order errors. Moreover, Simangunsong et al., (2012) also found 
other threats that affect information and technology used in the health industry at the 
organizational level, application or among organizations: technical breakdowns, misuse of 
information, computer viruses and information accessed by unauthorised individuals, among 
others. 
Further, lack of data standardisation likely to contribute to many data silos.  The difficulty 
faced by UK National Health Service (NHS) trusts is that the available data in a large volume 
whereas quality information is in short supply. In fact, in the NHS database, there are 130 
different information descriptions for a single product. Therefore, to promote operational 
improvement and healthcare supply chain integration, standardisation is of concern. 
Implementation of supply chain standard data contributes to information synchronisation so 
that all stakeholders in the industry can speak the same electronic language (Kreysa and 
Denecker, 2009).   
Asymmetries of information associated with unilateral decision-making and poor 
collaboration between the hospital and suppliers, or between the patient care units and the 
hospitals, which is a serious risk factors found in SC links. This leads to power relationships, 
lack of coordination and communication among the supply chain agents, rivalry conditions 
among the providers in the market, and limited use of communication and information 
technologies. Even worse, the healthcare industry exists as highly fragmented systems in 
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which manufacturers, distributors, wholesalers, and providers operate independently from 
one another. Burns et al., (2002) found that all members in the healthcare SC still lacked 
coordinated effort, strategic alliance formation, and information to share among the agents 
of the supply chain. A study by Gibbons (2009) underlined that healthcare is an information 
intensive environment and the availability of quality information is essential for the delivery 
of safe and effective healthcare services. Thus, due to lack of inter- or intra-organizational 
information sharing, the supply chain acts more to push products down the chain instead of 
pulling them from the customer (Burns et al., 2002).    
Lack of visibility concerning placement and availability of stock, for instance, may cause a drug 
shortage in the warehouses, which can lead to hospitals’ inadequate buffer stock. For 
example, the UK’s Chapel Allerton Orthopaedic Centre’s (CHOC) inefficient inventory 
management contributed to an overstock problem. Yet, the centre spend in excess of £3 
million on inefficient inventory management (Medwell, 2009). Research shows that in the 
retail or industrial sector there is less inventory accumulation compared with the health 
sector because of product-based supply chain cost, which is generally not the main driver of 
inventory decision-makings among healthcare organizations. In fact, the purpose of inventory 
is to meet the outcome of the service performance instead of cost saving.  
Dispensing or picking error-medication/packaging may arise from packaging through 
manually operating, sound-alike or look-alike drug names, same appearance from outside 
covers, similar packages and labelling, unclear or incomplete labelling information, 
handwritten prescriptions, or high delivering frequency per day. For example, handwritten 
recommendations for medicine can be dangerous because it can cause different medication 
errors, such as prescribing, transcribing, pre-dispensing, and dispensing. Moreover, 
fragmentation of the drug distribution process is also likely to cause disruption in hospital 
services. For example, about 50 per cent of medicine supplies come from a small number of 
wholesalers, however, the remaining is obtained directly from manufacturers. This means 
each hospital will receive up to 30 medicine deliveries every day, which is time-consuming for 
staff (Lord Carter’s report, 2016) and more opportunity for errors.  Furthermore, Breen (2008) 
showed that there was no uniform information sharing and decision making among the 
Pharmaceutical SC, which also led to such problems and affected the efficacy of the complete 
supply chain.    
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Weak logistics service infrastructure can be caused from poor service infrastructure, such as 
poor supplier routes, obsolete equipment in the warehouse, improper drug store 
environment and transportation facility/route, inefficient cold chain management during 
transportation that affects the quality and stability of temperature-sensitive products. In the 
hospital sector, certain categories of goods have a short shelf-life and need to be stored at 
specific temperatures. Sooksriwong (2009) also carried out a similar study and realised that if 
there is inefficient cold chain management during the transportation of goods, the quality 
and stability of products is highly affected. It is vitally important to maintain the freshness of 
pharmaceutical logistics because the reduced freshness of products, especially medicine, 
leads directly to serious impacts on human health. In particular, logistics services 
infrastructure affects the level of integration between an organization and its supply chain 
partners partly because with access to a well-developed infrastructure can support a range of 
logistics services and transportation modes enabling suppliers to meets distribution 
requirements for goods and services (Bookbinder and Tan, 2003). Moreover, several 
researchers also supported this viewpoint and emphasized that well developed infrastructure 
can promote organizations’ operating efficiency by facilitating shorter and more reliable 
replenishment lead times as well as accurate delivery of desired supplies (Zsidisin and Ellram, 
2003; Shirley and Winston, 2004; Narasimgan and Talluri, 2009).   Therefore, Zepeda et al., 
(2016) further suggested that the better developed a hospital’s local logistics services 
infrastructure, the lower the hospital’s inventory costs.  
In the UK, a number of NHS trusts have implemented Just-In-Time (JIT) logistics systems given 
its advantages of reducing inventory costs and involving the supplier the hospital SC 
operation. According to Wilson et al., (1992), the JIT approach can reduce inventory holding 
costs in the organization, while maintaining service levels. Nevertheless, the major issues with 
implementing JIT are demand fluctuation, which is hard to predict in the healthcare industry 
(Kowalski, 1986), and inadequate buffer stock level in hospital centre stores as JIT is more 
likely to reduce the inventory level as low as possible.  
An uncoordinated procurement hub is also likely to introduce more complexities and long 
lead times for drug orders until they arrive at the hospital’s central store. Procurement lead 
time is defined as the average duration of time between placing of the order and receipt of 
material. It may be divided into internal lead time (time required for organizational formalities 
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to be completed for placing the order) and external lead time (time interval in placement of 
order and receipt of drugs). Anand et al., (2016) found that average lead time between the 
preparation of indent and receipt of drugs in the hospital pharmacy is 161 days, while the 
average internal lead time is 114 days and the average external lead time is 47 days. Only 59% 
of the drugs were received in time.  Kamath et al., (2012) and Kanyoma et al., (2013) identified 
procurement related process risks that delays by the untrained procurement staff, lack of 
handling material, and the high product and supplier/brand variety, which can cripple the 
supply chain network. According to Lord Carter’s report (2016), a sample of 22 hospitals 
covering approximately 16 per cent of NHS spending revealed that in one year they used 
30,000 suppliers, 20,000 different product brands, and more than 400,000 manufacturers’ 
product codes with more than 7,000 people being able to place orders. This high product and 
supplier/brand variety disaggregates and undermines NHS buying power with the inevitable 
result of variation and higher prices. Furthermore, product variety is the root cause of hospital 
supply chain wastes, such as high inventories, expiration and obsolescence, and low value 
orders and delivery changes. 
Managing contracts effectively can save hospital substantial money each and every year. One 
problem that becomes a consistent issue is that hospitals may not remember that their 
contracts or leases automatically renew if they do not renegotiate or follow the end of lease 
terms detailed in the written contract. Hospital employee does not always know that they 
have existing contact in place, and may duplicate services such as a service and maintenance 
contract on a piece of medical equipment. Furthermore, there is another risk that the vendor 
could inadvertently fail to comply with all the terms of that contact.  
In any case, clinical professionals do not always prioritise efficient resource utilisation and 
cost-effectiveness due devoting their attention to the treatment effect rather than to 
corporate performance (Lega et al., 2013). Nevertheless, these demand-side problems often 
limit the cost-effective procurement of clinical solutions as those clinical professionals lack 
the awareness of cost containment. Because clinician education is founded on science and 
clinicians, it responds favourably to scientific, fact-based justification for proposed changes 
(Freidson, 1988). Moreover, Mckone-Sweet et al., (2005) also found that the primary 
challenge is to balance costs with physician and other clinician preferences because allowing 
the clinicians to be involved in product selection would add complexity since most lack any 
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formal training in supply chain practices. The findings are also in line with Böhme’s (2016) 
research, which was conducted among health organizations through a survey, which 
indicated that the executives give consultant clinicians a higher status as opposed to the 
supply professionals, leading to the high level of uncertainty in the hospital sector.   
 
5.2.2 Control risks 
The concept of controls as the assumptions, rules, procedures and systems that a firm 
employs to manage its processes (Christopher and Peck, 2004). Sub-levels of control risks are 
strategic risks, including a focus on short term SC planning than long term, prioritization 
conflict between patient/profits, and labour risks, including employee strikes, inadequate 
talents, and poor incentive mechanisms, as presented in Figure 5.4.   
 
 
 
 
 
 
 
 
Figure 5-4: A schematic classification of sources of the control risks 
Strategic risks are associated with the direction of fundamental decisions concerning an 
organization’s objectives. For example, a possible source of loss that might arise from the 
pursuit of an unsuccessful business plan, inadequate resource allocation or from a failure to 
respond well to changes in the business environment. Breen (2008) observed that good 
planning should focus on product quantities, nature, batch sizes, priorities, and safety stock 
policies and other control procedures that outline transport and asset management to 
address both short-term and long-term supply chain risks. Prioritization conflict between 
 
Control risks
Strategic risks
Focus on short term SC planning than long term
Priopritization-conflic between patients/profits
Labour risks
Strikes and lack of talents
Lack of incentive mechanism
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patients/profits are likely to arise from poor planning and poor focus on service delivery at 
the expense of profit making. It is likely to find hospitals making prescriptions and charges on 
drugs for profit rather than gains at the expense of quality and service delivery. Moreover, 
healthcare organizations face a variety of stakeholders who place demands and constraints 
on their managers. Thus, the presence of different stakeholders (e.g. taxpayers and recipients 
of services or industrial groups) requires healthcare organizations to pursue different and 
sometimes conflicting objectives (Lega et al., 2013). It has frequently been argued that public 
agents often meet distinctive goals, such as ethics, equity, or accountability, which are non-
existent in the private sector (Flynn, 2007).     
The range of actions available to healthcare organizations is restricted by political constraints. 
Political dynamics lead to frequent policy changes and the imposition of short time horizons 
on healthcare organizations (Lega et al., 2013). Therefore, developing comprehensive long-
term SC strategies and innovative projects is more difficult in this context (Zanjirani et al., 
2009). Focus on short term SC planning than long term may mean hospitals lack the basic 
infrastructure, such as IT and network designs. Supply chain orientation based on the 
functional not long term strategic objectives. It goes with short term profit rather than making 
long-term but necessary investment. Hospitals can thus experience inadequate information 
sharing and partner relationship management challenges and experience the improper 
selection of health facilities and poor sourcing of healthcare products. For instance, proper 
planning may consider single, dual, and multiple sourcing strategies to address issues of 
supplier reliability and minimise potential supplier-based disruptions in the supply chain 
network. 
Furthermore, strikes are associated with poor management or lack of incentive mechanisms 
that can motivate employees to work under challenging conditions or during extra hours. For 
example, in 2015 and 2016, England’s junior doctors took part several times in a general 
strike, such that up to 100,000 operations were affected and up to one million appointments 
were cancelled. Inadequate talent can cause lack of adequate process capacity, poor 
inventory management by pharmacies, and labour problems that can create core control 
breakdowns in operational processes within the hospital and the patient care unit. 
Inadequately skilled workers, strikes, carelessness, and poor motivation are likely to damage 
the reputation of the supply chain. Though the risks are regarded as short-term, they can 
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cause serious disruption to the control of the entire supply chain and should, therefore, be 
solved with a long-term perspective (Elleuch, 2014). McKone-Sweet’s (2005) research 
suggested that most health organizations with executives who possess high levels of supply 
chain information or experience always stand a higher chance of high levels of supply chain 
performance.  
 
5.2.3 Demand risks 
Demand risks specify the possibility of unexpected changes arising from market or 
downstream members (Christopher and Peck, 2004). Existing literature revealed that more 
attention is given to demand side risks than other sources of supply chain risks (Elleuch, 2014). 
Two sub-levels of demand risks adopted in this thesis are capability risks, which include the 
hospital’s inability to meet demand, poor flow of demand information; and forecast risks, 
which include wrong demand forecasting and demand uncertainty. A schematic presentation 
of the demand risk sources discussed is presented in Figure 5.5.  
 
 
 
 
 
 
 
 
 
Figure 5-5: A schematic classification of sources of the demand risks 
Capacity risks are caused by lack of flexibility towards environmental changes, inefficient 
production with over- or under-utilization capacity, poor planning, failed schedule, control 
production, and inventory organization. In the hospital sector, capacity risks may arise from 
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the lack of capacity or flexibility to meet the needs of the patients or patient care units. Supply 
chain system capacity is associated with response times and quality regarding drug 
management and delivery. In other words, these risks are associated with either financial 
constraints or time/staff constraints. Elmuti et al., (2013) found that the US healthcare 
industry’s major challenge is lack of training for the supply chain professionals. They surveyed 
700 healthcare organizations to measure their familiarity with, and utilization of, healthcare 
SCM initiatives. The results indicated that approximately 62 per cent of respondents reported 
no existing healthcare SCM programmes. The remaining organizations reported the duration 
of their SCM programme to be less than one year. The lack of attention to SCM was due to 
senior managers failing to recognise the importance of efficient SCM therefore the employees 
also paid less attention to SCM services (McKone-Sweet et al., 2005). Furthermore, regarding 
demand and flow complexity compared with industry, the disparate care processes and 
clinicians increasingly difficult to manage and align, resulting in greater risk to patients and 
inefficient use of system resource. Hence, understanding and quickly adapting to the ever-
changing needs of patients as they move through networks of healthcare providers is crucial 
to the success of the healthcare delivery system (Rust et al., 2013). For example, unlike other 
consumer products where the customer can either defer their purchase or acquire an 
alternative can be critical in providing patient care, as there may be no alternative option for 
treatment. Therefore, urgent orders need to be delivered immediately. Meanwhile, as the 
nurse-to-patient ratio decreases, nurses are under increasing pressure to spend more time 
with patients, and errors tend to occur. Friedrich (2017) found that a critical decrease in the 
number of nurses at a facility can have detrimental effects on patients. Studies show that 
there are different reasons that led to nursing shortages in the United States, such as the 
nation continues to age, foreshadowing an ever-growing need for care and nursing schools 
struggle to expand capacity to meet the need for care, and so forth. Moreover, another risk 
factor is triggered when clinicians and nurses bypass the official replenishment channels and 
directly order supplies from manufacturer or distributors.  In fact, a ‘vicious cycle’ is created 
because the real-time demand is not triggered directly by patients. As one SC manager 
reported, “We have the knee replacement parts found in their theatre which are worth a 
hundred thousand pounds, and the new surgeon won’t even touch them and require an 
alternative one” (Böhme et al., 2016).  
          
161 
 
Another theme raised by several researchers is demand uncertainty (Lee et al., 1997; 
Mustaffa and Potter, 2009; Zepeda et al., 2016; Böhme et al., 2016). In the case of the hospital 
sector, demand uncertainty is observed in the clinical requirements to treat patients at any 
given time (Gittell, 2002). In other words, demand uncertainty is a construct of demand 
invisibility, which is not known in advance, i.e., it is stochastic. There may also be uncertainty 
in the transport delays (Jurado et al., 2016).  Moreover, since the provision of hospital services 
requires both intangible services supported by supplies and supplies supported by intangible 
services (Berry and Bendapudi, 2007). The hospital’s tast environment will impact the ability 
to accurately predict the supplies necessary to carry out required tasks. For this reason, it is 
usual a push to get hospitals to prepare for healthcare supplies or intangible services to satisfy 
uncertain demand within time constraints. Therefore, the higher level of a hospital’s demand 
uncertainty for alternative clinical services, the higher the risk of stock out of needed items 
because the hospital’s task environment makes it increasingly difficulty to reliably forecast 
the supplies needed to meet patient’s demand (Lee et al., 1997; Sodhi and Lee, 2007). As a 
result, operational failures in hospitals can results from the inability of the related work 
system to reliably provide supplies when, where, and to whom they are needed (Tucker, 
2004).  
Therefore, the dynamic changes, fluctuation in demand, and other related risks call for close 
monitoring of the control process to identify novel hazards to enhance the risk assessment, 
control, and reduction in hospitals. Kanyoma (2013) found that low visibility of the sourcing 
and supply chain network is likely to hinder effective supervision and control. Jüttner (2005) 
also suggested that players within the healthcare supply chain should work as a team to 
improve transparency of all control activities that relate to medicine flows.   
 
5.2.4. Supply risks 
Supply risks may arise from the actual interruption or disruptions within the supply 
procedures and related operations that a firm adopts to let products or information flow 
within the supply chain network, commonly upstream from the firm (Christopher and Peck, 
2004). In this classification the risk factors are often related to the hospital’s external 
environment but arise from the internal network of the supply chain where services and 
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products flow. Conducting a critical interpretive synthesis of the literature, two sub-levels of 
supply risks adopted in this research are quality risks which may arise from counterfeiting, 
time limit of drugs/perishability, availability of raw materials and supplier risks related risks 
which may arise from the location of suppliers in relation to their availability, flexibility, 
shortage of drugs, availability of raw material-true, and the expected flow of cash/ cash 
management treated associated with small companies and hospitals. Figure 5.6 presents a 
schematic view of the supply risks. 
 
 
 
 
 
 
 
 
Figure 5-6: A schematic classification of sources of the supply risks 
Many healthcare organizations continue increasing rapidly with most of them getting 
involved in counterfeiting (Thun et al., 2011). Counterfeit drugs are defined as drugs sold 
under a product name without proper authorization, where the identify or the source of the 
drug is knowingly and intentionally mislabelled to suggests that it is an authentic Food Drug 
Administration (FDA) approved product (Maryland, 2012). According to Kamath et al., (2012), 
issues regarding counterfeiting can be managed by incorporating the current anti-
counterfeiting technologies such as the hologram, mass encoding systems, bar-codes, and 
Radio Frequenct iDentification (RFID) systems. The shortage of drugs can adversely affect 
patients’ health results and lead to extra spending on healthcare services. Shortages may be 
the result of limited supply or the poor quality of raw materials needed for manufacturing 
and regulatory or legislative issues, business or market factors, unanticipated increases in 
demand, natural disasters, or inventory control practices (Maryland, 2012). Previous studies 
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show that since 2011, in Malawi public hospitals have faced a serious shortage in drugs, which 
affected health delivery services leading to the increased patient deaths. In addition, delays 
in medical surgery, and worsened medical conditions of the patients among other effects 
(Kanyoma and Khomba, 2013). Moreover, a shortage of medicines forces the search for 
substitutes thereby causing over costs due to the difference in prices for available medicine 
on the market (United Nations, 2013).  Aguas et al., (2013) found that the main problems in 
the health systems are related to poor supply and unavailability of essential medicines. In 
their case from Colombia, about 15.8 per cent of patients had been prescribed medicine and 
received the wrong medication, while 21.2 per cent did not receive any medicine. Most 
pharmaceutical manufacturers source raw materials from remote and unstable areas where 
unanticipated events may occur, for instance civil wars or terrorist activities. The shortage 
may force manufacturers to use materials of low quality in the production of healthcare 
products. Thus, unavailable raw materials and poor quality of medicines are frequently 
experienced which lead to supply process disruption or even breakdown. For hospital, some 
raw material obtained from manufacturer, but manufacturer mergers often result in 
decisions to narrow the focus of product lines, resulting in the discontinuation of a key raw 
material. Meanwhile, the unique characteristics of the product perishability of some specific 
pharmaceutical items must always be stored under the strict temperature-monitoring 
environment. Therefore, it is necessary to manage risks caused by the unexpected changes in 
environmental conditions for delivery items during the distribution process, as such risks can 
directly or indirectly negatively affect the quality in purchased drugs from the supplier (Kim et 
al., 2016).  
Considering issues of remote location of pharmaceutical manufacturer or supplier, Colicchia 
and Strozzi (2012) observed that the current supply chain physical extension includes global 
sourcing which creates a massive volume of healthcare items bought and supplied worldwide. 
However, transport costs for hospitals and pharmaceutical distributors are likely to increase 
because of the high distance to travel to either deliver or collect supplies. In addition, different 
from the typical consumer products, where the customer can either postpone their purchase 
or obtain an alternative one, this can be critical in providing patient care as there may be no 
alternative treatment for the patient. Thus, the immediate response of urgent delivery may 
be required. For this reason, the stock levels of normal and urgent medicines need to be 
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monitoring as the daily work, due to the remote location of some pharmaceutical suppliers. 
Greater domestic manufacturing was considered to reduce the risk of medicine shortages 
especially in global crisis situations.      
The success of supply and control activities depends on the reliability and flexibility of 
suppliers within the healthcare supply chain. Low supplier flexibility and reliability are likely 
to force hospitals to incur high sourcing costs, storage problems, acute drug shortages, and 
poor monitoring of the supply activities (Brown et al., 2014). Thus, a reliable supplier is 
expected to give quantities and qualities ordered within a given time frame. Moreover, the 
flexible suppliers makes the supply chain quick able to respond to the changing consumer 
demands and other complex requirements. Otherwise, hospitals will frequently experience 
the supply process disruption or even breakdown in the supply market (Colicchia and Strozzi, 
2012). Meanwhile, in terms of cash flow, the risks arise from the delayed payment from 
hospitals to the small pharmaceutical companies.  More than a quarter of UK hospital trusts 
are now routinely delaying payments to their supplier because of cash flow problems. 
Obviously, the consequences of such activities could be significant challenges faced by several 
pharmaceutical suppliers as their cash flow would be interrupted, especially for those small-
scale companies. In fact, several NHS hospitals confirmed that some suppliers had put their 
account “on stop” and refused to deliver further supplies due to the late payments. Although 
both hospitals and suppliers are confronting such issues, though, it appears that this problem 
will last for a long time due to an increasing number of hospitals struggling to maintain 
adequate cash levels given recurring income and expenditure deficits.   
5.2.5. Environmental risks 
Environment risks refer to the unexpected events that may directly influence the focal firm, 
or impact directly the downstream or upstream flow of goods or services in the supply chain 
network (Christopher and Peck, 2004). Environmental risks are likely to arise when the events 
negatively affect the value stream such as the contamination of the healthcare products or 
damages. Sources of environmental risks are divided into two sub-levels which include natural 
risks and man-made risks.  Sources of natural risks include natural disaster, unexpected 
disease outbreaks, and unforeseen changes in environmental conditions such as adverse 
weather or natural catastrophe (Breen, 2008).  Man-made risks, on the other hand, may arise 
from regulatory issues, rigorous government interventions, and inadequate funds from the 
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government to support hospitals and the requirement of environment protection (Kamath et 
al., 2012), as shown in Figure 5.7.  
 
 
 
 
 
 
 
 
 
 
Figure 5-7: A schematic classification of sources of environmental risks 
A United Nations report indicates that frequent natural disasters and catastrophes, such as 
earthquakes or hostile weather conditions, are becoming more active and common in various 
parts of the world. In fact, earthquakes and heat waves, for instance, increase the chances of 
damaging drugs in transit. Meanwhile, flooding can cause delay in supplies or transportation 
of healthcare products. More importantly, the delay is highly likely to cause healthcare drugs 
perish, which can make hospitals experience drug shortages and cause tremendous losses. 
Unexpected disease outbreaks have caused significant losses in the healthcare supply chain 
as well. The World Health Organization (WHO) reported that a severe outbreak of acute 
respiratory syndrome that caused over approximately 800 deaths in Southern China between 
November 2002 and July 2003. The outbreak spread to over 36 countries within weeks (Breen, 
2008). The lack of essential drugs and medical staff as well as the government travel ban in 
the affected area resulted in the shutdown of 75 per cent of the plants and subsequently, 
significant economic losses (Colicchia and Strozzi, 2012). Therefore, the nature of disasters 
and disease outbreaks can reveal the cascade of problems that may have been unforeseen 
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and unplanned but overcome had officials been prepared and trained to deal with the 
complexities related to emergency management (VanVactor, 2012).  Unexpected changes in 
environment conditions, such as the impact of extreme weather events and climate change 
(i.e. heatwaves and coldwaves). The extreme weather may impair functionality of hospitals 
including medical equipment and shortage of medicines. More concerns is needed on the 
extent of such problems, especially since mortality risks during heatwaves are particularly 
high for vulnerable patients. Other issues, particularly transport systems, are likely to be 
disrupted by snow and ice, creating diffculities of access for patients needing to use health 
facilities and for domiciliary care staff in reaching their clients in their homes. Ambulance 
response times also fall during very cold weather.     
Government always plays an essential role in healthcare SCRM, not only allocating funds to 
the healthcare organizations, but also providing industry with informal regulatory guidance 
and recommendations. In the UK NHS, since 2015, the budget’s gaping hole was on social 
care, which is close to collapse and putting ever-increasing pressure on hospitals through bed-
blocking. Furthermore, the Local Government Association estimates a £1.3bn funding gap 
between what care providers need and what councils pay. Under this circumstance, the UK 
NHS front-line services simply lack the funding to manage. Besides, the increased demand has 
led to more people waiting longer to be seen in Accident and Emergency (A&E) over the 
festival period. Rigorous government interventions may adversely affect the total output 
(quantity and quality) of physicians and other healthcare providers. For example, if 
government uses its monopsony power to reduce prices of medical services and wages of 
healthcare employees, shortages of medical services might result. Those shortages would 
lead to higher mortality rates. Government regulation gives a distinct competitive advantage 
to companies large enough to maintain secure funding. For example, some drugs benefit from 
additional government incentives. Orphan drugs receive special consideration from the UK 
Medicine & Healthcare Products Regulatory Agency in order to encourage pharmaceutical 
companies to develop treatments for rare diseases. Incentives for the development of orphan 
drugs include quicker approval time and potential financial assistance for development. 
Companies are often permitted to charge substantial prices for orphan drugs, making them 
more profitable than they would be without government intervention.  Regulatory issues may 
arise from unpredictable regulations and legislations such as new licensing policies, changes 
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in the standards of requirements, drug recalls from the manufacturers, inconsistent 
government interventions, and quota restrictions. Any change in the manufacturing process 
necessitates a licence variation which often entails a delay (Breen 2008).  
 In the healthcare supply chain, the increasing attention on policy risk is emphasised on the 
safe use and disposal of hazardous drugs presents potential challenges to the surrounding 
environment and general supply chain operations. Improper drug disposals threatens human 
health as well as the ecological balance leading governments and other environmental 
conservation agencies to implement formal and informal regulatory policies (Scruggs et al., 
2014). The provided investigation estimated that some of these policies expose hospitals to 
hefty fines and potential financial losses. Therefore, it is advisable for hospitals to avoid loses 
by ensuring the safe disposal of used or expired drugs.  
 
5.3 RISK FACTORS IDENTIFICATION DATA ANALYSIS AND TAXONOMIC DIAGRAM 
VALIDATION 
The visibility of the supply chain related risks is one of the most challenging aspects of 
healthcare SCRM, it is therefore essential to comprehensively identify and validate risk factors 
existing in the healthcare SC. The foundation of effective SCRM requires three critical tasks: 
specification of sources, risk assessment and risk mitigation (Kleindorfer and Saad, 2005). This 
research started with identifying the risk factors that have been addressed in the relevant 
literatures (shown in Chapter two), and then a decomposition method was applied to classify 
unstructured risk factors into different risk domains. The preliminary structured hierarchical 
diagram of healthcare supply chain risks is developed as shown in Figures 5.8 to 5.11. 
5.3.1 Procedure for questionnaire design and pilot study  
The questionnaire was built to explore the feasibility of the developed risk classification 
taxonomic diagram and to explore if any other remaining risks were yet to be explored. 
Therefore, the performance of risk factors identification and classification is based on the 
expertise of the constructed group. The data was obtained and content validity was 
performed to improve the clarity of the developed questionnaire. Firstly, a draft version of 
the questionnaire and cover letter was developed. The questionnaire was examined by two  
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Figure 5-8: The preliminary hierarchical structure of healthcare supply chain risks 
 
Healthcare Supply 
Chain Risk Sources
External to the 
hospital but internal 
to the supply chain 
network
Supply risks
Quality risks
Supplier risks
Demand risks
Capacity risks
Forecast risks
Internal to the 
hospital
Process risks
Information risks
Logistics risks
Procurement risks
Control risks
Strategic risks
Labour risks
External to the supply 
chain network
Environmental 
risks
Natural risks
Man-made risks
Main Goal Level 0 Level 1 Level 2 Level 3 
          
169 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5-9: The preliminary External to the hospital but internal to the supply chain network risks hierarchical structure for healthcare SC 
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Figure 5-10: The preliminary Internal to the hospital risks hierarchical structure for healthcare SC
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Figure 5-11: The preliminary External to the supply chain network risks hierarchical structure for healthcare SC
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academic researchers and two specialists to comment on the appropriateness and clarify of 
the questions. Based on their feedbacks, the questionnaire was revisited for the pilot study. 
The pilot study was conducted by exploring different judges to pre-asses the questionnaire’s 
effectiveness, accuracy, and unambiguous communication. All items on the questionnaire 
were measured on a five-point Likert-type scale with response options ranging from 1 (very 
unimportant) to 5 (very important). Ethical approval was also obtained to further validate the 
questionnaire content and participant consent. The questionnaire (see Appendix One) as 
represented at the end of the pilot study was used for data collection.    
5.3.2 Selection of experts for validation  
As an exploratory study, a cross-section of experts or decision makers was considered for 
participation in the survey. The questionnaire survey was conducted with six experts from 
both the UK and China in academic fields as well as the healthcare industry to address the 
concerned risk-related events. The sample size was considered acceptable for this study. Satty 
(2001) stated that just a small sampling size (<10 responses) was necessary if the data 
collected were gathered from the experts. This is due to that fact that professionals should 
share consistent belief and thus diminish the need for a huge sample size. Experts working 
experience and academic qualifications were used as the selection threshold (John et al., 
2016).  Meanwhile, the group included experts from a wide variety of professionals with 
expertise from different functional groups, such as supply chain and logistics management, 
pharmacy science, and risk management, which are grouped for risk factors identification and 
assessment groups. Hammitt and Zhang (2013) emphasized that a sample size of 𝑁 experts 
(𝑖)(where 𝑖 =1,2,3,…, 𝑁) was necessary if the well-calibrated experts are of equal or unequal 
quality and their judgements are independent, positively or negatively dependent. In order 
to obtain a balanced view from different professional areas, the invited experts consisted of 
two heads of procurement (i.e. pharmacy department leader in Chinese hospital is the same 
as the head of procurement in UK NHS) in charge of all the supply chain and logistics activities 
in the hospital; two academic professors within a background in both pharmacy and supply 
chain and logistics management; and  one senior lecturer and one senior manager who have 
rich experience and knowledge in risk management. The risk validation and exploration 
procedure in this thesis includes two major parts: (1) the results of the questionnaire survey 
and (2) the results of email and face to face interview. Within the results obtained from the 
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questionnaire survey, this thesis firstly presents the confirmation of the identified risk factors 
and the developed classification model and the risk factors exploration. In the results of email 
and face to face interviews, the modified hierarchy model was confirmed.  
Different experts have different impacts on the final decisions and results, thus, the 
evaluation weighting criteria have been developed and allocated to each expert on the basis 
of their job position, qualification and work experience. According to Cooke et al., (2008), 
expert weighting criteria refer to the measure of the relevance of data that is considered as a 
function of professional duty (position in the organization) and work experience in terms of 
time in years. Table 5.3 presents the details of weighting and relevant description of each 
expert evaluation criteria used in identifying respondents. 
Table 5.3: Experts’ Weighting Criteria（expert evaluation） 
Weight 
value 
Keyword Description (either-or) 
20%-30% Highly 
relevant 
The respondents have many years of rich experience in 
pharmaceutical supply chain management; and they always 
hold the top position in pharmaceutical logistics activities; 
In academia, the respondents have a rich knowledge and in-
depth studies that make a demonstrate contribution to 
pharmacy or supply chain risk management.     
10%-19% Fairly 
relevant 
The respondents have at least 10 years work experience in 
pharmaceutical supply chain management or doing the similar 
work in other industry. 
In academia, the respondents have a good knowledge in 
pharmacy or supply chain risk management. They clearly 
understand the severity and consequence of supply chain 
disruption.  
1%-9% Relevant The respondents have basic work experience in 
pharmaceutical supply chain management or doing the similar 
work in other industry.  
In academia, they have the general understanding of the status 
of the healthcare industry and the pharmacy supply chain risk 
aspects.  
0 Irrelevant No experience or knowledge in relation to the research topic.  
  
Based on the experts weighting criteria proposed above, six experts were assigned the 
weighting on the basis of their individual background and experience as shown in Table 5.4. 
Expert A has the highest weighting (30 per cent) as he holds a position of head of procurement 
with a very long professional work experiences in the UK NHS hospitals. While, both experts 
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B and C have the same weighting (20 per cent) as they are either a specialist in pharmacy 
sciences or hold a managerial positions in the pharmacy department. The remaining three 
experts have the lowest weighting (10 per cent) among the experts group because their 
background is not relevant to the healthcare industry, but they have rich knowledge in supply 
chain and risk management.     
Table 5.4: Research expert weighting respondents’ profile 
Expert Weight Organization 
type 
Job title Years of 
experience 
Functional 
SCM/RM/Pharmacy 
experience 
Expert 
A 
30% hospital Head of 
Procurement 
>20 Procurement , warehousing 
and logistics 
Expert 
B 
20% Academic Professor   >20 Pharmacy and Biomolecular 
Sciences 
Expert 
C 
20% Hospital Pharmacy 
department 
leader 
10 Procurement , warehousing 
and logistics 
Expert 
D 
10% Academic Professor 13 Transportation and Logistics 
management 
Expert 
E 
10% Academic Senior 
Lecturer 
12 Risk and Operation 
management; supply chain 
management 
Expert 
F 
10% Logistics 
Company 
Senior 
Manager - 
Operations 
9 Supply Chain Risk 
management 
 
5.3.3 Data analysis and description 
The survey equally aimed at establishing the extent to which the identified risk factors are 
comprehensive. Accordingly, a reliability and validity test was carried out to test whether the 
study measures the required items and the reliability of the received responses. It should be 
mentioned that the reliability of the questionnaire survey is closely associated to its validity. 
A questionnaire survey cannot be valid unless it is reliable. Cronbach’s Alpha has become the 
widely accepted method in different types of research when multiple-item measures of a 
concept or construct are employed. This is because the method is much easier to use in 
comparison with other estimates as it only requires one test administration. The reliability of 
the obtained results was examined through employing Cronbach's Alpha method (Sijtsma, 
2009; Cohen and Swerdlik, 2010) by using the following functions and equations: 
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where K is defined as number of the questions in the investigation, 𝜎𝑥
2 is the variance of the 
total sample, 𝜎𝑌𝑖
2  is the variance of the current question, and 𝑖 is the question number. Eq. 5.1 
is for the calculation of Cronbach's Alpha, whereas Eq. 5.2 examines the Alpha based on 
standardised items, where K is defined as the number of the questions in the survey and ?̅? 
refers the meaning of the non-redundant correlation coefficients. 
The study tested 204 questions in total. The calculated Cronbach's Alpha value was 0.944. The 
Cronbach's Alpha based on standardised items was found to be 0.952. Alpha coefficient 
ranges in value between 0 and 1 and can be used to describe the reliability of factors extracted 
from the questionnaire. The higher the score, the more reliable the generated scale. In 
practice, a value of 0.8 indicates that the collected data is reliable. The data is also satisfactory 
if the value falls between 0.7 and 0.8. However, in principal, a value less than 0.7 shows poor 
internal consistency of the data (Chomeya, 2010). It can be deduced that the survey attains a 
high level of reliability. Table 5.5 presents the reliability test results of Cronbach’s Alpha. 
Table 5.5: The reliability test for the questionnaire survey 
 Reliability Statistics 
 Cronbach's 
Alpha 
Cronbach's Alpha Based on Standardized 
Items 
Number 
of 
questions 
 
Whole survey 
 
0.944 
 
 
0.952 
 
204 
 
Tables 5.6 and 5.7 illustrate the Sum, Mean, the Weighted Average and Standard Deviation 
(S.D.), and the ranking of the identified risk factors on the basis of expert judgements. 
Standard deviation is the measure of dispersion of a given data. The result analysis shows the 
standard deviation to range from 0 to 2.74. When the value of a standard deviation is high, it 
implies that the experts attribute a particular factor of measurement value to spread to a  
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Table 5.6: Results of the significance of healthcare supply chain risks (Questionnaire Survey) 
Identified risk factors How important is this risk factor to healthcare SC 
operations? 
Sum Mean Weighted 
Average 
S.D. 
Quality risks Counterfeiting (S1)  30 5 5 0 
Poor quality in the purchased drugs from suppliers (S2)   28 4.67 4.8 1.15 
Time limit of drug, Product perishability (S3)   25 4.17 4.2 0.91 
Supplier 
risks 
Shortage of drug, unavailability of drugs on the market  (S4)   27 4.5 4.6 1.22 
Location of manufacturer/supplier (not domestic based) (S5)  22 3.67 3.6 2.31 
Unavailability of raw material-true and commercially induced (S6)  22 3.67 3.7 1.15 
Cash flow/cash management threat associated with small  
companies and hospitals (S7)  
21 3.5 3.6 2.74 
Capacity 
risks 
Capability versus demand; inability of capacity to meet demand (S8)  26 4.33 4.3 1.15 
Demand trigged by the nurse, not the patient (S9)  25 4.17 4.1 2.2 
Forecast 
risks 
Demand uncertainty (S10) 22 3.67 3.7 1.7 
Wrong demand forecasting (S11)  24 4 4 1.41 
Information 
risks 
Poor IT system, lack of data standardization (S12)  27 4.5 4.4 1.22 
Asymmetries of the information, collaboration issues, restriction, 
not share information each department (S13)  
21 3.5 3.5 1.83 
Logistics 
risks 
Dispensing/picking errors-medication/packaging (S14)  27 4.5 4.5 1.87 
Weak logistics service infrastructure (S15)  27 4.5 4.4 1.22 
Fragmentation of the drug distribution process (S16)  23 3.83 3.7 2.2 
Inadequate buffer stock-JIT/Lean (S17)  22 3.67 3.5 2.61 
Lack of visibility concerning placement and availability of stock 
(S18) 
24 4 4 2 
Procurement 
risks 
Procurement Hub-introduce more complexity, long lead time (S19)  25 4.17 4.1 0.91 
Contract problems with suppliers (S20)  22 3.67 3.6 2.31 
Clinician's preference (S21)  25 4.17 4.2 2.61 
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High purchase price (S22)  27 4.5 4.6 1.22 
High product and supplier/brand variety (S23)  25 4.17 4.2 1.68 
Strategic 
risks 
Focus on short term SC planning than long term (S24)  22 3.67 3.5 1.68 
Prioritization-conflict between patients/profits (S25)  21 3.5 3.6 1.87 
Labour risks Strikes and lack talents (S26)  23 3.83 3.6 2.61 
Lack of incentive mechanism (S27)  22 3.67 3.4 1.83 
Natural risks External influences-disaster recovery (S28)  26 4.33 4.2 1.83 
Unexpected disease outbreaks (S29)  28 4.67 4.5 1.15 
Unexpected changes in environment conditions (S30)  25 4.17 4 1.68 
Man-made 
risks 
Regulatory issues-manufacturing using licensing/change of 
standards/drug recalls (S31)  
22 3.67 3.4 2.45 
Rigorous government interventions (S32)  22 3.67 3.4 2 
Lack of funds from government to the hospital (S33)  21 3.5 3.3 2.2 
The requirement of environment protection (S34)  22 3.67 3.6 1.83 
* S.D.= Standard Deviation 
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Table 5.7: Ranking of the significance of healthcare supply chain risks (Questionnaire Survey) 
Risk Factors Sum Rank (Sum) Mean Rank (Mean) Weighted Average Rank (W.A) S.D. Rank (S.D.) 
S1 30 30 5 5 5 5 0 0 
S2 28 28 4.67 4.67 4.8 4.8 1.15 0.91 
S3 25 28 4.17 4.67 4.2 4.6 0.91 0.91 
S4 27 27 4.5 4.5 4.6 4.6 1.22 1.15 
S5 22 27 3.67* 4.5 3.6* 4.5 2.31 1.15 
S6 22 27 3.67* 4.5 3.7* 4.5 1.15 1.15 
S7 21 27 3.5* 4.5 3.6* 4.4 2.74 1.15 
S8 26 27 4.33 4.5 4.3 4.4 1.15 1.22 
S9 25 26 4.17 4.33 4.1 4.3 2.2 1.22 
S10 22 26 3.67* 4.33 3.7* 4.2 1.7 1.22 
S11 24 25 4 4.17 4 4.2 1.41 1.22 
S12 27 25 4.5 4.17 4.4 4.2 1.22 1.41 
S13 21 25 3.5* 4.17 3.5* 4.2 1.83 1.68 
S14 27 25 4.5 4.17 4.5 4.1 1.87 1.68 
S15 27 25 4.5 4.17 4.4 4.1 1.22 1.68 
S16 23 25 3.83* 4.17 3.7* 4 2.2 1.7 
S17 22 24 3.67* 4 3.5* 4 2.61 1.83 
S18 24 24 4 4 4 4 2 1.83 
S19 25 23 4.17 3.83* 4.1 3.7* 0.91 1.83 
S20 22 23 3.67* 3.83* 3.6* 3.7* 2.31 1.83 
S21 25 22 4.17 3.67* 4.2 3.7* 2.61 1.87 
S22 27 22 4.5 3.67* 4.6 3.6* 1.22 1.87 
S23 25 22 4.17 3.67* 4.2 3.6* 1.68 2 
S24 22 22 3.67* 3.67* 3.5* 3.6* 1.68 2 
S25 21 22 3.5* 3.67* 3.6* 3.6* 1.87 2.2 
S26 23 22 3.83* 3.67* 3.6* 3.6* 2.61 2.2 
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S27 22 22 3.67* 3.67* 3.4* 3.6* 1.83 2.2 
S28 26 22 4.33 3.67* 4.2 3.5* 1.83 2.31 
S29 28 22 4.67 3.67* 4.5 3.5* 1.15 2.31 
S30 25 22 4.17 3.67* 4 3.5* 1.68 2.45 
S31 22 21 3.67* 3.5* 3.4* 3.4* 2.45 2.61 
S32 22 21 3.67* 3.5* 3.4* 3.4* 2 2.61 
S33 21 21 3.5* 3.5* 3.3* 3.4* 2.2 2.61 
S34 22 21 3.67* 3.5* 3.6* 3.3* 1.83 2.74 
* denotes the identified risk factors with both Mean and Weighted Average below 4.  
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Figure 5-12: Comparison the results based on Mean and Weighted Average 
 
range of many other values. Furthermore, a set of data was chosen based on the expert 
weighted average as the weighting of each expert has been considered.  
Figure 5.12 illustrates the comparison between the data based on Mean and Weight Average 
for each risk factor. It showed that the results are almost the same as the two lines are close 
to each other. Therefore, an indication is that the proposed expert weighting criteria is 
reliable. In the questionnaire survey, the experts were asked to respond to the items by 
indicating their level of agreement using a five-point Likert scale (i.e. 1=very unimportant, 
2=minor unimportant, 3=moderate, 4=minor important and 5=very important). Finally, some 
risk factors with Weighted Averages below 4 were omitted by the end of the score analysis as 
they are less important or moderate. Those eliminated risk factors are highlighted in grey as 
shown in Figures 5.13 to 5.16.  
As well, low Weighted Average values indicated that most of the experts expressed similar 
concerns about a particular factor. In this case, the remaining risk factors were observed to 
address other factors with low Means. The summary from the table shows the surveyed 
experts’ in relation to the identified categories of supply chain risks to suggest the concerned 
hazardous events. Moreover, it also justifies the reliability and validity of the research findings 
on the methods of supply chain risk classification methods in the healthcare industry.  
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Figure 5-13: The modified hierarchical structure of healthcare supply chain risks 
 
Healthcare Supply 
Chain Risk Sources
External to the 
hospital but internal 
to the supply chain 
network
Supply risks
Quality risks
Supplier risks
Demand risks
Capacity risks
Forecast risks
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Control risks
Strategic risks
Labour risks
External to the supply 
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Natural risks
Man-made risks
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Figure 5-14: The modified External to the hospital but internal to the supply chain network risks hierarchical structure for healthcare SC 
 
External to 
the hospital 
but internal 
to the supply 
chain 
network
Supply risks
Quality risks
Counterfeiting (S1) 
Poor quality in the purchased drugs from suppliers (S2)  
Time limit of drug, Product perishability (S3)    
Supplier risks
Shortage of drug, unavailability of drugs on the market (S4)  
Location of manufacturer/supplier (not domestic based) (S5) 
Unavailability of raw material-true and commercially induced (S6) 
Cash flow/cash management threat associated with small  companies and hospitals 
(S7)  
Demand risks
Capacity risks
Capability versus demand; inability of capacity to meet demand  (S8) 
Demand trigged by the nurse, not the patient (S9) 
Forecast risks
Demand uncertainty (S10) 
Wrong demand forecasting (S11) 
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Figure 5-15: The modified Internal to the hospital risks hierarchical structure for healthcare SC
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Information 
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Poor IT system, lack of data standardization (S12) Asymmetries of the information, collaboration issues, restriction, not share 
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Dispensing/picking errors-medication/packaging (S14) 
Weak logistics service infrastructure (S15) 
Fragmentation of the drug distribution process (S16) 
Inadequate buffer stock-JIT/Lean (S17) 
Lack of visibility concerning placement and availability of stork (S18) 
Procurement 
risks
Procurement Hub-introduce more complexity, long lead time (S19) 
Contract problems with suppliers (S20) 
Clinician's preference (S21) 
High purchase price (S22) 
High product and supplier/brand variety (S23) 
Control 
risks
Strategic risks
Focus on short term SC planning than long term (S24) 
Prioritization-conflic between patients/profits (S25) 
Labour risks
Strikes and lack talents (S26) 
Lack of incentive mechanism (S27) 
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Figure 5-16: The modified External to the supply chain network risks hierarchical structure for healthcare SC
     
                                            
 
  
External to 
the supply 
chain 
network
Environmental 
risks
Natural 
risks
External influences-disaster recovery (S28) 
Unexpected disease outbreaks (S29) 
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(S31) 
Rigorous government interventions (S32) 
Lack of funds from government to the hospital (S33) 
The requirement of environment protection (S34) 
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Among the total 34 risk factors, the results analysis according to the statistical means 
demonstrated that the quality related risks, including counterfeiting (grey market activity) (5) 
and poor drug quality from suppliers (4.8), supplier related risks including shortage of drugs 
in the market (4.6), logistics related risks including dispensing/ picking error-medication/ 
packaging (4.5), procurement related risks including high purchase price (4.6), and  natural 
disaster related risks, including unexpected disease outbreaks (4.5), are of high concern to the 
experts, which could frequently be experienced within the healthcare supply chain networks. 
The significance for each identified risk factor is ranked to suggest the significant and 
influential factors to healthcare SC operations. Nevertheless, although the invited experts 
consisting of the people from different fields and countries, the results also reflect the 
consensus of their opinion under a different contexts. Thus, a typological model of healthcare 
SC risk factors was developed through the preceding discussion of risk factors in the 
healthcare SCs and integrating summarised questionnaire results. The identified healthcare 
SC risk factors are ranked in each categorisation and outlined in a hierarchical structure, 
shown in Figure 5.17.   
Thereafter, to assure the validity and reliability of the developed hierarchy diagram, emails 
and face-to-face interviews were subsequently distributed and conducted with the 
“validation team” (six earlier experts as well as two academics with experience in supply chain 
and risk management who were not part of the expert panel).  Finally, experts agreed and the 
developed hierarchy diagram was accepted without modification. Additionally, the experts 
offered informal advice and opinions, such as this research attend more to the 15 key 
recommendations provided in Lord Carter’s report. Moreover, the risks can also be 
categorised as controllable and uncontrollable risk factors (Behnezhad et al., 2013). In this 
thesis, more attention is paied to the several controllable risks instead of uncontrollable risks 
(e.g. natural risks).  Collaboration and employing information communication technology 
(ICT) are also highly recommendations given by the experts as the key elements for efficiency 
risk mitigation strategies.     
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Figure 5-17: Final hierarchical structure of healthcare supply chain risks
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Poor quality in the purchased drugs from suppliers (S2)  4.8
Time limit of drug, Product perishability (S3)  4.2
Supplier risks Shortage of drug; unavailability of drugs on the market (S4)  4.6
Demand risks
Capacity risks
Capability versus demand; inability of capacity to meet demand (S5) 4.3
Demand trigged by the nurse, not the patient (S6) 4.1
Forecast risks Wrong demand forecasting (S7) 4
Internal to the 
hospital
Process risks
Information 
risks
Poor IT system, lack of data standardization (S8) 4.4
Logistics risks
Dispensing/picking errors-medication/packaging (S9) 4.5
Weak logistics service infrastructure (S10) 4.4
Lack of visibility concerning placement and availability of stock (S11) 4
Procurement 
risks
Procurement Hub-introduce more complexity, long lead time (S12) 4.1
Clinician's preference (S13) 4.2
High purchase price (S14) 4.6
High product and supplier/brand variety (S15) 4.2
External to the 
supply chain 
network
Environmental 
risks
Natural risks
External influences-disaster recovery (S16) 4.2
Unexpected disease outbreaks (S17) 4.5
Unexpected changes in environment conditions (S18) 4
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5.4 CONCLUSION 
This chapter recognises supply chain risk factors identification and classification as the 
significant process for conducting the efficient risk management. The literature review and 
the questionnaire survey serves as a base and guide to strengthen the knowledge base for 
supply chain risk factors identification. In order to identify the risk factors as completely as 
possible, the literature review investigated the broad risk classification methods addressed in 
the previous studies and the questionnaire survey and a series of emails as well as face-to-
face interviews were established to develop a structural hierarchy risk taxonomic diagram.  
In the thesis, a hierarchical risk classification is presented, which consists of five different 
supply chain risk categories (i.e. supply, demand, control, process and environment) based on 
organizational-related, network-related, and environmental-related. Thereafter, those five 
categories of risk factors were further divided into eleven different sub-categories risks: 
quality, supplier, capacity, forecast, information, logistics, procurement, strategic, labour, 
natural, and man-made risks.  
The empirical studies in this chapter were carried out to make an inference about the 
experts’attitudes and opinions in order to capture the risk factors in a more comprehensive 
and reliable way. Meanwhile, the importance of the performance of the identified risk factors 
and developed classification model for the healthcare SC system was addressed. There is a 
consensus between the inputs from academic and industry experts. It provided a portfolio of 
risks and suggested the most concerning hazardous events from both academic and industrial 
perspectives. In the next chapter, the captured risk factors can be assessed by applying both 
Fuzzy AHP and ISM models to discover the priorities and context relations among them.    
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6.CHAPTER SIX – HEALTHCARE SUPPLY CHAIN RISK ASSESSMENT  
 
6.1 INTRODUCTION 
This chapter focuses on risk assessment using Fuzzy AHP to prioritise and detect the critical 
risk factors that can lead to serious consequences for healthcare SC operations. Furthermore, 
it will analyse those important risk factors using an ISM model to provide a comprehensive 
outline by considering their interconnectedness. Empirical studies were conducted to collect 
the primary data on the risk factor weighting and risk factors inter-relationship. It also 
illustrates the applications of the proposed methods. This will facilitate the decision-making 
process for choosing appropriate strategies and take preventive/corrective actions in later 
stages for mitigating risks towards a successful healthcare supply chain management.  
 
6.2 METHODOLOGY FOR RISK ASSESSMENT IN HEALTHCARE SUPPLY CHAIN  
Based on the developed integrated risk management model, a generic Fuzzy AHP and ISM 
based risk assessment model is proposed for determining and assessing the critical levels and 
interrelationship of identified risk factors. The proposed model is a key part in the RM model 
and the schematic diagram of the proposed Fuzzy AHP and ISM based risk assessment model 
is illustrated in Figure 6.1. The proposed Fuzzy AHP and ISM based risk assessment model will 
be implemented on the healthcare SC sector during risk assessment phases via carrying out 
the following steps:  
Step 1: Developing a generic hierarchical structure based on the identified risk factors (this 
step has been done in the last chapter). 
Step 2: Conducting the Fuzzy AHP based questionnaire survey to obtain the experts’ 
judgement and opinions, the significance of the structured risk factors will be explored. These 
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judgements will be carried out in the form of the pre-defined linguistics variables which have 
been explained in Chapter four.   
Step 3: The linguistic variables then will be transformed into the Triangular fuzzy numbers 
(TFNs) for the pair-wise comparisons.  
Step 4: The consistency check test will be conducted on the comparison matrix in order to 
ensure that experts’ judgements and pair-wise comparisons were reasonable.  
Step 5: By use of the expert’s judgements and pair-wise comparisons matrices the local and 
global weights of the risk factors will be calculated. Moreover, the risk factors will be ranked 
directly per their numerical priorities in order to show their significance.  
Step 6: Those risk factors with high priorities will be selected to develop a structural self-
interaction matrix (SSIM) on the basis of pairwise comparison of the risk factors.  
Step 7: A questionnaire containing selected risk factors will be administered to the experts 
with an instruction to compare each and every pair of criteria depicted in SSIM.  
Step 8: Construction of reachability matrix from the SSIM and checking for transitivity 
property.  
Step 9: The obtained reachability matrix is partitioned into different levels.  
Step 10: Drawing a directed graph by removing the transitivity links and also on the basis of 
reachability matrix.  
Step 11: Conversion of diagraph into ISM model by replacing element nodes with statements. 
Moreover, the conceptual inconsistency of developed ISM model will be checked. 
Step 12: MICMAC analysis will be carried out by investigating the driving and dependence 
power among each risk factor. Those risk factors with weak driving power and weak 
dependence will be removed and the remaining risks will be used for the risk mitigation 
strategies identification and evaluation.    
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Risk Factors
 Identification
Risk Assessment Risk Mitigation
Chapter 5 Chapter 6 Chapter 7
Developing a hierarchy structure for risk factors
Construct the fuzzy comparison matrix 
Transform linguistic judgements into fuzzy numbers 
Consistency check
Calculate the fuzzy weight of criteria and sub-criteria s  
Ranking of the risk factors
AHP method under fuzzy environment
Construction of structural self-interaction matrix (SSIM) by 
pairwise comparison
Developing a reachability matrix from the SSIM and checking for 
transitivity
Ensuring the reachability matrix by appropriately partitioned into 
several levels
Drawing of diagraph with removed transitivity links
Conversion of diagraph into an ISM and checking of conceptual 
inconsistency
MICMAC analysis
Remove the risk factors with weak drivers and dependents 
 
Figure 6-1: Proposed Fuzzy AHP and ISM based risk assessment model for healthcare SC 
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6.3 RISK ASSESSMENT WITH FUZZY ANALYTIC HIERARCHY PROCESS (FUZZY AHP) 
For the purpose of solving various uncertain decision-making problems in the real world, it is 
necessary to handle the vagueness and uncertainty in the environment. Uncertainties in 
decision making process include, for example, ill-posed questions, imprecision in 
computation, ambiguity in data/knowledge representation, and some terms of expressing 
opinions, such as “neither agree nor disagree” and “nearly equal importance” can often be 
heard in daily life. It is acknowledged that some methods are widely used for dealing with 
these uncertainties, including heuristic approaches, possibility theory, probability theory, and 
fuzzy set theory (FST).  
FST was originally proposed by Zadeh (1965) to deal with vagueness in human judgement, 
which oriented with the rationality of uncertainty due to ambiguity or vagueness. It is defined 
by a membership function that maps elements to degree of membership within a certain 
interval between o and 1 (Patil and Kant 2014). The main advantage of FST is to provide a 
range to express the vague data and to tackle the ambiguities involved in the process of 
linguistic estimation. In practice, these linguistic terms can be represented by fuzzy numbers. 
According to Chang’s (1996) definition, the fuzzy number is established when various factors 
have been considered in formation of a closed interval. This is represented as follows:  
1) exists 𝑥0 ∈ 𝑅 such that 𝜇𝑀(𝑥0)=1.  
2) For any 𝑎 ∈ [0, 1].  
𝐴𝑎= [𝑥, 𝜇𝐴(𝑥)≥𝑎]    
Then the fuzzy number will be represented by:  
𝑀 ∈ 𝐹(𝑅) 
It is possible to use different fuzzy numbers according to the situation and in practice 
triangular and trapezoidal fuzzy numbers are the most commonly used (Klir and Yuan, 1995). 
Trapezoidal fuzzy numbers are specific case of triangular fuzzy numbers. A trapezoidal fuzzy 
number A is a fuzzy number denoted as A= (a, b, c, d) which membership function is defined 
as: 
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𝜇𝐴(𝑥) =
{
  
 
  
 
0,               𝑥 < 𝑎
𝜇𝑙𝐴(𝑥) =
𝑥−𝑎
𝑏−𝑎
, 𝑎 ≤ 𝑥 ≤ 𝑏
1,                       𝑏 ≤ 𝑥 ≤ 𝑐
𝜇𝑟𝐴(𝑥) =
𝑥−𝑑
𝑐−𝑑
, 𝑐 ≤ 𝑥 ≤ 𝑑
0,       𝑜𝑡ℎ𝑒𝑟𝑤𝑖𝑠𝑒
 
                                                                                           (6.1)         
where a, b, c, d are real numbers and a<b<c<d. If b=c, it is defined a triangular fuzzy number.In 
applications it is often suitable to work with Triangular Fuzzy Numbers (TFNs) due to their 
computation ease, they are useful in supporting illustration and information processing under 
a fuzzy environment (Ertugrul and Karakasoglu, 2007). Moreover, this research applied 
Chang’s (1996) extent analysis method. In this method an extent is quantified using triangular 
fuzzy number. This method is preferred over other fuzzy AHP method’s because the method 
is easy, simple and its application similar to conventional AHP.   
In this case, F(R) refers to all fuzzy sets established while R represents the set of real numbers. 
A fuzzy number M on R is defined as a triangular fuzzy number when its membership function, 
which is µM(X): R → [0, 1], is equivalent to the following function:   
 
𝜇𝑀(𝑥) =
{
 
 
 
 
𝑥
𝑚−𝑙
−
𝑙
𝑚−𝑙
 , 𝑥 ∈ {𝑙,𝑚}.
𝑥
𝑚−𝑢
−
𝑢
𝑚−𝑢
 , 𝑥 ∈ {𝑚, 𝑢}.
0,        𝑜𝑡ℎ𝑒𝑟𝑤𝑖𝑠𝑒
 
                                                                                              (6.2)                              
The membership function of TFN is illustrated in Figure 6.2.  
 
Figure 6-2: Membership function of TFN 
𝜇𝑀(𝑥) 
1 
0 𝑙 𝑚 𝑢 𝑥 
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In this case, u and l represent the respective upper and lower measures of the support of M, 
where m refers to the modal measure, and l ≤ m ≤ u. Therefore, (l, m, u) can be used to 
represent the triangular fuzzy number. In a situation where l = m = u, a non-fuzzy number is 
realized by convention. At the same time, the support of M is a collection of the following 
elements.  
{𝑥 ∈ 𝑅|𝑙 < 𝑥 < 𝑢} 
Consider two triangular fuzzy numbers 𝑀1and𝑀2,𝑀1=(𝑙1, 𝑚1, 𝑢1) and 𝑀2=(𝑙2, 𝑚2, 𝑢2). The 
distance measurement d(𝑀1, 𝑀2) is identical to the Euclidean distance. Then under fuzzy 
environments their basic operations laws such as addition i.e. +, multiplication i.e. ⊗ and 
their inverse can be depicted as follows:  
 
(𝑙1, 𝑚1, 𝑢1) + (𝑙2, 𝑚2, 𝑢2) = (𝑙1 + 𝑙2, 𝑚1 +𝑚2, 𝑢1+ 𝑢2)                                                            (6.3)    
(𝑙1, 𝑚1, 𝑢1) ⊗ (𝑙2, 𝑚2, 𝑢2) = (𝑙1𝑙2, 𝑚1𝑚2, 𝑢1𝑢2)                                                                       (6.4)       
(λ,λ,λ) ⊗ (𝑙1, 𝑚1, 𝑢1) = (λ𝑙1,λ𝑚1, λ𝑢1)  λ›0, λ⊂R.                                                                         
(6.5)           
 (𝑙1, 𝑚1, 𝑢1)
−1 ≈(1/𝑢1, 1/𝑚1, 1/𝑙1)                                                                                              (6.6)            
The Analytic Hierarchy Process (AHP) was initially devised by Saaty (1977, 1980) as a powerful 
and flexible decision making method for the complex criteria structure in different levels. In 
principle, it aims to facilitate the decision maker to decompose the complex problems into a 
series of smaller sub-problems and enable making several pair-wise comparisons, assign 
priority weights to each element in different levels. It helps to provide a preference list of the 
best criteria that have the significant influence. However, despite the advantages of applying 
the AHP method mentioned above, it is believed to have some drawbacks since it is often 
used in nearly crisp-decision applications. The experts usually feel more confidence to make 
interval judgements rather than expressing their opinion in the form of single numeric values. 
Therefore, Fuzzy AHP extends the conventional AHP method by combing it with fuzzy set 
theory (FST) to solve such problems. Although Fuzzy AHP requires tedious computations, it is 
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capable of capturing the experts’ judgement of ambiguity when complex multi-criteria 
decision making problems are considered.  
It can be observed that many researchers have proposed Fuzzy AHP method in different areas. 
Van Laarhoven and Pedrycz (1983) initially use it to compare fuzzy ratios described by 
triangular membership functions. Buckley (1983) further determined fuzzy priorities of 
comparison ratios whose membership functions are trapezoidal. Both studies extended 
Saaty’s conventional AHP method to deal with the imprecision and subjectivity of the pairwise 
comparison process using fuzzy numbers. Their fuzzy utilities need to be ranked to prioritise 
the concerned alternatives. This ranking method can be quite complex and may produce 
unreliable results. Mikhailov (2004) proposed a fuzzy preference programming method to 
derive optimal crisp priorities, which are obtained from fuzzy pairwise comparison 
judgements based on α-cuts decomposition of the fuzzy judgements into a series of interval 
comparisons. The most widely accepted Fuzzy AHP method is proposed by Chang (1992, 1996) 
to introduce a new extent analysis approach for the synthetic extent values of the pairwise 
comparison. The proposed method with extent analysis is simple and easy for 
implementation to prioritise decision variables as compared with the conventional AHP 
method.               
As suggested by Chang (1996), the fuzzy AHP’s pair-wise comparison scale uses triangular 
fuzzy numbers, which by integrating the extent analysis method, the introduction of the pair-
wise comparison’s synthetic extent value Si is achieved. The principle used is the comparison 
of fuzzy numbers to estimate the weight vectors.  The value of fuzzy synthetic extent can be 
defined by taking each object and carrying out an extent analysis for each goal. Considering 
that X = {x1, x2 ....,. xn} is a goal set and G= {g1, g2 ...., gn} as an object set, the m extent analysis 
values can be achieved for each object as follows:     
?̃?𝑔𝑖
1 , ?̃?𝑔𝑖
2 , …, ?̃?𝑔𝑖
𝑚, 𝑖 = 1,2, … 𝑛.                                          
Where the triangular fuzzy numbers are represented by the following: 
?̃?
𝑔𝑖
𝑗
. (𝑗 = 1,2, …𝑚) 
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The sequences of Chang’s analysis can be given in the following sections (Chang, 1996): 
Firstly: The value of fuzzy synthetic extent with respect to the 𝑖 th object is defined as: 
𝑆𝑖 =∑?̃?𝑔𝑖
𝑗  ⊗ [∑∑?̃?
𝑔𝑖
𝑗  
𝑚
𝑗=1
𝑛
𝑖=1
]
−1
                                                                                    
𝑚
𝑗=1
               (6.7) 
To obtain∑ 𝑀
𝑔𝑖
𝑗
𝑚
𝑗=1
, perform the fuzzy addition operation of m extent analysis value for a 
particular matrix such that:  
 
∑?̃?
𝑔𝑖
𝑗 = (∑𝑙𝑗,∑𝑚𝑗 ,∑𝑢𝑗
𝑚
𝑗=1
𝑚
𝑗=1
𝑚
𝑗=1
)
𝑚
𝑗=1
                                                                                                  (6.8) 
 
and to obtain[∑ ∑ ?̃?
𝑔𝑖
𝑗  𝑚𝑖=1
𝑛
𝑗=1 ]
−1
, perform the fuzzy addition operation of  
?̃?
𝑔𝑖
𝑗
(j= 1, 2, …, m) values such that: 
 
∑∑?̃?
𝑔𝑖
𝑗
𝑚
𝑗=1
= (∑𝑙𝑖,∑𝑚𝑖
𝑛
𝑖=1
,∑𝑢𝑖
𝑛
𝑖=1
𝑛
𝑖=1
)                                                                                        (6.9)
𝑛
𝑖=1
 
 
and then compute the inverse of the vector above, such that: 
[∑∑?̃?
𝑔𝑖
𝑗
𝑚
𝑗=1
𝑛
𝑖=1
]
−1
=  (
1
∑ 𝑢𝑖
𝑛
𝑖=1
,
1
∑ 𝑚𝑖
𝑛
𝑖=1
,
1
∑ 𝑙𝑛𝑖=1 𝑖
)                                                                       (6.10) 
 
Calculating the priority vectors of the fuzzy AHP requires the consideration of comparison for 
fuzzy numbers principle, which involves determining the fuzzy value of the greatest or least 
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number. This is achieved by evaluating the degree of possibility of ?̃?2 = (𝑙2,𝑚2, 𝑢2)  ≥ ?̃?1 =
(𝑙1,𝑚1, 𝑢1) , and it is defined as follows:                 
𝑉(?̃?2 ≥ ?̃?1) =  sup
𝑦≥𝑥
[min ( 𝜇?̃?1(𝑥), 𝜇?̃?2(𝑦))]                                                                           (6.11) 
and can be equivalently expressed as follows: 
𝑉(?̃?2 ≥ ?̃?1) = ℎ𝑔𝑡( ?̃?1 ∩ ?̃?2) =  𝜇?̃?2(𝑑)                                                                           (6.12) 
 
= 
{
 
 
1, 𝑖𝑓 𝑚2 ≥ 𝑚1
0, 𝑖𝑓 𝑙1 ≥ 𝑢2
𝑙1 − 𝑢2
(𝑚2 − 𝑢2) − (𝑚1 − 𝑙1)
, 𝑜𝑡ℎ𝑒𝑟𝑤𝑖𝑠𝑒 .
                                                          (6.13) 
 
Figure 6.3 illustrates Eq. 6.12 where d is the ordinate of the highest intersection point D 
between  𝜇?̃?1 and 𝜇?̃?2. To compare ?̃?1 and ?̃?2, it requires both the values of “𝑉(?̃?1 ≥
?̃?2)” and “(?̃?2 ≥ ?̃?1)” 
 
 
Figure 6-3: The intersection between 𝑴𝟏and 𝑴𝟐 
The degree of possibility for a convex fuzzy number to be greater than k convex fuzzy 
?̃?1(𝑖 = 1,2, 𝑘) numbers can be defined by:  
𝑉(?̃? ≥ ?̃?1, ?̃?2, … 𝑀𝑘) = 𝑉[(?̃? ≥ ?̃?1𝑎𝑛𝑑 (?̃? ≥ ?̃?2)𝑎𝑛𝑑 … . 𝑎𝑛𝑑 (?̃? ≥ ?̃?𝑘)] 
D 
𝑀1 𝑀2 
𝑀 
V(MI ≥ M2) 
𝑙2 𝑚2 𝑙1 𝑑 𝑢2 𝑚1 𝑢1 
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= 𝑚𝑖𝑛 𝑉(?̃? ≥ ?̃?𝑖), 𝑖 = 1,2,3, … , 𝑘                                                                                             (6.14)  
 
Assume that 𝑑(𝐴𝑖) = 𝑚𝑖𝑛𝑉(𝑆𝑖 ≥ 𝑆𝑘) for K= 1,2, …, n; k ≠i. then the weight vector is given 
by  
𝑊′ = (𝑑′(𝐴1),𝑑
′(𝐴2), … . , 𝑑
′(𝐴𝑛))
𝑇                                                                                            (6.15) 
 
Where 𝐴𝑖  is 𝑖th element and 𝑑
′(𝐴1),… . , 𝑑
′(𝐴𝑛) are priority weights calculated by Eq.6.13 
before their normalization.  
In the end, via normalization, the normalized weight vectors are: 
𝑊 = (𝑑(𝐴1),𝑑(𝐴2), … . , 𝑑(𝐴𝑛))
𝑇                                                                                                  (6.16) 
where 𝑊 is a non-fuzzy number.  
In this chapter, Chang’s extent analysis method is used since this approach is widely 
acceptable and easier than other Fuzzy AHP approaches. The triangular fuzzy numbers (TFNs) 
are applied as a pairwise comparison scale for deriving the weights of the criteria (i.e. risks) 
and sub-criteria (i.e. sub-risks). In practice, experts usually express the opinion using the 
linguistic variables to appraise the importance of one criterion over another or even to rank 
the alternatives with respect to various criteria. Table 6.1 illustrates the idea of the Fuzzy 
Multi-Attribute Criteria Decision-making (FMACD) has intentionally transformed the existing 
linguistic values to TFNs i.e. equal, weak, strong, very strong and absolute strong importance 
along with their values, and the illustration of membership function of triangular fuzzy 
numbers used in Fuzzy AHP is presented in Figure 6.4. The purpose of the transformation 
process is to illustrate the application of the proposed method and benchmark the empirical 
results using other precise value methods in the later analysis. Moreover Ma et al., (2007) 
and Karahalios (2009) highlighted the following issues when using linguistic variables:  
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 Experts need to select linguistic terms for presenting their opinions by their 
preference. It is not demanded that all experts must use the same linguistic terms. 
 It is not required for all linguistic terms to be placed symmetrically and to have total 
order. Therefore experts and decision makers have more independent right to present 
their opinions.  
 Each linguistic term should be treated as a whole and the only concern is on its 
determinacy and consistency.  
Among the commonly used fuzzy numbers, triangular and trapezoidal fuzzy numbers are 
likely to be the adoptive ones due to their ease in modelling easy interpretations. Anoop et 
al., (2006) explain it is known that for engineering applications, to reduce the computational 
complexity, fuzzy sets with triangular or trapezoidal form are most commonly used. Both 
triangular and trapezoidal fuzzy numbers are applicable to the present study; however, this 
study use TFN for Fuzzy AHP application due to its easiness in use. In practical applications, 
the triangular form of the membership function is used most often for representing fuzzy 
numbers (Ding and Liang, 2005; Karsak and Tolga, 2001). TFN can adequately represent the 
mentioned fuzzy linguistic variables, thus it is used for the analysis thereafter. During the 
calculations whenever it is supposed to carry out a pair-wise comparison between the same 
criterion e.g. to compare criterion 𝐶1 with 𝐶2, 𝐶2 with 𝐶3 etc obviously the result is equal is 1 
in which its converted TFN will be (1,1,1).   
Table 6.1: Linguistic scales for difficulty and importance 
Linguistic 
judgement 
Triangular fuzzy 
number (l,m,u) 
Inverse linguistic 
judgements 
Inverse triangular 
fuzzy scale 
Equal importance 
(Eq) 
(1, 1, 1) Equal importance 
(Eq) 
(1, 1, 1) 
Weak 
importance (Wk) 
(2/3, 1, 3/2) Weak importance 
(Wk) 
(2/3, 1, 3/2) 
Strong 
importance (St) 
(3/2, 2, 5/2) Strong importance 
(St) 
(2/5, 1/2, 2/3) 
Very strong 
importance (Vs) 
(5/2, 3, 7/2) Very strong 
importance (Vs) 
(2/7, 1/3, 2/5)  
Absolute strong 
importance (As)    
(7/2, 4, 9/2) Absolute strong 
importance (As) 
(2/9, 1/4, 2/7) 
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0           2/3            1           3/2          2          5/2          3          7/2          4          9/2
1
0.5
Wk                         St                         Vs                         As
 
Figure 6-4: The membership functions of the triangular fuzzy numbers 
 
6.4 AN EMPIRICAL STUDY ON THE APPLICABILITY OF THE FUZZY AHP METHOD  
To investigate the significance of the identified healthcare supply chain related risks, a Fuzzy 
AHP method has been developed. This study was executed in four phases: (1) conducting a 
questionnaire survey, including questionnaire formulation, pilot study, and the selection of 
experts, (2) data collection, description, and analysis, (3) testing the robustness of the 
proposed method and (4) the finding discussion.    
6.4.1 Conducting the Fuzzy AHP-based questionnaire survey   
Prior to actual data collection, content validity was performed to improve the clarification of 
the questionnaire. A cover letter and questionnaire were drafted and the same forward as 
well as backward translation process was applied on the questionnaires as was applied earlier. 
Two drafted versions of the questionnaires with different languages were further examined 
by two academic researchers and two specialists from Universities in the UK and China for 
comments. Their feedbacks were useful for the final drafted questionnaire, which was used 
for a pilot study. The pilot study was conducted by asking different judges to pre-assess the 
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questionnaires effectiveness, accuracy and unambiguous communication with the experts. 
Ethical approval was also obtained to further validate the questionnaire contents and 
participant consent. The final questionnaire is shown in Appendix Two.  
In Section A, the personal details of the experts were included in order to verify their 
organization, position, and length of working year, which can be used for the evaluation of 
each expert’s proficiency. Section B firstly provides the predefined linguistic terms for experts 
to make decisions in the rest of the questionnaire. The experts are asked to choose a set of 
pairwise comparisons for demonstrating the extent to which a risk factor is more important 
than another in each pair. The last part of Section B has ten matrices which need to be duly 
marked as per experts’ judgements.  
The target sample is selected from the National Health Service (NHS) Choices which provides 
the comprehensive health information service including all NHS hospitals in England, to 
support patients making the best choices. In China, the target sample was selected from a list 
from the Chinese National Hospital Association. The main factor in selecting experts was their 
expertise and their contribution to the fields related to the identified risk factors. Experts who 
specialize in supply chain and logistics related work in hospitals were selected as the 
respondents. The research also used publicly available directories and LinkedIn to obtain 
contact details. For the pharmaceutical manufacturer and distributor, the relevant 
information was provided from some hospitals involved into our empirical studies. Moreover, 
the NHS Supply Chain has been providing supply chain services to the UK NHS since 2006. As 
well, the LogHealth Center in Thailand is one of three research institutes that specialize in the 
healthcare supply chain management. Thus, those consulting organizations are also selected 
as the respondents in this research. In total 231 UK NHS hospitals, eleven Chinese hospitals, 
seven pharmaceutical distributors/companies, NHS Supply Chain, and LogHealth Center were 
selected and each organization was sent several questionnaire surveys to relevant 
departments, e.g. director, pharmacy department, operation department, material 
department, and procurement department. The target respondents were first asked by email 
or phone call whether they were willing to take participate in our survey. Then, the link to the 
online questionnaire via eSurveyCreator or email questionnaire were distributed.  In total 431 
          
201 
 
questionnaires were distributed in 14th Feb 2017 with 72 replies in three months, including 
56 valid and 16 invalid questionnaires as the respondents did not answer all the questions of 
this survey, within a month. The valid return rate is 13 per cent, see Table 6.2. 
Table 6.2: Questionnaires return detail 
Questionnaire 
distributed 
Questionnaire 
returned 
Invalid replies Valid replies Valid reply rate 
431 72 16 56 13% 
 
Table 6.3 presents the 56 respondents’ profile. Approximately 55 per cent of respondents 
have already worked within the healthcare industry for more than 16 years. This indicates 
that most respondents have long professional working experiences in the relevant supply 
chain and logistics operations and therefore the results of this survey have a high reliability. 
From the types of organization, most respondents are working in the hospital (76 per cent in 
total, 30 per cent from Chinese hospitals and 70 per cent from UK NHS), followed by the 
supply chain consulting agency (11 per cent in total, 5 experts from LogHealth Center and one 
from the NHS supply chain), and pharmaceutical distributor/companies (13 per cent, all 
respondents from China). Although in this survey the author has tried to distribute the 
questionnaire to the pharmaceutical distributor/companies in the UK since the response rates 
from different departments appeared to be quite different. The unbalanced samples might 
cause bias in the risk assessment. Nevertheless, the similar structure of the healthcare supply 
chain in both countries and each respondent from the Chinese pharmaceutical companies 
holding the position at a manager level may reduce such bias. In addition, the validity test of 
the survey results is conducted by some respondents from UK NHS could also ensure the 
reliability of this survey.  
In terms of the professional role, the largest type of respondent’ role is head of 
procurement/pharmacy department leader (38 per cent) in charge of all the hospital’s supply 
chain and logistics activities, and the second group is head of supply chain, logistics and 
warehouse manager (16 per cent). Most respondents hold a position at or above the manager 
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level and have the power to make decisions within healthcare organizations. From the 
classification degree China’s hospitals, most are 3A grade with at least 500 beds and 25 care 
departments, and so forth.  
Table 6.3: respondents’ profile 
 Number % 
What is the type of 
your organization? 
Pharmaceutical Manufacturer 0 0 
Pharmaceutical distributor 
(pharmaceutical company) 
7 13% 
Hospital 43 76% 
Other 6 11% 
What is your job 
title? 
Head of Procurement/Pharmacy 
department leader 
21 38% 
Purchase/procurement Manager (Non-
clinical, clinical) 
8 14% 
Head of Supply chain, Logistics, 
Materials, Warehouse 
9 16% 
Head of Contracts, category, IT manager, 
E-commerce 
3 5% 
General manager (pharmaceutical 
company) 
7 12% 
Supply chain consulting institute 6 11% 
Hospital Director 2 4% 
For how many years 
have you worked in 
the healthcare 
industry or 
healthcare supply 
chain? 
1 – 5 years 0 0 
6 – 10 years 9 16% 
11 – 15 years 16 29% 
16 – 19 years 13 23% 
≥20 years 18 32% 
Location based UK 31 55% 
China 20 36% 
Thailand 5 9% 
 
6.4.2 Numerical illustration  
The fuzzy AHP phase obtained respondents’ judgements about the relative importance of 
identified risk factors and calculated total weights. The details of the data analysis are 
described in the following steps.  
Step 1, Structure problem hierarchy 
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The first step is to construct the problem into a hierarchy including a goal, set of criteria and 
sub-criteria. As Fuzzy AHP method is employed only for the risk assessment in this research, 
thus the decision alternatives are not carried out in the hierarchy. The hierarchical structure 
was built from the previous chapter as shown in Figure 6.5.     
Step 2. Construct fuzzy pairwise comparison matrices 
Table 6.4: Linguistic judgements for Fuzzy AHP 
Linguistic judgements Explanations  
Equal importance (Eq) Two activities contribute equally to the 
objective 
Weak importance (Wk) Experience and judgement slightly favour one 
over another 
Strong importance (St) Experience and judgement strongly favour one 
over another 
Very strong importance (Vs) An activity is favoured very strongly over 
another 
Absolute strong importance (As) The evidence favouring one activity over 
another is of the highest possible order of 
affirmation 
 
In this step, the respondents were asked to compare each risk factor at a given level of the 
hierarchy on a pair-wise basis. This is to measure their relative importance. It is noteworthy 
that the input to the risks has to be well-defined to give the experts an exact understanding 
of all risks that have to be assessed. This research uses the basic linguistic preference as equal 
importance (Eq), weak importance (Wk), Strong importance (St), Very strong importance (Vs) 
and Absolute strong importance (As). Instead of using nine-point scales for the judgments as 
the traditional AHP, the fuzzy AHP uses linguistic preference to take into account the 
uncertain preference of the decision maker. Moreover, it is easier to use these terms to 
express the respondents’ feelings of judgements like good, bad etc (Kunal et al., 2013). The  
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Figure 6-5: Hierarchical structure of healthcare supply chain risks 
Hospital 
Pharmaceutical 
Supply Chain Risk 
Assessment
External to 
the hospital 
but internal to 
the supply 
chain network
Supply risks
Quality risks
Counterfeiting (S1) 
Poor quality in the purchased drugs from suppliers (S2)  
Time limit of drug, Product perishability (S3)    
Supplier risks Shortage of drug; unavailability of drugs on the market (S4)  
Demand 
risks
Capability 
risks
Capability versus demand; inability of capacity to meet demand (S5) 
Information flow/lack of demand information (S6) 
Forecast 
risks
Wrong demand forecasting (S7) 
Internal to the 
hospital
Process risks
Information 
risks
Poor IT system, too much information, lack of data standardization (S8) 
Logistics risks
Dispensing/picking errors-medication/packaging (S9) 
Weak logistics service infrastructure (S10)  
Lack of visibility concerning placement and availability of stork (S11)
Procurement 
risks
Procurement Hub-introduce more complexity, long lead time (S12) 
Clinician's preference (S13) 
High purchase price (S14) 
High product and supplier/brand variety (S15) 
External to the 
supply chain 
network
Environmen
tal risks Natural risks
External influences-disaster recovery (S16) 
Unexpected disease outbreaks (S17) 
Unexpected changes in environment conditions (S18) 
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linguistic judgements and their explanations used for measuring the importance of the risk 
factors in pair-wise comparisons are shown in Table 6.4.   
Step 3. Transform linguistic judgements into fuzzy numbers 
In this step, after received the 56 valid questionnaires, the linguistic terms need to transform 
into triangular fuzzy numbers as shown in Table 6.5. In order to save space, the author only 
presents the results of the fuzzy AHP for one selected respondent’s opinion. The result of the 
fuzzy pair-wise comparison matrix at criteria layer is shown in Table 6.6. The consistency ratio 
of the criteria level is 0.033.  
Table 6.5: Linguistic scales for difficulty and importance 
Linguistic 
judgement 
  Triangular fuzzy 
number (l,m,u) 
Inverse linguistic 
judgements 
Inverse triangular fuzzy 
scale 
Equal importance 
(Eq) 
(1, 1, 1) Equal importance 
(Eq) 
(1, 1, 1) 
Weak importance 
(Wk) 
(2/3, 1, 3/2) Weak less 
importance (Wk) 
(2/3, 1, 3/2) 
Strong importance 
(St) 
(3/2, 2, 5/2) Strong less 
importance (St) 
(2/5, 1/2, 2/3) 
Very strong 
importance (Vs) 
(5/2, 3, 7/2) Very strong less 
importance (Vs) 
(2/7, 1/3, 2/5)  
Absolute strong 
importance (As)    
(7/2, 4, 9/2) Absolute strong less 
importance (As) 
(2/9, 1/4, 2/7) 
  
Table 6.6: The fuzzy pair-wise comparison matrix of three criteria 
Linguistic judgement External to the 
hospital but internal 
to the supply chain 
network 
Internal to the 
hospital 
External to the 
supply chain 
network 
External to the 
hospital but internal 
to the supply chain 
network 
(1, 1, 1) (2/3, 1, 3/2) (3/2, 2, 5/2) 
Internal to the 
hospital 
(2/3, 1, 3/2) (1, 1, 1) (2/3, 1, 3/2) 
External to the supply 
chain network 
(2/5, 1/2, 2/3) (2/3, 1, 3/2) 
 
 
(1, 1, 1) 
C.R. = 0.033    
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The AHP method provides a measure of the consistency of pairwise comparisons by 
introducing the Consistency Index (CI) and Consistency Ratio (CR), which can be calculated by 
using Eq. 6.17 and Eq. 6.18. The 𝜆𝑚𝑎𝑥 is the maximum average of the values or the maximum 
eigenvalue of an n*n comparison matrix and is calculated by Eq. 6.19. RI is the random index 
for the matrix size, n and depends on the number of items being compared and is shown in 
Table 6.7 (Saaty, 1994). If CR is valued less than or equal to 0.1 then a consistency is indicated 
and the pairwise comparisons are reasonable.       
It needs to be mentioned that the survey will be sent back to the respondents to revise the 
choice if the C.R. is larger than 0.1.     
 
𝐶𝐼 =  
𝜆𝑚𝑎𝑥−𝑛
𝑛−1
                                                                                                                                     (6.17)                                                      
𝐶𝑅 =  
𝐶𝐼
𝑅𝐼
                                                                                                                                             (6.18)                                                    
∑ 𝑥𝑖𝑗
𝑛
𝑖=1 𝑤𝑖 = 𝜆𝑚𝑎𝑥𝑊𝑗;    where  i=1,2, …, n                                                                              (6.19 )                        
 
Table 6.7: Average random index value 
n 1 2 3 4 5 6 7 8 9 10 
RI 0 0 0.58 0.90 1.12 1.24 1.32 1.41 1.45 1.49 
Source: based on Saaty (1994) 
Before the fuzzy weights for each risk factor was calculated, every preferences made by the 
individual respondent were aggregated into a group preference for each risk factor. The 
aggregation of the triangular fuzzy numbers (TFNs) were performed by applying two 
mathematical models, namely an Arithmetic Mean method and a Geometric Average 
method. According to the literature, most researchers have highly recommended that the 
Geometric Average method as more reliable (Kahraman et al., 2003; Ramkumar, 2016), 
However, in order to obtain more reliable and accurate results in this thesis, both 
mathematical models have been applied. The result of the fuzzy matrix at the criteria layer 
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using Arithmetic Mean method is shown in Table 6.8; and the results of the fuzzy matrix at 
the criteria layer using Geometric Average method is shown in Table 6.9.    
Table 6.8: The fuzzy pair-wise comparison matrix of three criteria (Arithmetic Mean 
method) 
 External to the 
hospital but internal 
to the supply chain 
network 
Internal to the 
hospital 
External to the 
supply chain 
network 
External to the 
hospital but internal 
to the supply chain 
network 
(1, 1, 1) (1.23, 1.4, 1.64) (1.5, 1.85, 2.3) 
Internal to the 
hospital 
(0.97, 1.1, 1.26) (1, 1, 1) (1.6, 1.9, 2.3) 
External to the 
supply chain 
network 
(0.63, 0.78, 0.99) (0.65, 0.8, 0.99) 
 
 
(1, 1, 1) 
C.R. = 0.013    
 
Table 6.9: The fuzzy pair-wise comparison matrix of three criteria (Geometric Average 
method) 
 External to the 
hospital but internal 
to the supply chain 
network 
Internal to the 
hospital 
External to the 
supply chain 
network 
External to the 
hospital but internal 
to the supply chain 
network 
(1, 1, 1) (1, 1.15, 1.3) (1.25, 1.65, 1.96) 
Internal to the 
hospital 
(0.77, 0.87, 0.99) (1, 1, 1) (1.26, 1.56, 1.9) 
External to the 
supply chain 
network 
(0.51, 0.63, 0.8) (0.55, 0.64, 0.79) 
 
 
(1, 1, 1) 
C.R. = 0.001    
 
Step 4. Calculate fuzzy weights  
In this step, the fuzzy weights of the criteria and sub-criteria are calculated, based on the 
extent analysis method suggested by Chang (1996). It is a widely accepted methodology which 
has been used by several researchers owing to its simplicity. The extent analysis method was 
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applied to consider the extent of an object or criteria to be satisfied for the goal. (Kunal et al., 
2013)  
The numerical analysis of deciding the weight vectors of the criteria with respect to goal is 
discussed as follows: 
The fuzzy comparison matrix of the criteria by Arithmetic Mean method as an example which 
is shown in Table 6.9. The fuzzy synthetic extent value with respect to each criterion was 
calculated by using Eq. 6.7. 
The different values of fuzzy synthetic extent with respect to the three different criteria were 
denoted by𝑆1,𝑆2, 𝑆3, respectively.  
 
𝑆1 = (3.73, 4.25, 4.94) ⊗ (1/12.48, 1/10.83, 1/9.58) = (0.3, 0.39, 0.52) 
 
𝑆2= (3.57, 4, 4.56) ⊗ (1/12.48, 1/10.83, 1/9.58) = (0.29, 0.37, 0.48) 
 
𝑆3 = (2.28, 2.58, 2.98) ⊗ (1/12.48, 1/10.83, 1/9.58) = (0.18, 0.24, 0.31) 
 
These fuzzy synthesis values were compared with each other by using Eq. 6.13 of the extent 
analysis as follows: 
V(𝑆1 ≥ 𝑆2)= 1 
V(𝑆1 ≥ 𝑆3)= 1 
V(𝑆2 ≥ 𝑆1)= 
0.3−0.48
(0.37−0.48)−(0.39−0.3)
= 0.9 
V(𝑆2 ≥ 𝑆3)= 1 
Similarity,  V(𝑆3 ≥ 𝑆1)= 
0.3−0.31
(0.24−0.31)−(0.39−0.3)
 = 0.06 
           V(𝑆3 ≥ 𝑆2)= 
0.29−0.31
(0.24−0.31)−(0.37−0.29)
 = 0.13 
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Then priority weights were calculated by using Eq. 6.14 of the extent analysis as follows: 
d’(𝐶1)= min V(𝑆1 ≥ 𝑆2, 𝑆3) = min (1, 1) = 1, 
Similarity, d’(𝐶2)= min V(𝑆2 ≥ 𝑆1, 𝑆3) = min (0.9, 1) = 0.9 
                   d’(𝐶3)= min V(𝑆3 ≥ 𝑆1, 𝑆2) = min (0.06, 0.13) = 0.06 
 
Therefore the weight vector was given as  
W’= (1, 0.9, 0.06)𝑇 
 
Finally after normalisation of these value as per Eq. 6.16 of the extent analysis, the weight 
vector with respect to criteria𝐶1, 𝐶2, 𝐶3 is obtained as follows. The complete result is also 
given in Table 6.10.  
 
W= (0.51, 0.46, 0.03)𝑇 
 
Table 6.10: The fuzzy pair-wise comparison matrix of three criteria (Arithmetic Mean 
method) 
 External to the 
hospital but 
internal to the 
supply chain 
network 
Internal to the 
hospital 
External to the 
supply chain 
network 
Weight 
External to the 
hospital but 
internal to the 
supply chain 
network 
(1, 1, 1) (1, 1.15, 1.3) (1.25, 1.65, 1.96) 0.51 
Internal to the 
hospital 
(0.77, 0.87, 0.99) (1, 1, 1) (1.26, 1.56, 1.9) 0.46 
External to the 
supply chain 
network 
(0.51, 0.63, 0.8) (0.55, 0.64, 0.79) 
 
 
(1, 1, 1) 0.03 
C.R. = 0.001     
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Hospital 
Pharmaceutical 
Supply Chain 
Risk Sources
External to the 
hospital but 
internal to the 
supply chain 
network (A1) 
0.51
Supply risks 
(B1) 0.79/0.4
Quality risks 
(C1) 
0.61/0.25
Counterfeiting (S1) 0.61/0.15
Poor quality in the purchased drugs from suppliers (S2)  0.3/0.075
Time limit of drug, Product perishability (S3)  0.09/0.0225 
Supplier risks 
(C2) 
0.39/0.16
Shortage of drug, unavailability of drugs on the market  (S4)0.16/0.16
Demand risks 
(B2) 
0.21/0.11
Capability 
risks (C3) 
0.95/0.105
Capability versus demand, inability of capacity to meet demand  (S5) 0.81/0.085
Demand trigged by the nurse, not the patients (S6) 0.19/0.02
Forecast risks 
(C4) 
0.05/0.005
Wrong demand forecasting (S7) 0.005/0.005
Internal to the 
hospital (A2) 
0.46
Process risks 
(B3)0.46/0.46
Information 
risks (C5) 
0.29/0.133
Poor IT system, lack of data standardization  (S8) 0.133/0.133
Logistics risks 
(C6) 
0.46/0.212
Dispensing/picking errors-medication/packaging (S9) 0.49/0.104
Weak logistics service infrastructure (S10) 0.33/0.07
Lack of visibility concerning placement and availability of stork (S11) 0.18/0.038
Procurement 
risks (C7) 
0.25/0.115
Procurement Hub-introduce more complexity, long lead time (S12) 0.13/0.015
Clinician's preference (S13) 0.29/0.033
High purchase price (S14) 0.33/0.038
High product and supplier/brand variety (S15) 0.25/0.029
External to the 
supply chain 
network (A3) 
0.03
Environmenta
l risks 
(B4)0.03/0.03
Natural risks 
(C8) 
0.03/0.03
External influences-disaster recovery (S16) 0.32/0.0096
Unexpected disease outbreaks (S17) 0.63/0.0189
Unexpected changes in environment conditions (S18) 0.05/0.0015
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6-6:  Results in relation to Arithmetic Mean Method 
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Hospital 
Pharmaceutical 
Supply Chain Risk 
Sources
External to the 
hospital but 
internal to the 
supply chain 
network (A1) 
0.53
Supply risks 
(B1) 0.75/0.4
Quality risks 
(C1) 0.61/0.24
Counterfeiting (S1) 0.66/0.159
Poor quality in the purchased drugs from suppliers (S2)  0.33/0.079
Time limit of drug, Product perishability (S3)  0.01/0.002 
Supplier risks 
(C2) 0.39/0.16
Shortage of drug, unavailability of drugs on the market  (S4)  0.16/0.16
Demand risks 
(B2) 
0.25/0.133
Capability 
risks (C3) 
0.95/0.126
Capability versus demand,inability of capacity to meet demand  (S5) 0.86/0.108
Demand trigged by the nurse, not the patients (S6) 0.14/0.018
Forecast risks 
(C4) 
0.05/0.007
Wrong demand forecasting (S7) 0.007/0.007
Internal to the 
hospital (A2) 
0.43
Process risks 
(B3) 0.43/0.43
Information 
risks (C5) 
0.26/0.112
Poor IT system, lack of data standardization (S8) 0.112/0.112
Logistics risks 
(C6) 
0.48/0.206
Dispensing/picking errors-medication/packaging (S9) 0.47/0.097
Weak logistics service infrastructure (S10) 0.36/0.074
Lack of visibility concerning placement and availability of stork (S11) 0.17/0.035
Procurement 
risks (C7) 
0.26/0.112
Procurement Hub-introduce more complexity, long lead time (S12) 0.12/0.014
Clinician's preference (S13) 0.29/0.032
High purchase price (S14) 0.31/0.035
High product and supplier/brand variety (S15) 0.28/0.031
External to the 
supply chain 
network (A3) 
0.04
Environmental 
risks (B4) 
0.04/0.04
Natural risks 
(C8) 0.04/0.04
External influences-disaster recovery (S16) 0.33/0.013
Unexpected disease outbreaks (S17) 0.61/0.024
Unexpected changes in environment conditions (S18) 0.06/0.003
  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6-7: Results in relation to Geometric Average Method 
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Now the different sub-criteria are compared under each criteria separately by following the 
same procedure as discussed above. It needs to be mentioned that the value of the elements 
of the matrix must be normalized whenever the value is larger than zero and then the same 
process will be repeated again to calculate the weight vector of each attribute.  
Step 5. Calculate global weights  
Once the local weights of criteria and sub-criteria of different levels of the hierarchy were 
calculated, the final results were aggregated to obtain the final or global weights. The values 
are shown in both Figures 6.6 and 6.7.  
6.4.3 Testing the robustness of the proposed Fuzzy AHP approach  
6.4.3.1 Comparing the results of both methods (Geometric and Arithmetic mean)  
As described above, both mathematical methods were employed for the aggregation of the 
survey results in order to ensure the reliability and accuracy of the findings. Figure 6.8 
presents the comparison of the results obtained by using both methods. The summary of the 
results, as shown in Table 6.11, reveals that the higher risk weighting is obtained for “shortage 
of drug, unavailability of drugs on the market (S4)”, followed by “counterfeiting (S1)” and 
“poor IT system and lack of data standardization (S8)”. As a summary of the results, one can 
argue that for both methods, a minor deviation is observed in the outcomes, but it does not 
affect the final ranking. Thus, it can be concluded that the consequences are reliable. By the 
end, 11 risk factors with the highest priorities were chosen for further evaluation based on 
the results obtained by using the Geometric Average method.  
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Table 6.11: Summary of results from Arithmetic Mean and Geometric Average methods 
 Geometric Average Rank Global 
weights  
Arithmetic Mean Rank Global 
weights 
Shortage of drug, unavailability of drugs on the market  
(S4) 
1 0.16* Shortage of drug,, unavailability of drugs on 
the market  (S4) 
1 0.16 
Counterfeiting (S1) 2 0.159* Counterfeiting (S1) 2 0.15 
Poor IT system, lack of data standardization (S8) 3 0.112* Poor IT system, lack of data standardization 
(S8) 
3 0.133 
Capability versus demand; inability of capacity to meet 
demand (S5) 
4 0.108* Dispensing/picking errors-
medication/packaging (S9) 
4 0.104 
Dispensing/picking errors-medication/packaging (S9) 5 0.097* Capability versus demand, inability of capacity 
to meet demand  (S5) 
5 0.085 
Poor quality in the purchased drugs from suppliers (S2) 6 0.079* Poor quality in the purchased drugs from 
suppliers (S2) 
6 0.075 
Weak logistics service infrastructure (S10) 7 0.074* Weak logistics service infrastructure (S10) 7 0.07 
Lack of visibility concerning placement and availability of 
stork (S11) 
8 0.035* Lack of visibility concerning placement and 
availability of stork (S11) 
8 0.038 
High purchase price (S14) 9 0.035* High purchase price (S14) 9 0.038 
Clinician's preference (S13) 10 0.032* Clinician's preference (S13) 10 0.033 
High product and supplier/brand variety (S15) 11 0.031* High product and supplier/brand variety (S15) 11 0.029 
Unexpected disease outbreaks (S17) 12 0.024 Time limit of drug, product perishability (S3)  12 0.0225 
Demand trigged by the nurse, not the patients (S6) 13 0.018 Demand trigged by the nurse, not the patients  
 (S6) 
13 0.02 
Procurement Hub-introduce more complexity, long lead 
time (S12) 
14 0.014 Unexpected disease outbreaks (S17) 14 0.0189 
External influences-disaster recovery (S16) 15 0.013 Procurement Hub-introduce more complexity, 
long lead time (S12) 
15 0.015 
Wrong demand forecasting (S7) 16 0.007 External influences-disaster recovery (S16) 16 0.0096 
Unexpected changes in environment conditions (S18) 17 0.003 Wrong demand forecasting (S7) 17 0.005 
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Time limit of drug, product perishability (S3)  18 0.002 Unexpected changes in environment 
conditions (S18) 
18 0.0015 
“*” denotes those risk factors are significant and selected for further analyses  
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Figure 6-8: Comparison of the results from Arithmetic Mean and Geometric Average 
methods 
 
6.4.3.2 Reliability test for weights obtained by the pairwise comparison   
To implement the Fuzzy AHP method, the pairwise comparison was carried out by covering 
each variable in the hierarchical structure. The less important risk factors have been omitted 
from the initial developed structure based on their importance levels in the phase of risk 
identification. During the phase of risk assessment, only the remaining risks with experts’ 
comments are measured. As depicted in Figures 6.6 and 6.7, there are few risks to stay in 
isolation not involved in the comparison among the same level, i.e. “S4 shortage of drugs”, 
“S7 wrong demand forecasting”, “S8 poor IT system”. Therefore, this will give rise to concerns 
about the larger weight of these individual risks when compared those risks involved in either 
two or three-time comparison in each level. Therefore, in order to ensure the reliability of our 
results, a sensitivity analysis was done by gradually changing the weights for some sub-criteria 
while keeping other weights at the same value, and the impact on the concluding results was 
examined. Among those risk factors, 18 sub-criteria were selected for the evaluation. Until 
now, there is no study in the literature that determine the feasibility of individual weighting.  
0
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Figure 6-9: Results of the sensitive analysis (multiplication) 
 
 
 
0 0.1 0.2 0.3 0.4 0.5 0.6
S1 Counterfeiting
S2 Poor quality in the purchased drugs from suppliers
S3 Time limit of drugs, product perishability
S4 Shortage of drugs, unavailability of drugs on the market
S5 Capability versus demand, inability of capacity to meet demand
S6 Demand trigged by the nurse, not the patients
S7 Wrong demand forecasting
S8 Poor IT system, lack of data standardization
S9 Dispensing/picking errors-medication/ packaging
S10 Weak logistics service infrastructure
S11 Lack of visibility concerning placement and availability
S12 Procurement Hub-introduce more complexity, long lead time
S13 Clinician's preference
S14 High purchase price
S15 High product and supplier/brand variety
S16 External influences- disaster recovery
S17 Unexpected disease outbreaks
S18 Unexpected changes in environment conditions
After Multiplying Before Multiplying
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Figure 6-10: Results of the sensitive analysis (division) 
 
 
 
0 0.02 0.04 0.06 0.08 0.1 0.12 0.14 0.16 0.18
S1 Counterfeiting
S2 Poor quality in the purchased drugs from suppliers
S3 Time limit of drugs, product perishability
S4 Shortage of drugs, unavailability of drugs on the market
S5 Capability versus demand, inability of capacity to meet demand
S6 Demand trigged by the nurse, not the patients
S7 Wrong demand forecasting
S8 Poor IT system, lack of data standardization
S9 Dispensing/picking errors-medication/ packaging
S10 Weak logistics service infrastructure
S11 Lack of visibility concerning placement and availability
S12 Procurement Hub-introduce more complexity, long lead time
S13 Clinician's preference
S14 High purchase price
S15 High product and supplier/brand variety
S16 External influences- disaster recovery
S17 Unexpected disease outbreaks
S18 Unexpected changes in environment conditions
After Dividing Before Dividing
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Table 6.12: Summary of the sensitivity analysis for weight obtained by pairwise comparison 
Risk factors Before 
Multiplying (rank) 
After Multiplying 
(rank) 
Before Dividing 
(rank) 
After Dividing 
(rank) 
S1 Counterfeiting*  0.159 S4* 0.477 S1* 0.159 S4* 0.159 S1* 
S2 Poor quality in the purchased drugs from suppliers* 0.079 S1* 0.237 S9* 0.079 S1* 0.079 S5* 
S3 Time limit of drugs, product perishability 0.002 S8* 0.006 S2* 0.002 S8* 0.002 S9* 
S4 Shortage of drugs, unavailability of drugs on the market* 0.16 S5* 0.16 S10* 0.16 S5* 0.053 S2* 
S5 Capability versus demand, inability of capacity to meet 
demand* 
0.108 S9* 0.216 S5* 0.108 S9* 0.108 S10* 
S6 Demand trigged by the nurse, not the patients  0.018 S2* 0.036 S4* 0.018 S2* 0.018 S4* 
S7 Wrong demand forecasting 0.007 S10* 0.007 S14* 0.007 S10* 0.0023 S8* 
S8 poor IT system, lack of data standardization* 0.112 S11* 0.112 S13* 0.112 S11* 0.0373 S11* 
S9 Dispensing/picking errors-medication/packaging* 0.097 S14* 0.291 S15* 0.097 S14* 0.097 S14* 
S10 Weak logistics service infrastructure* 0.074 S13* 0.222 S8* 0.074 S13* 0.074 S13* 
S11 Lack of visibility concerning placement and availability 
stock* 
0.035 S15* 0.105 S11* 0.035 S15* 0.035 S15* 
S12 Procurement Hub-introduce more complexity, long lead 
time 
0.014 S17 0.056 S17 0.014 S17 0.014 S17 
S13 Clinician’s preference* 0.032 S6 0.128 S12 0.032 S6 0.032 S6 
S14 High purchase price* 0.035 S12 0.14 S16 0.035 S12 0.035 S12 
S15 High product and supplier/brand variety* 0.031 S16 0.124 S6 0.031 S16 0.031 S16 
S16 External influences-disaster recovery 0.013 S7 0.039 S18 0.013 S7 0.013 S18 
S17 Unexpected disease outbreaks 0.024 S18 0.072 S7 0.024 S18 0.024 S7 
S18 Unexpected changes in environment conditions 0.003 S3 0.009 S3 0.003 S3 0.003 S3 
“*” denotes those risk factors are significant and selected for further analyses 
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Thus, this research could be a preliminary study to deal with the pairwise comparison under 
such a context.    
The first step is to multiply each set of data which covers at least two risk factors by the same 
number of risk factors in the pairwise comparison group. For example, the quality risks consist 
of three various types of risk factors, which are “S1 counterfeiting”, “S2 poor quality in the 
purchase drugs”, and “S3 time limit of drugs”. Therefore, each risk factor will be multiplied by 
three to get a new weighted number (See Figure 6.9).  Along the same line, those individual 
risk factors will be divided by three, which is the amount of most sets of data (See Figure 
6.10). The summary of the results are in a list in Table 6.12, where the top 11 risk factors are 
retained as the same results before either multiplying or dividing calculation. Based on their 
high priority among all the risk factors, the results of pairwise comparison are not affected. 
As a result, it can be concluded that the proposed model is robust since the best result is 
impervious to the changes in weighting either by multiplying or dividing.  
 
6.4.4 Findings from Fuzzy AHP method  
It was found that healthcare supply chain related risk sources can be categorized into three 
risks “external to the hospital but internal to the supply chain network (A1)”, weighted 0.53; 
“internal to the hospital (A2)”, weighted 0.43; and “external to the supply chain network 
(A3)”, weighted 0.04. The results showed that factors “external to hospital but within supply 
chain” have the greatest effects in the healthcare supply chain. It is easy to understand that 
almost every organization faces challenges in the dynamic environment either from the 
unexpected demand or unstable supplier relationships and performance. These results 
corroborate the findings of Ho et al., (2015), who reviewed categorization of sources of supply 
chain risks and concluded that external factors to firms contribute to risks in the supply chain. 
The results also showed that “risks external to the hospital but internal to the supply chain 
network, A1”, are “supply risks (B1)” weighted as 0.75 and “demand risks (B2)” weighted as 
0.25. The weights result in an overall global weight of 0.75 × 0.53 = 0.3975, approximated 
as 0.4 for supply risk and 0.25 × 0.53 = 0.1325, approximated as 0.133 for demand risks. It 
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indicated that supply risks are about triple the weight of demand risks. This is because supplier 
performance and relationship management is very sensitive to the healthcare industry.  
6.4.4.1 Supply risks 
The results further show that those two components of supply risks are weighted as: “quality 
risks (C1)” weighted as 0.61 of 0.4 giving overall global weight of 0.24; and “supplier risks 
(C2)” weighted as 0.39 of 0.4 giving overall global weight of 0.16. Therefore, it is noted that 
quality risks have a higher weight than supplier risks. These results corroborate the findings 
by Tse and Tan (2011) who found that quality risks is an inherent part of the supply chain 
risks. In other words, it tends to encompass some or all of the risk elements in a multi-tier 
supply chains, such as disruption risks and operational risks. Therefore, it must be considered 
for successful management of multi-tier supply chains, especially in the healthcare setting as 
they are a major cause of health problems or even deaths.  
Furthermore, supplier risk is associated with “shortage of drug, unavailability of drugs on the 
market (S4)” weighted as 0.16, which is most important risk factors among 18 sub-criteria. As 
discussed in the previous chapter, such shortages/stock outs can have serious consequences 
on patients’ health since they can result in total failure of healthcare delivery systems (White 
and Modhzain, 2009). This finding is also in line with research by Aguas et al., (2013) and 
Kanyoma et al., (2013), who investigated the shortage of drugs caused by inadequate drugs 
in the healthcare industry, the health service delivery has perfomed poorly, resulted in delays 
in medical surgery, and led to more worsed medical conditions of patients. It was also found 
that the major causes of shortage, such as unexpected diease outbreaks, wrong demand 
forecasting, and lack of funds at the hospital. For example, supply of drugs should be linked 
to some specific environment, such as seasonality where during a certain season, more 
individuals are diagnosed with a certain disease, which means the demand for some particular 
drugs are substantially increased. Thus, special circumstances require that healthcare 
organizations be both efficient (in the care of products with predictable demand) and 
responsive (in the case of transplants, pharmaceutical and surgical supplies with an 
unpredictable demand) (Matopoulos and Michailidou 2013).   
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Thereafter, results show that of the three quality risk factors studied, “counterfeiting (S1)” 
accounted for 66 per cent of 0.24 giving overall weight for the risk factor as 0.159, “poor 
quality in the purchased drugs from suppliers (S2)” accounted for 33 per cent of 0.24 giving 
weight of 0.079 while “time limit of drug and product perishability (S3)” accounted for 1 per 
cent of 0.24 giving weight of 0.002. It is therefore noted that of the three studied quality risk 
factors, counterfeiting has the highest risk index followed by poor drug quality and time limit 
of drugs. The results also support some existing findings, e.g., findings from Kamath et al., 
(2012), Enyinda et al., (2014), Jaberidoost et al., (2015), and Lawrence and Kopcha (2017), 
that determined that counterfeiting also has serious risk consequences among other risk 
factors, especially when hospitals depend on third parties for medical commodities that can 
cause a breakdown in the healthcare SC, which can disrupt core health services. The research 
suggested managing the risks by incorporating the lastest anti-counterfeiting technologies 
such as hologram, mass encoding systems, bar-codes, and RFID system (Kamath et al., 2012). 
Since the supply of counterfeit drugs is a major threat as revealed by our data, which is 
consistent with Mackey et al.’s, (2015) findings show that over 51.3 per cent of drugs in supply 
chains are counterfeit. Thus, hospital management must set up a strict quality control and 
quality assurance department for curbing the supply of counterfieit drugs. However, in terms 
of the time limit for drugs and product perishability, it plays a less important role in healthcare 
SC with the smallest weight among 18 risk factors. This result reveals that although the 
concern should be given to the risks associated with the inefficient cold chain management 
during transportation and storage, healthcare providers still need to pay more attention to 
managing the other higher priority risks.   
6.4.4.2 Demand risks  
The results show that “demand risks (B2)” accounted for 25 per cent of the weight of risks 
“external to the hospital but internal to the supply chain network”, which is 25 per cent ×
0.53 = 0.133. “Demand risks” are categorized into two types: “capability risks (C3)”, which 
were weighted at 0.95 of 0.133 giving global weight of 0.126; and “forecast risks (C4)” 
weighted at 0.05 of 0.133, which gave global weight of 0.007. Under “forecast risks (C4)”, 
“wrong demand forecasting (S7)” was given weight of 0.007. “Capability risks” were 
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categorized into “capability versus demand, inability of capacity to meet demand (S5)” 
which was weighted at 0.86 of 0.126 giving a global weight of 0.108 and “demand trigged by 
the nurse, not the patients (S6)” weighted at 0.14 of 0.126 giving a global weight of 0.018. 
Compared with the sub-criteria “capability versus demand (S5)”, the weights of (S6) and (S7) 
are less notable. This may be explained by the fact that it is imperative to improve clinician 
and pharmacist education in relation to the relevant knowledge of supply chain management 
(Maryland 2012; Elleuch et al., 2014). Moreover, more effort has been made in developing a 
closer cooperative relationship between the hospital and its major suppliers or among 
hospitals in the same region. Such a movement increases operational capacity with less 
capital investment to deal with the uncertain demands.  
6.4.4.3 Process risks  
“Process risks (B3)” are classified under risks “internal to the hospital (A2)” and weighted as 
0.43. Results of Fuzzy AHP shows that the three risk factors under “process risks” were 
weighted as: “information risks (C5)” given weight of 0.26 of 0.43 giving 0.112 with “poor IT 
system, lack of data standardization (S8)” under it given similar weight of 0.112; “logistics 
risks (C6)” given weight of 0.48 of 0.43 giving 0.206; and “procurement risks (C7)” given 
weight of 0.26 of 0.43 giving 0.112. Categories of risks under “logistics risks” were weighted 
with “dispensing/picking errors-medication/packaging (S9)” at 0.47 of 0.206 which resulted 
in weight of 0.097, “weak logistics service infrastructure (S10)” at 0.36 of 0.206 which 
resulted in weight of 0.074 and “lack of visibility concerning placement and availability of 
stock (S11)” at 0.17 which resulted in weight of 0.035. “Procurement risks” sub-categories 
were “procurement hub-introduce more complexity, long lead time (S12)” weighted as 0.12 
of 0.26 giving 0.014, “clinician's preference (S13)” weighted as 0.29 of 0.26 giving 0.032, “high 
purchase price (S14)” weighted as 0.31 of 0.26 giving 0.035 and “high product and 
supplier/brand variety (S15)” weighted as 0.28 giving 0.031.  
Among those risk factors under the criterion “process risks”, “Poor IT system, lack of data 
standardization (S8) is the most important risks, followed by S9, S10, S11, S14, S13 and S15. 
These results confirm findings by several studies (Jaberidoost, et al., 2013; Bὃhme et al., 2016; 
Graudins, et al., 2016) that have suggested the necesssity of investing in the development of 
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a modern information system because of independent and loosely-coupled information 
systems that contain incomplete information and cannot be trusted. Moreover, the results 
also corroborate Kritchanchai’s (2012) results that implementation of standard data in the SC 
network would facilitate information synchronisation so that all stakeholders in the industry 
can speak the same electronic language. Meanwhile, it needs to be mentioned that “high 
purchase price (S14)” and “high product and supplier/brand variety (S15)” are matters of 
important concern in Lord Carter’s report (2016). It suggested the implementation of a new 
purchasing price index and eProcurement strategy as well as developing procurement 
partnerships between UK NHS trusts to manage those risks.  
6.4.4.4 Environmental risks  
“Environmental risks (B4)”, weighted as 0.04, are part of the “risks external to the hospital 
supply chain network (A3)”. Under “environmental risks” there were “natural risks (C8)” 
weighted 0.04. Natural risks were further categorized as: “external influences-disaster 
recovery (S16)” weighted as 0.33 of 0.04 giving 0.013; “unexpected disease outbreaks (S17)” 
weighted as 0.61 of 0.04 giving 0.024; and “unexpected changes in environment conditions 
(S18)” weighted as 0.06 of 0.04 giving 0.003. Among the 18 risk factors, the weight of these 
three risks are significantly lower than the others. These three risks are often beyond the 
control of hospitals, which means that it is difficult to reduce their impact through likelihood 
reduction. To reduce these risks, these supply chains should be designed to accommodate 
readiness of unplanned events, to be ready to offer efficient and quick response in case of an 
emergency. They should also be able to recover to the original state of the health facility after 
the disruption event and make the state even better than it was before (Ponomarov and 
Holcomb 2009).   
6.4.4.5 Summary of Fuzzy AHP results  
Results of fuzzy AHP process were summarized in Table 6.11. The 18 risk factors were ranked 
according to their weights from highest to lowest. “Shortage of drug, unavailability of drugs 
on the market (S4)” with global weight of 0.160 has the highest risk compared with other risk 
items, followed by “counterfeiting (S1)” with global weight of 0.159; “poor IT system, lack of 
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data standardization (S8)” with global weight of 0.112; “capability versus demand; inability 
of capacity to meet demand (S5)” with global weight of 0.108; and “dispensing/picking 
errors-medication/packaging (S9)” with global weight of 0.097, “poor quality in the 
purchased drugs from suppliers (S2)” with global weight of 0.079; “weak logistics service 
infrastructure (S10)” with global weight of 0.074; “lack of visibility concerning placement 
and availability of stock (S11)” with global weight of 0.035; “high purchase price with global 
weight of 0.035; clinician’s preference (S13)” with global weight of 0.032 and “high product 
and supplier/brand variety (S15)” with global weight 0.031. Each of these factor has a 
significant impact on supply chain operational performance, the uncertainty associated with 
these factors will make the supply chain more complex to manage and therefore more 
attention must be paid to them and acknowledgment of their work. It is not surprising to see 
“shortage of drug, unavailability of drugs on the market (S4)” at the top of the risk ranking 
because unlike other consumer products where the customer can either defer their purchase 
or acquire an alternative, shortage of drugs can adversely affect patient outcomes and 
increase health care costs. Therefore, this risk factors need to be analysed and eliminated 
precisely during the future works.  
By using the developed risk-based model, risk managers can obtain a broad view of the risk 
factors in healthcare supply chain. The proposed risk-based model is suitable for 
comprehensive risk assessments. It can be developed by different users in the healthcare 
industry. The developed risk-based model can be simply established at various hierarchical 
levels according to the needs of users and existing data. Additional, it can aggregate various 
groups of risk factors along with a consistent order to generate useful risk-based information 
for decision makers. It can be simply applied on the other risk factors not mentioned in this 
study (such as patient pathway related risks, etc). In next step, the ISM model is applied to 
supports risk managers in identifying and understanding interdependencies among those 
selected 11 supply chain risks.  
6.5 RISK ASSESSMENT WITH INTERPRETIVE STRUCTURAL MODELLING (ISM) 
Interpretive Structural Modelling (hereinafter, “ISM”) is a qualitative and interpretive method 
that supports the decision-making process to identify the structure of complex relations of 
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elements by analysing two elements pair-wisely (Pfohl et al., 2011). The structural mapping 
of the ISM model provides decision makers with the solutions to complex issues by 
highlighting the interconnections of elements in a graphical manner. It is seen as an 
interactive learning process by considering different direct and indirect relations among each 
risk factor so that complex interconnections of risks can be portrayed within a model. In fact, 
knowledge of individual risks alone may not be enough for an organization planning to 
understand the relationship between the various risks. In this respect, ISM can provide 
insightful understanding of those relations to describe the situation more accurately than the 
individual risks taken in isolation (Chaudhuri et al., 2016). In SCRM studies, ISM has been 
applied by several researchers focusing on various problems (Pfohl et al., 2011; Srivastara et 
al., 2015; Chaudhuri et al., 2016; Prakash et al., 2017).  
ISM generates an understanding of a complex system by considering the hierarchy and 
relationships among the system’s elements (Sage, 1977). ISM is being considered interpretive 
because of the decision from the experts’ judgement on how and whether the elements are 
related is the basic idea in the ISM process. It is also described as structured because it 
eventually decomposes a complicated system into several elements and constructs a 
multilevel structural model (Srivastara et al., 2015). Thus, the model is appropriate for use in 
capturing experts’ practical experience and knowledge for modelling and to portray a 
structure in a carefully designed pattern. In this research, the ISM model is applied to 
determine the interdependencies among the selected risk factors from the last phase and 
obtain a hierarchy to synthesize the knowledge about these risks. It will facilitate the decision 
makers in easily understanding the dependence and driving power of those significant risks 
in their SC network while formulating the appropriate risk mitigation strategies.     
There are several steps that are involved in ISM modelling, which include the following:  
Step 1. Recognizing elements that are relevant to the problem through group or survey 
problem solving approach. Starting point is the identification of the relevant elements to the 
problem. This can be done by primary research techniques including: questionnaire survey, 
interview, focus group etc, or secondary research including: desk research etc.  
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Step 2. Creating an appropriate relationship between the identified elements. In this stage, 
the contextual relation must be explicitly illustrated among the elements. Relations may be 
of various types such as comparative, influence, neutral or temporal relations (Austin and 
Burns, 1985; Warfield, 1994).    
Step 3. Creating a structural self-interaction matrix (SSIM) for all the elements. It is through 
such a matrix that the pair-wise relationship accorded for the system’s elements is 
established. In this stage, the experts are required to make the decision upon which one 
element leads to another one. Keeping in mind the contextual relationship for each element, 
the existence of a relation between any two sub-elements ( 𝑖 𝑎𝑛𝑑 𝑗  ) and the associated 
direction of the relation is questioned. Four symbols are used to denote the direction of the 
relationship between the elements 𝑖 𝑎𝑛𝑑 𝑗: 
V – for the relation from 𝑖 𝑡𝑜 𝑗 but not in both directions; 
A – for the relation from 𝑗 𝑡𝑜 𝑖 but not in both directions; 
X – for both direction relations from  𝑖 𝑡𝑜 𝑗 and 𝑗 𝑡𝑜 𝑖; and 
O – if the relation between the elements does not appear to be valid.  
Step 4. Creating a reachability matrix in accordance with the created SSIM and checking for 
transitivity.  The SSIM is transformed into a binary matrix, called the initial reachability matrix 
by substituting 1 or 0 for the original symbols, V, A, X and O. The rules for the substitution are 
the following: 
(1) If the (𝑖 , 𝑗) entry in the SSIM is V, then the (𝑖 , 𝑗)  entry in the reachability matrix 
becomes 1 and the (𝑗 , 𝑖) entry becomes O.  
(2) If the (𝑖 , 𝑗) entry in the SSIM is A, then the (𝑖 , 𝑗)  entry in the reachability matrix 
becomes O and the (𝑗 , 𝑖) entry becomes 1.  
(3) If the (𝑖 , 𝑗) entry in the SSIM is X, then both the (𝑖 , 𝑗)  and (𝑗  , 𝑖 ) entries of the 
reachability matrix become 1.  
(4) If the (𝑖 , 𝑗) entry in the SSIM is O, then both the (𝑖 , 𝑗)  and (𝑗  , 𝑖 ) entries of the 
reachability matrix become O.  
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Following these rules, the initial reachability matrix for the elements is built. Then the final 
reachability matrix is developed by incorporating the transitivity which is a basic assumption 
in ISM. It stated that if element A is related to B and B is related to C, it may be inferred that 
A is related to C. If element (𝑖 , 𝑗) of the initial reachability matrix is zero, which means there 
is neither any direct nor indirect relationship from element  𝑖  to element 𝑗 . The initial 
reachability matrix may not have this characteristic because when there is no direct but an 
indirect relationship from element  𝑖 to 𝑗, entry (𝑖 , 𝑗) is also zero. Indirect relationships can 
be found by raising the initial reachability matrix (with diagonal entries set to 1) to successive 
powers until no new entries are obtained (Malone, 1975).  
Step 5. Ensuring that the reachability matrix is appropriately partitioned into several levels. In 
this stage, two different sets (reachability and antecedent sets) can be obtained from the final 
reachability matrix by level partitioning. The purpose of this step is to facilitate the 
construction of the diagraph from the reachability matrix (Prohl et al., 2011). The reachability 
set R (𝑆𝑖) consists of the element itself and other elements which are reachable from 𝑆𝑖 , 
whereas the antecedent set A (𝑆𝑖) consists of the element itself and other elements that may 
impact it. Thereafter, an intersection of the reachability set and antecedent set (R(𝑆𝑖) ∩ A(𝑆𝑖)). 
The element for which the reachability and the intersection sets are the same occupies the 
top-level position in the ISM hierarchy. The top-level element in the hierarchy has no relation 
to any other elements above its own level. Once top-level elements are identified, they are 
discarded from the other elements. The same process is then repeated until the levels of all 
elements are achieved.  
Step 6. Drawing of diagraph with removed transitivity links. An initial diagraph including 
transitivity links is found from the conical form of the reachability matrix. Then, by partitioning 
the reachability matrix by rearranging the elements according to their level, the appropriate 
conical matrix is achieved.  That means all the elements having the same level are pooled. For 
the sake of simplicity, sketching the final digraph in relation to the affiliations identified in the 
reachability matrix and ensuring that transitive links are removed. If there is a relationship 
between risk  𝑖  and  𝑗, this is shown by an arrow which points from 𝑖  to  𝑗. 
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Step 7. Conversion of diagraph into an ISM and checking of conceptual inconsistency. 
Translating the resultant digraph into an ISM-based model. This can be done by putting 
statements in places of element nodes. Finally, the ISM model is reviewed to check 
conceptual inconsistency. 
MICMAC analysis. MICMAC stands for Matriced’Impacts Croisἑs-Multiplication Appliquἑe 
a’un Classement, which means “cross-impact matrix multiplication applied to classification”. 
The object of the MICMAC analysis is to assess the driving power and dependence of each 
element (Mandal and Deshmukh, 1994; Saxena and Sushil, 1990). All elements have been 
classified into four categories based on their dependence and driving power: 
(1) Autonomous elements, which have weak driver power and weak dependence.  
(2) Dependent elements, which have weak driver power and strong dependence.  
(3) Linkage elements, which have both strong driving and dependence power. 
(4) Independent elements, which have strong driving power but poor dependence power. 
 
6.6 AN EMPIRICAL STUDY ON THE APPLICABILITY OF THE ISM MODEL 
A survey was conducted to facilitate a general understanding and knowledge of the 
contextual interrelations among the selected risk factors. This study was conducted in three 
phases: (1) Conducting the questionnaire survey, (2) application of the proposed ISM model 
and (3) discussion of the results. Each of the phases will be discussed below. 
6.6.1 Conducting the ISM-based questionnaire survey  
Similarly, prior to actual data collection and, to eliminate content ambiguity in the questions, 
a pilot study was conducted to validate the developed questionnaire. Frist, a draft version of 
the questionnaire was developed and the same forward as well as backward translation 
process were applied on these questionnaire as was applied earlier. The questionnaire was 
examined by the same people who participated in a previous pilot study of an AHP-based 
questionnaire for experts to comment on the appropriateness of the question and whether 
any were unclear. Based on their feedback, the questionnaire was revised for the pilot study. 
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Ethical approval was also obtained to further validate questionnaire contents and participant 
consent. The final questionnaire is shown in Appendix Three.  
The participating experts who would decide pairwise relationships of risks were selected from 
the previous AHP survey because they are experts in the healthcare supply chain and risk 
management and familiar with the research topic. Hence, these experts were contacted again 
through either email or telephone to briefly explain the purpose of the survey and their 
involvement and the reasons for their interest. Additionally, in the context of this research, 
this would have amounted to filling up another 55 times pairwise comparison which was 
considered a highly labour-intensive task through a survey. Eleven participants who 
responded to the survey confirmed their willingness to participate in the study as they were 
interested in the topic of research, since most of them faced similar problems with the supply 
chain in their organizations. Thereafter, one of these contracts suggested involvement of 
another manager from his own hospital leading the inventory management department and 
he was allowed to join also the expert panel. Thus, a panel of twelve experts was secured to 
participate in this survey. The experts, represented multiple roles within the healthcare 
industry like procurement, warehousing and logistics, and demand planning, SC consulting, 
and they possessed the requisite experience to participate in the research. The experts’ 
profiles are presented in Table 6.13.  The presence of each expert with a different background, 
reduced the individual researcher bias (Oppermann, 2000). In addition, unlike the Fuzzy AHP 
survey conducted, considering the highly labour-intensive task in the ISM survey, thus the 
interview proved to be more reliable than an assessment based on paper-based 
questionnaires only. Hence, the questionnaire were sent to them first and their inputs were 
solicited through in different ways (i.e. telephonic interview, email and face-to-face interview) 
between 10th June and 3th Aug 2017.  
       
Table 6.13: respondents’ profile 
No Participant Position Method Location 
Operating 
Base 
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It is recommended that the researcher share the study objectives and classify the meaning of 
each risk factor with the experts. This step provides an exact understanding of all risks to 
ensure that their responses concentrated on the direct relationships between each pairwise 
comparison. In the subsequent stage, the replies were combined, analysed and a convergence 
in various relationships identified by the research. Finally, the results were discussed with the 
experts and a final matrix was arrived at reflecting the experts’ consensus (Srivastava et al., 
2015).  
6.6.2 Interpretive structural modelling (ISM) and MICMAC analysis  
Each step of employing the ISM model has been discussed above. The details of the practical 
application are as follows: 
Step 1. Construction of structural self-interaction matrix (SSIM) by pairwise comparison. 
During this stage, the twelve experts decided upon the pairwise relationship between the 
selected 11 risk factors from the previous section. Thus. four symbols were used to denote 
the direction of the relationship between the element I and j (i.e. V, measure I will influence 
measure j; A measure j will be influence by measure I; X, measure I and j will help influence 
each other; O, measure I and j are unrelated). For the sake of the simplicity, in the survey, 
1 Chinese Hospital 1 Stock Manager Telephone China 
2 Chinese Hospital 1 Pharmacy department leader Telephone China 
3 Chinese Hospital 2 Pharmacy department leader Telephone China 
4 Chinese Hospital 3 Pharmacy department leader Telephone China 
5 Chinese Hospital 4 Pharmacy department leader Telephone China 
6 Chinese Hospital 5 Pharmacy department leader Telephone China 
7 Chinese Hospital 5 Stock Manager Telephone China 
8 Pharmaceutical 
Company 
General Manager Telephone China 
9 LogHealth Center Researcher/Consulting Telephone Thailand 
10 University Researcher/Consulting Face-to-Face 
interview 
UK 
11 NHS Trust 1 Head of Procurement Face-to-Face 
interview 
UK 
12 NHS Trust 2 Purchase and Supply Manager Face-to-Face 
interview 
UK 
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four symbols were replaced by four Arabic numerals as 1=V, 2=A, 0=O, 3=X. Thereafter, based 
on these contextual relationships, the SSIM developed for all the 11 relevant risk factors are 
shown in Table 6.14.  
Step 2. Developing a reachability matrix from the SSIM and checking for transitivity.  
During this stage, following the rules for the substitution (i.e. the entry V, A, X and O of the 
SSIM are converted into 1 and 0), the initial reachability matrix for the variables was 
developed as shown in Table 6.15. Next, the final reachability matrix was then obtained by 
incorporating the transitivities rules as if element A is related B and B is related to C, it may 
be inferred that A is related to C. This is shown in Table 6.16. Moreover, in this table, the 
driving power and dependence of each risk are also presented. The driving power of a 
particular risk factor is the total number of risk factors (including the risk factor itself) that it 
impacts. For example, “counterfeiting (S1)” impacts eight other risks and so has a driving 
power of 8. On the other hand, the dependence is the total number of risk factors that may 
impact a particular risk factor, such as “weak logistics service infrastructure (S3)” is impacted 
by 10 other risk factors and so has a dependence power of 10. Based on these driving power 
and dependence, those risk factors have later been classified in MICMAC analysis. 
Step 3. Ensuring that the reachability matrix is appropriately partitioned into several levels 
In this stage, a hierarchical ordering will be extracted from the reachability matrix by level 
partitioning. It aims to facilitate the construction of the digraph from the reachability matrix. 
Thus, the reachability and antecedent set for each variable are obtained from the final 
reachability matrix (Warfield, 1974). As indicated above, the “reachability set” for a particular 
variable consists of the variable itself and the other variables which it may help achieve. The 
“antecedent set” consists of the variable itself and other variable which may help in achieving 
it. (Srivastava et al., 2015). 
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Table 6.14: Structural self-interaction matrix (SSIM) of risk factors in healthcare supply chain 
Notes: V, measure I will influence measure j; A measure j will be influence by measure I; X, measure I and j will help influence each other; O, 
measure I and j are unrelated (1=V, 2=A, 0=O, 3=X) 
 
Risk factors S11 S10 S9 S8 S7 S6 S5 S4 S3 S2 S1 
S1 Counterfeiting 3 0 2 0 2 0 1 1 0 0  
S2 Capability versus demand, inability of 
capability to meet demand 
0 0 0 0 3 1 0 3 0  
S3 Weak logistics service infrastructure 2 0 0 0 3 3 0 0  
S4 Shortage of drug, unavailability of drugs 
on the market 
0 0 3 2 2 0 0  
S5 Poor quality in the purchased drugs from 
suppliers 
2 0 0 0 0 2  
S6 Dispensing/picking errors 
medication/packaging 
2 0 0 0 0  
S7 Poor IT system; lack of data 
standardization 
0 0 0 3  
S8 Lack of visibility concerning placement 
and availability of stock 
3 0 0  
S9 High purchase price 3 2  
S10 Clinician's preference 1  
S11 High product and supplier/brand variety  
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Table 6.15: Initial Reachability Matrix 
Risk factors S1 S2 S3 S4 S5 S6 S7 S8 S9 S10 S11 
S1 0 0 0 1 1 0 0 0 0 0 1 
S2 0 0 0 1 0 1 1 0 0 0 0 
S3 0 0 0 0 0 1 1 0 0 0 0 
S4 0 1 0 0 0 0 0 0 1 0 0 
S5 0 0 0 0 0 0 0 0 0 0 0 
S6 0 0 1 0 1 0 0 0 0 0 0 
S7 1 1 1 1 0 0 0 1 0 0 0 
 
S8 0 0 0 1 0 0 1 0 0 0 1 
S9 1 0 0 1 0 0 0 0 0 0 1 
S10 0 0 0 0 0 0 0 0 1 0 1 
S11 1 0 1 0 1 1 0 1 1 0 0 
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Table 6.16: Final Reachability Matrix 
Risk factors S1 S2 S3 S4 S5 S6 S7 S8 S9 S10 S11 Driving 
power 
S1 1 1* 0 1 1 1* 0 1* 1* 0 1 8 
S2 1* 1 1* 1 1* 1 1 1* 1* 0 0 9 
S3 1* 1* 1 1* 1* 1 1 1* 0 0 0 8 
S4 1* 1 0 1 0 1* 1* 0 1 0 1* 7 
S5 0 0 0 0 1 0 0 0 0 0 0 1 
S6 0 0 1 0 1 1 1* 0 0 0 0 4 
S7 1 1 1 1 1* 1* 1 1 1* 0 1* 10 
S8 1* 1* 1* 1 1* 1* 1 1 1* 0 1 10 
S9 1 1* 0 1 1* 1* 0 1* 1 0 1 8 
S10 1* 1* 0 1* 1* 1* 0 1* 1 1 1 9 
S11 1 0 1 1* 1 1 1* 1 1 0 1 9 
Dependence 9 8 6 9 10 10 7 8 8 1 7  
       Note: 1* entries are indicated as transitivity 
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More precisely, reachability set of the risk is the set of elements of a final reachability matrix 
which contain 1 in row of that particular risk. Coversely, antecedent set of the risk is the set 
of elements which contain 1 in column of that particular risk (Pfohl et al., 2011). Based on the 
reachability set and antecedent set, the intersection sets have been derived for all elements. 
Intersection sets are the common elements of both reachability set and the antecedent set. 
The case where the elements of both reachability and intersection sets are the same, which 
is the indicator of top-level element in the ISM hierarchy. For example, “poor quality in the 
purchased drugs from suppliers (S5)” have been identified as top-level elements as shown in 
Table 6.17 (Iteration 1). The top-level variables have no relation to any other variable above 
their own level. Once the top-level element is identified, it is discarded from the other 
remaining variables. Then, the same process is repeated till the levels of all elements are 
achieved. The subsequent iterations identified other levels aiding in building the diagraph and 
ultimately the final ISM model. The stepwise level partitions of all 11 risk factors have been 
completed in six iterations are presented from Tables 6.17 to 6.22. The summary of all 
partition levels has been represented in Table 6.23.  
 
Table 6.17: Iterations of the partition of reachability matrix to arrive at ISM diagram 
Elements 
Iteration 
1 
Reachability set Antecedent set Intersection Level 
S1 1,2,4,5,6,8,9,11 1,2,3,4,7,8,9,10,11 1,2,4,8,9,11  
S2 1,2,3,4,5,6,7,8,9 1,2,3,4,7,8,9,10 1,2,3,4,7,8,9  
S3 1,2,3,4,5,6,7,8 2,3,6,7,8,11 2,3,6,7,8  
S4 1,2,4,6,7,9,11 1,2,3,4,7,8,9,10,11 1,2,4,7,9,11  
S5 5 1,2,3,5,6,7,8,9,10,11 5 I 
S6 3,5,6,7 1,2,3,4,6,7,8,9,10,11 3,6,7  
S7 1,2,3,4,5,6,7,8,9,11 2,3,4,6,7,8,11 2,3,4,6,7,8,11  
S8 1,2,3,4,5,6,7,8,9,11 1,2,3,7,8,9,10,11 1,2,3,7,8,9,11  
          
236 
 
S9 1,2,4,5,6,8,9,11 1,2,4,7,8,9,10,11 1,2,4,8,9,11  
S10 1,2,4,5,6,8,9,10,11 10 10  
S11 1,3,4,5,6,7,8,9,11 1,4,7,8,9,10,11 1,4,7,8,9,11  
 
 
Table 6.18: Iterations of the partition of reachability matrix to arrive at ISM diagram 
Elements 
Iteration 
2 
Reachability set Antecedent set Intersection Level 
S1 1,2,4,6,8,9,11 1,2,3,4,7,8,9,10,11 1,2,4,8,9,11  
S2 1,2,3,4,6,7,8,9 1,2,3,4,7,8,9,10 1,2,3,4,7,8,9  
S3 1,2,3,4,6,7,8 2,3,6,7,8,11 2,3,6,7,8  
S4 1,2,4,6,7,9,11 1,2,3,4,7,8,9,10,11 1,2,4,7,9,11  
S6 3,6,7 1,2,3,4,6,7,8,9,10,11 3,6,7 II 
S7 1,2,3,4,6,7,8,9,11 2,3,4,6,7,8,11 2,3,4,6,7,8,11  
S8 1,2,3,4,6,7,8,9,11 1,2,3,7,8,9,10,11 1,2,3,7,8,9,11  
S9 1,2,4,6,8,9,11 1,2,4,7,8,9,10,11 1,2,4,8,9,11  
S10 1,2,4,6,8,9,10,11 10 10  
S11 1,3,4,6,7,8,9,11 1,4,7,8,9,10,11 1,4,7,8,9,11  
 
 
Table 6.19: Iterations of the partition of reachability matrix to arrive at ISM diagram 
Elements 
Iteration 
3 
Reachability 
set 
Antecedent set Intersection Level 
S1 1,2,4,8,9,11 1,2,3,4,7,8,9,10,11 1,2,4,8,9,11 III 
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S2 1,2,3,4,7,8,9 1,2,3,4,7,8,9,10 1,2,3,4,7,8,9 III 
S3 1,2,3,4,7,8 2,3,7,8,11 2,3,7,8  
S4 1,2,4,7,9,11 1,2,3,4,7,8,9,10,11 1,2,4,7,9,11 III 
S7 1,2,3,4,7,8,9,11 2,3,4,7,8,11 2,3,4,7,8,11  
S8 1,2,3,4,7,8,9,11 1,2,3,7,8,9,10,11 1,2,3,7,8,9,11  
S9 1,2,4,8,9,11 1,2,4,7,8,9,10,11 1,2,4,8,9,11 III 
S10 1,2,4,8,9,10,11 10 10  
S11 1,3,4,7,8,9,11 1,4,7,8,9,10,11 1,4,7,8,9,11  
 
 
Table 6.20: Iterations of the partition of reachability matrix to arrive at ISM diagram 
Elements 
Iteration 
4 
Reachability set Antecedent set Intersection Level 
S3 3,7,8 3,7,8,11 3,7,8 IV 
S7 3,7,8,11 3,7,8,11 3,7,8,11 IV 
S8 3,7,8,11 3,7,810,11 3,7,8,11 IV 
S10 8,10,11 10 10  
S11 3,7,8,11 7,8,10,11 7,8,11  
 
 
Table 6.21: Iterations of the partition of reachability matrix to arrive at ISM diagram 
Elements 
Iteration 
5 
Reachability set Antecedent set Intersection Level 
S10 10,11 10 10  
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S11 11 10,11 11 V 
 
 
Table 6.22: Iterations of the partition of reachability matrix to arrive at ISM diagram 
Elements 
Iteration 
6 
Reachability set Antecedent set Intersection Level 
S10 10 10 10 VI 
 
 
Table 6.23: Iterations of the partition of reachability matrix to arrive at ISM diagram 
Elements 
 
Reachability set Antecedent set Intersection Level 
S1 1,2,4,5,6,8,9,11 1,2,3,4,7,8,9,10,11 1,2,4,8,9,11 III 
S2 1,2,3,4,5,6,7,8,9 1,2,3,4,7,8,9,10 1,2,3,4,7,8,9 III 
S3 1,2,3,4,5,6,7,8 2,3,6,7,8,11 2,3,6,7,8 IV 
S4 1,2,4,6,7,9,11 1,2,3,4,7,8,9,10,11 1,2,4,7,9,11 III 
S5 5 1,2,3,5,6,7,8,9,10,11 5 I 
S6 3,5,6,7 1,2,3,4,6,7,8,9,10,11 3,6,7 II 
S7 1,2,3,4,5,6,7,8,9,11 2,3,4,6,7,8,11 2,3,4,6,7,8,11 IV 
S8 1,2,3,4,5,6,7,8,9,11 1,2,3,7,8,9,10,11 1,2,3,7,8,9,11 IV 
S9 1,2,4,5,6,8,9,11 1,2,4,7,8,9,10,11 1,2,4,8,9,11 III 
S10 1,2,4,5,6,8,9,10,11 10 10 VI 
S11 1,3,4,5,6,7,8,9,11 1,4,7,8,9,10,11 1,4,7,8,9,11 V 
 
 
          
239 
 
Step 4. Drawing of diagraph with removed transitivity links.  
An initial digraph including transitivity links was obtained from the conical form of the 
reachability matrix. The conical matrix is achieved from the partitioned reachability matrix by 
rearranging the elements according to their level, which means all the elements having the 
same level are pooled. For the sake of simplicity, transitivity links are removed to obtain the 
final digraph. If there is a relationship between risk 𝑖 and j , this is shown by an arrow which 
points from 𝑖 to 𝑗.   
Step 5. Conversion of digraph into an ISM and checking of conceptual inconsistency.  
The resultant digraph is converted into an ISM-based model by replacing element nodes with 
statements. Finally, the ISM model is reviewed by research in order to check for 
incompatibilities, if any, the result will be sent back to the experts for revision. The final ISM 
diagram indicated the contextual relations between each risk factor is shown in Figure 6.10.   
Step 6. Matriced’Impacts Croisés Multiplication Appliquéea’un Classement (MICMAC) analysis 
MICMAC is an indirect classification method to critically analyse the scope of each variables 
(Pfohl et al., 2011). MICMAC analysis is part of a structural analysis that aims to identify the 
most important variables of a system from a matrix that establishes the relations among them 
(Villacorta et al., 2012). It is carried out to classify each risk factor in accordance with their 
driving power and dependence power, as shown in Figure 6.11. Thus, in MICMAC analysis, 
the dependence power and driving power of each risk factor was analysed. Cluster I consists 
of autonomous risk factors with weak driving power and weak dependence and do not have 
much influence on the system. Therefore, it does not need much managerial focus from risk 
mitigation perspective. A close look at Figure 6.11 reveals that there is no risk in this cluster. 
Cluster II includes independent risk factors, which have strong driving power but weak 
dependence and are at the lower level of the model. Only one risk factor is identified in this 
cluster, “clinician’s preference (S10)”, which requires attention from the management in the 
event of change since it is beyond control. Cluster III comprises linkage risk factors which have 
both strong driving and dependence power. Figure 6.11 shows that most of the risk factors 
come under the linkage cluster namely, “shortage of drugs, unavailability of drugs on the 
market (S4)”, “counterfeiting (S1)”, “poor IT system, lack of data standardization (S7)”, 
“capability versus demand; inability of capacity to meet demand (S2)”, “weak logistics service 
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infrastructure (S3)”, “lack of visibility concerning placement and availability of stock (S8)”, 
“high purchase price (S9)” and “high product and supplier/brand variety (S11)”. These factors 
form the middle level of the ISM hierarchy model. Though the lower level risk factor induces 
or affect these risks, these also have significant driving power to influence some other risks, 
which are at the top of the model (Prohl et al., 2011). More importantly, these risk factors are 
unstable because if any change occurs to these risks that will have an effect on other risks 
(Samantra et al., 2016). Thus, these risks need continuous managerial focus and attention.  
Cluster IV includes the dependent risk factors with weak driving power and strong 
dependence. As expected, “poor quality in the purchased drugs from suppliers (S5)” and 
“dispensing/picking errors-medication/ packaging (S6)” are grouped into this cluster. In fact, 
these are consequences and are at the top of the ISM hierarchy. The lower level risks also 
have a significant resulting power for other risks at the top level of the model. It is good to 
note that the risk factors are always unstable because if there are any changes, one risk factor 
will lead to more consequences for other risks. Therefore, more attention should be given to 
these risks so that management identifies and understands the dependence of these risks on 
the lower levels and these will help to achieve the SCRM goals as well as the objectives. 
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S5 Poor quality in the purchased drugs from 
supppliers
S6 Dispensing/picking errors medication/
packaging, prescription management
S1 Counterfeiting
S4 Shortage of 
drugs
S9 High purchase 
price
S2 Capability 
versus demand
S3 Weak logistics 
service infrastructure
S8 Lack of visibility 
concerning placement 
and availability of stock
S7 poor IT system; lack 
of data standardization
S11 High product and supplier/brand variety
S10 Clinician s preference
 
Figure 6-11: ISM-based hierarchy model 
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Figure 6-12: Driving power and dependence diagram 
 
6.6.3 Finding from ISM model  
Risks are all about choice and how decisions are made (Khan and Burnes, 2007), thus, in this 
chapter, an attempt has been made to apply the ISM model in the healthcare industry in order 
to uncover interdependencies of supply chain related risks. Experts stated that management 
always lacks awareness regarding how the risks relate to each other and how they can affect 
one another. Thus, improvement initiatives to address the risk factors are not implemented 
due to either lack of strategic focus or do not obtain the management buy-in. (Srivastava et 
al., 2015). Therefore, the contextual relationships between pairs of elements were examined 
for the selected 11 risk factors based on the results of Fuzzy AHP method. The structural self-
interaction matrix (SSIM) was developed to indicate pair-wise relationships between each risk 
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factor as shown in Table 6.13. This matrix was converted to initial reachability matrix (RM) 
and its transitivity was checked in conformity with recommendations in literature (Upadhye, 
et al., 2014). Thereafter, the final reachability matrix represented in Table 6.23 was used to 
create the ISM based model, as shown in Figures 6.10. Moreover, MICMAC analysis has been 
carried out for the 11 risk factors and classified into four clusters (autonomous, dependent, 
linkage, independent) based on their driving power and dependence power, as shown in 
Figure 6.11. The results provide an understanding of the identified risk factors in different 
levels of the ISM model. In order to facilitate prioritization of the risks for the decision-making 
process, the developed hierarchical ISM model contains all types of risks starting from the 
highest to the lowest in different levels. Accordingly, this mapping of inter-relationships is a 
useful method for supply chain risk managers to evaluate supply chain risks and learn about 
the impact chains of these risks (Pfohl et al., 2011). Thus, understanding the impact of risks 
at each level is indeed important as it will help managers to construct and implement 
successful risk management strategies towards achieving the efficacy of the healthcare supply 
chain management (Samantra et al., 2016).  
It can be observed that “poor quality in the purchased drugs from suppliers (S5)” has the 
lowest driving power (1) and highest dependence (10), thus it is placed in the top level as 
shown in the ISM based model. In such a case, it could be riskier than the others that can 
produce major impacts in the healthcare SC because all other risks which are being placed 
just below the top level, strongly influence to it. Therefore, hospital managers should pay 
special attention to control them to reduce risks to patient’s health.  
One of the experts who is in a leadership role in procurement commented 
 “When the drugs are received at the drugstore site, all the supplies have to pass strict 
inspection before they are delivered to the internal drugstore as part of the resupply. If a drug 
has a quality problem, it is returned to the supplier. It should be noted that both suppliers and 
hospital pharmacists have to ensure appropriate temperature conditions in their storage 
areas, and make necessary investments in real-time serial communication of the temperature 
monitoring system. In addition, it is required that the pharmacy department are working 
under supervision of the pharmacy administration committee which comprises some clinician, 
pharmacist and other department leaders. The pharmacy department through collaboration 
with the pharmacy administration committee will then put in place policies aimed at ensuring 
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that drug selection, their distribution as well as subsequent clinical usage to meet the 
minimum set of standards. It sets up where the pharmacy department directly manages all 
the pharmaceutical supplies, then the pharmacy administration committee should be put in 
place to ensure that the roles of drugs procurement are not solely left in the hands of a single 
individual.”  
Furthermore, quality associated risks should be emphasized in different approaches, such as 
getting a suitable logistic provider and designing an appropriate alliance with them to help in 
managing unplanned risks. Another participating manager in a pharmaceutical company, 
concurred with this result. He commented “To ensure appropriate flow and good quality of 
drugs in the pharmaceutical company should consistent adherence to the guidelines of the 
supply chain management professionals. What this implies is that all activities pertaining to 
the sourcing, procurement, logistics as well as conversions are properly planned and managed. 
In general, we had selected the lowest cost third party logistics service provider. Subsequently, 
we ran into problems due to pilferage and contamination issues, improper temperature 
control, and so forth. In essence, the management team should aim at optimizing supply 
through elimination of the established bottlenecks, ensuring there is a close connection with 
the logistics service providers as well as to be willing to pay them appropriately through well-
designed contracts that will maintain the interests for both parties.  More importantly, the 
supplier should ensure that the quality of drugs meets the safety standards set by the 
European Medicines Agency (EMA) and Medicines and Healthcare products Regulatory 
Agency (MHRA), Good Manufacturing Practice (GMP).” In contrast, lower level risks (e.g. 
“clinician’s preference (S10)”) have the high driving power (9) with lowest dependence 
power (1) and strongly influence the middle-level factors such as “high purchase price (9)” 
and “high product and supplier/brand variety (11)” (see Figure 6.8). This had indeed been a 
source of concern for many procurement leaders as the clinician’s preference is characterized 
by a lack of awareness of cost containment. More importantly, doctors were taking money 
from pharmaceutical companies, which influences their judgement about a medicine. 
According to a new database published by Association of the British Pharmaceutical Industry 
(ABPI) in 2016, the practices of NHS staff who take up to £100,000 in advisory fees per year 
from pharmaceutical companies have been exposed by various Telegraph investigations. In 
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this case, it raises concerns regarding the possibility of conflicts of interest between the 
individual commercial and hospital work. 
Those middle-level risks seem to influence the risks at the same level or above in the ISM 
diagraph such as: “counterfeiting (S1)” influence “shortage of drug, unavailability of drugs on 
the market (S4)” and “poor quality in the purchased drugs from suppliers (S5)”. Literature 
confirms that counterfeiting leads to risks of shortage or unavailability of quality drugs as 
evidenced by the findings of Koczwara and Dressman (2017) and Patel (2017). In addition, 
“high purchase price (S9)” in turn directly results in “counterfeiting (S1)”. It means that high 
pharmaceutical prices have a high likelihood of pushing suppliers to counterfeiting to keep 
business despite the perceived risks and other implications (Patel, 2017).  
One of the pharmacy department leaders in a hospital commented: “Though the 
management of counterfet drugs is not easy, most hospitals have tried to set up the Drug and 
Therapeutics Committee (DTC) in the facility which aims to ensure effective management of a 
list of approved medicines, reviewing the drugs in place as well as reporting any adverse 
effects of the supplied drugs. In this committee, each member should have diverse 
backgrounds from pharmacy, nursing, hospital adminstrations as well as quality assurance 
department. In the selection of the suppliers, the pharmaceutical manufactures or companies 
should to be considered are those with Good Manufacturing Practices (GMP), Good 
Distribution Practice (GDP) as well as Good Supplying Practice (GSP) certificates administered 
by the MHRA and EMA or China Food and Drug Administration (CFDA).”  
In addition, the DTC should also design a mechanism to ensure that there is effective 
monitoring of medicine use in the hospital. The committee should also advise on the selection 
of formulary drugs appropriate for treatment of diseases diagnosed at the facility for lowering 
the risk of stocking generic duplicate drugs that have lower demand. Although the primary 
consideration should be cost effectiveness, there is also a need for management to consider 
some very crucial aspects of the selected drug, such as its toxicity, pharmacokinetics, 
bioequivalence, therapeutic equivalence, and most importantly its efficacy. Moreover, 
“counterfeiting risks (S1)” was also found to be influenced by “Poor IT system; lack of data 
standardization (S7)” where it could not be easy to verify genuine from counterfeits (Jiang et 
al., 2016). Experts and practitioners believe that a poor IT system and lack of standardization 
of data can lead to poor anti-counterfeiting performance and these are likely to gain more 
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importance in the future. Moreover, it can also be observed that “shortage of drug, 
unavailability of drugs on the market (S4)” was found to be influenced by a “poor IT system, 
lack of data standardization (S7)” and “lack of visibility concerning placement as well as 
availability of stock (S8)”. This finding corroborates the findings in literature that precise 
demand forecasting, timeliness and adequacy of order, reorder patterns and inventory 
management are affected by a reliable IT system (Bam et al., 2017; Iqbal et al., 2017; Qrunfleh 
and Tarafdar, 2014). It may be worth mentioning that “poor IT system, lack of data 
standardization (S7)” and “lack of visibility concerning placement and availability of stock 
(S8)” have been identified as risks with both high driving and dependence power.  
One of the pharmacy department leaders during the telephone interview stated: “For the 
reason of the importance of information system management and integration as a vital 
element to drive towards added value in healthcare supply chain management. Most 
managers must concentrate on various types of information related risks, such as: inadequate 
or absence of information management platforms, manual processes, inadequate or lack of 
standardized product identification, lack of product traceability and integrated system with 
suppliers, limited information systems which cover logistics activities.” The comments are 
consistent with the findings from the literature review. Kitsiou et al., (2007) presents different 
kinds of technological approaches that can be implemented in the healthcare SC, including 
Electronic data interchange (EDI), XML, Health level seven (HL7), Common object request 
broker architecture (CORBA), Distributed healthcare environment (DHE), Web services and 
RFID. Thus, it clearly shows that the facilitation of an efficient information technology system 
would increase the visibility of product information and demand predictability, establish 
integrated process methods to support decision making and balance costs and demands. In 
terms of lack of visibility concerning placement and availability of stock, one of the purchase 
and supply managers in the NHS hospital also stated.  
“There are various challenges that are faced by our organization, such as lack of space for 
storage, the procedures needed the involvement of clinicians, wastage of products and lack of 
traceability as well as product visibility. We are highly concerned with inventory management 
because the fluctuated level of stock, product identification was difficult, and storage was 
spread across the hospital. Thus, these problems prompted us to adopt an innovative 
inventory management system, which beyond our early expectations, both financially and 
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from a service viewpoint. The cost-savings in the theatre was £1.78 million and the 
consignment stock savings was £350,000. We also realised that the wastages had been 
reduced and there was a £885,000 stock reduction, and the hospitals have realised a space 
savings of £31,000. In addition, discovering 13 types of barcode made us to adopt the GSI 
standards and that helped us to come up with a database that was accurate and up-to-date 
information, and that was fed in the management systems of our inventory This type of 
technology has enabled our hospital to really move forward with our aim to achieve supply 
chain excellence.”   
“Capability versus demand, inability of capability to meet demand (S2)” and “weak logistic 
service infrastructure (S3)” have been identified as the risks with high driver and dependence 
power as well. These two risk factors have a direct influence on “dispensing/picking errors 
medication/packaging (S6)”. The findings agree with that of Liu et al.’s (2017) findings that 
the lack of skilled staff and handling material could lead to the human error in handing or 
storing of drugs. One re-occurring issue was the larger number of patient transports made by 
nursing staff, despite it being the transportation departments’ responsibility (Granlund and 
Wiktorsson, 2013). The transportation department was perceived as lacking the capacity to 
handle all transports and often late with deliveries, thus the nurses were forced to carry out 
transportation which is time wastage and the products are likely to be spoilt hence increasing 
chances of errors. Meanwhile, automatic transport systems are introduced as a founding 
principle for current hospital logistics, such as automated guided vehicles (AGVs) that handle 
the major part of all deliveries of food, linen, waste, and goods, while pneumatic dispatch 
systems are used for samples, blood, and medicine shipments. According to Granlund and 
Wiktorsson (2013), healthcare internal logistics strives for a high degree of automation, e.g. 
IT systems for ordering supplies, tracing equipment and staff. Equipment for picking and 
packing medicine for patients are supposed to be integrated with the pneumatic dispatch 
system. As a result, the ISM model provides the conceptualization of healthcare SC risks and 
to understand mutual influence between 11 risk factors that have been identified. Therefore, 
lower level factors are mainly responsible for increasing the degree of risk extent as they have 
a strong influence on the higher or equal level factors. In this regard, it is recommended that 
interdependency among various risk factors plays an important role in assessing the risk 
effects on healthcare SCM (Samantra et al., 2016).  
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6.7 CONCLUSION  
This chapter presents the implementation of the combined Fuzzy AHP and ISM model to 
analyse and evaluate the risks in the healthcare SC. The application of the combined models 
indicated its feasibility as a tool of analysis as well as a decision-support tool that facilitates 
understanding of the problem. The problem of the study was to determine the exposure level 
and the relationship of the risks of the supply chain to healthcare products delivery. The fuzzy 
approach adopted in the chapter is significant especially under circumstances where the 
uncertainties exist when making decisions. The pairwise analysis of each risk is based on the 
experts’ knowledge from both academic and practitioner fields, that is, contributions from 
those who understand the issues. Therefore, the developed models from this study will 
increase awareness among stakeholders and the decision makers to better understand the 
priority weighting, the relationship and the effects of different supply chain risks and 
consequences. Therefore, this implies decisions about risk mitigation strategies.     
In terms of the findings, the Fuzzy AHP method was used to determine the weights of the 
criteria and sub-criteria, which are more accurate than the direct weights received from the 
decision makers. It can be noted that eleven sub-criteria risk factors with high priority 
weighting were selected. Subsequently, they were used as inputs for the ISM model for 
evaluating their inter-relationships and providing a concept of identification and classification 
of those risk factors in four different clusters based on their driving power and dependence 
power. In this regard, it is recommended that interdependency among various risk factors 
play an important role in assessing the risk effects on healthcare SCM (Samantra et al., 2016). 
Lower level factors are mainly responsible for increasing the degree of risk extent as they are 
influencing strongly to the higher or equal level factors. The ISM model provides the 
conceptualization of healthcare SC risks and the insightful understanding of mutual influence 
between 11 risk factors. As a result, the key finding is that no risks are categorized as the 
autonomous risk, which are weak drivers and weak dependents and with little influence on 
the system.  All the 11 risk factors should be considered when determining the relevant risk 
mitigation strategies in the next chapter. 
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7.CHAPTER SEVEN – IDENTIFICATION AND EVALUATION OF RISK 
MITIGATION STRATEGIES 
 
7.1 INTRODUCTION 
This chapter focuses on the last stage of the risk management process, i.e. identification, 
validation and evaluation of current implemented risk mitigation strategies. The current 
implemented risk mitigation strategies are identified through conducting empirical studies 
from both China and UK healthcare industries (i.e. official documentation review, direct-
observation and semi-structured interview). The validation of the identified risk mitigation 
strategies and the exploration of new risk mitigation strategies are conducted via the semi-
structured interviews. The overview of each identified risk mitigation strategy is presented. 
The identified strategies are prioritized over the previously identified risk factors using a Fuzzy 
TOPSIS method.    
 
7.2 METHODOLOGY FOR RISK MITIGATION STRATEGY IDENTIFICATION AND EVALUATION  
Based on the developed integrated RM model, a generic risk mitigation model is proposed for 
determining and evaluating the implemented risk mitigation strategies. It is a key part in the 
proposed RM model for healthcare organizations. The schematic diagram of the generic risk 
mitigation model is illustrated in Figure 7.1.  
The proposed risk mitigation model will be implemented for healthcare organizations through 
the following steps:  
Step 1: Exploiting the current implemented risk mitigation strategies on the basis of the 
identified significant risk factors though empirical studies.  
Step 2: Develop a questionnaire to evaluate the identified risk mitigation strategies to the 
case organizations and distributed to the participating experts to contribute their 
judgements.  Next, the Fuzzy TOPSIS method is applied to rank the significance of these 
strategies.  
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Risk Factors
Identification
Risk Assessment Risk Mitigation
Chapter 5 Chapter 6 Chapter 7
Conduct the empirical studies for identifying the implemented risk 
mitigation strategies
Choose the appropriate linguistic values for alternatives with respect to 
criteria
Compute aggregate fuzzy ratings for the alternatives
Conduct the weighted normalized fuzzy decision matrix
Construct the fuzzy decision matrix and the normalized fuzzy decision 
matrix
Determine and calculate the distance of each alternative from FPIS and 
FNIS
Calculate the closeness coefficient (CCi) of each alternatives
Rank the alternatives (Rank risk management strategies in HCSC)
TOPSIS method under fuzzy environment
  
Figure 7-1: A generic risk mitigation model for healthcare supply chain 
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7.3 IDENTIFICATION OF RISK MITIGATION STRATEGIES FROM EMPIRICAL STUDIES  
Various risk mitigation strategies exist in both the general and healthcare supply chain setting. 
However, the existing literature is rather limited and fragmented. This thesis therefore 
focuses on the current risk mitigation strategies in both UK and China healthcare 
organizations. It provides the latest information that can reflect the current situation in both 
countries’ healthcare industry. Especially, instead of identifying the risk mitigation strategies 
through a literature review, this research explored the currently implemented strategies which 
turned out to be more reasonable in actual situations. Although it is good to have choices of 
strategies for supply chain risk mitigation, how to tailor them with their various features and 
benefits is still a big challenge for many healthcare organizations. In this thesis, the healthcare 
provider (i.e. hospitals) is taken as a focal organization in the context of the supply chain. 
Based on the identified risk factors in previous chapters, a number of risk mitigation strategies 
are identified and their efficiency will be evaluated through the developed method.  
An empirical studies approach is employed to explore the healthcare supply chain operations 
in the hospital context. It provides description of what is transpiring by using in-depth 
interviews, direct observations, and documentation review, which are referenced as both 
qualitative and quantitative studies (Christensen et al. 2011; Creswell and Creswell 2017; 
Taylor et al., 2015; Yanow and Schwartz-Shea 2015). The purpose of empirical studies is to 
verify current existing or newly proposed collected evidence about research on the basis of 
empirical data. Long (2014) reported that an empirical study is based on ‘field’ experiences or 
direct observation, enabling researchers to conduct investigations on modern phenomenon 
in depth and in its natural context where there is no clear evidence between phenomenon 
and context. According to Yin (2013), the research design is used to judge the quality of 
empirical studies that consist of reliability and construct validity, internal validity, and external 
validity. In this chapter, construct validity is achieved when multiple sources of evidence were 
employed for data collection. More specifically, semi-structured interviews were used as the 
primary data collection approach, while site observation and official documentation review 
were also gathered for triangulation purposes.  
Empirical studies were conducted in both UK and China healthcare industries to extract the 
appropriate number of mitigation strategies for further evaluation. The studies were 
conducted in three phases: (1) review of official documentation and other published 
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materials, (2) direction observation, and (3) conducting semi-structured interviews. Each of 
the phase is discussed below.  
7.3.1 Description of the procedure of conducting the empirical studies 
The research followed the particular steps to ensure that all sources were used in the study. 
To begin with, some relevant documentation was reviewed critically, such as NHS England 
Risk Management Policy and Process Guide; Lord Carter’s report; NHS Supply Chain Case 
studies; NHS eProcurement Strategy; Eight UPS Pain in the Chain Survey; and McKinsey and 
Company reports and other Department of Health and Social Care official documents. 
Especially, some official documentation was provided by the participating organizations in the 
survey.  Documentary research has the advantage of ensuring that the researcher gaints 
access to information which would otherwise be challenging to acquire using other means 
like people who may be difficult to track down or may be unwilling to engage in an official 
study. In most cases, documentation review is an effective mechanism to track change over 
a long period of time. It is also less expensive, especially when documents may be accessed 
easily. After documentations review, some mitigation strategies are identified. For example, 
Lord Carter’s report has given the discussion on the savings which could be supplied from 
good e-procurement practices. The strong emphasis is placed on the employee issues as well 
as informatization of hospital supply chain network. Among these recommendations, some 
key lessons have been retrieved in relation to our research:  
 
 Collaboration (i.e. local, regional, national) 
“By collaborating with suppliers and leveraging the NHS’s purchasing power on a national 
scale (aggregating national demand and releasing funds) the Future Operating Model …”  
 Outsourcing the supply chain activities to the third party. (capitalise on economies of 
scale in the provision of non-core services to reduce back-office costs). 
 NHS eProcurement strategy (electronic invoicing by suppliers direct into the Oracle 
system; GS1 Product bar coding technology; modernizing the complete purchase-to-pay 
process.  
 Information technology and system (RFID etc.) 
        “Integrated IT platforms that allow each function within the operating model to work                
        seamlessly..(NHS Procurement Transformation Programme Future Operating Model    
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        (FOM)). (Lord Carter’s report, 2016) 
 
The in-depth observation presented here was conducted in the UK and China. The author 
visited three hospitals as well as one pharmaceutical company: 𝐻𝐴 (children’s hospital), 𝐻𝐵 
(public hospital) and 𝐻𝐶  (university hospital), which differ in terms of patient group, size of 
hospital, and location. 𝐻𝐴 is one of the largest childrens’ hospitals (309 beds) in the United 
Kingdom and Europe. It currently employs about 2,400 staff and treats over 270,000 children 
from across the UK each year. The other two hospitals 𝐻𝐵 and 𝐻𝐶  are state-owned hospitals 
in China and third-grade class-A hospital (2,100 beds and 11,000 beds, respectively). 𝐻𝐶  is 
located in one provincial capital city while 𝐻𝐵 is located in a third-tier city, and 𝐻𝐵 currently 
employs about 2,447 staff and treats over 1,060,000 outpatients and 60,000 inpatients per 
year, while, 𝐻𝐶  currently employs about 11,859 staff and treats over 5,700,000 outpatients 
and 410,000 inpatients every year.  During the site visits, the author received a tour of the 
different sites for observation, which was especially helpful in gathering data pertaining to 
operational aspects. Importantly, carrying out direct observations has a major benefit of 
ensuring that the author can actually observe what is done or said by the intended 
participants with interviews (Yin, 2015). Human beings, by their very nature, would not 
normally be willing to tell strangers their thoughts during interviews or to write their honest 
opinions on questionnaires. Therefore, observations enable the researcher to access the 
meaning and context of what people say and do. Nonetheless, a direct observation also has 
its weaknesses that can be overcome by other data collection methods. 
In the last stage, the semi-structured interviews were conducted in the healthcare industry of 
the two countries by inviting nine experts from seven Chinese hospitals and three experts 
from one UK hospital and another two general managers from different pharmaceutical 
companies to take part in the survey as shown in Table 7.1. Most respondents were involved 
our previous surveys and a regular contact was maintained from the point of contacting until 
the research project’s completion. Interviews were held face-to-face or telephonically with 
participants from different hierarchical levels of each healthcare organization. It was 
important to examine if information from participants were consistent throughout the 
different organizational levels of the cases. Therefore, involving various hierarchical levels as 
well as different types of organization interviews aided in determining the integrity and 
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validity of data within cases. In addition to this, as discussed in the previous chapter, 
organizations were selected on the basis of their experience with supply chain disruptions 
and represent a leading organization in the healthcare industry (e.g. the selected Chinese 
hospitals are all the third-grade class-A hospitals). Positions held by the interviewees included 
pharmacy department leader, stock manager, former director of hospital, material 
department manager, and general manager in a pharmaceutical company.  Most interviewees 
were helpful in gaining access to additional documentation.  
 
Table 7.1: Respondents’ profile 
Participant Position Method 
Chinese Hospital A Pharmacy department leader Telephone interview (40 min) 
Chinese Hospital A Stock Manager Face-to-Face interview (30 
min) 
Chinese Hospital B Pharmacy department leader Face-to-Face interview (30 
min) 
Chinese Hospital B Pharmacy department senior 
manager 
Face-to-Face interview (30 
min) 
Chinese Hospital C Pharmacy department leader Face-to-Face interview (30 
min) 
Chinese Hospital D Pharmacy department leader Face-to-Face interview (30 
min ) 
Chinese Hospital E Pharmacy department leader Face-to-Face interview (50 
min) 
Chinese Hospital F Former director Telephone interview (30 min) 
Chinese Hospital G Pharmacy department leader Face-to-Face interview (40 
min) 
UK  Hospital A Head of Procurement Face-to-Face interview (30 
min) 
UK Hospital A Material department Manager Face-to-Face interview  (30 
min) 
UK  Hospital A Pharmacy department Manager Face-to-Face interview (40 
min) 
Chinese 
Pharmaceutical 
Company A 
General Manager Face-to-Face interview (40 
min) 
Chinese 
Pharmaceutical 
Company B 
Vice-general Manager Telephone interview (40 min) 
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The interviewees were asked to validate the identified strategies from the previous steps to 
determine if they thought the strategies were inappropriate. More so, by providing their 
opinions about whether some strategies had been addressed. A semi-structured interview in 
research as a technique has a number of advantages (Creswell and Creswell 2017). It is reliable 
and efficient to generate a huge amount of details. Therefore, based on the selected 11 sub-
criteria risk factors for the cases and interviewees, questions were designed for one hour 
interviews time. This ensured enough time to get sufficient data to answer research 
questions, whilst the amount of time was deemed acceptable for any research participant to 
invest in the research. During the interview, as some confidential topic would be of concern 
to the interviewees (e.g. especially in China), the interviewees might be uncomfortable with 
being recorded. Hence, the author had honed a pen-and-paper note taking method to record 
the information due to the interviewees’ refusal to allow audio-recorders.  Furthermore, the 
notes would be given to the interviewee to make sure the essence of their comments were 
transcribed.  
The interviews were spread over three months and included four site visits by the author. 
Each time, the author visited a placement based on the interviewees’ locations. Sites visited 
by the author included hospital’s pharmacy department, material management department, 
centre store, and dispensary and a distribution centre as well as a warehouse in the 
pharmaceutical company. Three of four visited sites were located in China, whilst the fourth 
site was located in the United Kingdom. Consequently, integrating the three sources, 
documentation, direct observation, and interviews ensured research with reduced bias. In the 
end, nine risk mitigation strategies were identified and discussed below. 
 
7.3.2 Overview of identified implemented mitigation strategies in hospital setting 
As presented in Figure 7.2, the identified risk mitigation strategies are summarized and more 
details will be discussed below.  
7.3.2.1   Strategy 1: Building efficient distribution management 
- Poor quality in the purchased drugs from suppliers (S2) 
- Weak logistics service infrastructure (S7) 
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The main goal of distribution management is to ensure that pharmaceutical supplies are 
smooth and maintained to the hospitals where they are required and ensuring that resources 
are effectively utilized (Jaberidoost et al., 2013). Costs of distribution, such as transportation, 
are an important issue for running a supply system of a public health supply system. In 
countries covering large geographical areas like China, the cost of transportation might 
surpass the distributed medicines’ value (Syahrir and Vanany 2015). Therefore, minimizing 
these costs may imply that more money would be present for clinical care and for the 
purchase of medicine. A distribution system is considered good only when it is cost-effective 
and provides quality service.    
 
 
 
Figure 7-2: Summary of the identified risk mitigation strategies 
The distribution cycle starts with the dispatch of pharmaceuticals by suppliers or 
manufacturers and ends with the reporting of information regarding medicine consumption 
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to the facility’s procurement department (Jaberidoost et al., 2013). The main activities 
involved in pharmaceutical logistics management are varied. Cold chain management, for 
example, is one of the most important HCSCM tasks and generally defined as a temperature-
controlled supply chain that warrants and extends the shelf life of goods like pharmaceutical 
drugs, seafood, fresh agricultural products, and frozen food. According to Purssell (2015) and 
Ogboghodo et al., (2017), understanding cold chain management is important to supply chain 
management since it manages temperature to minimizes the challenges of risks affecting 
efficacy and safety of medicines, especially high cost vaccines, stored in large quantities and 
temperature labile (i.e. safety and efficacy may be compromised by excessive heat or 
freezing). In particular, it is a sequence of activities involved in distribution to steadily 
maintain this temperature to safeguard drugs from manufacturing to consumption points. 
The unique characteristics of the product perishability of some specific pharmaceutical items 
must always be stored under the strict temperature-monitoring environment. Therefore, it is 
necessary to manage risks caused by the unexpected changes in environmental conditions for 
delivery items during the distribution process, as such risks can directly or indirectly 
negatively affect the quality in purchased drugs from the supplier. Meanwhile, when logistics 
services infrastructure is poor, it also lead to the poor supplier routes, obsolete equipment in 
the warehouse, improper drug store environment and transportation facility/route, 
inefficient cold chain management during transportation.  According to a report produced by 
the UPS Company (2015),  
“There are many organizations which have succeeded in addressing the issue of product 
damage as well as spoilage last year. The main reasons for success cited are partnering with 
higher-quality carriers, using faster shipping service levels, and using temperature-monitoring 
devices.”   
One general manager in a pharmaceutical company stated that:  
“Transparency has to be critical. Applying real time monitoring and recording devices would 
help us identify where to find the product and evaluate the condition in which the product is 
found. It can also tell where it can be stored. For example, for the various types of sensors, 
there are sensors and tags which have been installed on the transportation facilities such as a 
delivery item, worker, or container. These tags are used when distributing items from one 
place to another. They are used in the identification of the entities according to the unique 
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identifiers given to the tags. A sensor is defined as a device that measures environmental 
conditions according to the environmental features like Thermocouples, Resistance 
Temperature Detectors (RTD) and Vaccine Vial monitoring (VVM). We use VVM whereby the 
RTD is found on the Vial label which when exposed to the high temperature it becomes dark. 
”   (Pharmaceutical Company A)  
On the other hand, in the hospital setting, refrigerated medicines must be stored at 2-8⁰C. 
Most non-refrigerated medicines must be stored at less than 25⁰C. However, some medicines 
can be stored at up to 30⁰C. Sensitivity to changes in temperature varies depending on the 
medicine. One stock manager mentioned:  
“We have to ensure that all medicines are stored within the manufacturers recommended 
temperature range. Otherwise, it could invalidate the expiry date and cause manufacturers to 
disclaim responsibility for any apparent failure of the medicine as the safety and efficacy of 
such medicines can be significantly compromised or unknown.” (Chinese Hospital A)  
 
Another pharmacy department leader used vaccine management for example and said:  
“In our hospital, all the employees who carry out any activity involving medicine such as 
transportation, storage as well as administration should be given proper training. This training 
will help them to ensure that all the medicine or vaccines are in their right status. The 
pharmacist is the one supposed to be dealing with cold chain management of all the vaccines 
which are stored in the hospital stores. The nurse manager is responsible for the medicines 
that are removed from the store and they store them in the clinic refrigerators as they wait 
for administration to the patient.  Once the medicine is transferred from the stores to the 
ward, they should also be monitored and kept under cool conditions using the battery-
operated thermometer. The persons who transfers the medicines should ensure that they are 
packed well and the temperatures are monitored from the time they are being transferred to 
the time they reach the ward. The person who receives the vaccine should record their receipt 
and that the cold chain was maintained during transfer on the Health Vaccine Refrigerator 
Temperature Chart. The vaccines must be unpacked and stored immediately in the ward/clinic 
refrigerator. After that the nurse administering the vaccine is responsible for maintaining the 
cold chain from the time it has been removed from the refrigerator to administration. 
Especially, during these process, when the refrigerator temperature readings fall outside the 
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range 2⁰C to 8⁰C this must be reported to the service/ward manager for risk assessment and 
appropriate action.”  (Chinese Hospital E)  
The other activities are receipt and inspection. Kanyoma et al., (2013) noted that central 
stores staff must accurately inspect all shipments as soon as they are received from local 
suppliers or the port. The shipments must be kept separate from other stock until the 
inspection is completed, which should focus on missing and damaged items. The inspection 
should also pay attention to compliance with agreement conditions relating to labeling, 
packaging, presentation, quantity, drug type, and other special requirements. It is essential 
to inspect every shipment promptly and accurately in order to ensure that suppliers fulfill the 
contracts, where receipts and distribution (R&D) are responsible for matching receipts to 
orders and arranging the internal delivery schedule. A pharmacy department leader 
mentioned: 
“When expecting a delivery of a refrigerated medicine, the designated accountable person 
must ensure that whoever accepts the delivery is aware of the need to maintain the cold chain 
and check the order for leakage, damage and discrepancies. All deliveries of refrigerated 
medicines must be unpacked immediately on arrival and placed in a pharmacy refrigerator. 
Items must remain in the manufacturer’s original packaging to protect them from light. If 
there is any concern that the cold chain has been broken prior to delivery, the staff cannot 
accept the delivery and report the reason for non-acceptance to the distributor.” (Chinese 
Hospital C) 
7.3.2.2   Strategy 2: Developing advanced information technology and system 
- Counterfeiting (S1) 
- Poor IT system, lack of data standardization (S5) 
- Dispensing/picking errors-medication/packaging (S6) 
- Lack of visibility concerning placement and availability of stock (S8) 
The issues regarding counterfeiting can be managed by incorporating the current anti-
counterfeiting technologies such as the hologram, mass encoding systems, bar-codes etc. 
With regard to mitigating risks in the supply chain, the empirical studies revealed a number 
of IT-related techniques currently used. These include data standardization, information 
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sharing, drugs traceability, integrated IT platform, RFID, and EDI (Coustasse et al., 2013). 
According to Lord Carter’s report,  
“All hospital trusts should have the key digital information systems in place where it is fully 
integrated and utilized e-catalogue and inventory systems for procurement, RFID systems. For 
example, there is one hospital which has adopted the same technology like that of the well-
known United Kingdom’s largest retailers-real time Amazon-style which deals with purchase-
to-pay platform. It has an in built catalogue and product information solution which it uses to 
monitor the processes of the supply chain management. The procurement platform enables 
the trust to ensure safe delivery and leads to a reduction cost of a £3 millions annual costs. It 
enables the company to develop transparency, visibility as well as step-change in the 
interoperability in the health organizations.” (Lord Carter’s report, 2016) 
In the UK, the Department of Health (DH) has announced a guideline called “Coding for 
success”, which is related to the implementation of an automatic identify and data capture 
programme (DH, 2010).  To address patient safety issues, the National Health System 
Connecting for Health (NHS CFH) entered into the agreement with GS1 UK to issue the 
adoption of the GS1 coding standard. In addition to coding, it also encourages manufacturers 
to implement GTINs while driving the NHS to implement effective supply chain technologies 
(GS1, 2010). According to Wu et al., (2013), GS1 is the world’s leading supply chain 
organization. The GS1 system is composed of four key standards: barcodes (used to 
automatically identify things), eCom, global data synchronization standards (GDSS), which 
allow business partners to have consistent item data in their systems at the same time) and 
EPC global (which uses RFID technology to immediately track an item). GS1 coding standards 
are, therefore, integral in the supply chain as they standardize data and require all players to 
implement the same data standard and system so that they can speak the same electronic 
language to achieve end to end traceability. Furthermore, GS1 also allows for product 
traceability through Automatic Identification and Data Capture (AIDC) systems, including 
barcodes and RFID. The RFID also continuously monitors and provides reports concerning 
temperature, humidity, and voltage (Coustasse et al., 2013). Through this technology, after 
the medicines are unpacked from the box or pallet, they also can be tracked or traced. As 
such, increasing the visibility of stock as well as decreasing the dispensing or picking error-
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medication can be interpreted as a reduction in the degree of exposure to supply chain risk.  
One head of procurement mentioned: 
“We have discovered that most medicine products on the shelf did not have a unique identifier. 
We found thirteen various types of barcode. In addition, there were many codes from the 
manufacturers, distributors, suppliers’ manufacturers leading to a lack of clarity and poor 
data. Hence, it requires us to adopt GS1 standards and ensure the managers are focused.”  
(UK hospital A)  
The key challenges for the efficient inventory management process include a lack of stock 
control and visibility along with a shortage of management information. A material 
department manager stated: 
“We have worked with Ingenica Solutions to implement a GS1 standards-based inventory 
management system (GS1 Global Trade Item Numbers (GTINS)) in the hospital’s operating 
theatres. It enables us to manage the processes, secure efficiency savings as well as release 
valuable clinical time back to patients. Scanning the barcode once the items are received, 
moved and used in the hospital which help us to capture data electronically as well as 
exchanged without manual intervention.” (UK Hospital A)  
Another pharmacy department manager also mentioned:  
“Since the GS1 was implemented, everything from patient ID bracelets and bandages, to A4 
paper and medical implants, is now trackable.”  (UK Hospital A) 
Moreover, counting items in the pharmacy inventory and using auto-ID technology, e.g. RFID 
(cycle-count policy) to provide inventory visibility and items traceability is now possible. 
During the empirical study, the author found that several hospitals are applying RFID-enabled 
real-time inventory management systems. A head of procurement mentioned: 
“We had already equipped each cabinet with RFID tags which have records of all the 
transactions and the information like what was removed, who removed it and for which 
patient the product is intended. When the hospital has been implemented with the Hospital 
Information System (HIS), real-time data captured by RFID reader is able to feed the medical 
document for the patient in the documentation system, modify expiration data as well as 
eliminating the need to maintain excess inventory.”   (UK Hospital A) 
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Last, RFID has been gaining increasing attention for reducing counterfeiting and enabling 
monitoring of drug quality in supply chains from improved traceability. During the visit 
observation in the case hospitals, the application of the RFID-enabled traceability system 
could be learned: 
“Once receiving a product in the centre store, after undergoing careful inspection, the staff 
scan the manufacturer’s barcode on the package to obtain the relevant information (e.g. 
product, serial number and expiry data). The obtained information is then moved to the 
middleware in real time to save specific information such as requesting department/specialty, 
the internal product number and product description, the specific storage location where the 
product needs to be put away. Thereafter, the RFID printer prints a transferrable self-adhesive 
label which consists of the RFID transponder that is unique as well as any other related 
information such as the storage location. The RFID label is thereafter affixed to the packaging 
of the product.  Once the product is delivered to the user department, clinical staff use the 
RFID board to swipe the product, the information will update to the application database, 
which confirms the delivery time and location as well as the status of product as ready for use. 
Then the product is stored in a specific storage location. Once the product is selected and 
dispensed to the doctor, and the product has been used for a certain procedure the automatic 
transfer of the captured information will trigger the replenishment process to the inventory 
management system that the hospital HIS has.” (UK Hospital A) 
Whenever the product is used for a specific procedure, the replenishment process will be 
automatically triggered to transfer the captured information to the inventory management 
application hosted on the hospital’s HIS system. Therefore, the end-to-end traceability of 
medical products in the healthcare SC becomes an important strategy to avoid or reduce the 
impact from supply and IT related risk factors.  
7.3.2.3   Strategy 3: Developing inter and intra organizational collaborations 
- Shortage of drug, unavailability of drugs on the market (S3) 
- Capability versus demand, inability of capacity to meet demand (S4) 
- High purchase price (S10) 
Supply chain collaboration is often defined as two or more chain members working together 
to create a competitive advantage through sharing information, making joint decisions, and 
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sharing benefits which result from greater profitability of satisfying end customer needs than 
acting alone (Simatupang and Sridharan, 2005). Studies on service-dominant logic (SDL), for 
example by Schmenner et al., (2009), significantly show how customer and supplier are no 
longer external to the system. Instead, they play the important roles in the process of value 
creation in the central company in the supply chain via the application and sharing of one 
another’s competencies. Similarly, exchanges involve numerous suppliers because of the 
reliance on a wide range but specialised sources and forms of information and material 
supplies in the hospital supply chain. And, these exchanges may suggest collaboration 
because in the healthcare supply chain where independent partners are connected in co-
creating values.   
The findings, likewise, revealed that collaboration is a great way to mitigate supply chain risks. 
According to Lord Carter’s report:  
“Most evidence was done by close working relationships among Trusts at national, regional, 
and local levels and collaboration with pharmacy wholesalers and manufacturers. This 
collaboration resulted to the consolidation of medicines supply chain, which led to full 
utilization of e-ordering, invoicing, aggregating and rationalizing deliveries to be used in the 
wards. Combining drugs stock-holding and modernizing the supply chain to combine and 
rationalize distributions to decrease stock-holding days from 20 to 15, deliveries to less than 
5 per day. It also makes certain that about 90 per cent of invoices and orders are electronically 
processed and delivered”   (Lord Carter’s report, 2016) 
In order to realize these supply chain benefits through collaboration, substantial 
consolidation has been occurring through the formation of hospital systems that entail 
common ownership of two or more hospitals. In the UK, a Multi Trust Aggregation (MTA) was 
adopted by most hospital trusts to integrate the requirements across many affiliated 
hospitals. The procurement activities are aligned to enable each member to take advantage 
of volume economies and gain better negotiating leverage with suppliers. As such, group 
buying helps mitigate supply chain-related risks because it confers product variety, price 
stability, and produces availability for members irrespective of their size and location, which 
they may otherwise not achieve if they purchased individually (Zepeda et al., 2016). For this 
reason, the Group Purchasing Organization (GPO) has received increasing attention from both 
academic and industrial fields (Burns and Lee 2008; Rego et al., 2014; Zepeda et al., 2016; 
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Yang et al., 2017). According to the Healthcare Supply Chain Association (HSCA), a GPO is “an 
entity which assist the clinicians at hospitals, nursing homes, and home health agencies to 
obtain savings and efficiencies by combining purchasing volume as well as using that power 
to negotiate discounts with their vendors, distributor or manufacturers.”  GPOs do not 
purchase products for their own facility but instead support their members in their contract 
development and management and negotiate contracts with respective vendors. In addition 
to discounts, many GPOs also offer supply chain optimization consulting services and provide 
healthcare facilities valuable insights. One former hospital director stated:  
“In China, hospitals are increasing relying on their GPO partners for a broad range of services 
beyond cost-saving, although cost-saving and delivering the quality products are the main 
elements to the GPOs’ core mission. Moreover, many GPOs are expanding their services to 
meet evolving hospital and provider needs, such as market research, innovative technology 
integration, electronic product tracking and supply chain experts to share best practices.” 
(Chinese Hospital F)  
Meanwhile, “risk sharing” and “reduced inventory costs” are additional benefits from 
collaboration between hospitals, especially at the local system. It allows the affiliated 
hospitals to avoid a drug shortage by filling orders from other affiliated hospitals’ central stock 
with inventory on hand. More importantly, this means the inventory is not always physically 
consolidated at a single location. Instead, the hospitals can physically or virtually access the 
inventory used by affiliated hospitals allowing the inventories to be shared among demand 
locations reducing the use of the inventory rate and related costs while achieving required 
service levels. One pharmacy department leader mentioned: 
“Since 2007, we signed the contract with other three hospitals in the same regional area to 
provide the supply chain consolidation and reduced stock holding. It allows us to obtain 
needed stock from another hospital, especially when the urgent need for supplies arises. With 
this back-up arrangement, it enables us to reduce our safety stock and thus avoid the massive 
waste.” (Chinese Hospital B)  
It is noteworthy that most healthcare organizations are under pressure to make savings each 
year. One important reason is a lack of cross-functional department involvement in the 
procurement process. A pharmacy department leader mentioned:  
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“We have a large number of stakeholders working on product specifications, it meant difficulty 
reaching consensus and often led to purchasing several different versions of the same product. 
Hence, we set up the Pharmacy Administration Committee, which is composed of one vice 
president of hospital, pharmacy department leader, material department manager, several 
clinicians and a head nurse. Those members were given responsibility for making decisions on 
the how and where products could be purchased more efficiently.” (Chinese Hospital C)  
Working closely with other departments aids in the collaboration across internal boundaries 
and provides of a structure which enables swift communication. This is also in line with 
findings from Lord Carter’s report (2016): 
“…improving employee management capacity, building greater engagement and creates an 
engaged and inclusive environment for all colleagues by significantly improving leadership 
capability from “Ward to board.”” (Lord Carter’s report, 2016)   
7.3.2.4   Strategy 4: Building efficient inventory management 
- Capability versus demand, inability of capacity to meet demand (S4) 
- Poor IT system, lack of data standardization (S5) 
- Lack of visibility concerning placement and availability of stock (S8) 
Excess inventories may add costs, drugs expiration and result in huge hits to the hospital’s 
bottom line. Since the early 1990s, healthcare organizations began to adopt the idea of Just 
in Time (JIT) supply chains to decrease the rate of inventory holding costs and reduce 
employing more labour for managing the inventory management. The implementation of JIT 
management has a positive impact on the healthcare supply chain processes. In this case, the 
main objective is to ensure that they remove all stock in the central store. It means that 
suppliers deliver products to each point-of-use location in the hospitals without intermediate 
buffer inventories. The different collaborative arrangements between hospitals and 
pharmaceutical suppliers, such as “ward box”, where hospitals place orders of the products 
required in a specific ward directly and the suppliers deliver to each ward without taking the 
detour to the central store. However, it is difficult to accurately forecast the demand due to 
considerable variability and unpredictability. The healthcare providers must transform their 
relationships with their key suppliers from an adversary to a long-term business partner to 
improve the supply efficiency and lower the inventory costs. Meanwhile, the healthcare 
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providers should be working with their suppliers to determine the capability of current 
logistics systems in order to identify and categorise all types of products and their predicted 
utilization.  Moreover, material managers have to be actively involved since they have an 
integral role in assisting health facilities to implement more and better standards.  Among the 
key activities that were revealed from the empirical study, a head of procurement said: 
“Our new hospital was built in June 2015, since that, our Central Stores have now been 
replaced by the Receipts and Distribution facility, that does not have to have so many stock. 
The amount of stocks held by the General Stores Department is now decreased due to the Just-
in-Time approach, as well as ensuring that most of the purchases are done through the NHS 
Supply Chain (NHS SC) route. The NHS SC supplies to the hospital three times per week now so 
there is no need have so much stocks on site because the stock is readily available in the nearby 
warehouse which can be delivered in the shortest time possible. In addition to the above, the 
ward/department level took the responsibility to create the shopping lists on Oracle e-ordering 
system for their own requirements. Therefore, each ward/department can manage and 
control their own budgets and stock levels more closely as they are more accurately predict 
activity. Because of this, our stockholding costs reduced by 58 per cent to £86,000. There are 
two people who have been allocated in the General Stores who are supposed to leave under 
the Mutually Agreed Severance Scheme (MASS) and they save about £40,000. This has realised 
a reduction in the workload in General Stores because of the few items that are handled 
locally. In addition to those, ongoing savings of £80,000 in the health care organization 
hospital based on more exact estimation of activity affecting the  purchases. ” (UK Hospital A)  
Another inventory management strategy, apart from the aforementioned, is adopting 
inventory management systems. In some cases, a lack of visibility of stock level had let to 
inefficient processes. For this reason, hospitals only know what is spent and not what is held, 
consumed, and wasted and use IT as an enabler to initiate a change in the stock management 
and replenishment process. 𝐴𝑡𝑡𝑖𝑐𝑢𝑠𝑇𝑀  is the first GS1 compliant inventory management 
solution, which helped UK NHS hospitals reduce wastage and historical inefficiencies by 
facilitating greater transparency, better stock and data management. A pharmacy 
department manager stated: 
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“Using the system enabled us to significantly improve the control functions of our corporate 
stores service and has achieved significant savings and visibility. Today consumption of stock 
is recorded at point of use at the same time ordering is based on exact consumption, allowing 
a reduction in stock holding. As a result, it has created more space due to being cleared of 
stock, and more has been reassigned for clinical usage. This has reduced the labour force of 
the people who deal with stock management saving more than 7,000 hours clinical time which 
has been initially reallocated to frontline care.”  (UK Hospital A)   
7.3.2.5   Strategy 5: Implementing eProcurement strategy 
- Counterfeiting (S1) 
- Poor IT system, lack of data standardization (S5) 
- Dispensing/picking errors-medication/packaging (S6) 
- Lack of visibility concerning placement and availability of stock (S8) 
- High purchase price (S10) 
- High product and supplier/brand variety (S11) 
To increase supply chain efficiency and ensure patient safety, Kritchanchai et al., (2016) 
suggested that standardized healthcare infrastructures are the important means of managing 
healthcare supply chain and logistics to increase visibility and security. In their study, the 
infrastructure was composed of five main areas including: Standardized Product and Location 
Identification; Electronic product catalogues; eProcurement enabled by Electronic Data 
Interchange (EDI); Automatic Identification and Data Capture (AIDC) systems, e.g. barcodes 
and RFID; and traceability systems. The findings are also in line with the elements of 
eProcurement Strategy, such as E-catalogue management, location identification, and GS1 
Global Data Synchronisation Network.  To address the problem of supply chain capability, 
Lord Carter’s interim report (2016) also suggested that all NHS trusts should work in 
collaboration both with national procurement strategies and to explore common systems 
adoption, such as enhancing current purchase to pay systems and adopting GS1 and PEPPOL 
standards which are all included in the eProcurement strategy.  
eProcurement Strategy can be defined as “the act of using technology application in 
automating procurement information exchange in the whole supply chain system.” The UK 
Department of Health (DH) announced its aim to implement global standards throughout the 
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healthcare sector and support machine-machine processing of transactions with little or no 
human intervention. More specially, the commonly used standards reported by various 
hospitals and their suppliers are GS1 coding and Pan European Public Procurement On-Line 
(PEPPOL). GS1 is meant for data synchronisation, location coding, and product coding (Bartsch 
et al., 2012; Lichtner et al., 2016). It can be seen that using master data across the whole 
healthcare supply chain network is essential to achieving effective management of long, 
complex SCs, e.g. procurement activities. In brief, master data is the definitive and accurate 
version of the information held about an item. However, the main issue for using master data 
is the same item coded and described differently by healthcare providers and suppliers. To 
address this issue, adopting GS1 standards provides an opportunity for the healthcare 
providers to benchmark and analyse medicine expenditure from their systems with other 
providers, sharing the purchasing requirements when tendering. Moreover, the adoption of 
these standards will enable interoperability between healthcare provider and supplier 
systems. Figure 7.3 displays how GS1 master data are maintained between the suppliers and 
healthcare provider catalogue solution.  
 
SUPPLIER SOURCE DATAPOOL NHS DATAPOOL
HOSPITAL 
CATALOGUE
Product 
Information 
Management 
System
Master data Publish  data Request  data Manage data Master data
 
Figure 7-3: GS1 Global Data Synchronization Network in NHS system 
(source from NHS E-procurement Strategy) 
 
At the beginning, suppliers need to place the information in the GS1 specialised data pool 
Then, DH develops a GS1 certified NHS data pool, which takes the supplier master product 
data from any GS1 certified source datapool and makes it the data repository for master data 
according to products purchased by the healthcare provider. Next, the national Product 
Information Management (PIM) system was established by DH to integrate the NHS datapool 
with local healthcare provider catalogue solutions. Each provider uses the PIM to request and 
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manage master product data from the datapool, then request master product data from the 
source datapool selected by a supplier. Also, the GS1 Global Data Synchronisation Network 
was applied to ensure the master data to be synchronized in near real time, thereby ensuring 
that healthcare provider catalogues always contain accurate master data.   
Master item data synchronized from a GS1 accredited datapool to the healthcare provider 
catalogue system which is then retrieved in the management of logistics activities in the SC 
by employing Automatic Identification Data Capture (AIDC) devices to scan barcodes. As 
discussed above, those capture devices and systems can track and trace items through a lot 
numbers and serial numbers, manage expiry dates, provide the interface with patient records 
to support traceability.  Pharmaceutical manufacturers should record the unique random 
serial numbers according to every products in a database by matching it with the barcode 
printed on the product packaging. So that the product can be scanned at the point of 
dispensing and checked against the database. A system of pharmaceutical verification to 
prevent counterfeiting is determined by user.  
Furthermore, in the UK NHS, the purchase order transactions are processed using the GHX 
Pharmacy Messaging Service platform, which integrates both the buying order system and 
the selling order processing system. To achieve automated machine-to-machine purchase 
order and invoice transactions performed among providers and suppliers, both are supposed 
to operate in a common messaging standard. Thus, PEPPOL (Pan European Public 
Procurement On Line) is recommended as a messaging standard to be adopted by both 
provider and suppliers. PEPPOL provides a set of messaging standards to exchange key 
documents (i.e. invoice messaging, advice note, and purchase order) between selling and 
buying organizations electronically with no manual intervention via PEPPOL ‘access points’.  
Figure 7.4 presents the architecture for the provision of a messaging platform for the NHS 
provider and its suppliers using PEPPOL messaging standards.  
 
          
270 
 
NHS provider systems SUPPLIER systems
NHS provider 
ACCESSPOINT
SUPPLIER 
ACCESSPOINT
Purchase order Invoice
 
Figure 7-4: the architecture of PEPPOL messaging platform 
(source from NHS E-procurement Strategy) 
 
The NHS provider access point is integrated to the NHS provider purchase order processing 
system. The access point receives the purchase orders from the NHS provider and converts 
them to the PEPPOL messaging standard. The PEPPOL-compliant purchase order message is 
exchanged with the supplier access point, which in turn is incorporated into the supplier sales 
order processing system. As a result, a purchase order from an NHS provider is transmitted 
and loaded directly into the supplier’s sales order processing system without manual 
intervention. Lastly, this process works in reverse to accommodate the exchange of invoice 
data between supplier accounts receivable systems and NHS provider accounts payable 
systems.  
7.3.2.6   Strategy 6: Implementing outsourcing strategy   
- Weak logistics service infrastructure (S7) 
Outsourcing the non-core supply chain activities is one risk mitigation strategy. Several 
studies showed that outsourcing the supply chain related activities to the third party logistics 
service providers (3rd LSPs) would helps in creating the significant efficiency advantages for 
both parties because of economies of scale and scope, focus on core competencies, and fixed 
cost reduction (Azzi et al., 2013; Lannone et al., 2014; Volland et al., 2017). Supply chain 
activities can be contracted to the 3rd LSPs with specialisation and more experience in logistics 
than the internal organisation’s logistics department. According to Guimarães and de 
Carvalho (2012), the most important aspect of outsourcing to the 3rd LSPs is building 
          
271 
 
relationships and integration of IT information are all accomplished, as logistics companies 
would endeavour to ensure that their clients’ (in this case healthcare facilities) requirements 
are quickly and accurately delivered. Waters and Rinsler (2014) argued that the trend of 
outsourcing has increased over the last few years in healthcare sector, and extended from 
meals preparation and washing to division management in the supply chain.  
Today, patients are increasingly demanding and informed and they request healthcare more 
frequently and earlier (Christopher, 2016). Subsequently, healthcare departments require 
additional focus on their core business more than in previous years. Outsourcing some key 
elements within the hospital supply chain like pharmaceuticals may result in more efficient 
inventory management leading to cost savings directly. Hospitals can put more investments 
into clinical trials and researches linked to their main business in order to meet patients’ 
different and numerous demands with the saved capital. The number of 3rd LSPs offering 
healthcare inventory management services together with their expertise levels has 
significantly increased over the last few years. Through their professional experiences, the 
providers have successfully reduced inventory costs in the healthcare sector. Thus, in the 
literature on healthcare outsourcing reviewed, the most cited outsourcing drivers include: 
cost reduction, risk mitigation, and rapid change without compromising internal resources 
(Roberts, 2001; Volland et al., 2017).  
According to the empirical studies, some hospitals outsourced their two-echelon distribution 
network, from central store to each “point-of-use” department for non-critical medical items 
(i.e. latex gloves, plastic/disposable sheets) does not compromise on the quality of care. In 
addition, Lord Carter’s report (2016) also recommended that:  
“…buying and supply services do not need to be handled by hospital staff. It is recommended 
that those hospitals which have not outsourced their outpatient dispensing services (i.e. 
community pharmacy providers) should look for a way through outsourcing to improve their 
productivity and efficiency. This can be done through adopting alternative supply route and 
make sure that that more than 80 per cent of hospitals’ pharmacist resource is utilized for 
direct medicines optimization activities, medications governance and safety concerns while at 
the same time revising the provision of all local organizational services, which could be 
delivered collaboratively with another trust or through a 3rd party provider.” (Lord Carter’s 
report, 2016) 
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In the meantime, during the interview, a pharmacy department manager stated that:  
“We wanted to free up time for clinicians so that they are able to focus on their main 
responsibilities. Achieving this would let us to invest in additional services. We outsourced 
stock replenishment and maintenance to a logistics provider since last year. It means our 
resources are more appropriately focused on collaborative arrangements; the clinical element 
of the service are now out of direct stock procurement and stock control. ” (Chinese Hospital 
D)  
7.3.2.7   Strategy 7: Implementing agility strategy 
- Shortage of drug, unavailability of drugs on the market (S3) 
- Capability versus demand, inability of capacity to meet demand (S4) 
The healthcare industry systems are often characterized as particularly complex systems 
operating in a changing environment, interacting with a wide variety of heterogeneous actors, 
interests and factors, often with disparate demands (Tolf et al., 2015). Thus, agility requires 
both reactive and proactive strategies to enable healthcare organizations to thrive in high-
frequency changing, turbulent, and unpredictable environments.  According to Ebel et al., 
(2013), agility not only implies quick responses to emergency circumstances, but also implies 
the ability to remove change as an ad hoc disturbance and make it an essential condition of 
organizational behaviour.  Although most studies argued that the agility strategy is effective 
in reengineering the patient pathway (Aronsson et al., 2011; Vries and Huijsman 2011; Guven-
Uslu et al., 2014), some maintained that it ensures productivity objectives and SC integration. 
The enabler for an agile organization was explored by Tolf et al., (2015), who focused on the 
interaction between each party in the SC network and its surrounding context. Breen et al., 
(2008) emphasized that it is impractical for one organization to have everything it takes to 
fully meet customer demands. Thus, an agile organization should use the competencies and 
strengths of network partners.  
The different stakeholders within the supply chain, regulators and government must be 
dedicated to working together to ensure that patients can continue to receive medicines on 
time and conveniently (e.g. under normal circumstances, the medicines should be received 
from pharmacies within 24 hours). Therefore, the pharmacies’ and doctors’ dispensaries must 
have contingency arrangements are in place to source items where understocked from the 
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supplier. In this case, reasonable steps should be taken to have reciprocal arrangements with 
neighbouring pharmacies to meet urgent demands and the use of manufacturers’ 
contingency order arrangements.  
The cases hospitals highlight the importance of out of hours, urgent and emergency deliveries 
for major incidents or medical emergencies. NHS Supply Chain, an organization run by the 
DHL supply chain on behalf of the NHS Business Services Authority, provided a dedicated 
supply chain service and products to each NHS trust in England. In the event of unexpected 
emergencies by providing 24 hours emergency service to deliver the order within five hours. 
For some products not stocked within their distribution centre network, such as Blue 
Diamond (e.g. non-stock items but can be consolidated and sent out with NHS Supply Chain 
delivery) or eDirect product (e.g. delivered separately, direct from manufacturer), they will 
endeavour to obtain stock for delivery within the shortest time (i.e. less than 24 hours). During 
the interview, a head of procurement stated: 
“Most of the time, when we have an urgent requirement for our intensive care unit. We make 
a call to NHS Supply Chain and to our delight, the delivery arrives one hour later. This is 
absolutely an exceptionally quick service by anyone’s standards. Because of this, we can avoid 
many serious consequences.” (UK Hospital A)     
7.3.2.8   Strategy 8: Developing internal capability management 
- Clinician’s preference (S9) 
Capability management is a set of activities to facilitate learning and knowledge sharing within 
the organization (Dow et al., 2013). It identifies the organization’s capabilities needed to meet 
its strategic objectives while ensuring continual alignment of staff talent management, career 
progression, and employee development to the dynamic business needs. More specifically, 
Ferlie et al., (2015) argued that capability management includes succession management for 
all employees and leaders at lower levels, talent pool management, talent reviews, 
competency maintenance, and modelling, career development and planning, and skills 
transferability. In the supply chain context, managers use training to learn about different 
supply chain risk sources and how to employ appropriate SCRM tactics (Riley et al., 2016).  
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In any case, clinician education is founded on science and clinicians therefore tend to respond 
favourably to scientific, fact-based justifications for proposed changes. Thus clinical 
professionals often pay more attention to patient management rather than to organizational 
performance. The issue should be solved by providing clinicians with empirical evidence that 
supply chain redesign will streamline processes, improve outcomes, and reduce expenses 
without lowering levels of clinical effectiveness. Even though the healthcare SCM has 
attracted increasing attention by several researchers in recent years, the overall tendency in 
the healthcare sector is to slowly embrace new SCM practice (McKone-Sweet et al., 2005). It 
reveals that lack of supply chain education and awareness are a common phenomenon to 
most healthcare providers. According to the empirical studies, most healthcare providers paid 
attention to staff training as they continually put investment into activities related to training 
and development.  One pharmacy department manager mentioned that:  
“We hold regular staff training sessions to train the relevant staff to avoid or at least reduce 
the failures caused by human errors.  Our aims to ensure that about 75 percent of staffs who 
responsible for material/purchasing management roles could get membership of the 
Chartered Institute of Purchasing and Supply Qualifications.”  (UK Hospital A)  
Moreover, NHS Procurement and Commercial Standards were launched by Department of 
Health (DH) in 2012; they provide a clear vision of continual improvement and advisory panel 
of NHS Procurement professionals. In particular, people and skills are the key elements to be 
mentioned in the report.  For example:  
“All new staff undertaking procurement supply chain operations should, however, have a 
training plan in place; this should be tailored to the amount of time expected to be spent on 
them. The procurement team should have a relevant mix of skills to enable strategic and 
transactional working as needed. Procurement staff can demonstrate a commitment to 
continuous professional development (CPD), such as having relevant professional qualification 
(e.g. CIPS & IACCM) and evidence of CPD. Good mix of “on the job” training and classroom 
training provided to the Procurement teams.” (NHS Procurement and Commercial Standards, 
2016) 
7.3.2.9   Strategy 9: Implementing single sourcing strategy 
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- High purchase price (S10) 
- High product and supplier/brand variety (S11) 
Sourcing decisions have become among the most commonly used strategies not only in the 
healthcare sector, but also in other industries. According to Yu et al., (2009), three sourcing 
approaches were identified as follows: 
 Single sourcing, in which a buyer chooses a single main supplier even though other 
comparable suppliers do exist.  
 Dual sourcing, in which a buyer employs two suppliers, one of which may dominate 
the other in terms of business share, price and reliability.  
 Multiple sourcing, in which a buyer is involved in a business with various suppliers and 
plays one supplier against the other via the bidding process to enjoy the best purchase 
conditions.   
Yu et al., (2009) suggested that a single sourcing strategy represents the narrowest form of 
supply base and strives for a strategic collaboration between a buyer and a supplier and also 
improve shared profits, can be used to proactively manage supply risks. Moreover, single 
sourcing can significantly minimize the supervisory and administrative roles of contracting 
many firms to perform the same work.  In agreement, Tomlin (2006) observed that by 
adopting Just-in-Time (JIT) management, healthcare providers will constantly source from a 
single supplier for the given products to establish close relationships with mutual 
interdependence and a close strategic relationship, cooperative action, short lead times. 
Therefore, it is sometimes seen as the best option to reduce logistics costs, as placing all 
purchasing orders with one single supplier. However, Hou et al., (2010) opposed such a 
strategy, arguing that buyers should have more than one supplier to avoid putting all the eggs 
in one basket there by increasing the supply risk. Kanyoma et al., (2013) further argued that 
mutual dependency is the one major limitation related to single sourcing. The relevance of 
single sourcing is further emphasized by Burke et al., (2007), whereby single sourcing is an 
ideal solution only when supplier capacities are enough to handle product demand and when 
the buying organization does not obtain variation in benefits. 
This high product and supplier/brand variety disaggregates and undermines hospital’s buying 
          
276 
 
power with the inevitable result of variation and higher prices. Furthermore, product variety 
is the root cause of hospital supply chain wastes, such as high inventories, expiration and 
obsolescence, and low value orders and delivery changes. According to the empirical studies, 
two observed hospital cases using a single sourcing system, rely on a government instituted 
supplier namely the “Sinopharm Group”, which is the biggest Chinese pharmaceutical 
company. The company manages factories, Research and Developmeng (R&D) laboratories, 
traditional Chinese medicine plantations, and marketing and distribution networks that cover 
all 31 provinces in China. One pharmacy department leader stated: 
“We have emphasized the importance of collaboration with Sinopharm Group since 2005. As 
for the single sourcing strategy, which improved our bargaining power and reduced costs as 
well as decreased effort to track supplier performance. In particular, they can deliver the 
urgent order very quickly from their nearby distribution center or from other hospitals which 
are under the same contract with them. (Chinese Hospital A)” 
A general manager from a pharmaceutical company stated: 
“To be honest, as a pharmaceutical supplier, it is far better for us to be approved as a sole 
partner of hospitals. If they do, we can upgrade our quality of logistics services as well as price 
discount, and these efforts eventually lead to win-win scenario. As the rich experience in 
operating logistics activities, we are in discussion with our partner hospitals about whether 
they could outsource their second tier pharmacy to us. That would free up time for pharmacists 
so they could focus on their main responsibilities.”  (Pharmaceutical Company B)  
    
7.4 EVALUATION OF RISK MITIGATION STRATEGIES  
Technique for order Preference by Similarly to Ideal Solution (TOPSIS) is one of the most 
practical and useful methods for solving multi-criteria decision-making (MCDM) problem 
(Hwang and Yoon, 1981). The basic idea of the method is to rank and select possible 
alternatives, which have the longest distance from the negative-ideal solution (i.e. the 
solution that maximizes the cost criteria and minimizes the benefits criteria) and the shortest 
distance from the positive-ideal solution (i.e. the solution that maximizes the benefit criteria 
and minimizes the cost criteria).  Despite the benefits of the TOPSIS method, namely that it 
supports managers for selecting the most suitable alternatives, it has certain drawbacks. One 
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major drawback is its inability to handle vagueness and imprecision inherent in the process 
of mapping the perceptions of decision-makers. Fuzzy TOPSIS has been successfully used to 
solve such problems.  In this research, the focus is on the fuzzy TOPSIS by combined TOPSIS 
with fuzzy set theory. The fuzzy TOPSIS method is suitable for solving the group decision-
making problem under the fuzzy environment (Vinodh et al., 2014).  More features of fuzzy 
TOPSIS are detailed in the following sections. There are several fuzzy TOPSIS methods 
proposed by various researchers. Chen (2000) has used the extensions of the TOPSIS for group 
decision-making under a fuzzy environment. As per the theory of the TOPSIS, the author has 
defined a closeness coefficient to conclude the ranking order of all alternatives by calculating 
the distances to both the fuzzy positive-ideal solution and fuzzy negative-ideal solution at the 
same time. Nazam et al., (2015) fomulated the fuzzy AHP-TOPSIS framework to calculate the 
weight of each risk criterion and rank the risks associated with implementation of green 
supply chain management practices under the fuzzy environment. The proposed models 
helps the researchers and practitioners to understand the importance of conducting 
appropriate risk assessment when implementing green supply chain initiatives. The  
incorporation of fuzzy risk assessment, fuzzy Delphi and fuzzy TOPSIS as an integrated 
methodology has been proved by Wang et al., (2017) to be a systematic and practical 
decision-making tool supporting a very effective supply chain risk communication and risk 
mitigation strategy evaluation.  
In this research, a Fuzzy AHP method has been used for determining the priority weights of 
the risk factors (i.e. criteria and sub-criteria). Fuzzy TOPSIS can be utilized for selecting the 
most appropriate risk mitigation strategies (i.e. alternatives). Using the Fuzzy AHP in Chapter 
six, the relative weights of the risk factors in the healthcare supply chain systems were 
calculated.  
Using the mentioned fuzzy approach, the chosen fuzzy TOPSIS process is then addressed as 
follows (Chen, 2000).  
Step 1: Choose the appropriate linguistic variables for the importance weight of the criteria 
and the linguistic rating values for alternatives with respect to criteria. It can be assumed that 
there are m possible alternatives called A= {𝐴1, 𝐴2, 𝐴3…𝐴𝑚} which are to be analysed in 
relation to the criteria, C= {𝐶1, 𝐶2, 𝐶3…𝐶𝑛}  The criteria weights are denoted by 𝑤𝑗 (𝑗 =
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1, 2, …𝑛). The performance ratings of each expert 𝐷𝑘 (𝐾 = 1, 2, …𝐾) for each alternative 
𝐴𝑖  (𝑖 = 1, 2, …𝑚)  with respect to criteria 𝐶𝑗  (𝑗 = 1,2, … 𝑛)  are denoted by ?̃?𝑘  = ?̃?𝑖𝑗𝑘(𝑖 =
1,2, …𝑚; 𝑗 = 1,2, … 𝑛; 𝑘 = 1,2…𝐾 )  membership function 𝜇?̃?𝑘(𝑥) . In this thesis, it is 
suggested that the experts use the linguistic variables (Shown as Tables 7.2 and 7.3) to 
evaluate the importance of the criteria and the ratings of alternatives with respect to various 
criteria, and the illustration of membership function for linguistic expressions is presented in 
Figure 7.5. 
 
Table 7.2: Linguistic variables for the importance weight of each criterion and sub-criteria 
Linguistic judgement Triangular fuzzy number (l, m, u) 
Equal importance (Eq) (1, 1, 1) 
Weak importance (Wk) (2/3, 1, 3/2) 
Strong importance (St) (3/2, 2, 5/2) 
Very strong importance (Vs) (5/2, 3, 7/2) 
Absolute strong importance (As) (7/2, 4, 9/2) 
 
Table 7.3:  Linguistic variables for the alternatives rating 
Very poor (VP) (1, 1, 3) 
Poor (P) (1, 3, 5) 
Medium (M) (3, 5, 7) 
Good (G) (5, 7, 9) 
Very good (VG) (7, 9, 11) 
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Figure 7-5: Fuzzy membership function for linguistic expressions 
Step 2: Aggregate the weight of criteria to get the aggregated fuzzy weight ?̃?𝑗 of criterion 𝐶𝑗 
and pool the experts’ opinions to get the aggregated fuzzy rating ?̃?𝑖𝑗 of alternative 𝐴𝑖  under 
criterion𝐶𝑗. If the fuzzy ratings of all experts are described as TFN ?̃?𝑘 = (𝑎𝑘, 𝑏𝑘, 𝑐𝑘), 𝑘 =
1,2, …𝐾 then the aggregated fuzzy rating is given by ?̃? = (𝑎, 𝑏, 𝑐) 𝑘 = 1,2, . . 𝐾 where 
𝑎 =
𝑚𝑖𝑛
𝑘
{𝑎𝑘}, 𝑏 =
1
𝑘
∑𝑏𝑘𝑖
𝐾
𝑘=1
, 𝑐 =
𝑚𝑎𝑥
𝑘
{𝑐𝑘}                                                                                 (7.1) 
 
Assume that the fuzzy rating of the kth expert is ?̃?𝑖𝑗𝑘 = (𝑎𝑖𝑗𝑘, 𝑏𝑖𝑗𝑘 , 𝑐𝑖𝑗𝑘), 𝑖 = 1,2, …m, 𝑗 =
1,2, … n then the aggregated fuzzy ratings ?̃?𝑖𝑗 of alternatives with respect to each criterion 
are given by ?̃?𝑖𝑗(𝑎𝑖𝑗, 𝑏𝑖𝑗, 𝑐𝑖𝑗), where  
 
𝑎𝑖𝑗 =
𝑚𝑖𝑛
𝑘
{𝑎𝑖𝑗𝑘}, 𝑏 =
1
𝑘
∑𝑏𝑖𝑗𝑘
𝐾
𝑘=1
, 𝑐 =
𝑚𝑎𝑥
𝑘
{𝑐𝑖𝑗𝑘}                                                                      (7.2) 
Step 3: Construct the fuzzy decision matrix and the normalized fuzzy decision matrix. The 
fuzzy decision matrix for the alternatives (?̃?) is constructed as follows:  
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𝐴1
𝐴𝑖
⋮
𝐴𝑚
     𝐶1 𝐶2 … 𝐶𝑗 …       𝐶𝑛      
[
 
 
 
 
?̃?11 ?̃?12 … … … ?̃?1𝑛
?̃?21 ?̃?22 … … … ?̃?2𝑛………
?̃?𝑚1
………
?̃?𝑚2
………
…
………
…
………
…
………
?̃?𝑚𝑛]
 
 
 
 
=  ?̃?                                                                                (7.3) 
 
?̃? = [?̃?1, ?̃?2, … , ?̃?𝑗 , … , ?̃?𝑛]                                                                                                               (7.4) 
 
where ?̃?𝑖𝑗 , 𝑖 = 1,2, … . ,𝑚; 𝑗 = 1,2, … . , 𝑛  and  ?̃?𝑗 , 𝑗 = 1,2, … , 𝑛  are linguistic TFNs, ?̃?𝑖𝑗 =
(𝑎𝑖𝑗, 𝑏𝑖𝑗, 𝑐𝑖𝑗)  and  ?̃?𝑗 = (𝑎𝑗1, 𝑏𝑗2, 𝑐𝑗3) . Note that ?̃?𝑖𝑗  is the performance rating of the 𝑖 th 
alternative, 𝐴𝑖, with respect to the 𝑗th criterion, ?̃?𝑗represents the weight of the 𝑗th criterion, 
𝐶𝑗. The normalised fuzzy decision matrix denoted by ?̃? is shown in Eq. 7.5: 
?̃? = [?̃?𝑖𝑗]𝑚 × 𝑛                                                                                                                                    (7.5) 
 
where B and C are the set of benefit criteria and cost criteria, respectively, and 
?̃?𝑖𝑗 = (
𝑎𝑖𝑗
𝑐𝑗
∗ ,
𝑏𝑖𝑗
𝑐𝑗
∗ ,
𝑐𝑖𝑗
𝑐𝑗
∗) , 𝑗 ∈ 𝐵; 
?̃?𝑖𝑗 = (
𝑎𝑗
−
𝑐𝑖𝑗
,
𝑎𝑗
−
𝑏𝑖𝑗
,
𝑎𝑗
−
𝑎𝑖𝑗
) , 𝑗 ∈ 𝑐; 
𝑐𝑗
∗ =
𝑚𝑎𝑥
𝑖
𝑐𝑖𝑗      𝑖𝑓  𝑗 ∈ 𝐵; 
𝑎𝑗
− =
𝑚𝑖𝑛
𝑖
𝑎𝑖𝑗     𝑖𝑓 𝑗 ∈ 𝐶.                                                                                                                  (7.6) 
 
Step 4; Construct the weighted normalized fuzzy decision matrix. The weighted normalized 
matrix ṽ for criteria is computed by multiplying the weights (𝑤𝑗) of evaluation criteria with 
the normalized fuzzy decision matrix ?̃?𝑖𝑗.  
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?̃? = [
?̃?11 ?̃?12
?̃?21 ?̃?22
…
…
?̃?1𝑛
?̃?2𝑛
⋮ ⋮ ⋱ ⋮
?̃?𝑚1 ?̃?𝑛2 ⋯ ?̃?𝑚𝑛
] = [
?̃?1?̃?11 ?̃?2?̃?12
?̃?1?̃?21 ?̃?2?̃?22
…
…
?̃?𝑛?̃?1𝑛
?̃?𝑛?̃?2𝑛
⋮ ⋮ ⋱ ⋮
?̃?1?̃?𝑚1 ?̃?2?̃?𝑚2 ⋯ ?̃?𝑛?̃?𝑚𝑛
]                                             (7.7) 
 
Step 5: Determine the fuzzy ideal solution (FPIS) and fuzzy negative ideal solution (FNIS)  
The FPIS and FNIS of the alternatives is computed as follows: 
 
𝐴∗ = (?̃?1
∗, ?̃?2
∗, … , ?̃?𝑛
∗) = {(𝑚𝑎𝑥𝑖?̃?𝑖𝑗|𝑖 = 1,… ,𝑚)𝑗 = 1,2, … , 𝑛}                                                (7.8) 
𝐴− = (?̃?1
−, ?̃?2
−, … , ?̃?𝑛
−), {(𝑚𝑖𝑛𝑖?̃?𝑖𝑗|𝑖 = 1,… ,𝑚)𝑗 = 1,2, … , 𝑛}                                                  (7.9) 
 
Maximun and minimum operations do not give TFN but it is likely to state the approximated 
values of minimum and maximum as TFNs (Kwang, 2005). It is known that the elements ?̃?𝑖𝑗∀𝑖𝑗 
are normalised positive TFNs and their ranges belong to the closed interval [0, 1]. Thus, it can 
define the fuzzy positive ideal solution and the negative ideal solution as ?̃?𝑗
∗ = (1,1,1)  and  
?̃?𝑗
− = (0,0,0) 𝑗 = 1,2, … 𝑛 (Patil and Kant, 2014).  
Step 6: Calculate the distance of each alternative from FPIS and FNIS, respectively. The 
distance of each alternative from 𝐴∗ and 𝐴− can be currently calculated as  
 
𝑑𝑖
∗ =∑𝑑(?̃?𝑖𝑗 , ?̃?𝑗
∗)
𝑛
𝑗=1
, 𝑖 = 1,2, … ,𝑚.                                                                                              (7.10) 
𝑑𝑖
− =∑𝑑(?̃?𝑖𝑗, ?̃?𝑗
−),
𝑛
𝑗=1
𝑖 = 1,2, … . ,𝑚.                                                                                            (7.11) 
 
where d (. , .) is the distance measurement between two fuzzy numbers.  
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Step 7: Calculate the closeness coefficient of each alternative. 
The closeness coefficient 𝐶𝐶𝑖 represents the distances to the fuzzy positive ideal solution 
(𝐴∗) and the fuzzy negative ideal solution (𝐴−) simultaneously. The closeness coefficient of 
each alternative is calculated as:  
 
𝐶𝐶𝑖 =
𝑑𝑖
−
𝑑𝑖
−+𝑑𝑖
∗ , 𝑗 = 1,2, … . ,𝑚.                                                                                                         (7.12)   
 
Step 8: According to the closeness coefficient, the ranking order of all alternatives can be 
determined.  
 
7.5 AN EMPIRICAL STUDY ON THE APPLICABILITY OF THE FUZZY TOPSIS METHOD 
In order to complete the predefined integrated risk management (RM) model, the identified 
risk factors must be mitigated to complete the RM model. To investigate the priorities of the 
identified mitigation strategies over the previous risk factors, the Fuzzy TOPSIS method was 
developed.  A survey was conducted to facilitate an insightful understanding and knowledge 
of the significance of the implemented risk mitigation strategies and formulate appropriate 
risk management solutions. This study was conducted in three phases: (1) conducting the 
survey, (2) application of the proposed Fuzzy TOPSIS method, and (3) sensitivity analysis. Each 
of the phases will be discussed in this section.   
7.5.1 Conducting the Fuzzy TOPSIS-based questionnaire survey  
The questionnaire survey was conducted over five weeks from 17th Oct to 21th  Nov 2017, 
with the respondents selected based on their involvement within the healthcare supply chain 
management, disruption experience, and understanding of risk management related to this 
research’s objectives. However, in order to increase the valid response rate, the respondents 
were contacted in advance to determine if they would agree to participate into our survey. 
As explained in Chapter three, the selected respondents consisted of experts from both 
academic and practitioner fields in order to balance their professional areas.  
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At the beginning, a pilot study was conducted to address the content ambiguity and other 
bias in the questions. The draft version of the questionnaire was examined by four academic 
researchers from both UK and China Universities to comment on the appropriateness and 
clarify of the questions. Moreover, the ethical approval was also obtained to further validate 
questionnaire contents and participant consent. The revised questionnaire as represented at 
the end of the pilot study was sent out to those twenty experts for data collection. The 
questionnaire was web-based using eSurvey Creator, and thus a link was emailed to the 
experts. In addition, the cover letter was offered to respondents prior to the main question 
page (see Appendix Five).   
Table 7.4 demonstrates the profile of the respondents who participated the questionnaire 
survey. The respondents were expected to have expertise in risk mitigation design, strategy, 
and operations, thus this survey limited participants to department leader, logistics or supply 
chain executives and risk management professionals. All experts from healthcare 
organizations are at the manager level or higher. The survey yielded a 90 per cent valid 
response rate as two experts did not answer all the questions of this survey, within five weeks. 
Figure 7.6 shows that most of the participant experts come from hospital sectors by 60 per 
cent, 10 per cent were general manager in pharmaceutical companies and the remaining 30 
per cent experts from university or consultative institutes.  
Table 7.4: The profile of survey respondents 
No Participant Position Method Location 
Operating 
Base 
1 Hospital Stock Manager Email China 
2 Hospital Pharmacy department leader Email China 
3 Hospital Pharmacy department leader Email China 
4 Hospital Pharmacy department leader Email China 
5 Hospital Pharmacy department leader Email China 
6 Hospital Pharmacy department leader Email China 
7 Hospital Former Director Email China 
8 Hospital Director Email China 
9 Hospital  Stock Manager Email China 
10 Pharmaceutical 
Company 
General Manager Email China 
11 LogHealth Center Researcher/Consulting Email UK 
12 LogHealth Center Professor Email UK 
13 University Researcher/Consulting Email UK 
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14 University  Professor Email China 
15 University Senior Lecturer Email UK 
16 University Researcher/Consulting Email UK 
17 NHS Trust Head of Procurement Email UK 
18 NHS Trust Pharmacy Purchasing Manager Email UK 
19 NHS Trust E-Procurement and Inventory 
Systems Team Manager 
Email UK 
20 Pharmaceutical 
Company 
General Manager Email  China 
 
 
Figure 7-6: Distribution of respondents 
 
7.5.2 Evaluation of identified risk mitigation strategies  
In Chapter six all of the relative weights for risk factors (i.e. criteria and sub-criteria) in the 
healthcare supply chain were calculated. In this chapter, nine mitigation strategies (i.e. 
alternatives) which were identified previously in Section 7.3 will be applied on healthcare 
supply chain operations using the Fuzzy TOPSIS method. The hierarchical structure of this 
decision problem is shown in Figure 7.7. This process is carried out to rank the alternatives as 
per their priorities for risk mitigation purpose as per the following steps.  
Step 1: Choose the appropriate linguistic ratings values for alternatives with respect to criteria.  
The participant experts were consulted to construct a fuzzy evaluation matrix using a linguistic 
scale for subjective judgments presented in Table 7.5. This research uses the basic linguistic 
preference as very poor (VP), poor (P), medium (M), good (G) and very good (VG). As discussed 
above, the concept of linguistic variables is suitable for dealing with real-world decision-
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70%
Hospital Pharmaceutical company University and consultative institude
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making problems, which are usually complex, partially defined and related to uncertainty 
(Chatterjee and Kar, 2016). Hence, the linguistic judgements are used to measure the 
performance of the identified risk mitigation strategies when managing each risk factor. Due 
to space limitations, the linguistic evaluation matrix and fuzzy evaluation matrix of three 
experts under sub-criteria counterfeiting risks (S1) are given here only in Tables 7.6 and 7.7. 
Then, the linguistic terms were converted into assigned TFNs to construct the fuzzy evaluation 
matrix as shown in Table 7.7.
          
286 
 
 
 
Figure 7-7: Decision hierarchy for the performance of implemented risk mitigation strategies
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External to the 
hospital but internal 
to the supply chain 
network (C1) 
Counterfeiting (S1) 0.159
Poor quality in the purchased drugs 
from suppliers (S2) 0.079
Shortage of drug, unavailability of 
drugs on the market  (S3)  0.16
Capability versus demand,inability of 
capacity to meet demand  (S4) 0.108
Internal to the hospital 
(C2) 
Poor IT system, lack of data 
standardization (S5) 0.112
Dispensing/picking errors-
medication/packaging (S6) 0.097
Weak logistics service infrastructure 
(S7) 0.074
Lack of visibility concerning placement 
and availability of stock (S8) 0.035
Clinician's preference (S9) 0.032
High purchase price (S10) 0.035
High product and supplier/brand 
variety (S11) 0.031
Building efficient distribution management (A1) 
Developing advanced information technology and 
system (A2) 
Developing inter and intra organizational 
collaboration (A3) 
Building efficient inventory management (A4) 
Implementing eProcurement strategy (A5) 
Implementing outsourcing strategy (A6) 
Implementing agility strategy (A7) 
Developing internal capability management (A8) 
Implementing single sourcing strategy (A9) 
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Table 7.5:  Linguistic variables for the ratings 
 
Table 7.6: The ratings of alternatives by three experts under sub-criteria counterfeiting risks 
(S1) 
Sub-criteria Alternative Participant Experts 
  E1 E2 E3 
counterfeiting risks (S1) Logistic management (A1) G VP P 
 Information Technology System 
(A2) 
G VG G 
 Collaboration (A3) VG VG G 
 Inventory management (A4) VG P P 
 e-Procurement strategy (A5) G G G 
 Outsourcing (A6) VP M G 
 Agility (A7) P VG P 
 Capability management (A8) M VP M 
 Single sourcing (A9) P G G 
 
Table 7.7: Fuzzy evaluation matrix for the implementation of risk mitigation strategies 
Sub-criteria Alternative Participant Experts 
  E1 E2 E3 
counterfeiting 
risks (S1) 
Logistic management (A1) (1, 3, 5) (1, 1, 3) (1, 3, 5) 
 Information Technology 
System (A2) 
(5, 7, 9) (7, 9, 11) (5, 7, 9) 
 Collaboration (A3) (7, 9, 11) (7, 9, 11) (5, 7, 9) 
 Inventory management (A4) (7, 9, 11) (1, 3, 5) (1, 3, 5) 
 e-Procurement strategy (A5) (5, 7, 9) (5, 7, 9) (5, 7, 9) 
Very poor (VP) (1, 1, 3) 
Poor (P) (1, 3, 5) 
Medium (M) (3, 5, 7) 
Good (G) (5, 7, 9) 
Very good (VG) (7, 9, 11) 
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 Outsourcing (A6) (1, 1, 3) (3, 5, 7) (5, 7, 9) 
 Agility (A7) (1, 3, 5) (7, 9, 11) (1, 3, 5) 
 Capability management (A8) (3, 5, 7) (1, 1, 3) (3, 5, 7) 
 Single sourcing (A9) (1, 3, 5) (5, 7, 9) (5, 7, 9) 
 
Step 2: Aggregate the weight of criteria to get the aggregated fuzzy weight ?̃?𝑗 of criterion 𝐶𝑗 
and pool the experts’ opinions to get the aggregated fuzzy rating ?̃?𝑖𝑗 of alternative 𝐴𝑖  under 
criterion𝐶𝑗. In this step, aggregating fuzzy weights of the alternatives are computed using Eq. 
(7.1) discussed in section 7.4 and presented in Table 7.8.     
Step 3: Construct the fuzzy decision matrix and the normalized fuzzy decision matrix. In this 
research, all the criteria are the risks in the healthcare supply chain, as per the goal mitigation 
of these risks is required. Hence, all the risks are termed as cost criteria and normalization 
performed by Eq. (7.6) and for further detail (see Table 7.9).  
Step 4; Construct the weighted normalized fuzzy decision matrix. This step is to obtain a fuzzy 
weighted evaluation matrix. Using the sub-criteria weight calculated by Fuzzy AHP (see 
Chapter six), the weighted evaluation matrix is established using the Eq. (7.7) which is shown 
in Table 7.10. 
Step 5: Determine the fuzzy ideal solution (FPIS) and fuzzy negative ideal solution (FNIS). 
Step 6: Calculate the distance of each alternative from FPIS and FNIS, respectively. In this 
study, all the sub-criteria risks are the cost criteria. Hence, fuzzy positive-ideal solution 
(FPIS,𝐴∗) and fuzzy negative-ideal solution (FNIS, 𝐴−) as   ?̃?∗= (0,0,0) and ?̃?−=(1,1,1) for all 
these sub-criteria. Then compute the distance 𝑑𝑣  of each alternative form FPIS (𝐴
∗ ) and 
FNIS  ( 𝐴− ) using the Eq. (7.10) and Eq. (7.1). For example, the distance 𝑑𝑣(𝐴1, 𝐴
∗)  and 
𝑑𝑣(𝐴1, 𝐴
−)  for alternative  𝐴1  and sub-criteria 𝐶1  from (FPIS, 𝐴
∗ ) and (FNIS,  𝐴− ), are 
calculated as follows.  
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Table 7.8: Aggregate fuzzy decision matrix for the implementation of risk mitigation strategies 
 C1 C2 C3 C4 C5 C6 C7 C8 C9 C10 C11 
A1 （1, 5, 11） (1, 6.7, 11) (1, 7.1, 11) (1, 7.2, 11) (1, 5.9, 11) (3, 8.1, 11) (1, 4.6, 9) (1, 7.1, 11) (1, 4.7, 9) (1, 4.8, 9) (1, 5.1, 11) 
A2 (3, 7.4, 11) (3, 7.5, 11) (1, 7.5, 11) (3, 7.9, 11) (1, 7.5, 11) (1, 6.8, 11) (5, 8.8, 11) (1, 8.2, 11) (1, 6.1, 11) (1, 6.6, 11) (1, 7, 11) 
A3 (1, 7.5, 11) (1, 8, 11) (1, 5.3, 11) (3, 6.3, 11) (1, 5.5, 11) (1, 6.4, 11) (1, 4.8, 11) (1, 3.9, 9) (1, 8.2, 11) (1, 7.7, 11) (1, 7.7, 11) 
A4 (1, 5.9, 11) (1, 7.1, 11) (1, 7.1, 11) (1, 7.3, 11) (1, 5.4, 11) (1, 7.7, 11) (1, 4.4, 9) (5, 8.7, 11) (1, 5.6, 9) (1, 5.4, 11) (1, 5, 11) 
A5 (1, 7.3, 11) (3, 6.6, 11) (1, 5.6, 11) (3, 6.4, 11) (1, 5.9, 11) (1, 5.1, 9) (1, 6.7, 11) (1, 5.6, 11) (1, 5.7, 11) (1, 6.5, 11) (3, 6.8, 11) 
A6 (1, 2.1, 9) (1, 2.5, 9) (1, 2.1, 9) (1, 2.4, 9) (1, 2.8, 11) (1, 2.5, 9) (1, 2.1, 9) (1, 2.4, 11) (1, 2.8, 9) (1, 2.4, 9) (1, 2.3, 9) 
A7 (1, 3.7, 7) (1, 5.7, 11) (1, 4.3, 11) (1, 5.5, 11) (1, 4.5, 11) (1, 4.3, 7) (1, 2.3, 11) (1, 2.5, 9) (1, 2.8, 11) (1, 3.4, 11) (1, 3.1, 7) 
A8 (1, 4.2, 9) (1, 5.8, 11) (1, 5.1, 11) (1, 4.5, 9) (1, 3.6, 9) (1, 4.4, 11) (1, 3.6, 7) (1, 4.2, 9) (1, 4.1, 11) (1, 5.6, 11) (1, 4.3, 9) 
A9 (1, 4.2, 11) (1, 3.6, 11) (1, 1.9, 9) (1, 2.6, 11) (1, 2.3, 11) (1, 2.1, 9) (1, 1.9, 9) (1, 2.1, 9) (1, 2.7, 11) (1, 2.3, 9) (1, 2.7, 11) 
 
Table 7.9: Normalized fuzzy decision matrix for the implementation of risk mitigation strategies 
  C1 C2 C3 C4 C5 C6 
A1 (0.09, 0.2, 1) (0.09, 0.15, 1) (0.09, 0.14, 1) (0.09, 0.14, 1) (0.09, 0.17, 1) (0.09, 0.12, 0.33) 
A2 (0.09, 0.14, 0.33) (0.09, 0.13, 1) (0.09, 0.13, 1) (0.09, 0.13, 0.33) (0.09, 0.13, 1) (0.09, 0.15, 1) 
A3 (0.09, 0.13, 1) (0.09, 0.13, 1) (0.09, 0.19, 1) (0.09, 0.16, 0.33) (0.09, 0.18, 1) (0.09, 0.16, 1) 
A4 (0.09, 0.17, 1) (0.09, 0.14, 1) (0.09, 0.14, 1) (0.09, 0.14, 1) (0.09, 0.19, 1) (0.09, 0.13, 1) 
A5 ((0.09, 0.14, 1) (0.09, 0.15, 0.33) (0.09, 0.18, 1) (0.09, 0.16, 0.33) (0.09, 0.17, 1) (0.11, 0.2, 1) 
A6 (0.11, 0.48, 1) (0.11, 0.4, 1) (0.11, 0.48, 1) (0.11, 0.42, 1) （0.09, 0.36, 1) (0.11, 0.4, 1) 
A7 (0.14, 0.27, 1) (0.09, 0.18, 1) (0.09, 0.23, 1) (0.09, 0.18, 1) （0.09, 0.22, 1) (0.14, 0.23, 1) 
A8 (0.11, 0.24, 1) (0.09, 0.17, 1) (0.09, 0.2, 1) (0.11, 0.22, 1) (0.11, 0.28, 1) (0.09, 0.23, 1) 
A9 (0.09, 0.24, 1) (0.09, 0.28, 1) (0.11, 0.53, 1) (0.09, 0.38, 1) (0.09, 0.43, 1) (0.11, 0.48, 1) 
  C7 C8 C9 C10 C11 
A1 (0.11, 0.22, 1) (0.09, 0.14, 1) (0.11, 0.21, 1) (0.11, 0.21, 1) (0.09, 0.2, 1) 
A2 (0.09, 0.11, 0.2) (0.09, 0.12, 1) (0.09, 0.16, 1) (0.09, 0.15, 1) (0.09, 0.14, 1) 
A3 (0.09, 0.21, 1) (0.11, 0.26, 1) (0.09, 0.12, 1) (0.09, 0.13, 1) (0.09, 0.13, 1) 
A4 (0.11, 0.23, 1) (0.09, 0.11, 0.2) (0.11, 0.18, 1) (0.09, 0.19, 1) (0.09, 0.2, 1) 
A5 (0.09, 0.15, 1) (0.09, 0.18, 1) (0.09, 0.18, 1) (0.09, 0.15, 1) (0.09, 0.15, 0.33) 
A6 (0.11, 0.48, 1) (0.09, 0.42, 1) (0.11, 0.36, 1) (0.11, 0.42, 1) (0.11, 0.43, 1) 
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A7 (0.09, 0.43, 1) (0.11, 0.4, 1) (0.09, 0.36, 1) (0.09, 0.29, 1) (0.14, 0.32, 1) 
A8 (0.14, 0.28, 1) (0.11, 0.24, 1) (0.09, 0.24, 1) (0.09, 0.18, 1) (0.11, 0.23, 1) 
A9 (0.11, 0.53, 1) (0.11, 0.48, 1) (0.09, 0.37, 1) (0.11, 0.43, 1) (0.09, 0.37, 1) 
 
Table 7.10: Weighted normalized fuzzy decision matrix for the implementation of risk mitigation strategies 
  C1  C2 C3  C4  C5  C6  
A1 (0.014, 0.032, 0.159) （0.01, 0.016, 0.108) (0.009, 0.014, 0.097)  (0.014, 0.022, 0.16) (0.007, 0.013, 0.079) (0.007, 0.009, 0.024) 
A2 (0.014, 0.022, 0.052) (0.01, 0.014, 0.108) (0.009, 0.013, 0.097) (0.014, 0.021, 0.053) (0.007, 0.01, 0.079) (0.007, 0.011, 0.074) 
A3 (0.014, 0.021, 0.159) (0.01, 0.14, 0.108) (0.009, 0.018, 0.097) (0.014, 0.026, 0.053) (0.007, 0.014, 0.079) (0.007, 0.012, 0.074) 
A4 (0.014, 0.027, 0.159) (0.01, 0.015, 0.108) (0.009, 0.014, 0.097) (0.014, 0.022, 0.16) (0.007, 0.015, 0.079) (0.007, 0.01, 0.074) 
A5 (0.014, 0.022, 0.159) (0.01, 0.016, 0.036) (0.009, 0.017, 0.097) (0.014, 0.026, 0.053) (0.007, 0.013, 0.079) (0.008, 0.015, 0.074) 
A6 (0.017, 0.076, 0.159) (0.012, 0.043, 0.108) (0.011, 0.047, 0.097) (0.018, 0.067, 0.16) ((0.007, 0.028, 0.079) (0.008, 0.03, 0.074) 
A7 (0.022, 0.043, 0.159) (0.01, 0.019, 0.108) (0.009, 0.022, 0.097) (0.014, 0.029, 0.16) (0.007, 0.017, 0.079) (0.01, 0.017, 0.074) 
A8 (0.017, 0.038, 0.159) (0.01, 0.018, 0.108) (0.009, 0.019, 0.097) (0.018, 0.035, 0.16) (0.009. 0.022, 0.079) (0.007, 0.017, 0.074) 
A9 (0.014, 0.038, 0.159) (0.01, 0.03, 0.108) (0.011, 0.051, 0.097) (0.014, 0.061, 0.16) (0.007, 0.034, 0.079) (0.008, 0.036, 0.074) 
Weight 0.159 0.108 0.097 0.16 0.079 0.074 
  C7  C8 C9  C10  C11  
A1 (0.012, 0.025, 0.112) (0.003, 0.005, 0.035) (0.004, 0.007, 0.035) (0.004, 0.007, 0.032） (0.003, 0.006, 0.031) 
A2 (0.01, 0.012, 0.022) (0.003, 0.004, 0.035) (0.003, 0.006, 0.035) （0.003, 0.005, 0.032) (0.003, 0.004, 0.031) 
A3 (0.01, 0.024, 0.112) (0.004, 0.009, 0.035) (0.003, 0.004, 0.035) (0.003, 0.004, 0.032) (0.003, 0.004, 0.031) 
A4 (0.012, 0.026, 0.112) (0.003, 0.004, 0.007) (0.004, 0.006, 0.035) (0.003, 0.006, 0.032) (0.003, 0.006, 0.031) 
A5 (0.01, 0.017, 0.112) (0.003, 0.006, 0.035) (0.003, 0.006, 0.035) (0.003, 0.005, 0.032) (0.003, 0.005, 0.01) 
A6 (0.012, 0.054, 0.112) (0.003, 0.015, 0.035) (0.004, 0.013, 0.035) (0.004, 0.013, 0.032) (0.003, 0.01, 0.031) 
A7 (0.01, 0.048, 0.112) (0.004, 0.014, 0.035) (0.003, 0.013, 0.035) (0.003, 0.009, 0.032) (0.004, 0.01, 0.031) 
A8 (0.016, 0.031, 0.112) (0.004, 0.008, 0.035) (0.003, 0.008, 0.035) (0.003, 0.006, 0.032) (0.003, 0.007, 0.031) 
A9 (0.012, 0.059, 0.112) (0.004, 0.017, 0.035) (0.003, 0.013, 0.035) (0.004, 0.014, 0.032 (0.003, 0.011, 0.031) 
Weight 0.112 0.035 0.035 0.032 0.031 
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𝑑(𝐴1, 𝐴
∗) = √
(0−0.014)2+(0−0.032)2+(0−0.159)2
3
 
 
𝑑(𝐴1, 𝐴
∗)= 0.0939876 
 
𝑑(𝐴1, 𝐴
−) = √
(1−0.014)2+(1−0.032)2+(1−0.159)2
3
 
 
𝑑(𝐴1, 𝐴
−) = 0.933899 
 
Similarly, calculations are done for other sub-criteria for solutions of alternative 𝐴1 and the 
cumulative distances of 𝑑𝑖
+ and 𝑑𝑖
− as 𝑑𝑖
+= 0.514646 and 𝑑𝑖
−= 10.63685 are computed.  
Step 7: Calculate the closeness coefficient of each alternative. 
Step 8: According to the closeness coefficient, the ranking order of all alternatives can be 
determined.  
By using Eq. (7.12), the closeness coefficient (𝐶𝐶𝑖) of alternative 𝐴1 is computed as follows:  
 
𝐶𝐶𝑖 =
𝑑𝑖
−
𝑑𝑖
−+𝑑𝑖
∗ = 
10.63685
10.63685+0.514646
 = 0.95385 
 
The same procedure can be adopted to compute the distances and (𝐶𝐶𝑖 ) values of the 
remaining alternatives. The final results are summarized in Table 7.11. Based on the (𝐶𝐶𝑖) 
values, alternatives were ranked in descending order. The strategy A2 “developing advanced 
information technology and system” is regarded as the best strategy for managing supply 
chain related risks. The strategt A5 “implementing eProcurement strategy” within alternative 
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ranked second and the strategy A1 “building efficient distribution management” ranked third. 
Therefore, those strategies are determined as the priority strategies for the case 
organizations to further implement in order to mitigate their supply chain risks.  
 
Table 7.11: Fuzzy TOPSIS results and final ranking for the implementation of risk mitigation 
strategies 
Alternatives 𝑑𝑖
+ 𝑑𝑖
− (𝐶𝐶𝑖) Rank 
A1 Distribution management 0.514646 10.63685 0.95385 3 
 
A2 Information technology and 
system 
0.370368 10.72934 0.966633 ○1  
A3 Collaboration 0.522004 10.61581 0.953132 4 
 
A4 Inventory management 0.526529 10.63193 0.952814 5 
 
A5 eProcurement strategy 0.431122 10.68783 0.961226 ○2  
A6 Outsourcing 0.582634 10.53498 0.947594 9 
 
A7 Agility 0.554765 10.58862 0.950216 7 
 
A8 Capability management 0.549148 10.59833 0.950738 6 
 
A9 Single sourcing 0.577029 10.54913 0.948138 8 
 
 
7.5.3 Sensitivity analysis  
A sensitivity analysis is proposed to investigate the influence of different sub-criteria weights 
on selection of risk mitigation strategies. It generates different scenarios that may change the 
ranking of alternatives and be needed to reach a consensus. If the ranking order be changed 
by increasing or decreasing the importance of the sub-criteria, the results are expressed to 
be sensible otherwise it is robust. In this research, sensitivity analysis is implemented to see 
how sensitive the alternatives change with the importance of the sub-criteria. More 
specifically, the author has exchanged each sub-criterion’s weights with another sub-
criterion’s weights, and hence ten combinations of the eleven sub-criterion’s weights were 
analysed, with each combination stated as a condition. For each condition, the relative 
closeness to the ideal solution 𝐶𝑗
∗  was computed. This type of sensitivity analysis has been 
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applied by several researchers (Ӧnὒt and Soner 2007; Gumus 2009; Perçin 2009 and Bianchini 
2018). The results of sensitivity analysis are summarized in Table 7.12 and the graphical 
representation of these results is shown in Figure 7.7.      
The first condition in Table 7.12 shows the original ranking (A2, A5, A1, A3, A4, A8, A7, A9 and 
A6, respectively), where the strategy A2 obtained 0.967.  From Table 7.12 and Figure 7.8, it is 
possible to observe that the strategies A2 and A5 take turns leading the top in every 
conditions since they have the higher priorities of relative closeness 𝐶𝑗
∗  in each combination.  
In other words, strategy A2 will be selected if conditions 1,3,5,8 and 9 are met. Otherwise, 
strategy A5 will be selected in conditions 2,4,6,7 and 10. The result gives great effort to 
facilitate the implementation of both strategies for managing the risks under different 
contexts. Meanwhile, no significant sensitivity for the remaining alternatives in changing 
between different conditions can be observed, especially for strategies A6, A7, A8 and A9, 
which always have the lower 𝐶𝑗
∗  value in each combination. Therefore, since the weights of 
sub-criterion are based on experts’ assessments, managers could adjust the strategic 
deployment according to their own conditions.               
 
Figure 7-8: Sensitivity analysis: computation of the relative closeness to the ideal solution 
for each evaluated combination 
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Table 7.12: Results of the sensitivity analysis 
Weights of criteria  𝐶𝑗
∗ 
Conditions 𝑊1 𝑊2 𝑊3 𝑊4 𝑊5 𝑊6 𝑊7 𝑊8 𝑊9 𝑊10 𝑊11  A1 A2 A3 A4 A5 A6 A7 A8 A9 
1 0.159 0.108 0.097 0.16 0.079 0.074 0.112 0.035 0.035 0.032 0.031 𝐶𝑗
∗ 0.954 0.967 0.9531 0.9528 0.961 0.9476 0.95 0.951 0.9481 
            Ranking 3 1 4 5 2 9 7 6 8 
2 0.031 0.032 0.035 0.035 0.112 0.074 0.079 0.16 0.097 0.108 0.159 𝐶𝑗
∗ 0.954 0.957 0.953 0.958 0.959 0.9479 0.95 0.951 0.9477 
            Ranking 4 3 5 2 1 8 7 6 9 
3 0.112 0.035 0.035 0.032 0.031 0.159 0.108 0.097 0.16 0.079 0.074 𝐶𝑗
∗ 0.957 0.961 0.953 0.955 0.956 0.9477 0.95 0.951 0.9478 
            Ranking 2 1 5 4 3 9 7 6 8 
4 0.079 0.16 0.097 0.108 0.159 0.031 0.032 0.035 0.035 0.112 0.074 𝐶𝑗
∗ 0.952 0.959 0.955 0.953 0.963 0.9478 0.95 0.951 0.9482 
            Ranking 5 2 3 4 1 9 7 6 8 
5 0.16 0.159 0.112 0.108 0.097 0.079 0.074 0.035 0.035 0.032 0.031 𝐶𝑗
∗ 0.954 0.964 0.955 0.953 0.961 0.9476 0.95 0.951 0.9483 
            Ranking 4 1 3 5 2 9 7 6 8 
6 0.031 0.032 0.035 0.035 0.074 0.079 0.097 0.108 0.112 0.159 0.16 𝐶𝑗
∗ 0.954 0.958 0.953 0.956 0.959 0.9478 0.95 0.951 0.9477 
            Ranking 4 2 5 3 1 8 7 6 9 
7 0.108 0.159 0.16 0.097 0.074 0.079 0.035 0.112 0.032 0.031 0.035 𝐶𝑗
∗ 0.954 0.96 0.955 0.956 0.961 0.9476 0.95 0.951 0.948 
            Ranking 5 2 4 3 1 9 7 6 8 
8 0.032 0.031 0.035 0.035 0.074 0.112 0.16 0.079 0.159 0.108 0.097 𝐶𝑗
∗ 0.955 0.96 0.953 0.954 0.957 0.9478 0.949 0.951 0.9475 
            Ranking 3 1 5 4 2 8 7 6 9 
9 0.112 0.108 0.16 0.159 0.035 0.074 0.079 0.097 0.031 0.032 0.035 𝐶𝑗
∗ 0.954 0.964 0.957 0.955 0.961 0.9475 0.95 0.951 0.9478 
            Ranking 5 1 3 4 2 9 7 6 8 
10 0.032 0.035 0.074 0.031 0.079 0.097 0.035 0.108 0.112 0.159 0.16 𝐶𝑗
∗ 0.9545 0.955 0.952 0.956 0.959 0.9479 0.95 0.951 0.9477 
            Ranking 4 3 5 2 1 8 7 6 9 
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7.6 DISCUSSION AND MANAGERIAL IMPLICATIONS 
Choosing the appropriate risk mitigation strategies is deemed to be an important step in 
mitigating supply chain related risks. Although the hospital managers did not realized that 
they had similar approaches to ensure the supply chain operates more efficiency. Instead of 
identifying the relevant mitigation strategies based on the literature review, in this research, 
the current implemented management strategies were identified as the risk management 
solutions through empirical studies. Thereafter, the Fuzzy TOPSIS method was employed to 
rank the importance levels of those mitigation strategies in relation to 11 risk factors. The 
mechanism of the Fuzzy TOPSIS model was to analyse twenty experts’ subjective judgements. 
It is an appropriate tool to help MADM under a fuzzy environment where the available data 
is subjective and vague.  Moreover, these strategies also consider all potential risks and the 
effectiveness of individual strategies in mitigating these risks. It provides a practical decision 
support tool for taking explicit account of multiple types of risk in aiding decision-making, and 
compares and ranks alternative strategies in indicator basis individually. To change any 
management practices or implement any new strategies would require significant additional 
resources and time before they can commit to investing in the new practices. Theoretically 
speaking, the costs for implementing these strategies can be viewed as “insurance premiums” 
that will safeguard the supply chains from major disruptions. However, it is difficult to 
quantify the return on these insurance premiums, especially in the absence of reliable data 
(probability that a disruption would occur, potential loss due to a disruption, etc.). More 
importantly, the healthcare industry is currently under increasing pressure to reduce costs 
while maintaining the quality of care. The decision of adopting appropriate mitigation 
strategies requires a trade-off between cost saving and the benefits of implementing such 
strategies. Therefore, the alternatives with the highest ranking should be given the priority in 
formulating the strategic plan, i.e. strategy A2, “developing advanced information technology 
and system” and strategy A5, “implementing eProcurement strategy.” More importantly, the 
findings are also in line with the recommendations provided by Lord Carter in their interim 
report to England NHS trusts.  
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Furthermore, through our interview with the hospital managers, the major challenge of 
implementing those strategies is to have supply chain risk management become a part of the 
job responsibility across different departments with all functions involved collaborating and 
communicating effectively. The use of the tool as a cross-functional risk mitigating and 
monitoring process should be considered as a long-term objective. And as such, the 
involvement of top managers from different areas is essential in establishing a thorough 
consideration of critical issues and interdepencies in determining a complete supply chain risk 
management process. In addition to this, Van Vuuren (2000) stated that the success of a 
strategy is related to the congruency between organizations’ strategies and culture. Risk 
management culture is embedding formally risk management within the decision-making 
processes at every level of the compant operating within the culture of the organization. It is 
emphasized that risk management culture can impact on manager’s ability to process risk and 
disruption information, rationalize and exercise discretion in their vulnerability mitigation 
decision-making processes. The risk management culture within an organization is important 
to transform vulnerability awareness into mitigation actions. Therefore, hospital managers 
should give importance to risk management culture, which can become a tool to provide the 
legal path for risk decisions in a supply chain operation.   
More especially, the strategy A2, “developing advanced information technology and systems” 
provides enabler for managing the healthcare supply chain to increase visibility, traceability 
and security. As mentioned earlier, advances in interoperability standards and other 
technology tools, the advanced information technology and system helps in facilitating the 
aggregation as well as ensuring a timely exchange of useful data among the stakeholders in 
the supply chain. This, in turn, could provide a rich pool of data to support regulation and 
oversight of the medicine delivery system from the initial to the end. Instead, paper-based 
systems are still be common at most hospitals, which are all but “drowning” in paperwork. 
Therefore, it requires an effort to develop an infrastructure capable of connecting, integrating 
and supporting various information systems as well as applications at health facilities 
nationwide. In spite of the demonstrated benefits, financial constraints in many hospitals 
means creasting different systems for different settings is not feasible. The challenge will be 
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generating a flexible system, duplicable for various circumstances without investing extra 
resources. Further, the benefits of developing new information technology and systems are 
not immediately visible, but the costs are. For instance, the cost of an RFID tag can range from 
£950 to £1,150 per reader. As the fully functioning RFID system requires tags, readers, 
infrastructure, middleware, and printers and can cost a hospital millions of pounds. However, 
a significant resistance to adoptation of technology and changes in work processes and 
reluctance in the division of labour among health care specialists is actually existing. There is 
a significant impact in implementing technologies and tools that can only be realized if 
management can persuade the supporting staff to change their work practices and 
organization.  
Furthermore, strategy A5, “implementing eProcurement strategy” is one of the most effective 
ways to facilitate the order and demand information among each member in the chain. As 
such, it is critical for hospital managers to ensure that they share the integrated system with 
supplier under the same standard (i.e. global GS1 coding and PEPPOL messaging), which as a 
consequence, will be more collaborative than conducting the traditional approach for the 
procurement procedure. Employing e-procurement process means that the healthcare 
provider must simplify the existing procurement procedure and shorten the administration 
lead time. Beyond the benefit that comes from the efficient operation process and enhanced 
collaboration among trading partners, the strategy also drives patient safety benefits. 
Automatic Identification and Data Capture like barcodes based on the GS1 standards, can now 
be accessed and read at any point in the supply chain process. This enables them to quickly 
locate the safety alert regarding the product. Besides the benefits, there is a significant up-
front cost and the continuing costs of implementing this practice are particularly burdensome 
for small-size hospitals or individual healthcare providers. The relevant costs include the cost 
of hardware, software and technical support and also the costs of intensive staff training. 
Hence, this is a considerable limitation to currently implementing the strategy at the national 
level.  
The least important is strategy A6, “outsourcing the non-core supply chain activities to the 3rd 
party logistics service provider.” The healthcare organizations benefit more through 
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outsourcing expanding activities beyond core and clinical activities and build an environment 
which is more cooperative with their suppliers. However, some healthcare organizations do 
not achieve the expected benefits from the outsourcing strategy because outsourcing 
activities are incredibly complicated and lack a formal outsourcing decision making process, 
such as medium and long-term cost-benefit analyses, reluctance to embrace any changes. 
Moreover, it also requires a decision on which activities should remain within the hospital or 
be outsourced, whether all or part of the supply chain activities should be outsourced, and 
also how to manage relationships with suppliers rather than internal functions and processes. 
Another major issue that concerned by hospitals managers is losing good long-term 
employees if they outsource some functions. Hence, mistakes in identifying core and noncore 
activities can lead hospitals to outsource their competitive advantages, which are difficult to 
rebuild. Therefore, this may explain why this strategy became the least important one among 
the nine identified strategies.  
 
7.7 CONCLUSION 
This chapter presented the last step in the supply chain risk management process, i.e. risk 
mitigation strategies identification and evaluation. In this research, all strategies were 
retrieved from real-life by employing empirical studies from both China and UK healthcare 
industries. This research empirically identified nine risk mitigation strategies, including:  
strategy A1, “building efficient distribution management”; strategy A2, “Developing advanced 
information technology and system”; strategy A3, “developing inter and intra organizational 
collaboration”; strategy A4, “building efficient inventory management”; strategy A5, 
“implementing eProcurement strategy”; strategy A6, “implementing outsourcing strategy”; 
strategy A7, “implementing agility strategy”;  strategy A8, “developing internal capability 
management” and strategy A9, “implementing single sourcing strategy”.  After the 
identification, a risk mitigation-strategy questionnaire survey was used to rank the 
importance of these strategies. To address risk management issues, both quantitative and 
qualitative methods have been adopted by both researchers and practitioners. However, risk 
management is a complex subject involving vagueness and uncertainty in the decision-making 
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process. Therefore, a Fuzzy TOPSIS model was implemented to provide a practical decision 
support tool for evaluating risk mitigation strategies. The application of the fuzzy 
methodology is also useful in situations where uncertainties exist in the decision-making 
process. The nine strategies are ranked according to their overall priorities i.e. A2, A5, A1, A3, 
A4, A8, A7, A9, and A6. This is generally consistant with the recommendation provided by 
Lord Carter’s interim report. Strategy A2, “developing advanced information technology and 
system” and strategy A5, “implementing eProcurement Strategy” have the highest relative 
closeness indices and should therefore be recommended as the top strategies for the 
healthcare organizations to implement. 
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8.CHAPTER EIGHT - CONCLUSION  
 
8.1 INTRODUCTION 
This concluding chapter presents a brief overview of the research and introduces future 
directions for developing the work. Initially, the chapter returns to the defined research 
objectives and research questions to delineate the research’s important findings. This is 
followed by description of the contribution to established knowledge and its practical 
implications. The chapter then explores limitations and future research direction arising from 
this research.  
 
8.2 RESEARCH FINDINGS  
Based on the literature review in Chapter two, several research gaps were identified. The 
primary research gap was the lack of the comprehensive framework proposed to evaluate 
SCRM (e.g., risk factors identification, risk assessment, and risk mitigation) performance in the 
public healthcare sector. The second research gap was the limited attention given to 
systematic risk factors identification in healthcare SC. The third research gap was related to 
the need for systematic and holistic risk assessment as existing studies have tended to provide 
independent risk concepts without concerning interconnection and interconnectedness of 
risk factors. The fourth research gap identified was the lack of studies examining the 
performance of the currently implemented supply chain risk mitigation strategies under 
different risk contexts in public healthcare organisations.  
To address these gaps, research questions for this study were developed. To answer the 
questions, a multi-methodology approach involving the questionnaire survey, documentation 
review, direct observation and semi-structured interviews were adopted. RQ1 was concerned 
with the proposed novel conceptual framework which presents a platform to support 
managers in making significant strategic decisions on SCRM. Moreover, when the SCRM 
          
301 
 
process comprise of risk factors identification, risk assessment and risk mitigation are 
considered, RQ2, RQ3, and RQ4 were concerned with identification and assessment of 
healthcare SC risks, whereas RQ5 and RQ6 focused on risk mitigation. A summary of the 
research outputs specific to each question is given as follows:  
RQ1. What is the most effective HCSCRM framework that can be implemented to deal with 
the HCSC risks? 
A novel conceptual framework was developed to support managers in proactively controlling 
the risks by considering risk drivers and sources, decision-making, SC strategies, performance 
outcomes, and the risk management process. The focus is towards the proposed framework, 
recognizing that the key components provide a more robust portrayal of the factors that 
affect the nature of risk management responses under different situations. It has a sequential 
process that is repetitive in nature and articulated in a circular process, indicating that one 
component is dependent on another component. For risk management to be successful, the 
risk drivers to establish the potential nature of the risks must be identified. This is then 
followed by the phase of determining the available risk resources expected to facilitate and 
support risk management initiatives. Based on different attitudes of risk appropriate for the 
case, a healthcare organization can implement various risk management initiatives for the 
desired change to be realized. In terms of the performance outcomes, due to the difference 
perspectives, the focus in the healthcare provider is towards both cost reduction and service 
quality improvement as well as the employee satisfaction. The proposed conceptual 
framework can be acting as a risk management platform to address the industrial needs for 
practical decision support methodology, and to facilitate the integration of innovative 
approaches such as Fuzzy AHP, ISM and Fuzzy TOPSIS into the healthcare supply chain risk 
management process.   
RQ2. What are the main sources of risk factors causing public sector healthcare supply 
chains to be vulnerable and how to identify and classify those risks? 
It is important for healthcare organizations to be aware of the specification of sources of risks 
due to the invisibility of risks existing in the supply chain network. Identification of risk factors 
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is the first step of the supply chain risk management process. In this thesis, the author 
identifies a comprehensive list of risk factors in the healthcare supply chain system initially 
through a literature review. It is particularly noteworthy that healthcare supply chain systems 
have risk factors in common with conventional supply chain risks, but also unique risk factors 
that can be differentiated from the traditional supply chain risks. In particular, the 
“counterfeiting risks”; “time limit of drugs, product perishability”; “demand trigged by the 
nurse, not the patient”; “fragmentation of drug distribution process”; “clinician’s preference”; 
“lack of funds from government to the hospital” and “regulatory issues-manufacturing using 
licensing/change of standards/drugs recalls” appeared to generate unique threats to 
healthcare supply chain systems. In addition, various entities involved in the healthcare 
supply chain network can generate fresh risk areas in inter-organizational and intra-
organizational relationships. Thereafter, a total of 34 risk factors were found to reside in the 
healthcare supply chain operations and classified into three main categories including: 
“external to the hospital but internal to the supply chain network” (i.e. supply, demand risks), 
“internal to the hospital” (i.e. process and control risks) and “external to the supply chain 
network” (i.e. environmental risks). Furthermore, a new classification model applied in this 
thesis divided the risks into eleven sub-categories: quality, supplier, capacity, forecast, 
information, logistics, procurement, strategic, labour, natural and man-made risks.  Based on 
the addressed risk factors, a questionnaire survey was conducted to ensure the feasibility of 
the developed risk classification method and to determine the important levels of identified 
risk factors. An interesting insight is that “counterfeiting risks”, “poor quality in the purchased 
drugs from suppliers”, “shortage of drugs” and “high purchase price” attract more attention 
than other risk factors from the participant experts’ viewpoint. In order to broadly outline the 
sources of healthcare supply chain risks, a hierarchical structure model was developed. To 
assure the validity and reliability of the developed hierarchy diagram, a series of emails and 
face-to-face interviews were subsequently sent out and conducted with the “validation team” 
(six earlier experts as well as two academic researchers with experience in supply chain and 
risk management who were not part of the expert panel).  Finally, agreement among the 
experts was received, and the hierarchy diagram was accepted.   
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RQ3. Which risk factors are relatively more significant to a hospital’s supply chain 
management performance? 
In risk assessment research, Fuzzy AHP was used to determine the priority weight among the 
identified risk factors. It needs to be mentioned that risk assessment is inherently uncertain 
and imprecision, therefore, any analysis that ignores this uncertainty and imprecision may 
cause information to be seriously misleading and thus cause major mistakes. In this thesis, 
Fuzzy AHP was developed along the lines of fuzzy set theory to manage the uncertainty 
associated with the mapping of experts’ judgements.  56 valid replies were received from 
selected respondents from China, the UK, and Thailand. The respondents are working in both 
academic and industrial fields. The results indicate that risks associated in “external to the 
hospital but internal to the supply chain network” (0.53) and “internal to the hospital” (0.43) 
are much greater than that of “external to the supply chain network” (0.04). Under the criteria 
“external to the hospital but internal to the supply chain network”, “supply risks” (0.75) is the 
top risk in the same level. It is particularly noteworthy that “shortage of drugs” (0.16), 
“counterfeiting” (0.159), “poor IT system” (0.112), “capability versus demand” (0.108), 
“dispensing/picking errors” (0.097), “poor quality in the purchased drugs from suppliers” 
(0.079), “weak logistics service infrastructure” (0.074), “lack of visibility concerning placement 
and availability of stock” (0.035), “high purchase price” (0.035), “clinicians’ preference” 
(0.032)  and “high product and supplier/brand variety” (0.031) are the key risk factors for 
hospital’s supply chain performance.  
RQ4. How are these risk factors interacting with each other? 
This thesis sought interactions between each risk by employing an ISM model. A total of 12 
industrial and academic experts were invited to identify the relationships between risk 
elements, analysed with the ISM technique. The results provide an understanding of 
identified risk factors in different levels of ISM hierarchy model and the cluster in MICMAC 
diagram. The developed hierarchical ISM model comprises 11 risk factors.  Among the 11 risk 
factors, “poor quality in the purchased drugs from suppliers” and “dispensing/picking errors” 
were placed on the top level. These are the risks that can produce a major impact on 
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healthcare SC systems. Furthermore, lower level risks like “clinician’s preference” and “high 
produce and supplier/brand variety” have strong influence to the middle-level risks like 
“counterfeiting”, “shortage of drugs”, “capability versus demand”, “high purchase price”, 
“weak logistics service infrastructure”, “poor IT system”, and “lack of visibility concerning 
placement and availability of stock”. Also, the aforementioned middle-level risks again seen 
to influence the top-level in the ISM model. Top-level factors are more risky than the others 
and can cause serious consequences for supply chain systems. Nevertheless, lower level 
factors are mainly responsible for increasing the degree of risk exposure as they have strong 
influence to the top-level factors. In this regard, it is worth noting that interdependency 
among various risk factors plays an important role in the assessment of risk impact on the 
healthcare supply chain performance.  
MICMAC analysis was carried out by classifying the 11 risk factors into four clusters 
comprising autonomous, dependent, linkage, and independent, based on their driving power 
and dependence power. The risk factors are namely, “poor quality in the purchased drugs 
from suppliers” and “dispensing/picking errors” are dependent factors. The impact of these 
risks depends on the remaining risks of the healthcare supply chain and seriously affects the 
supply chain system. Similarly, the risk factor “clinician’s preference” has been found 
independent with strong driving power: it plays a key role in influencing others and finally 
intensifies to the strength of its impact on the healthcare supply chain system. The remaining 
risk factors are clustered as linkage risks with both strong driving and dependence power. 
Those should be assigned as high priority and the manager should understand the 
dependence of these risks on lower level risks, in achieving the risk management objectives. 
Autonomous risks are weak driving power and dependence power and lack influence on the 
supply chain system. In this research, no risk factor in this cluster. As a result, this cluster 
analysis provides valuable insight into the extant body knowledge to the researchers to 
understand and assess the intensity of risk factors as well as to manage these risks by 
implementing an effective risk management strategy.  
RQ5. How can the hospitals from both UK and China effectively manage their supply chain 
related risks?  
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This research employed empirical studies from the UK and China healthcare organizations to 
identify their currently implemented supply chain risk management strategies. The empirical 
study is based on ‘field’ experiences or direct observations, and it allows the researcher to 
investigate a contemporary phenomenon in depth and within its real-life context when the 
boundaries between phenomenon and context may not be clearly evident. In this thesis, a 
large amount of official documents and other published materials were reviewed critically. 
Thereafter, multiple departments in three hospitals and one pharmaceutical company were 
visited to ensure the collected data was accurate and reliable in nature.  By combining direct 
observation with various other methods, the research results can give a complete picture of 
the performance situation. The author conducted semi-structured interviews with 14 experts 
from seven Chinese hospitals, one UK hospital, and two different pharmaceutical companies. 
The interviews were spread over three months and included four site visits by the author. As 
a result, healthcare organizations involved in healthcare supply chain operations have 
implemented nine basic strategies: (1) “strategy A1: building efficient distribution 
management”, (2) “strategy A2: developing advanced information technology and system”, 
(3) “strategy A3: developing inter and intra organizational collaboration”, (4) “strategy 
A4:building efficient inventory management”, (5) “strategy A5: implementing eProcurement 
Strategy”, (6) “strategy A6: implementing outsourcing strategy”, (7) “strategy A7: 
implementing agility Strategy”,  (8) “strategy A8: developing internal capability management” 
and (9) “strategy A9: implementing single sourcing strategy”. 
RQ6. What are the main risk mitigation strategies to be considered?  
In this thesis, Fuzzy TOPSIS was used to rank risk mitigation strategies. The model incorporates 
the fuzzy set theory and conventional TOPSIS methods to capture the vagueness of 
uncertainty in the evaluation of alternative risk mitigation strategies.  Twenty experts from 
both academia and industry were invited to participate the survey. The analysis results 
indicate that the “strategy A2, developing advanced information technology and system” had 
the highest ranking among the alternative mitigation strategies, closely followed by “strategy 
A5, implementing eProcurement strategy”. On the contrary, “strategy A6, implementing 
outsourcing strategy” fell behind other strategies due to the outsourcing activities being 
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incredibly complicated and lacked formal outsourcing decision-making processes, such as 
medium and long-term cost-benefit analyses, and reluctance to embrace any changes.     
 
8.3 RESEARCH CONTRIBUTION TO KNOWLEDGE  
The significance of this thesis is to complement the existing literature by proposing a 
comprehensive framework that provided abundant insights into how risks in the healthcare 
supply chain systems can be understood and how organizations involved in the healthcare 
industry can effectively manage these risks. Specifically, this research is the first study to 
provide an integrated SCRM model by using both qualitative and quantitative techniques for 
risk factors identification, assessment, and mitigation in the healthcare supply chain setting. 
Although there are studies on this topic, their research scope was limited to a specific mode 
or a certain phase of supply chain risk management, thus their studies lacked a holistic view 
of risk management (Breen, 2008; Enyinda et al., 2014). The novelty of the proposed model 
lies in the fact that it incorporates the Fuzzy AHP, ISM model and Fuzzy TOPSIS as an integrated 
methodology, which has been proposed enabling the specific decision maker’s preferences to 
be considered in making the strategic decision on a healthcare SCRM. Moreover, the model 
also considers the uncertainties caused by unknown data. Therefore, the application of fuzzy 
logic theory can help organizations to solve the problem of handling uncertainty in decision-
making in a timely manner. Additionally, compared with most of the SCRM literature using 
secondary data for simulation, this research makes practical contributions by conducting 
empirical studies in both the UK and China healthcare industries to support a resource 
effective and time-efficient decision-making tool for managers. It provides the latest 
information that can reflect the current situation in both countries’ healthcare industry. 
Especially, instead of identifying the risk mitigation strategies through a literature review, this 
research explored the currently implemented mitigation strategies which turned out to be 
more reasonable in actual situations. Therefore, healthcare organizations can evaluate the 
current status of their risk management efforts with the risk mitigation strategies and 
practices suggested in this research. Nine strategies were introduced with practical examples 
from case hospitals, which provide practical ideas as to how the organizations can manage 
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risks.  Furthermore, the profile of healthcare supply chain risks will enable managers to 
anticipate and proactively deal with potential risks. Although the risks discussed in this thesis 
are not completely exhaustive, the work is still meaningful because those are explored by 
literature, Lord Carter’s report and experts from different fields involved in a healthcare supply 
chain and risk management. To the end, although the case discussed in this research is 
healthcare provider, i.e. hospital, the results could be generalised to similar industry or other 
service-based environments.   
 
8.4 RESEARCH LIMITATION 
The limitations of this research are discussed below. 
• Firstly, in this study, the risk factors have been retrieved mainly from eleven research 
literatures and one official interim reports due to the limited research focused on 
healthcare supply chain risk management to date. Meanwhile, data collection was 
limited between the years 2003 and 2017 by systematic identification, screening, and 
synthesis of quality data sources. It provides a way to focus the development of 
research in the past 14 years but also limited the study’s time frame. It would be more 
comprehensive if the omitted literature could be reviewed.  
• Secondly, the confidential nature of the healthcare industry when conducting the 
empirical studies highlights the difficulty of gathering primary and secondary data. In 
addition, the sample selection is limited to specific professional roles. Most 
participants involved in this research either have abundant knowledge in academia or 
rich practical experience in the field and hold a position at or above the manager level 
in practitioner fields. Therefore, a further limitation of the research is reflected in the 
size of the sample.  
• Thirdly, the proposed integrated model is highly dependent on the respondents’ 
knowledge, experience, and attitude that might lead to the subjective bias. For 
instance, respondents and their attitudes or perceptions might be affected by the 
surrounding environment in which they participated in the survey. The unexpected 
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factors, such as personal issues, or other external factors might have impacts on their 
attitudes. Furthermore, another factor that needs to be considered is the length of 
the interview. In this study, the interview questions were designed to limit interviews 
to one hour (interviewing time), but some participants might have thought that there 
were too many questions and these feelings would have negatively affected their 
attitudes toward the questions.  
• Fourthly, this study does not address all the identified 34 risk factors in detail due to 
the time constraints and the size of the questionnaire survey, which mostly required 
pair-wise comparison between each factor.      
 
8.5 RECOMMENDATION AND FUTURE RESEARCH   
A number of research areas need to be investigated for further study. It is advocated that the 
following areas should be addressed going forward: 
• Further research is expected for the generalisability of the developed conceptual 
framework and integrated risk management model into other industry sectors and 
being applied into different tiers of the supply chain network. The application of the 
same research process to other areas will broaden knowledge into supply chain risk 
management.  
• The cross-validation of the proposed risk management model can be possible by 
widening the geographical scope of the research. This thesis investigated risk 
management for hospitals in the UK and China. Both countries are selected for 
sampling because of their advanced healthcare systems, the larger and costly market 
and the enormous healthcare demands. Therefore, it is noteworthy that a 
comparative analysis between countries with different social and economic systems 
and different healthcare and hospital systems will provide fresh insights into the 
development of risk management initiatives.  
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• Supply chain risk management has been defined as “the management of supply chain 
related risks including both internal and external risks through a coordinated approach 
among each SC member to managing supply chain vulnerability as a whole” 
(Christopher et al., 2002). In the healthcare supply chain setting, hospitals are closely 
linked to other channel stakeholders, such as pharmaceutical manufacturer, supplier, 
distributor, GPO, insurance company, government, and third-party logistics provider. 
It requires a coordinated effort from all key members involved in order to mitigate 
risks and build a resilient healthcare supply chain. Another further research direction 
is to incorporate the views of other SC members into the decision-making process.  
• As mentioned in Chapter five, many types of risk factors exist in the healthcare supply 
chain, such as strategic risks, labour risks and man-made risks are omitted as they are 
less significant; nonetheless, they should be of concern. Therefore, it would be more 
comprehensive to consider all kinds of risks in the structural model so that more 
complete results could be obtained.  
•  As any strategic implementation requires substantial investments, the decision to 
adopt appropriate risk management mitigation strategies requires a trade-off 
between the benefits and costs involved. Further research can cover cost and benefit 
analysis to support significant strategic decisions on SCRM. 
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Questionnaire used in Survey A for the purpose of Chapter five
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Research on Risk Management for Healthcare Supply Chain in Hospital  
 
Dear Sir/Madam,  
My name is Lei Wang, who is currently the PhD candidate at the Liverpool Logistics Offshore 
and Marine Research Institute (LOOM) in Liverpool John Moores University. My research topic 
is “Research on risk management for healthcare supply chain in hospital”. The research aims 
to propose a novel risk management methodology to identify, evaluate and mitigate the risk 
factors in hospital supply chain.  
I should be very pleased if you can take part in this study in view of your professional 
knowledge in risk management, supply chain management or in hospital. It is necessary to 
pre-test the reliability and validity of the identified risk factors in the research and your 
assistance would be greatly appreciated in making this a meaningful questionnaire. The 
information gathered is this survey will be treated in the strictest confidence. The researcher 
will make every effort to prevent anyone who is not on the research team from knowing that 
you provided this information, or what the information is. If you have any questions about 
this study, please feel free to contract me either email L.Wang@2015.ljmu.ac.uk or by phone. 
You also can contact my supervisor, Dr Jun Ren, at (44)1512312236, or by email 
j.ren@ljmu.ac.uk  
Yours faithfully, 
 
 
Lei Wang, 
PhD Candidate, 
Liverpool Logistics Offshore and Marine Research Institute (LOOM) 
Tel: +(44)7510535904 or (86)13223898880 
Email: L.Wang@2015.ljmu.ac.uk 
Room 121, James Parsons Building 
Liverpool John Moores University, Byrom Street, Liverpool, L3 3AF, UK
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Section A: Respondent Profile 
1. What is the type of your organization? 
Pharmaceutical 
Manufacturer  
Pharmaceutical 
distributor 
(pharmaceutical 
company ) 
Hospital 
(Procurement department; 
Material management 
department etc.) 
Other 
☐ ☐ ☐ ☐ 
 
2. What is your job title?  
 
3. For how many years have you worked in the healthcare industry or healthcare supply 
chain?  
☐1-5 years  ☐6-10 years  ☐11-15 years   ☐16-19 years  ☐≥20 years 
4.  Would you like to provide additional information and participate in the next survey if 
necessary? 
                                                        ☐Yes                  ☐No 
 
 
 
Section B:  
Based on the research, the purpose categorizing the risks in hospital supply chain into three 
main categories: 1) external to the hospital but internal to the supply chain network; 2) 
internal to the hospital; 3）external to the supply chain network. (See the figure below for a 
schematic of where these risks are focused) The following questions are related to the rank 
and modify the identified risk factors in the hospital supply chain. 
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For the identified risk factors in the hospital supply chain, the important levels can be 
marked based on the corresponding numbers:  
1=Very Unimportant;  
2=Minor Unimportant;  
3=Moderate;  
4= Minor Important;  
5=Very Important 
 
 
External to the hospital but internal to the supply chain network (i.e. arise from interactions 
between organizations within the supply chain) 
 Supply risks (i.e. adversely affects inward flow of any type of resource to enable 
operations to take place or the transpiration of significant and/or disappointing 
failures with inbound goods and service) 
 Quality risks 
 Supplier risks 
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Identified Risk Factors 
(Quality risks) 
Important level 
 
 
 
 
 
 
Quality risks S1 Counterfeiting ☐1 ☐ 2☐  3 ☐4☐ 5 
S2 Poor quality in the purchased drugs from 
suppliers 
☐1 ☐ 2☐  3 ☐4☐ 5 
S3 Time limit of drug, product perishability ☐1 ☐ 2☐  3 ☐4☐ 5 
 
Identified Risk Factors 
(Supplier risks) 
Important level 
 
 
 
 
 
 
Supplier risks S4 Shortage of drugs, unavailability of drugs on 
the market 
☐1 ☐ 2☐  3 ☐4☐ 5 
S5 Location of manufacturer/supplier (not the 
domestic based); (e.g. sourcing from the global, 
long lead time, high costs) 
☐1 ☐ 2☐  3 ☐4☐ 5 
S6 Unavailability of raw material – true and 
commercially induced. 
☐1 ☐ 2☐  3 ☐4☐ 5 
S7 Cash flow/cash management threat 
associated with small pharmaceutical 
companies and hospitals; 
☐1 ☐ 2☐  3 ☐4☐ 5 
 
Considering the above structure, elements contributing to risks associated with supply risks 
are categorized into “quality risks” and “supplier risks”. Do you think this categorization is 
appropriate? 
Risk element categories Yes No  Any comments 
Quality risks    
Supplier risks    
Any other elements should be 
considered? 
 
 
 Demand risks (i.e. the possibility of unexpected changes arising from market or 
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downstream customers) 
 Capability risks 
 Forecast risks 
 
Identified Risk Factors 
(Capability risks) 
Important level 
 
 
 
 
 
 
Capability risks 
(the capabilities 
such as 
technical skills, 
knowledge and 
leadership 
competencies of 
individuals and 
the collective 
group 
responsible for 
managing the 
demand, plus 
the relationships 
within and 
outside 
organizations 
and individuals) 
S8 Capacity versus demand, inability of 
capacity to meet demand; 
☐1 ☐ 2☐  3 ☐4☐ 5 
S9 Demand triggered by the nurse, not the 
patient 
☐1 ☐ 2☐  3 ☐4☐ 5 
 
Identified Risk Factors 
(Forecast risks)  
Important level 
 
 
 
 
 
 
Forecast risks S10 Demand uncertainty ☐1 ☐ 2☐  3 ☐4☐ 5 
S11 Wrong demand forecasting ☐1 ☐ 2☐  3 ☐4☐ 5 
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Considering the above structure, elements contributing to risks associated with demand risks 
are categorized into “capability risks” and “forecast risks”. Do you think this categorization is 
appropriate? 
  
Risk element categories Yes No  Any comments 
Capability risks    
Forecast risks    
Any other elements should be 
considered? 
 
 
Internal to the hospital (i.e. the risk sources lie within the boundaries of the supply chain 
parties and range from labour to IT-system uncertainties). 
 Process risks (i.e. the risks lie in the sequences of value-adding and managerial 
activities undertaken by the firm). 
 Information risks 
 Logistics risks 
 Procurement risks 
Identified Risk Factors 
(Information risks) 
Important level 
 
 
 
 
 
 
Information 
risks 
S12 Poor IT system, lack of data 
standardization;  
(e.g. lack of information management 
platform) 
☐1 ☐ 2☐  3 ☐4☐ 5 
S13  Asymmetries of the information, 
collaboration issues, restriction, not share 
information each department  
 
☐1 ☐ 2☐  3 ☐4☐ 5 
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Identified Risk Factors 
(Logistics risks) 
Important level 
 
 
 
 
 
 
Logistics risks 
(the risks are 
associated to 
all the logistic 
activities in/or 
between each 
organizations) 
 
S14 Dispensing/picking error 
medication/packaging 
☐1 ☐ 2☐  3 ☐4☐ 5 
S15 Weak logistics service infrastructure (e.g. 
Obsoleted equipment in the warehouse; 
Improper drug store environment and 
transportation facility, route etc. ) 
☐1 ☐ 2☐  3 ☐4☐ 5 
S16 Fragmentation of drug distribution processes ☐1 ☐ 2☐  3 ☐4☐ 5 
S17 Inadequate buffer stock-JIT/Lean ☐1 ☐ 2☐  3 ☐4☐ 5 
S18 Lack of visibility concerning placement and 
availability of stock 
☐1 ☐ 2☐  3 ☐4☐ 5 
 
Identified Risk Factors 
(Procurement risks) 
Important level 
 
 
 
 
 
 
Procurement 
risks 
 
 
S19 Procurement Hubs-introduce more 
complexity, Long lead time; (e.g. from placing 
the order until receiving) 
☐1 ☐ 2☐  3 ☐4☐ 5 
S20 Contract problems with suppliers (e.g. 
contracting treated as a commodity-big 
contracts equals big risk) 
☐1 ☐ 2☐  3 ☐4☐ 5 
S21 Clinician’s preference; (e.g. lack the 
awareness of cost containment) 
☐1 ☐ 2☐  3 ☐4☐ 5 
S22 High purchase price ☐1 ☐ 2☐  3 ☐4☐ 5 
S23 High product and supplier/brand variety ☐1 ☐ 2☐  3 ☐4☐ 5 
 
Considering the above structure, elements contributing to risks associated with process risks 
are categorized into “information risks”, “logistics risks” and “procurement risks”. Do you 
think this categorization is appropriate? 
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Risk element categories Yes No  Any comments 
Information risks    
Logistics risks    
Procurement risks    
Any other elements should be 
considered? 
 
 
 Control risks (i.e. the assumptions, rules, systems and procedures that govern how an 
organization exerts control over the processes. In terms of the supply chain they may 
be order quantities, batch sizes, safety stock policies etc. Control risk is therefore the 
risk arising from the application or misapplication of these rules)  
 Strategic risks 
 Labour risks 
Identified Risk Factors 
(Strategic risks) 
Important level 
 
 
 
 
 
 
Strategic risks 
(a possible 
source of loss 
that might 
arise from 
the pursuit of 
an 
unsuccessful 
business 
plan.) 
 
S24 Focus on short term SC planning than long 
term 
☐1 ☐ 2☐  3 ☐4☐ 5 
S25 Prioritization-conflict between 
patients/profits; (e.g. doctors would advise 
patients to take a lot of unnecessary medical 
measures and drugs in order to increase the 
profits of hospital) 
 
☐1 ☐ 2☐  3 ☐4☐ 5 
 
Identified Risk Factors 
(Labour risks) 
Important level 
 
 
 
 
 
 
Labour risks 
 
S26 Strikes and lack talents ☐1 ☐ 2☐  3 ☐4☐ 5 
S27 Lack of incentive mechanism  
 
☐1 ☐ 2☐  3 ☐4☐ 5 
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Considering the above structure, elements contributing to risks associated with control risks 
are categorized into “Strategic risks” and “labour risks”. Do you think this categorization is 
appropriate? 
Risk element categories Yes No  Any comments 
Strategic risks    
Labour risks    
Any other elements should be 
considered? 
 
 
External to the supply chain network (i.e.can be defined as events driven by external forcers 
such as weather, earthquakes, political, regulatory and market forces). 
 Environmental risks  
 Natural risks 
 Man-made risks 
Identified Risk Factors 
(Natural risks) 
 
Important level 
 
 
 
 
 
 
Natural  risks S28 External influences- disaster recovery; (e.g. 
natural disaster) 
☐1 ☐ 2☐  3 ☐4☐ 5 
S29 Unexpected disease outbreaks; (e.g. 
emerging virus diseases)  
☐1 ☐ 2☐  3 ☐4☐ 5 
S30 Unexpected changes in environment 
conditions 
☐1 ☐ 2☐  3 ☐4☐ 5 
 
Identified Risk Factors 
(Man-made risks) 
Important level 
 
 
 
 
 
 
Man-made  
risks 
(intentional or 
unintentional 
S31 Regulatory issues-manufacturing using 
licensing/change of standards/drug recalls 
☐1 ☐ 2☐  3 ☐4☐ 5 
S32 Rigorous government interventions; (e.g. 
policy) 
☐1 ☐ 2☐  3 ☐4☐ 5 
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acts that cause 
products or 
supply chains 
to react 
differently 
than originally 
intended. e.g. 
political 
instability, 
elections, 
labor strikes 
can completely 
shut down 
business and 
government 
operations) 
S33 Lack of funds from government to the 
hospital 
☐1 ☐ 2☐  3 ☐4☐ 5 
S34 The requirement of environment 
protection 
☐1 ☐ 2☐  3 ☐4☐ 5 
 
Considering the above structure, elements contributing to risks associated with 
environmental risks are categorized into “natural risks” and “man-made risks”. Do you think 
this categorization is appropriate? 
Risk element categories Yes No  Any comments 
Natural risks    
Man-made risks    
Any other elements should be 
considered? 
 
 
 
 
 
 
 
 
 
 
 
 
THANK YOU ONCE AGAIN FOR YOUR KIND PARTICIPATION IN THIS SURVEY.YOUR 
ANSWERS WILL BE KEPT CONFIDENTIAL 
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医疗供应链风险管理 
问卷调查 
 
尊敬的专家： 
 
您好！我叫王磊。来自利物浦约翰莫尔斯大学(LJMU)物流和海洋研究所的
博士研究生。我的研究课题是提出一种全新的、系统化和结构化的方法针
对医院药品供应链过程中产生的风险因素进行识别、分析和控制。 
对于占用您宝贵的时间我深感歉意。也同时非常的荣幸能够邀请您参加到
我的研究课题当中。您对于医疗供应链管理和风险管理的宝贵经验将对此
次问卷调查的起到非常重要的作用。同时需要强调的是，根据研究课题组
的要求，本次调查的信息将会被严格的保密；其中所涉及到的相关单位及
个人信息会采取匿名的方式。 
本次调查需要 10 分钟左右的时间。如果您有任何问题，请通过电子邮件 
L.Wang@2015.ljmu.ac.uk 联系我。您也可以通过电子邮件 J.Ren@ljmu.ac.uk 
联系我的导师任军教授。 
 
王磊 
博士研究生 
Liverpool Logistics Offshore and Marine Research Institute (LOOM) 
Tel: +(44)7510535904  
Email: L.Wang@2015.ljmu.ac.uk 
Room 121, James Parsons Building 
Liverpool John Moores University, Byrom Street, Liverpool, L3 3AF, UK
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基于前期的文献研究，我们将医疗药品供应链中存在的风险因为分为三个主要种类：
1）供应链网络内部风险；2）医院内部风险；3)供应链网络外部环境风险。以下问题
是针对所识别出的风险因素的重要性进行评分，并修改和添加遗漏的其他风险因素。  
供应链网络内部风险 (此类风险产生于供应链网络内部，由组织成员之间相互作用引
起) 
供应风险 (围绕供应链运营中的药品供应过程的潜在的和实际的风险) 
质量风险:  
- (S1) 假药; 
- (S2) 购买药品的质量不合格；  
- (S3) 药品的易腐性，保质期周期短; 
针对已识别出的质量风险因素，您认为在医疗供应链当中，这些风险各自的重要性得
分是多少？另外还有哪些风险未被考虑在内？ 
(1=完全不重要; 2=不重要; 3=不是很重要; 4=一般重要; 5= 比较重要; 6=很重要; 7=非常重
要) 
识别出的风险因素 影响程度 
质量风险 S1 假药 ☐1 ☐ 2☐  3 ☐4☐ 5 ☐ 6☐ 7 
S2 购买药品的质量不合格 ☐1 ☐ 2☐  3 ☐4☐ 5 ☐ 6☐ 7 
S3 药品的易腐性，保质期周期
短 
☐1 ☐ 2☐  3 ☐4☐ 5 ☐ 6☐ 7 
您是否认为还有
其它因素？ 
 ☐1 ☐ 2☐  3 ☐4☐ 5 ☐ 6☐ 7 
 ☐1 ☐ 2☐  3 ☐4☐ 5 ☐ 6☐ 7 
 ☐1 ☐ 2☐  3 ☐4☐ 5 ☐ 6☐ 7 
 
供应商风险: 
- (S4) 药品短缺; 
- (S5) 药品供应商的地址偏远，非本地或者本国供应(例如：进口药品会产生高额费
用，由下单到收获的过程耗时长 ) 
- (S6) 原材料在市场上供应短缺，其中原因包括因商业诱导而导致采购困难 
- (S7) 规模较小的药品供应商的现金流中断，缺乏可靠性； 
针对已识别出的供应商风险因素，您认为在医疗供应链当中，这些风险各自的重要性
得分是多少？另外还有哪些风险未被考虑在内？ 
(1=完全不重要; 2=不重要; 3=不是很重要; 4=一般重要; 5= 比较重要; 6=很重要; 7=非常重
要) 
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识别出的风险因素 影响程度 
供应商风险 S4 药品短缺 ☐1 ☐ 2☐  3 ☐4☐ 5 ☐ 6☐ 7 
S5 药品供应商的地址偏远，非
本地或者本国供应 
☐1 ☐ 2☐  3 ☐4☐ 5 ☐ 6☐ 7 
S6 医院与供应商之间的合作以
短期为主，缺乏长期合作机制 
☐1 ☐ 2☐  3 ☐4☐ 5 ☐ 6☐ 7 
S7 规模较小的药品供应商的现
金流中断，缺乏可靠性 
☐1 ☐ 2☐  3 ☐4☐ 5 ☐ 6☐ 7 
您是否认为还有
其它因素？ 
 ☐1 ☐ 2☐  3 ☐4☐ 5 ☐ 6☐ 7 
 ☐1 ☐ 2☐  3 ☐4☐ 5 ☐ 6☐ 7 
 ☐1 ☐ 2☐  3 ☐4☐ 5 ☐ 6☐ 7 
 
需求风险 (指供应链下游中不可预知的变化所导致的风险) 
能力风险: 
- (S8) 医院整体实力与各科室需求不匹配，出现供不应求的情况； 
- (S9) 需求由护理人员驱动而非患者，导致真实需求信息不正确而产生过量采购等问
题； 
针对已识别出的能力风险因素，您认为在医疗供应链当中，这些风险各自的重要性得
分是多少？另外还有哪些风险未被考虑在内？ 
(1=完全不重要; 2=不重要; 3=不是很重要; 4=一般重要; 5= 比较重要; 6=很重要; 7=非常重
要) 
识别出的风险因素 影响程度 
能力风险 S8 医院整体实力与各科室需求
不匹配，出现供不应求的情况 
☐1 ☐ 2☐  3 ☐4☐ 5 ☐ 6☐ 7 
S9 需求由护理人员驱动而非患
者，导致真实需求信息不正确
而产生过量采购等问题 
☐1 ☐ 2☐  3 ☐4☐ 5 ☐ 6☐ 7 
您是否认为还有
其它因素？ 
 ☐1 ☐ 2☐  3 ☐4☐ 5 ☐ 6☐ 7 
 ☐1 ☐ 2☐  3 ☐4☐ 5 ☐ 6☐ 7 
 ☐1 ☐ 2☐  3 ☐4☐ 5 ☐ 6☐ 7 
 
预测风险:  
- (S10) 需求不确定; 
- (S11) 错误的需求预测; 
针对已识别出的预测风险因素，您认为在医疗供应链当中，这些风险各自的重要性得
分是多少？另外还有哪些风险未被考虑在内？ 
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(1=完全不重要; 2=不重要; 3=不是很重要; 4=一般重要; 5= 比较重要; 6=很重要; 7=非常重
要) 
识别出的风险因素 影响程度 
预测风险 S10 需求不确定 ☐1 ☐ 2☐  3 ☐4☐ 5 ☐ 6☐ 7 
S11 错误的需求预测 ☐1 ☐ 2☐  3 ☐4☐ 5 ☐ 6☐ 7 
您是否认为还有
其它因素？ 
 ☐1 ☐ 2☐  3 ☐4☐ 5 ☐ 6☐ 7 
 ☐1 ☐ 2☐  3 ☐4☐ 5 ☐ 6☐ 7 
 ☐1 ☐ 2☐  3 ☐4☐ 5 ☐ 6☐ 7 
 
医院内部风险 (此风险来源在医院内部的供应链运营流程，如采购、物流、仓储等) 
流程风险 (风险源产生于组织的增值和管理活动的流程中.) 
信息风险:  (一定概率由于信息的不正确、不完整或者非法访问而导致组织损失) 
- (S12) 落后的信息系统；单一的信息传送渠道；信息传输缓慢; (例如：缺乏信息管理
系统) 
- (S13) 各科室之间存在合作壁垒，科室之间信息不共享;  
针对已识别出的信息风险因素，您认为在医疗供应链当中，这些风险各自的重要性得
分是多少？另外还有哪些风险未被考虑在内？ 
(1=完全不重要; 2=不重要; 3=不是很重要; 4=一般重要; 5= 比较重要; 6=很重要; 7=非常重
要) 
识别出的风险因素 影响程度 
信息风险 S12 落后的信息系统；单一的信
息传送渠道；信息传输缓慢 
☐1 ☐ 2☐  3 ☐4☐ 5 ☐ 6☐ 7 
S13 各科室之间存在合作壁垒，
科室之间信息不共享 
☐1 ☐ 2☐  3 ☐4☐ 5 ☐ 6☐ 7 
您是否认为还有
其它因素？ 
 ☐1 ☐ 2☐  3 ☐4☐ 5 ☐ 6☐ 7 
 ☐1 ☐ 2☐  3 ☐4☐ 5 ☐ 6☐ 7 
 ☐1 ☐ 2☐  3 ☐4☐ 5 ☐ 6☐ 7 
 
物流风险: (指组织内部以及供应链成员之间的物流活动中产生的风险) 
- (S14) 医院内部药品的拣选、包装和运输出现错误; 
- (S15) 物流服务基础设施薄弱（例如：药品库房中陈旧的设备, 不适当的药品储存环境
和运输设备、路径） 
- (S16) 分散的药品配送流程; 
- (S17) 缓冲库存不足（运用 Lean/Just in Time 保持较低的库存水平）; 
- (S18) 库存管理的可视化程度低; 
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针对已识别出的物流风险因素，您认为在医疗供应链当中，这些风险各自的重要性得
分是多少？另外还有哪些风险未被考虑在内？ 
(1=完全不重要; 2=不重要; 3=不是很重要; 4=一般重要; 5= 比较重要; 6=很重要; 7=非常重
要) 
识别出的风险因素 影响程度 
物流风险 S14 医院内部药品的拣选、包装
和运输出现错误 
☐1 ☐ 2☐  3 ☐4☐ 5 ☐ 6☐ 7 
S15 物流服务基础设施薄弱  ☐1 ☐ 2☐  3 ☐4☐ 5 ☐ 6☐ 7 
S16 分散的药品配送流程 ☐1 ☐ 2☐  3 ☐4☐ 5 ☐ 6☐ 7 
S17 缓冲库存不足（运用
Lean/Just in Time 保持较低的库
存水平） 
☐1 ☐ 2☐  3 ☐4☐ 5 ☐ 6☐ 7 
S18 库存管理的可视化程度低 ☐1 ☐ 2☐  3 ☐4☐ 5 ☐ 6☐ 7 
您是否认为还有
其它因素？ 
 ☐1 ☐ 2☐  3 ☐4☐ 5 ☐ 6☐ 7 
 ☐1 ☐ 2☐  3 ☐4☐ 5 ☐ 6☐ 7 
 ☐1 ☐ 2☐  3 ☐4☐ 5 ☐ 6☐ 7 
 
采购风险: 
- (S19) 采购中心工作复杂性程度高，从采购到交货的流程过长； 
- (S20) 与供应商的合同问题; 
- (S21) 医生的个人偏好加重采购的成本； 
- (S22) 过高的采购价格； 
- (S23) 采购药品种类和供应商的数量过多;  
针对已识别出的采购风险因素，您认为在医疗供应链当中，这些风险各自的重要性得
分是多少？另外还有哪些风险未被考虑在内？ 
(1=完全不重要; 2=不重要; 3=不是很重要; 4=一般重要; 5= 比较重要; 6=很重要; 7=非常重
要) 
识别出的风险因素 影响程度 
采购风险 S19 采购中心工作复杂性程度
高，从采购到交货的流程过长 
☐1 ☐ 2☐  3 ☐4☐ 5 ☐ 6☐ 7 
S20 与供应商的合同问题 ☐1 ☐ 2☐  3 ☐4☐ 5 ☐ 6☐ 7 
S21 医生的个人偏好加重采购的
成本 
☐1 ☐ 2☐  3 ☐4☐ 5 ☐ 6☐ 7 
S22 过高的采购价格 ☐1 ☐ 2☐  3 ☐4☐ 5 ☐ 6☐ 7 
S23 采购药品种类和供应商的数
量过多 
☐1 ☐ 2☐  3 ☐4☐ 5 ☐ 6☐ 7 
 ☐1 ☐ 2☐  3 ☐4☐ 5 ☐ 6☐ 7 
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您是否认为还有
其它因素？ 
 ☐1 ☐ 2☐  3 ☐4☐ 5 ☐ 6☐ 7 
 ☐1 ☐ 2☐  3 ☐4☐ 5 ☐ 6☐ 7 
 
控制风险  
战略风险: (战略行为影响整个供应链体系，战略风险可根据其战略特征得到。) 
- (S24) 医院将供应链管理视为短期效应，不重视供应链与物流管理的战略意义; 
- (S25) 优先级-患者/利润冲突;   
针对已识别出的战略风险因素，您认为在医疗供应链当中，这些风险各自的重要性得
分是多少？另外还有哪些风险未被考虑在内？ 
(1=完全不重要; 2=不重要; 3=不是很重要; 4=一般重要; 5= 比较重要; 6=很重要; 7=非常重
要) 
识别出的风险因素 影响程度 
战略风险 S24 医院将供应链管理视为短期
效应，不重视供应链与物流管
理的战略意义 
☐1 ☐ 2☐  3 ☐4☐ 5 ☐ 6☐ 7 
S25 优先级-患者/利润冲突 ☐1 ☐ 2☐  3 ☐4☐ 5 ☐ 6☐ 7 
您是否认为还有
其它因素？ 
 ☐1 ☐ 2☐  3 ☐4☐ 5 ☐ 6☐ 7 
 ☐1 ☐ 2☐  3 ☐4☐ 5 ☐ 6☐ 7 
 ☐1 ☐ 2☐  3 ☐4☐ 5 ☐ 6☐ 7 
 
人力风险:  
- (S26) 医护或后勤人员罢工; 
- (S27) 缺乏激励机制;  
针对已识别出的战略风险因素，您认为在医疗供应链当中，这些风险各自的重要性得
分是多少？另外还有哪些风险未被考虑在内？ 
(1=完全不重要; 2=不重要; 3=不是很重要; 4=一般重要; 5= 比较重要; 6=很重要; 7=非常重
要) 
识别出的风险因素 影响程度 
人力风险 S26 医护或后勤人员罢工 ☐1 ☐ 2☐  3 ☐4☐ 5 ☐ 6☐ 7 
S27 缺乏激励机制 ☐1 ☐ 2☐  3 ☐4☐ 5 ☐ 6☐ 7 
您是否认为还有
其它因素？ 
 ☐1 ☐ 2☐  3 ☐4☐ 5 ☐ 6☐ 7 
 ☐1 ☐ 2☐  3 ☐4☐ 5 ☐ 6☐ 7 
 ☐1 ☐ 2☐  3 ☐4☐ 5 ☐ 6☐ 7 
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供应链网络外部环境风险 (可以定义为由供应链外部环境因素如自然灾害、宏观经济、
政府政策等产生的风险) 
自然灾害风险: 
- (S28) 外部影响-灾难恢复缓慢； 
- (S29) 突发性重大疫情爆发； 
- (S30) 环境状况出现意外变化； 
针对已识别出的自然灾害风险因素，您认为在医疗供应链当中，这些风险各自的重要
性得分是多少？另外还有哪些风险未被考虑在内？ 
(1=完全不重要; 2=不重要; 3=不是很重要; 4=一般重要; 5= 比较重要; 6=很重要; 7=非常重
要) 
识别出的风险因素 影响程度 
自然灾害风险 S28 外部影响-灾难恢复缓慢 ☐1 ☐ 2☐  3 ☐4☐ 5 ☐ 6☐ 7 
S29 突发性重大疫情爆发 ☐1 ☐ 2☐  3 ☐4☐ 5 ☐ 6☐ 7 
S30 环境状况出现意外变化 ☐1 ☐ 2☐  3 ☐4☐ 5 ☐ 6☐ 7 
您是否认为还有
其它因素？ 
 ☐1 ☐ 2☐  3 ☐4☐ 5 ☐ 6☐ 7 
 ☐1 ☐ 2☐  3 ☐4☐ 5 ☐ 6☐ 7 
 ☐1 ☐ 2☐  3 ☐4☐ 5 ☐ 6☐ 7 
人为制造风险: 
- (S31) 监管问题-制造许可使用/更改标准/药品召回； 
- (S32) 严格的政府干预； 
- (S33) 医院缺乏政府的资金拨给; 
- (S34) 环境保护的需求得不到改善； 
针对已识别出的人为制造风险因素，您认为在医疗供应链当中，这些风险各自的重要
性得分是多少？另外还有哪些风险未被考虑在内？ 
(1=完全不重要; 2=不重要; 3=不是很重要; 4=一般重要; 5= 比较重要; 6=很重要; 7=非常重
要) 
识别出的风险因素 影响程度 
人为制造风险 S31 监管问题-制造许可使用/更
改标准/药品召回 
☐1 ☐ 2☐  3 ☐4☐ 5 ☐ 6☐ 7 
S32 严格的政府干预 ☐1 ☐ 2☐  3 ☐4☐ 5 ☐ 6☐ 7 
S33 医院缺乏政府的资金拨给 ☐1 ☐ 2☐  3 ☐4☐ 5 ☐ 6☐ 7 
S34 环境保护的需求得不到改善 ☐1 ☐ 2☐  3 ☐4☐ 5 ☐ 6☐ 7 
您是否认为还有
其它因素？ 
 ☐1 ☐ 2☐  3 ☐4☐ 5 ☐ 6☐ 7 
 ☐1 ☐ 2☐  3 ☐4☐ 5 ☐ 6☐ 7 
 ☐1 ☐ 2☐  3 ☐4☐ 5 ☐ 6☐ 7 
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再次感谢您在此次调查中提供的帮助 
您的回答将会被保密 
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APPENDIX TWO 
 
 
 
 
 
 
 
 
 
 
Questionnaire used in Survey B for the purpose of Fuzzy AHP in Chapter six 
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Research on Risk Management for Healthcare Supply Chain in Hospital 
Questionnaire  
 
 
Dear Sir/Madam,  
My name is Lei Wang, who is currently the PhD candidate at the Liverpool Logistics Offshore 
and Marine Research Institute (LOOM) in Liverpool John Moores University. My research topic 
is “Research on risk management for healthcare supply chain in hospital”. The research aims 
to propose a novel risk management methodology to identify, evaluate and mitigate the risk 
factors in hospital supply chain. The purpose of the questionnaire is to evaluate the risk 
factors for determining of their priority (weight) of concern.  
I would be very pleased if you can take part in this study in view of your professional 
knowledge in risk management, supply chain management or in hospital. The information 
gathered in this survey will be treated in the strictest confidence, as this has always been the 
policy of the Liverpool John Moores University. The questionnaire is anonymous, thus your 
response can not be attributed to you or your organization. 
If you have any questions about this study, please feel free to contract me either email 
L.Wang@2015.ljmu.ac.uk or by phone. You also can contact my supervisor, Dr Jun Ren, at 
(44)1512312236, or by email j.ren@ljmu.ac.uk  
 
Yours faithfully, 
 
Lei Wang, 
PhD Candidate, 
Liverpool Logistics Offshore and Marine Research Institute (LOOM) 
Tel: +(44)7510535904 or (86)13223898880 
Email: L.Wang@2015.ljmu.ac.uk 
Room 121, James Parsons Building 
Liverpool John Moores University, Byrom Street, Liverpool, L3 3AF, UK 
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Section A: Respondent Profile 
1. What is the type of your organization? 
Pharmaceutical 
Manufacturer  
Pharmaceutical 
distributor 
(pharmaceutical 
company ) 
Hospital 
(Procurement department; 
Material management 
department etc.) 
Other 
☐ ☐ ☐ ☐ 
 
2. What is your job title? (optional) 
3.  
 
3. For how many years have you worked in the healthcare industry or healthcare supply 
chain?  
☐1-5 years ☐6-10 years ☐11-15 years   ☐16-19 years ☐≥20 years 
Section B: Analytical Hierarchical Process (AHP) 
Part A: Introduction and Explanation  
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For your opinion as an expert, the pair-wise comparison scale can be used to assess or express 
the importance of one element over another. The linguistic judgements and their 
explanations used for evaluating the importance of the elements in pair-wise comparison 
shown in Table 1.  
Table 1. Linguistic judgements for fuzzy AHP 
Linguistic judgements Explanations  
Equal importance (Eq) Two activities contribute equally to the 
objective 
Weak importance (Wk) Experience and judgement slightly favour one 
over another 
Strong importance (St) Experience and judgement strongly favour one 
over another 
Very strong importance (Vs) An activity is favoured very strongly over 
another 
Absolute strong importance (As) The evidence favouring one activity over 
another is of the highest possible order of 
affirmation 
                                                                   
Part B: Questionnaire  
1) Regarding the three main criteria, in your opinion what is the relative importance of the 
risk factor in healthcare supply chain (HCSC)?  
Key definitions:   
 External to the hospital but internal to the supply chain network (i.e. arise from 
interactions between organizations within the supply chain) 
 Internal to the hospital (i.e. the risk sources lie within the boundaries of the supply chain 
parties and range from labour to IT-system uncertainties.) 
 External to the supply chain network (i.e. can be defined as events driven by external 
forcers such as weather, earthquakes, political, regulatory and market forces) 
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External to 
the hospital 
but internal 
to the supply 
chain 
network 
☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ Internal to the 
hospital 
External to 
the hospital 
but internal 
to the supply 
chain 
network 
☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ External to the 
supply chain 
network 
Internal to 
the hospital 
☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ External to the 
supply chain 
network 
 
2) Regarding the sub-criteria, in your opinion what is the relative importance of the risk 
factor under “external to the hospital but internal to the supply chain network”?  
 Supply risks (i.e. adversely affects inward flow of any type of resource to enable 
operations to take place or the transpiration of significant and/or disappointing 
failures with inbound goods and service) 
 Demand risks (i.e. the possibility of unexpected changes arising from market or 
downstream customers) 
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Supply risks ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ Demand risks 
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3) Regarding the quality and supplier risks, in your opinion what is the relative importance 
of these two risks under supply risks in HCSC?  
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Quality risks ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ Supplier risks 
 
4) Regarding the capability and forecast risks, in your opinion what is the relative importance 
of these two risks under demand risks in HCSC?  
 Capabilities risk (i.e. the capabilities such as technical skills, knowledge and leadership 
competencies of individuals and the collective group responsible for managing the 
demand, plus the relationships within and outside organizations and individuals) 
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Capability risks ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ Forecast risks 
 
5) Regarding the information, logistics and procurement risks, in your opinion what is the 
relative importance of these two risks under process risks in HCSC?  
 Logistics risks (i.e. the risks are associated to all the logistic activities in/or between 
each organizations) 
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Information 
risks 
☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ Logistics risks 
Information 
risks 
☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ Procurement 
risks 
Logistics risks ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ Procurement 
risks 
 
6) Regarding the sub-criteria, in your opinion what is the relative importance of these risks 
under quality risks in HCSC?  
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Counterfeiting 
 
☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ Poor quality in 
the purchased 
drugs from 
suppliers 
Counterfeiting 
 
☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ Time limit of 
drug, product 
perishability, 
Poor quality in 
the purchased 
drugs from 
suppliers 
☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ Time limit of 
drug, product 
perishability, 
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7) Regarding the sub-criteria, in your opinion what is the relative importance of these risks 
under capability risks in HCSC?  
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Capability 
versus 
demand; 
inability of 
capacity to 
meet demand 
☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ Demand 
trigged by the 
nurse, not the 
patient 
 
 
 
8) Regarding the sub-criteria, in your opinion what is the relative importance of these risks 
under logistics risks in HCSC? 
 Weak logistics service infrastructure (i.e. obsolete equipment in the warehouse; 
Improper drug store environment and transportation facility, route) 
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Dispensing/
picking 
errors 
medication/
packaging, 
☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ Weak logistics 
service 
infrastructure 
Dispensing/
picking 
errors 
medication/
packaging 
☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ Lack of 
visibility 
concerning 
placement and 
availability of 
stock 
Weak 
logistics 
service 
☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ Lack of 
visibility 
concerning 
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infrastructu
re 
placement and 
availability of 
stock 
 
9) Regarding the sub-criteria, in your opinion what is the relative importance of these risks 
under procurement risks in HCSC? 
 Procurement Hubs-introduce more complexity, Long lead time (i.e. from placing the 
order until receiving)  
 Clinician’s preference (i.e. lack the awareness of cost containment) 
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Procuremen
t Hub-
introduce 
more 
complexity, 
long lead 
time 
☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ Clinician's 
preference 
 
Procuremen
t Hub-
introduce 
more 
complexity, 
long lead 
time 
☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ High purchase 
price 
 
Procuremen
t Hub-
introduce 
more 
complexity, 
long lead 
time 
☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ High product 
and 
supplier/brand 
variety 
Clinician's 
preference 
☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ High purchase 
price 
Clinician's 
preference 
☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ High product 
and 
supplier/brand 
variety 
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High 
purchase 
price 
☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ High product 
and 
supplier/brand 
variety 
 
 
10) Regarding the sub-criteria, in your opinion what is the relative importance of these risks 
under natural risks in HCSC?  
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External 
influences-
disaster 
recovery 
☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ Unexpected 
disease 
outbreaks 
External 
influences-
disaster 
recovery 
☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ Unexpected 
changes in 
environment 
conditions 
Unexpected 
disease 
outbreaks 
 
☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ Unexpected 
changes in 
environment 
conditions 
 
 
 
 
 
 
 
THANK YOU ONCE AGAIN FOR YOUR KIND PARTICIPATION IN THIS SURVEY. 
YOUR ANSWER WILL BE KEEP CONFIDENTIAL. 
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                  医疗药品供应链风险管理问卷调查 
 
 
 
尊敬的专家： 
 
         您好！我叫王磊。来自利物浦约翰莫尔斯大学(LJMU)物流和海洋研究所的博士研
究生。我的研究课题是提出一种全新的、系统化和结构化的方法针对医院药品供应链
过程中产生的风险因素进行识别、分析和控制。 
本次问卷的目的是： 
         针对已经识别出存在于医疗供应链中的风险因素，根据专家的经验与意见对其风
险因素之间的重要性大下进行比较，并最终得到各个风险因素的优先级权重。  
         对于占用您宝贵的时间我深感歉意。也同时非常的荣幸能够邀请您参加到我的研
究课题当中。您对于医疗供应链管理和风险管理的宝贵经验将对此次问卷调查的起到
非常重要的作用。同时需要强调的是，根据研究课题组的要求，本次调查的信息将会
被严格的保密；其中所涉及到的相关单位及个人信息会采取匿名的方式。本次调查需
要 5-10 分钟左右的时间。如果您有任何问题，请通过电子邮 L.Wang@2015.ljmu.ac.uk 
联系我。您也可以通过电子邮件 J.Ren@ljmu.ac.uk 联系我的导师任军教授。最终的研
究成果将无偿分享给您和您所在的单位。   
         
王磊 
博士研究生 
 
Liverpool Logistics Offshore and Marine Research Institute (LOOM) 
Tel: 13223898880 
Email: L.Wang@2015.ljmu.ac.uk or wlthegreat24@hotmail.com 
Room 121, James Parsons Building 
Liverpool John Moores University, Byrom Street, Liverpool, L3 3AF, UK
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第一部分：受访者基本情况 
1.   请问您所在的单位是以下哪一个？ 
 
医药制造企业 
 
医药批发企业 
 
医药零售企业 
 
医院 
 
其它 
☐ ☐ ☐ ☐ ☐ 
 
4. 请问您的职位是什么？（可选） 
 
 
3.    请问您从事医药物流和供应链的工龄多久？ 
☐1-5 年  ☐6-10 年  ☐11-15 年   ☐16-19 年  ☐≥20 年 
第二部分：风险因素之间权重大小对比 
1）简介与解释 
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根据您的观点对各个风险因素之间的重要性进行两两比较打分。评分标准列在表格 1
中。  
表格 1. 风险因素两两比较评分标准 
      评分标准 解释  
同等重要 两个风险的重要性同等重要 
稍微重要 其中一个风险比另一个风险稍微重要 
稍强重要 其中一个风险比另一个风险稍强重要 
非常重要 其中一个风险比另一个风险非常重要 
极端重要 其中一个风险比另一个风险极端重要 
                                                                      
2） 问卷内容 
I. 针对整个医疗供应链，根据您的意见对以下三个部分的风险因素的重要性进行
对比。  
含义解释： 
 供应链网络内部风险 
  (此风险产生于医疗供应链成员之间，例如医药批发商与医院之间， 医药制造商与医
药批发商之间产生的风险) 
 医院内部风险 
 (此风险产生于医院内部，例如采购风险，物流配送风险等) 
 供应链网络外部风险 
(此风险产生于供应链网络外部，例如自然灾害，国家法律法规，政策等) 
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  极
端
重
要
 
    
  非
常
重
要
 
  
  稍
强
重
要
 
  稍
微
重
要
 
  同
等
重
要
 
  稍
微
重
要
 
   
稍
强
重
要
 
 非
常
重
要
 
  极
端
重
要
 
 
 
供应链网络内部风险 ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ 医院内部风险 
供应链网络内部风险 ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ 供应链网络外部风险 
医院内部风险 ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ 供应链网络外部风险 
 
 
II. 针对供应链网络内部风险，根据您的意见对以下两个风险的重要性进行对比。 
 供应风险 (围绕供应链运营中的药品供应过程的潜在的和实际的风险) 
 需求风险 (指供应链下游中不可预知的变化所导致的风险) 
 
 
 
 
  极
端
重
要
 
    
  非
常
重
要
 
  
  稍
强
重
要
 
  稍
微
重
要
 
  同
等
重
要
 
  稍
微
重
要
 
   
稍
强
重
要
 
 非
常
重
要
 
  极
端
重
要
 
 
 
供应风险 ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ 需求风险 
 
III. 针对供应风险，根据您的意见对以下两个风险的重要性进行对比。 
 
 
 
 
  极
端
重
要
 
    
  非
常
重
要
 
  
  稍
强
重
要
 
  稍
微
重
要
 
  同
等
重
要
 
  稍
微
重
要
 
   
稍
强
重
要
 
 非
常
重
要
 
  极
端
重
要
 
 
 
质量风险 ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ 供应商风险 
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IV. 针对需求风险，根据您的意见对以下两个风险的重要性进行对比。 
 能力风险 （医院整体实力与各科室需求不匹配，出现供不应求的情况；缺乏需
求信息，有关客户需求和市场等的信息不完整等) 
 
 
 
 
  极
端
重
要
 
    
  非
常
重
要
 
  
  稍
强
重
要
 
  稍
微
重
要
 
  同
等
重
要
 
  稍
微
重
要
 
   
稍
强
重
要
 
 非
常
重
要
 
  极
端
重
要
 
 
 
能力风险 ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ 预测风险 
 
V. 针对医院内部流程风险，根据您的意见对以下三个风险的重要性进行对比。 
 流程风险 (风险源产生于组织的增值和管理活动的流程中.) 
 信息风险  (一定概率由于信息的不正确、不完整或者非法访问而导致组织损失) 
 物流风险  (指组织内部以及供应链成员之间的物流活动中产生的风险) 
 
 
 
 
  极
端
重
要
 
    
  非
常
重
要
 
  
  稍
强
重
要
 
  稍
微
重
要
 
  同
等
重
要
 
  稍
微
重
要
 
   
稍
强
重
要
 
 非
常
重
要
 
  极
端
重
要
 
 
 
信息风险 ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ 物流风险 
信息风险 ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ 采购风险 
物流风险 ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ 采购风险 
 
VI. 针对质量风险，根据您的意见对以下三个风险的重要性进行对比。 
 
 
 
 
  极
端
重
要
 
    
  非
常
重
要
 
  
  稍
强
重
要
 
  稍
微
重
要
 
  同
等
重
要
 
  稍
微
重
要
 
   
稍
强
重
要
 
 非
常
重
要
 
  极
端
重
要
 
 
 
假药 ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ 购买药品的质量不合
格 
假药 ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ 药品的易腐性，保质
期周期短 
购买药品的质量不合
格 
☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ 药品的易腐性，保质
期周期短 
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VII. 针对能力风险，根据您的意见对以下两个风险的重要性进行对比。 
 
 
 
 
  极
端
重
要
 
    
  非
常
重
要
 
  
  稍
强
重
要
 
  稍
微
重
要
 
  同
等
重
要
 
  稍
微
重
要
 
   
稍
强
重
要
 
 非
常
重
要
 
  极
端
重
要
 
 
 
医院整体实力与各科
室需求不匹配 
☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ 需求由护理人员驱动
而非患者， 导致真
实需求信息不正确从
而产生过量的采购等
问题 
 
VIII. 针对医院内部物流风险，根据您的意见对以下三个风险的重要性进行对比。 
 
 
  极
端
重
要
 
    
  非
常
重
要
 
  
  稍
强
重
要
 
  稍
微
重
要
 
  同
等
重
要
 
  稍
微
重
要
 
   
稍
强
重
要
 
 非
常
重
要
 
  极
端
重
要
 
 
 
医院内部药品的拣
选，包装和运输出错 
☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ 物流服务基础设施薄
弱 
医院内部药品的拣
选，包装和运输出错 
☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ 库存管理的可视化程
度低 
物流服务基础设施薄
弱 
☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ 库存管理的可视化程
度低 
 
IX. 针对医院内部的采购风险，根据您的意见对以下四个风险的重要性进行对比。 
 采购中心工作复杂性程度高，从采购到交货的流程过长 
 医生的个人偏好加重采购的成本 (医生有各自对于药品使用的偏好，医生更多
关注药效而忽视药品价格) 
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  极
端
重
要
 
    
  非
常
重
要
 
  
  稍
强
重
要
 
  稍
微
重
要
 
  同
等
重
要
 
  稍
微
重
要
 
   
稍
强
重
要
 
 非
常
重
要
 
  极
端
重
要
 
 
 
采购中心工作复杂性
程度高 
☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ 医生的个人偏好 
采购中心工作复杂性
程度高 
☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ 过高的采购价格 
采购中心工作复杂性
程度高 
☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ 采购药品的种类和供
应商的数量过多 
医生的个人偏好 ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ 过高的采购价格 
医生的个人偏好 ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ 采购药品的种类和供
应商的数量过多 
过高的采购价格 ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ 采购药品的种类和供
应商的数量过多 
 
X. 针对供应链网络外部自然风险，根据您的意见对以下三个风险的重要性进行对
比。 
 
 
 
 
  极
端
重
要
 
    
  非
常
重
要
 
  
  稍
强
重
要
 
  稍
微
重
要
 
  同
等
重
要
 
  稍
微
重
要
 
   
稍
强
重
要
 
 非
常
重
要
 
  极
端
重
要
 
 
 
外部影响-灾难恢复缓
慢 
☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ 突发性重大疫情爆发 
外部影响-灾难恢复缓
慢 
☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ 环境状况出现意外变
化 
突发性重大疫情爆发 ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ 环境状况出现意外变
化 
 
 
 
 
 
再次感谢您在此次调查中提供的帮助 
您的回答将会被严格保密 
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APPENDIX THREE 
 
 
 
 
 
 
Questionnaire used in Survey C for the purpose of ISM model in Chapter six 
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Research on Risk Management for Healthcare Supply Chain in hospital 
Questionnaire 
 
Dear Sir/Madam,  
My name is Lei Wang, who is currently the PhD candidate at the Liverpool Logistics Offshore 
and Marine Research Institute (LOOM) in Liverpool John Moores University. My research topic 
is “Research on risk management for healthcare supply chain in hospital”. The research aims 
to propose a novel risk management methodology to identify, evaluate and mitigate the risk 
factors in hospital supply chain. The purposes of the questionnaire is to develop contextual 
relationships to analyze the inter-relationships among healthcare supply chain risk factors. 
I would be very pleased if you can take part in this study in view of your professional 
knowledge in risk management, supply chain management or in hospital. The information 
gathered in this survey will be treated in the strictest confidence, as this has always been the 
policy of the Liverpool John Moores University. The questionnaire is anonymous, thus your 
response can not be attributed to you or your organization.If you have any questions about 
this study, please feel free to contract me either email L.Wang@2015.ljmu.ac.uk or by phone. 
You also can contact my supervisor, Dr Jun Ren, at (44)1512312236, or by email 
j.ren@ljmu.ac.uk  
Yours faithfully, 
Lei Wang, 
PhD Candidate, 
Liverpool Logistics Offshore and Marine Research Institute (LOOM) 
Tel: +(44)7510535904 or (86)13223898880 
Email: L.Wang@2015.ljmu.ac.uk 
Room 121, James Parsons Building 
Liverpool John Moores University, Byrom Street, Liverpool, L3 3AF, UK 
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Section A: Respondent Profile 
1. What is the type of your organization? 
Pharmaceutical 
Manufacturer  
Pharmaceutical 
distributor 
(pharmaceutical 
company ) 
Hospital 
(Procurement department; 
Material management 
department etc.) 
Other 
☐ ☐ ☐ ☐ 
 
5. What is your job title? (optional) 
 
 
3. For how many years have you worked in the healthcare industry or healthcare supply 
chain?  
☐1-5 years  ☐6-10 years  ☐11-15 years   ☐16-19 years  ☐≥20 years 
Section B: Interpretive Structural Modelling (ISM) 
The occurrence of one risk gives rise to multiple risks resulting into a domino effect which 
makes it very importance for the managers to control these risks before they occur. The 
following questions are related to analyze the inter-relationships among the identified risk 
factors.  
Contextual relationship = leads to  What to enter in the cells: 
1) Enter 1 when the column influences the row and the row not influences  the column 
2) Enter 2 when the column influences the row  and the row not influences the row 
3) Enter 0 when there is no relation between the row and the column 
4) Enter 3 when row and column influences each other   
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Risk factors S11 S10 S9 S8 S7 S6 S5 S4 S3 S2 S1 
S1 Counterfeiting             
S2 Capability versus demand,  inability of capacity to 
meet demand 
          
S3  Dispensing/picking errors medication/packaging          
S4 Shortage of drug, unavailability of drugs on the 
market 
        
S5 Poor quality in the purchased drugs from suppliers         
S6  Weak logistics service infrastructure       
S7 Poor IT system,  lack of data standardization      
S8 Lack of visibility concerning placement and availability 
of stock 
    
S9 High purchase price    
S10 Clinician's preference   
S11 High product and supplier/brand variety  
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THANK YOU ONCE AGAIN FOR YOUR KIND PARTICIPATION IN THIS SURVEY. 
YOUR ANSWER WILL BE KEEP CONFIDENTIAL. 
          
391 
 
医疗药品供应链风险管理问卷调查 
 
 
尊敬的专家： 
 
         您好！我叫王磊。来自利物浦约翰莫尔斯大学(LJMU)物流和海洋研究所的博士研
究生。我的研究课题是提出一种全新的、系统化和结构化的方法针对医院药品供应链
过程中产生的风险因素进行识别、分析和控制。 
本次问卷的目的是： 
         针对已经识别出存在于医疗供应链中的风险因素，根据专家的经验与意见对其风
险因素之间的相互影响关系进行评估。 
         对于占用您宝贵的时间我深感歉意。也同时非常的荣幸能够邀请您参加到我的研
究课题当中。您对于医疗供应链管理和风险管理的宝贵经验将对此次问卷调查的起到
非常重要的作用。同时需要强调的是，根据研究课题组的要求，本次调查的信息将会
被严格的保密；其中所涉及到的相关单位及个人信息会采取匿名的方式。 
         本次调查需要 5-10 分钟左右的时间。如果您有任何问题，请通过电子邮件 
L.Wang@2015.ljmu.ac.uk 联系我。您也可以通过电子邮件 J.Ren@ljmu.ac.uk 
联系我的导师任军教授。最终的研究成果将无偿分享给您和您所在的单位。   
         
 
王磊 
博士研究生 
 
Liverpool Logistics Offshore and Marine Research Institute (LOOM) 
Tel: 13223898880 
Email: L.Wang@2015.ljmu.ac.uk or wlthegreat24@hotmail.com 
Room 121, James Parsons Building 
Liverpool John Moores University, Byrom Street, Liverpool, L3 3AF, UK
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第一部分：受访者基本情况 
1.   请问您所在的单位是以下哪一个？ 
 
医药制造企业 
 
医药批发企业 
 
医药零售企业 
 
医院 
 
其它 
☐ ☐ ☐ ☐ ☐ 
 
6. 请问您的职位是什么？（可选） 
 
 
3.    请问您从事医药物流和供应链的工龄多久？ 
☐1-5 年  ☐6-10 年  ☐11-15 年   ☐16-19 年  ☐≥20 年 
第二部分：解释结构模型法 
一个风险的发生会引起其他多个风险，继而在组织中产生多米诺效应。下列问题是针
对于风险之间的相互影响关系进行评估。  
相互之间的关系= 导致 
填入方块中的数字各自代表的意思： 
5) 填入 1 表示纵列中的风险因素会影响或导致横行中的风险因素， 但横行中的风
险因素不会影响或导致纵列中的风险因素。 
6) 填入 1 表示横行中的风险因素会影响或导致纵列中的风险因素， 但纵列中的风
险不会影响或导致横行中的风险因素。 
7) 填入 0 表示纵列和横行中的风险因素互不影响。 
8) 填入 3 表示纵列和横行中的风险因素互相影响。 
注：由于篇幅原因，横行中的风险因素仅以数字代替，例如 S11 表示采购药品的种类
和供应商的数量过多。
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风险因素 S11 S10 S9 S8 S7 S6 S5 S4 S3 S2 S1 
S1 假药            
S2 医院整体实力与各科室需求不匹配           
S3  医院内部药品的拣选，包装和运输出错          
S4 药品短缺         
S5 购买药品的质量不合格        
S6 物流服务基础设施薄弱       
S7 落后的信息系统；单一的信息传送渠道；信息传
输缓慢 
     
S8 库存管理的可视化程度低     
S9 过高的采购价格    
S10 医生的个人偏好 (医生有各自对于药品使用的偏
好，医生更多关注药效而忽视药品价格) 
  
S11 采购药品的种类和供应商的数量过多  
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再次感谢您在此次调查中提供的帮助。 
您的回答将会被严格保密。 
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APPENDIX FOUR 
 
 
 
 
 
 
 
List of Semi-structured Interview Questions for the purpose of Chapter seven 
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1. What is your job titles? 
____________________________________________ 
2. The number of years in your organization:  
_______________years and ______________months 
3. The number of employee or beds in your organization: __________________   
4. Is your organization concerned about supply chain risks? 
_______________________________________ 
5. Have you had any issues or incidents in the past 12 months resulting in supply chain 
disruption to your organization or to any other customer? 
________________________________________ 
6. In your opinion, list the main risks in hospital supply chain regarding to five risk factors 
（demand, supply, process, control and environmental risks）: 
________________________________________ 
7. Does your organization have the formal mechanisms for identifying and documenting 
risks facing your area? If you answered “yes”,  
 How long it has been implemented? 
   _________________________________________   
 What elements does your risk management program cover? 
   _________________________________________  
 As circumstances change, risks may also change. How often is your risk factors 
identification reviewed and undated? 
   _________________________________________ 
 Do you think what is the key factor in execution the mechanisms? 
   __________________________________________ 
8. If you do not have formal risk factors identification mechanisms, how do you ensure 
coverage of key risks? 
__________________________________________  
9. Does your organization operate risk management strategy so far? If you answered “yes”, 
 How long it has been implemented?  
__________________________________________ 
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 Which department or procedure are using the strategy? 
__________________________________________ 
 For your opinion, what are the advantages and disadvantages for using the 
strategy in your organization? 
___________________________________________  
10. The hospital supply chain is constituted by three main components which are 
procurement, warehouse and transportation activities. So for your opinion, which 
component is more high risk than other two? 
____________________________________________  
11. Does the decision maker play the key role for managing risks in your organization? 
_____________________________________________ 
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APPENDIX FIVE  
 
 
 
 
 
 
 
Questionnaire used in Survey D for the purpose of TOPSIS method in Chapter 
seven
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Research on Risk Management for Healthcare Supply Chain in 
Hospital Questionnaire  
 
 
Dear Sir/Madam,  
 
My name is Lei Wang, who is currently the PhD candidate at the Liverpool Logistics Offshore 
and Marine Research Institute (LOOM) in Liverpool John Moores University. My research topic 
is “Research on risk management for healthcare supply chain in hospital”. The research aims 
to propose a novel risk assessment methodology to identify, evaluate and mitigate the risk 
factors in hospital supply chain. The purpose of the questionnaire is to examine the best 
solutions for the risk mitigation of the healthcare supply chain in hospital sector.  
I would be very pleased if you can take part in this study in view of your professional 
knowledge in risk management, supply chain management or in hospital. The information 
gathered in this survey will be treated in the strictest confidence, as this has always been the 
policy of the Liverpool John Moores University. The questionnaire is anonymous, thus your 
response can not be attributed to you or your organization.If you have any questions about 
this study, please feel free to contract me either email L.Wang@2015.ljmu.ac.uk or by phone. 
You also can contact my supervisor, Dr. Jun Ren, at (44)1512312236, or by email 
j.ren@ljmu.ac.uk  
 
Yours faithfully, 
Lei Wang, 
PhD Candidate, 
Liverpool Logistics Offshore and Marine Research Institute (LOOM) 
Tel: +(44)7510535904 or (86)13223898880 
Email: L.Wang@2015.ljmu.ac.uk 
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Section A: Introduction and Explanation 
 
Based on the findings from the previous survey, the following factors have been weighted 
by the experts as the most importance risks:    
 S1 Counterfeiting  
 S2 Capability versus demand; inability of capacity to meet demand (e.g. not able to 
response the demand, procurement is not sufficient to copy with demand. Lack of 
human resource(inherent efficiencies and recruitment and retention problems with the 
pharmacy profession), lack of information accuracy; the number of lifts is limited, and 
it is not capable to support the delivering process during the rush hour)   
 S3 Dispensing/picking errors medication/packaging (e.g. Manually operate; delay 
delivery, urgent delivery; sound-alike or look-alike drug names, similarities in the outer 
appearance of medicines’ packages and labeling as well as unclear or incomplete 
labeling information; high delivering frequency per day; handwritten prescription leads 
to various types of medication error such as prescribing error, transcribing error, pre-
dispensing and dispensing error.)     
 S4 Shortage of drugs  
 S5 Poor quality in the purchased drugs from suppliers 
 S6 Weak Logistics service infrastructure (e.g. Obsolete equipment in the warehouse; 
Improper drug store environment and transportation facility, route, inefficient cold 
chain management during transportation affects the quality and stability of 
temperature-sensitive products) 
 S7 Poor IT System, too much information, lack of data standardization (e.g. slowly 
information transmission and single transmission channel; lack of information 
management platform, manual process, lack of standardized product identification 
(RFID, QR code), Lack of product traceability and integrated system with suppliers, 
limited information system which covering logistics activities.) 
 S8 Lack of visibility concerning placement and availability of stock 
 S9 High purchase price 
 S10 Clinician’s preference (e.g. lack the awareness of cost containment) 
 S11 High product and supplier/brand variety (e.g. high stock levels)     
 
We further need to determine which relevant risk mitigation solutions has become the key 
strategic consideration. The following 9 appropriate risk management strategies have been 
identified through the empirical studies from both UK and China hospitals.  For your opinion 
as an expert, please kindly give your comments about the performance of following 
mitigation solutions with respect to manage each risk factor.  
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Section B: Questionnaire 
Q1. With respect to manage S1 Counterfeiting, please determine the importance of each risk 
mitigation strategy.    
 
 
 
 Important level  
Risk Mitigation Strategies Very Poor Poor Medium Good Very good 
Logistics Management 
e.g. appropriate distribution 
route and used temperature-
monitoring devices  
☐ ☐ ☐ ☐ ☐ 
Information Technology System 
e.g. Data standardization, 
information sharing, drugs 
traceability, integrated IT 
platform, RFID, EDI 
☐ ☐ ☐ ☐ ☐ 
Collaboration 
 Vertical and Horizontal (e.g. 
clinical staff engagement, 
supplier relationship 
management; GPO, etc) 
☐ ☐ ☐ ☐ ☐ 
Inventory Management 
e.g. Consignment stock, 
visibility, Drugs expiry date 
management, Just-in -time  
☐ ☐ ☐ ☐ ☐ 
eProcurement Strategy 
(the application of technology 
to automate the exchange of 
procurement information 
through the SC)  
☐ ☐ ☐ ☐ ☐ 
Outsourcing 
e.g. Stock replenishment, 
maintenance and repairs; 
outsourcing non-core services 
☐ ☐ ☐ ☐ ☐ 
Agility 
e.g. out of hours, urgent 
deliveries; responsiveness; 
flexibility   
☐ ☐ ☐ ☐ ☐ 
Capability Management 
e.g. Staff training, set up a 
central control of logistics 
activities to manage people 
☐ ☐ ☐ ☐ ☐ 
Single Sourcing 
e.g. long-term contract with 
only one supplier 
☐ ☐ ☐ ☐ ☐ 
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Q2. With respect to manage S2 Capability versus demand, please determine the importance 
of each risk mitigation strategy.    
 
Q3. With respect to manage S3 Dispensing/picking errors medication/packaging, please 
determine the importance of each risk mitigation strategy.    
Q4. With respect to manage S4 Shortage of drugs, please determine the importance of each 
risk mitigation strategy.    
 
 Important level 
Risk Mitigation Strategies Very Poor Poor Medium Good Very good 
Logistics Management ☐ ☐ ☐ ☐ ☐ 
Information System ☐ ☐ ☐ ☐ ☐ 
Collaboration ☐ ☐ ☐ ☐ ☐ 
Inventory Management ☐ ☐ ☐ ☐ ☐ 
eProcurement Strategy ☐ ☐ ☐ ☐ ☐ 
Outsourcing ☐ ☐ ☐ ☐ ☐ 
Agility ☐ ☐ ☐ ☐ ☐ 
Capability Management ☐ ☐ ☐ ☐ ☐ 
Single Sourcing ☐ ☐ ☐ ☐ ☐ 
 Important level 
Risk Mitigation Strategies Very Poor Poor Medium Good Very good 
Logistics Management ☐ ☐ ☐ ☐ ☐ 
Information System ☐ ☐ ☐ ☐ ☐ 
Collaboration ☐ ☐ ☐ ☐ ☐ 
Inventory Management ☐ ☐ ☐ ☐ ☐ 
eProcurement Strategy ☐ ☐ ☐ ☐ ☐ 
Outsourcing ☐ ☐ ☐ ☐ ☐ 
Agility ☐ ☐ ☐ ☐ ☐ 
Capability Management ☐ ☐ ☐ ☐ ☐ 
Single Sourcing ☐ ☐ ☐ ☐ ☐ 
 Important level 
Risk Mitigation Strategies Very Poor Poor Medium Good Very good 
Logistics Management ☐ ☐ ☐ ☐ ☐ 
Information System ☐ ☐ ☐ ☐ ☐ 
Collaboration ☐ ☐ ☐ ☐ ☐ 
Inventory Management ☐ ☐ ☐ ☐ ☐ 
eProcurement Strategy ☐ ☐ ☐ ☐ ☐ 
Outsourcing ☐ ☐ ☐ ☐ ☐ 
Agility ☐ ☐ ☐ ☐ ☐ 
Capability Management ☐ ☐ ☐ ☐ ☐ 
Single Sourcing ☐ ☐ ☐ ☐ ☐ 
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Q5. With respect to manage S5 Poor quality in the purchased drugs from suppliers, please 
determine the importance of each risk mitigation strategy.    
 
Q6. With respect to manage S6 Weak logistics service infrastructure, please determine the 
importance of each risk mitigation strategy.    
 
Q7. With respect to manage S7 Poor IT system, too much information, lack of data 
standardization, please determine the importance of each risk mitigation strategy.    
 
 Important level 
Risk Mitigation Strategies Very Poor Poor Medium Good Very good 
Logistics Management ☐ ☐ ☐ ☐ ☐ 
Information System ☐ ☐ ☐ ☐ ☐ 
Collaboration ☐ ☐ ☐ ☐ ☐ 
Inventory Management ☐ ☐ ☐ ☐ ☐ 
eProcurement Strategy ☐ ☐ ☐ ☐ ☐ 
Outsourcing ☐ ☐ ☐ ☐ ☐ 
Agility ☐ ☐ ☐ ☐ ☐ 
Capability Management ☐ ☐ ☐ ☐ ☐ 
Single Sourcing ☐ ☐ ☐ ☐ ☐ 
 Important level 
Risk Mitigation Strategies Very Poor Poor Medium Good Very good 
Logistics Management ☐ ☐ ☐ ☐ ☐ 
Information System ☐ ☐ ☐ ☐ ☐ 
Collaboration ☐ ☐ ☐ ☐ ☐ 
Inventory Management ☐ ☐ ☐ ☐ ☐ 
eProcurement Strategy ☐ ☐ ☐ ☐ ☐ 
Outsourcing ☐ ☐ ☐ ☐ ☐ 
Agility ☐ ☐ ☐ ☐ ☐ 
Capability Management ☐ ☐ ☐ ☐ ☐ 
Single Sourcing ☐ ☐ ☐ ☐ ☐ 
 Important level 
Risk Mitigation Strategies Very Poor Poor Medium Good Very good 
Logistics Management ☐ ☐ ☐ ☐ ☐ 
Information System ☐ ☐ ☐ ☐ ☐ 
Collaboration ☐ ☐ ☐ ☐ ☐ 
Inventory Management ☐ ☐ ☐ ☐ ☐ 
eProcurement Strategy ☐ ☐ ☐ ☐ ☐ 
Outsourcing ☐ ☐ ☐ ☐ ☐ 
Agility ☐ ☐ ☐ ☐ ☐ 
Capability Management ☐ ☐ ☐ ☐ ☐ 
Single Sourcing ☐ ☐ ☐ ☐ ☐ 
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Q8. With respect to manage S8 Lack of visibility concerning placement and availability of 
stock, please determine the importance of each risk mitigation strategy.    
 
Q9. With respect to manage S9 High purchase price, please determine the importance of each 
risk mitigation strategy.    
 
Q10. With respect to manage S10 Clinician’s preference, please determine the importance of 
each risk mitigation strategy.    
 
 Important level 
Risk Mitigation Strategies Very Poor Poor Medium Good Very good 
Logistics Management ☐ ☐ ☐ ☐ ☐ 
Information System ☐ ☐ ☐ ☐ ☐ 
Collaboration ☐ ☐ ☐ ☐ ☐ 
Inventory Management ☐ ☐ ☐ ☐ ☐ 
eProcurement Strategy ☐ ☐ ☐ ☐ ☐ 
Outsourcing ☐ ☐ ☐ ☐ ☐ 
Agility ☐ ☐ ☐ ☐ ☐ 
Capability Management ☐ ☐ ☐ ☐ ☐ 
Single Sourcing ☐ ☐ ☐ ☐ ☐ 
 Important level 
Risk Mitigation Strategies Very Poor Poor Medium Good Very good 
Logistics Management ☐ ☐ ☐ ☐ ☐ 
Information System ☐ ☐ ☐ ☐ ☐ 
Collaboration ☐ ☐ ☐ ☐ ☐ 
Inventory Management ☐ ☐ ☐ ☐ ☐ 
eProcurement Strategy ☐ ☐ ☐ ☐ ☐ 
Outsourcing ☐ ☐ ☐ ☐ ☐ 
Agility ☐ ☐ ☐ ☐ ☐ 
Capability Management ☐ ☐ ☐ ☐ ☐ 
Single Sourcing ☐ ☐ ☐ ☐ ☐ 
 Important level 
Risk Mitigation Strategies Very Poor Poor Medium Good Very good 
Logistics Management ☐ ☐ ☐ ☐ ☐ 
Information System ☐ ☐ ☐ ☐ ☐ 
Collaboration ☐ ☐ ☐ ☐ ☐ 
Inventory Management ☐ ☐ ☐ ☐ ☐ 
eProcurement Strategy ☐ ☐ ☐ ☐ ☐ 
Outsourcing ☐ ☐ ☐ ☐ ☐ 
Agility ☐ ☐ ☐ ☐ ☐ 
Capability Management ☐ ☐ ☐ ☐ ☐ 
Single Sourcing ☐ ☐ ☐ ☐ ☐ 
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Q11. With respect to manage S11 High product and supplier/brand variety, please determine 
the importance of each risk mitigation strategy.    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                THANK YOU ONCE AGAIN FOR YOUR KIND PARTICIPATION IN THIS SURVEY. 
YOUR ANSWER WILL BE KEEP CONFIDENTIAL. 
 Important level 
Risk Mitigation Strategies Very Poor Poor Medium Good Very good 
Logistics Management ☐ ☐ ☐ ☐ ☐ 
Information System ☐ ☐ ☐ ☐ ☐ 
Collaboration ☐ ☐ ☐ ☐ ☐ 
Inventory Management ☐ ☐ ☐ ☐ ☐ 
eProcurement Strategy ☐ ☐ ☐ ☐ ☐ 
Outsourcing ☐ ☐ ☐ ☐ ☐ 
Agility ☐ ☐ ☐ ☐ ☐ 
Capability Management ☐ ☐ ☐ ☐ ☐ 
Single Sourcing ☐ ☐ ☐ ☐ ☐ 
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医疗药品供应链风险管理 
问卷调查 
 
尊敬的专家： 
 
您好！我叫王磊。来自利物浦约翰莫尔斯大学(LJMU)物流和海洋研究所的博士研究生。
我的研究课题是提出一种全新的、系统化和结构化的方法针对医院药品供应链过程中
产生的风险因素进行识别、分析和控制。本次问卷的目的是评价不同风险控制策略在
面对不同的风险因素时的重要程度。 
对于占用您宝贵的时间我深感歉意。也同时非常的荣幸能够邀请您参加到我的研究课
题当中。您对于医疗供应链管理和风险管理的宝贵经验将对此次问卷调查的起到非常
重要的作用。同时需要强调的是，根据研究课题组的要求，本次调查的信息将会被严
格的保密；其中所涉及到的相关单位及个人信息会采取匿名的方式。 
本次调查需要 10 分钟左右的时间。如果您有任何问题，请通过电子邮件 
L.Wang@2015.ljmu.ac.uk 联系我。您也可以通过电子邮件 J.Ren@ljmu.ac.uk 
联系我的导师任军教授。 
 
 
 
王磊 
博士研究生 
Liverpool Logistics Offshore and Marine Research Institute (LOOM) 
Tel: +(44)7510535904  
Email: L.Wang@2015.ljmu.ac.uk 
Room 121, James Parsons Building 
Liverpool John Moores University, Byrom Street, Liverpool, L3 3AF, UK 
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第一部分：简介 
根据此前的调查研究，我们识别出以下存在于医院供应链之中最重要的 11个风险因素： 
S1 假药 
S2 医院整体实力与各科室需求不匹配 (例如：不能够有效及时地对满足需求，出现供不应求
的情况； 相应的工作人员缺乏；缺少准确信息；在需求高峰期时，电梯的数量不足，不能够
及时将药物配送的各个科室等) 
S3 医院内部药品的拣选，包装和运输出错 (例如：手动操作容易引起操作失误；相似包装的
药品或者不清晰的条形码信息容易造成药品拣选，配送出错；每个工作日中高批量的配送等) 
S4 药品短缺 
S5 购买药品的质量不合格 
S6 落后的物流服务设施 (例如：药品库房设备陈旧；不适当的药品储存环境和运输设备，路
径； 冷链控制不当等) 
S7 落后的信息系统，过量的信息，缺乏药品数据标准化 (例如：信息传送缓慢，单一的信息
传送渠道；缺乏同意的信息服务平台；自动化操作程度低； 缺乏统一的药品代码； 缺乏药品
的可追踪性以及与供应商的信息系统不整合等) 
S8 库存管理的可视化程度低 
S9 过高的采购价格 
S10 医生的个人偏好加重采购的成本 (医生有各自对于药品使用的偏好，医生更多关注药效
而忽视药品价格) 
S11 采购药品的种类和供应商的数量过多 (例如：过高的库存量造成浪费等) 
针对于以上 11个高风险因素，我们通过在英国和中国的医院内部进行实证研究，识别出 10个
相应的风险管理策略。请您以专家的观点对其在管理不同的风险时的重要程度进行打分，并提
出不同的改进意见。 
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第二部分:问卷部分 
问题一:针对降低 S1假药的风险,请问以下各风险策略的重要程度。 
 
 
 
 重要程度 
风险管理策略 非常差 差 一般 好 非常好 
物流管理 
例如：合理的运输路径，采取
先进的温度控制设备提高冷链
效率等 
☐ ☐ ☐ ☐ ☐ 
信息技术系统 
例如：数据标准化，信息共
享，药品的可追溯性，先进的
信息系统等 
☐ ☐ ☐ ☐ ☐ 
注重合作 
例如：医院内部各个科室之间
以及医院与上游供应商之间建
立长期有效的合作机制，临床
医生参与采购等物流活动等 
☐ ☐ ☐ ☐ ☐ 
库存管理 
例如: 库存可视化管理；药品
期效管理;JIT库存管理等 
☐ ☐ ☐ ☐ ☐ 
电子采购战略 
例如：采购流程电子化，信息
化等 
☐ ☐ ☐ ☐ ☐ 
外包 
例如：将医院内部非核心的物
流活动外包给第三方管理；二
级库房外包等 
☐ ☐ ☐ ☐ ☐ 
敏捷管理 
例如：针对突发事件进行快速
反应等   
☐ ☐ ☐ ☐ ☐ 
能力管理 
例如：注重员工技能培训(采
购，配送，拣选等) 
☐ ☐ ☐ ☐ ☐ 
单一化采购 
例如：只与一家大的药品供应
商建立长期合作，其供应商提
供医院内部药品用量的 90%以
上，降低多向采购带来的质量
等问题 
☐ ☐ ☐ ☐ ☐ 
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问题二:针对降低 S2 医院整体实力与各科室需求不匹配的风险,请问以下各风险策略的重要程
度。 
问题三:针对降低 S3 医院内部药品的拣选,包装和运输出错的风险,请问以下各风险策略的重
要程度。 
 重要程度 
风险管理策略 非常差 差 一般 好 非常好 
物流管理 
 
☐ ☐ ☐ ☐ ☐ 
信息技术系统 
 
☐ ☐ ☐ ☐ ☐ 
注重合作 
 
☐ ☐ ☐ ☐ ☐ 
库存管理 
 
☐ ☐ ☐ ☐ ☐ 
电子采购战略 
 
☐ ☐ ☐ ☐ ☐ 
外包 
 
☐ ☐ ☐ ☐ ☐ 
敏捷管理 
 
☐ ☐ ☐ ☐ ☐ 
能力管理 
 
☐ ☐ ☐ ☐ ☐ 
单一化采购 
 
☐ ☐ ☐ ☐ ☐ 
 重要程度 
风险管理策略 非常差 差 一般 好 非常好 
物流管理 
 
☐ ☐ ☐ ☐ ☐ 
信息技术系统 
 
☐ ☐ ☐ ☐ ☐ 
注重合作 
 
☐ ☐ ☐ ☐ ☐ 
库存管理 
 
☐ ☐ ☐ ☐ ☐ 
电子采购战略 
 
☐ ☐ ☐ ☐ ☐ 
外包 
 
☐ ☐ ☐ ☐ ☐ 
敏捷管理 
 
☐ ☐ ☐ ☐ ☐ 
能力管理 
 
☐ ☐ ☐ ☐ ☐ 
单一化采购 
 
☐ ☐ ☐ ☐ ☐ 
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问题四:针对降低 S4药品短缺的风险,请问以下各风险策略的重要程度。 
 
问题五:针对降低 S5购买药品的质量不合格的风险,请问以下各风险策略的重要程度。 
 
 重要程度 
风险管理策略 非常差 差 一般 好 非常好 
物流管理 
 
☐ ☐ ☐ ☐ ☐ 
信息技术系统 
 
☐ ☐ ☐ ☐ ☐ 
注重合作 
 
☐ ☐ ☐ ☐ ☐ 
库存管理 
 
☐ ☐ ☐ ☐ ☐ 
电子采购战略 
 
☐ ☐ ☐ ☐ ☐ 
外包 
 
☐ ☐ ☐ ☐ ☐ 
敏捷管理 
 
☐ ☐ ☐ ☐ ☐ 
能力管理 
 
☐ ☐ ☐ ☐ ☐ 
单一化采购 
 
☐ ☐ ☐ ☐ ☐ 
 重要程度 
风险管理策略 非常差 差 一般 好 非常好 
物流管理 
 
☐ ☐ ☐ ☐ ☐ 
信息技术系统 
 
☐ ☐ ☐ ☐ ☐ 
注重合作 
 
☐ ☐ ☐ ☐ ☐ 
库存管理 
 
☐ ☐ ☐ ☐ ☐ 
电子采购战略 
 
☐ ☐ ☐ ☐ ☐ 
外包 
 
☐ ☐ ☐ ☐ ☐ 
敏捷管理 
 
☐ ☐ ☐ ☐ ☐ 
能力管理 
 
☐ ☐ ☐ ☐ ☐ 
单一化采购 
 
☐ ☐ ☐ ☐ ☐ 
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问题六:针对降低 S6落后的物流服务设施的风险,请问以下各风险策略的重要程度。 
 
问题七:针对降低 S7落后的信息系统,过量的信息,缺乏数据标准化的风险,请问以下各风险策
略的重要程度。 
 
 重要程度 
风险管理策略 非常差 差 一般 好 非常好 
物流管理 
 
☐ ☐ ☐ ☐ ☐ 
信息技术系统 
 
☐ ☐ ☐ ☐ ☐ 
注重合作 
 
☐ ☐ ☐ ☐ ☐ 
库存管理 
 
☐ ☐ ☐ ☐ ☐ 
电子采购战略 
 
☐ ☐ ☐ ☐ ☐ 
外包 
 
☐ ☐ ☐ ☐ ☐ 
敏捷管理 
 
☐ ☐ ☐ ☐ ☐ 
能力管理 
 
☐ ☐ ☐ ☐ ☐ 
单一化采购 
 
☐ ☐ ☐ ☐ ☐ 
 重要程度 
风险管理策略 非常差 差 一般 好 非常好 
物流管理 
 
☐ ☐ ☐ ☐ ☐ 
信息技术系统 
 
☐ ☐ ☐ ☐ ☐ 
注重合作 
 
☐ ☐ ☐ ☐ ☐ 
库存管理 
 
☐ ☐ ☐ ☐ ☐ 
电子采购战略 
 
☐ ☐ ☐ ☐ ☐ 
外包 
 
☐ ☐ ☐ ☐ ☐ 
敏捷管理 
 
☐ ☐ ☐ ☐ ☐ 
能力管理 
 
☐ ☐ ☐ ☐ ☐ 
单一化采购 
 
☐ ☐ ☐ ☐ ☐ 
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问题八:针对降低 S8 库存管理的可视化程度低的风险,请问以下各风险策略的重要程度。 
 
问题九:针对降低 S9过高的采购价格的风险,请问以下各风险策略的重要程度。 
 
 重要程度 
风险管理策略 非常差 差 一般 好 非常好 
物流管理 
 
☐ ☐ ☐ ☐ ☐ 
信息技术系统 
 
☐ ☐ ☐ ☐ ☐ 
注重合作 
 
☐ ☐ ☐ ☐ ☐ 
库存管理 
 
☐ ☐ ☐ ☐ ☐ 
电子采购战略 
 
☐ ☐ ☐ ☐ ☐ 
外包 
 
☐ ☐ ☐ ☐ ☐ 
敏捷管理 
 
☐ ☐ ☐ ☐ ☐ 
能力管理 
 
☐ ☐ ☐ ☐ ☐ 
单一化采购 
 
☐ ☐ ☐ ☐ ☐ 
 重要程度 
风险管理策略 非常差 差 一般 好 非常好 
物流管理 
 
☐ ☐ ☐ ☐ ☐ 
信息技术系统 
 
☐ ☐ ☐ ☐ ☐ 
注重合作 
 
☐ ☐ ☐ ☐ ☐ 
库存管理 
 
☐ ☐ ☐ ☐ ☐ 
电子采购战略 
 
☐ ☐ ☐ ☐ ☐ 
外包 
 
☐ ☐ ☐ ☐ ☐ 
敏捷管理 
 
☐ ☐ ☐ ☐ ☐ 
能力管理 
 
☐ ☐ ☐ ☐ ☐ 
单一化采购 
 
☐ ☐ ☐ ☐ ☐ 
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问题十:针对降低 S10医生的个人偏好加重采购的成本的风险,请问以下各风险策略的重要程
度。 
 
问题十一:针对降低 S11采购药品的种类和供应商的数量过多的风险,请问以下各风险策略的
重要程度。 
 重要程度 
风险管理策略 非常差 差 一般 好 非常好 
物流管理 
 
☐ ☐ ☐ ☐ ☐ 
信息技术系统 
 
☐ ☐ ☐ ☐ ☐ 
注重合作 
 
☐ ☐ ☐ ☐ ☐ 
库存管理 
 
☐ ☐ ☐ ☐ ☐ 
电子采购战略 
 
☐ ☐ ☐ ☐ ☐ 
外包 
 
☐ ☐ ☐ ☐ ☐ 
敏捷管理 
 
☐ ☐ ☐ ☐ ☐ 
能力管理 
 
☐ ☐ ☐ ☐ ☐ 
单一化采购 
 
☐ ☐ ☐ ☐ ☐ 
 重要程度 
风险管理策略 非常差 差 一般 好 非常好 
物流管理 
 
☐ ☐ ☐ ☐ ☐ 
信息技术系统 
 
☐ ☐ ☐ ☐ ☐ 
注重合作 
 
☐ ☐ ☐ ☐ ☐ 
库存管理 
 
☐ ☐ ☐ ☐ ☐ 
电子采购战略 
 
☐ ☐ ☐ ☐ ☐ 
外包 
 
☐ ☐ ☐ ☐ ☐ 
敏捷管理 
 
☐ ☐ ☐ ☐ ☐ 
能力管理 
 
☐ ☐ ☐ ☐ ☐ 
单一化采购 
 
☐ ☐ ☐ ☐ ☐ 
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再次感谢您在此次调查中提供的帮助 
您的回答将会被严格保密 
